data_1maj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1maj _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.756 0.312 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.543 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.518 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 98' ' ' HIS . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.783 0.325 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 67' ' ' PHE . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.404 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.469 ' O ' ' NE2' ' A' ' 6' ' ' GLN . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.463 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.456 ' HG1' ' CG ' ' A' ' 95' ' ' GLN . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 24.6 tttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 t -74.76 158.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.618 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.496 ' SD ' HD23 ' A' ' 29' ' ' LEU . 84.2 mmm -122.43 101.99 7.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.986 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.91 136.95 37.42 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.321 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.545 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 34.6 tt0 -126.83 146.4 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.46 164.99 19.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.423 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 7.0 Cg_endo -75.71 176.57 43.08 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.412 -1.495 . . . . 0.0 110.99 -1.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.78 -25.15 56.16 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -140.21 143.41 36.02 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.601 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tp -134.11 70.07 74.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.279 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.04 113.16 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.936 1.757 . . . . 0.0 111.238 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.01 170.36 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.505 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -111.27 89.84 3.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.106 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 14' ' ' SER . 67.2 mt -8.69 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.079 0.862 . . . . 0.0 112.871 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.87 -35.26 0.37 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.615 -1.278 . . . . 0.0 110.774 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.77 179.11 7.88 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -92.04 161.31 14.83 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.997 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.53 165.08 16.99 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.616 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -159.6 88.8 0.86 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.152 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 mt -85.61 127.6 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.986 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.5 t -87.4 150.2 23.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.99 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.01 132.79 4.32 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.551 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 179.64 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -109.44 157.86 18.53 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.713 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 t -68.67 -23.21 64.38 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.76 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.63 -57.14 0.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.6 137.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.496 HD23 ' SD ' ' A' ' 4' ' ' MET . 74.7 mt -88.36 -45.78 9.72 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 29' ' ' LEU . 76.2 t -36.62 125.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.879 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.068 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -74.09 122.84 23.32 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 94' ' ' SER . 0.9 OUTLIER -141.51 132.99 26.83 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.035 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 2.6 p-10 -124.95 127.01 46.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -94.44 175.07 6.82 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.514 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -160.55 168.16 25.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.88 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tp -151.89 116.69 5.14 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.77 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -93.84 132.2 38.48 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.433 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.124 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.827 0.346 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.92 -39.82 2.08 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.524 ' CD1' ' NH2' ' A' ' 59' ' ' ARG . 16.8 mm -138.83 146.19 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.3 p90 -143.66 32.58 1.29 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.206 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -177.57 55.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 57' ' ' SER . 48.3 t 36.98 83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.253 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 79.18 70.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.941 0.877 . . . . 0.0 110.342 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.05 106.08 0.2 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.373 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -77.09 163.42 26.64 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 61' ' ' SER . 44.6 t80 -91.77 172.94 8.14 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 54.5 p -60.23 -47.04 87.64 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.434 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.75 50.92 2.91 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 119.595 -1.288 . . . . 0.0 112.321 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' CG1' HH11 ' A' ' 59' ' ' ARG . 44.3 t -141.49 122.88 8.93 Favored Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.1 164.23 32.89 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.993 1.795 . . . . 0.0 111.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 67' ' ' PHE . 6.6 p-10 -69.74 -7.4 39.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.95 0.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.538 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 64.9 m-85 -122.68 155.98 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 t -161.61 112.05 1.65 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.51 147.11 18.31 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -161.46 -176.48 5.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 153.74 171.42 20.83 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.604 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -80.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.691 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.4 -49.16 0.06 OUTLIER Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -113.62 17.64 18.1 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.72 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.71 133.53 16.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.516 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 55.0 m-85 -147.03 168.93 20.32 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.455 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.7 m -152.76 141.76 21.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.341 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 10.4 tt -113.22 112.63 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -110.3 151.68 27.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.468 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 81' ' ' SER . 97.0 mt -124.71 139.65 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -69.63 -23.99 63.58 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.004 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -170.17 113.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.8 110.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.931 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.02 172.03 8.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.603 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.96 73.64 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.141 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 -13.73 59.8 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.43 -26.33 58.25 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.752 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 mt -53.74 150.19 7.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.38 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.89 178.9 17.76 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.945 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 mm -86.0 108.29 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.729 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -77.38 156.42 31.23 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -143.7 164.66 29.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 93' ' ' CYS . 30.8 p -148.55 82.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.673 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' HD22 ' A' ' 38' ' ' LEU . 71.1 m -89.18 -178.35 5.63 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.007 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -135.22 157.8 45.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 t -127.29 45.22 2.76 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.21 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 29' ' ' LEU . 18.6 m -114.4 -52.62 2.71 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 65.7 m-70 -86.86 145.68 26.49 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.911 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.475 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 47.1 t -113.82 138.64 22.81 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.853 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -70.55 164.35 81.7 Favored 'Cis proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.668 -1.388 . . . . 0.0 111.504 -0.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.81 120.16 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.522 1.481 . . . . 0.0 110.67 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -91.7 112.63 24.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.242 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -84.37 151.51 24.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.73 157.9 29.79 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.579 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.475 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 134.93 -175.74 20.41 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.545 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 141.74 55.11 0.04 OUTLIER Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.161 -1.495 . . . . 0.0 111.857 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.433 ' CB ' HE21 ' A' ' 6' ' ' GLN . 16.2 m -99.06 115.23 28.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.617 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 93.97 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.123 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.9 83.07 6.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.724 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 153.97 28.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.0 132.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.869 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.1 tttm . . . . . 0 C--N 1.303 -1.453 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.278 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.2 t . . . . . 0 C--O 1.214 -0.797 0 CA-C-O 120.876 0.37 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.447 ' N ' ' HB2' ' A' ' 26' ' ' SER . 46.8 t -69.0 153.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.313 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.421 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 30.1 mtp -135.06 92.8 2.92 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -79.19 121.1 24.62 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.016 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.489 ' CB ' ' H ' ' A' ' 106' ' ' GLY . 0.7 OUTLIER -97.8 129.05 44.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.721 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.31 151.56 37.2 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.23 -179.82 27.24 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.716 -1.368 . . . . 0.0 111.648 0.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 -33.29 53.59 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.054 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 m -130.27 153.16 48.91 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.829 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 tp -143.3 73.63 17.68 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.97 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.41 106.58 1.25 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.886 1.724 . . . . 0.0 110.645 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.3 m -132.34 170.47 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.45 150.26 22.36 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 33.9 mt -73.74 90.54 1.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.38 -21.3 1.07 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 18' ' ' GLN . 7.0 m-20 -84.54 -154.52 0.18 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.055 -0.572 . . . . 0.0 110.369 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.454 ' H ' ' HB3' ' A' ' 17' ' ' ASP . 25.8 mt-30 -125.25 164.55 20.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.555 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.97 160.95 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.011 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 m -149.94 95.39 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.48 133.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.023 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -92.07 159.51 15.66 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.504 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 3.3 m -156.47 105.92 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.865 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -100.97 124.98 47.5 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.029 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 78.0 p -87.9 147.34 25.12 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -49.03 -68.17 0.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.742 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 59.46 1.55 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 t 61.6 173.88 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.966 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.5 mt -131.73 21.36 4.63 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.89 122.72 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.011 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.71 0.291 . . . . 0.0 110.485 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 156.78 41.61 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.654 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -173.31 105.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.54 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -96.54 105.26 17.33 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.625 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.472 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 43.2 m95 -84.94 148.76 26.06 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 103' ' ' PHE . 41.0 m-85 -136.72 157.24 47.22 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp -136.7 110.43 8.1 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.79 121.77 37.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' CE ' ' HA ' ' A' ' 86' ' ' GLU . 7.4 tttt . . . . . 0 C--N 1.303 -1.421 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.195 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.9 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.889 0.376 . . . . 0.0 110.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.4 mt -120.38 -55.56 2.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.224 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -120.11 158.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.587 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 30.1 p90 -138.17 -28.17 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.878 -1.129 . . . . 0.0 112.254 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -101.31 -51.29 3.53 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.31 -41.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -138.47 -31.86 0.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.837 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.11 120.05 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 36.0 mtm-85 -77.54 157.65 30.27 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.295 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 85.4 t80 -73.77 160.41 31.53 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 38.2 t -62.6 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.349 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.7 -19.62 3.52 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 40.7 t -81.54 118.5 72.45 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.62 155.98 39.52 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.917 1.745 . . . . 0.0 111.993 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.87 -19.29 6.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.219 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -49.52 -26.38 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.811 -0.755 . . . . 0.0 111.284 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -100.57 128.22 46.7 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.507 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.7 p -141.8 128.59 20.49 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.259 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.36 150.53 18.4 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.63 147.54 10.38 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.217 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.596 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -166.07 125.89 1.4 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 m -95.1 67.29 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.79 -91.37 0.5 Allowed Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.114 -1.517 . . . . 0.0 112.144 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.1 p -121.9 1.55 9.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.348 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -106.16 97.81 7.57 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.954 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.596 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 73.4 m-85 -114.41 147.43 39.24 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 m -149.83 133.88 17.09 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.002 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 8.4 tt -92.16 112.09 23.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.194 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -107.05 129.19 54.85 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.83 134.51 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.692 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 36.7 m -83.41 -19.14 36.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.276 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 81' ' ' SER . 4.1 mtt-85 -145.53 97.15 2.94 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.596 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 15' ' ' LEU . 51.6 t -75.68 117.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.354 -0.939 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -115.65 172.53 7.07 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.5 12.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.714 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.464 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 1.3 mt-10 -68.45 -36.72 79.41 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -59.96 -15.02 18.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.842 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.43 136.46 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.608 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -167.42 27.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.25 118.43 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.689 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -84.4 147.51 27.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.156 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 67.1 m-85 -141.1 167.28 22.57 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.476 ' N ' HE22 ' A' ' 6' ' ' GLN . 24.1 p -155.95 102.13 2.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.1 p -88.63 171.25 10.16 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 3.4 pt20 -127.76 112.0 14.3 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.1 p -81.11 55.31 2.47 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.843 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 m -128.52 -53.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.31 177.49 5.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.44 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 96.7 t -145.9 135.51 11.57 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.495 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -70.87 139.61 58.9 Favored 'Cis proline' 0 C--N 1.317 -1.1 0 C-N-CA 123.558 -1.434 . . . . 0.0 111.462 -0.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 118.48 5.52 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.717 1.611 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.4 p -66.45 160.57 24.65 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.946 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -112.39 38.2 2.8 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.736 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.68 -178.93 31.29 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.464 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.439 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -90.83 -50.53 2.86 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.489 ' H ' ' CB ' ' A' ' 6' ' ' GLN . . . 127.57 95.4 0.88 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.056 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.8 m -100.37 120.77 40.46 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.11 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -78.5 118.43 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tt -113.16 100.54 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.77 159.28 23.28 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 tt -65.14 168.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.558 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tmtt? . . . . . 0 N--CA 1.489 1.479 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.956 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 C--O 1.215 -0.744 0 CA-C-O 120.73 0.3 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.92 132.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.278 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 54.5 mmm -125.46 93.5 3.88 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 m -78.71 116.08 18.83 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.606 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 1.2 mp0 -101.83 148.9 24.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.927 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.58 163.12 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.501 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -77.41 177.29 40.04 Favored 'Cis proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.59 -1.421 . . . . 0.0 110.711 -1.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.9 -26.61 63.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.7 p -145.43 146.64 31.6 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.701 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 78.19 75.02 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.375 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.93 108.53 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.862 1.708 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 12.5 m -144.52 153.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.249 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.93 152.18 26.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.89 88.76 0.57 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.031 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.65 -27.81 0.6 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.82 171.25 15.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 26.5 mt-30 -87.16 134.25 33.55 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.331 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -107.01 155.18 20.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 m -149.09 97.76 2.73 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.17 161.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.786 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.6 t -122.17 146.22 47.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.692 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.606 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.9 m -150.34 104.92 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -112.14 134.68 53.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.801 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.465 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 54.5 p -98.51 152.29 19.71 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.297 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 p -73.02 -35.12 66.72 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 28' ' ' SER . 7.3 tp60 -121.12 148.72 43.81 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.454 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -50.3 142.91 9.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.26 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.55 43.35 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.048 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -102.14 135.5 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.423 ' CG ' ' HH ' ' A' ' 37' ' ' TYR . 4.3 t-80 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.796 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 6.3 m-30 -86.65 72.86 10.15 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.34 132.59 55.89 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.532 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -126.14 165.48 18.8 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.524 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.593 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 50.9 m95 -114.52 154.32 28.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.0 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.21 163.5 29.47 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.632 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -155.66 136.99 13.95 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.821 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -115.92 123.29 47.72 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.575 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.7 tptp . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.643 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.7 tp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -72.41 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.986 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.2 mm -120.28 164.67 16.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.479 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.5 p90 -155.69 156.44 34.93 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 13.6 mttm 48.25 22.33 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.923 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' TYR . 78.4 t 63.89 127.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.568 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p 41.94 56.86 3.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.834 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 9.8 m120 -127.67 -21.73 3.71 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.358 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 65' ' ' ASP . 3.8 mtt180 54.47 101.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.97 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.25 160.21 8.76 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.638 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p -56.27 112.51 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.621 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.23 7.64 20.77 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -112.05 104.57 56.12 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 66' ' ' ARG . 4.5 Cg_exo -59.37 155.08 43.0 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.002 1.801 . . . . 0.0 112.078 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.16 -15.81 0.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.789 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -51.98 -34.96 44.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.774 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -95.15 129.28 42.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.881 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.86 93.28 3.28 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.7 106.27 2.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.628 -1.272 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.6 m -113.68 -176.64 2.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.047 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.624 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 154.14 117.8 0.65 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.9 t -98.1 67.76 1.92 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.144 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.76 -109.51 1.48 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.549 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 65.3 p -101.95 9.65 40.36 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.662 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 8.2 p-10 -113.73 139.49 49.05 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.624 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 96.7 m-85 -147.82 156.27 42.54 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -150.04 152.75 35.34 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.752 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 40' ' ' TRP . 6.8 tt -115.96 92.74 3.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 6.1 mttt -92.23 126.89 37.5 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.006 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.7 mt -114.42 132.44 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.059 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -60.16 -73.64 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.275 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.671 HH12 ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -123.39 100.44 6.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.526 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.33 145.89 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.983 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.671 ' CG ' HH12 ' A' ' 82' ' ' ARG . 2.4 mm-40 -126.48 172.84 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.478 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.73 -29.67 54.15 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.49 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.19 -41.1 90.68 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -33.06 41.02 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.81 130.87 38.46 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.7 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.47 8.75 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.64 116.58 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.272 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.53 153.71 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.159 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -154.76 179.96 8.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.1 p -165.22 163.36 20.23 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.942 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.471 ' CB ' ' CD2' ' A' ' 103' ' ' PHE . 8.4 t -147.03 -173.32 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.834 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -136.54 108.12 6.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -82.84 43.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.047 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -58.16 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.849 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -88.76 171.78 9.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.297 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 57.4 t -139.17 138.72 21.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -71.39 148.8 90.88 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.276 -1.552 . . . . 0.0 111.336 -1.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.62 113.4 1.94 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.762 1.641 . . . . 0.0 110.084 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 87.39 4.56 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 94' ' ' SER . 1.5 t80 -83.5 111.46 19.08 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.882 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.89 152.21 6.61 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.439 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -167.34 -128.18 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.06 100.27 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 C-N-CA 117.641 -2.218 . . . . 0.0 113.632 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -158.35 104.17 1.83 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.82 156.19 18.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.396 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 93.89 3.15 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.816 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -106.82 31.94 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.696 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER 61.91 170.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttm . . . . . 0 N--CA 1.49 1.544 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.018 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.429 HG23 ' CD2' ' A' ' 98' ' ' HIS . 64.1 t . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.4 0.619 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.06 116.27 17.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mtp -93.94 89.76 6.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.054 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -77.08 112.23 13.5 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.64 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.701 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 38.1 tt0 -100.05 154.95 17.99 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -161.45 161.4 22.91 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.307 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.03 178.12 36.68 Favored 'Cis proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.522 -1.449 . . . . 0.0 110.314 -2.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.26 -21.56 66.32 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.469 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 p -154.83 152.38 29.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.607 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -129.59 77.51 77.02 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.019 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.43 102.75 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.699 1.599 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.17 -167.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.805 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.22 153.0 34.61 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 111' ' ' ILE . 63.9 mt -75.46 87.03 2.6 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.443 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.64 -26.34 0.52 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.58 -170.65 2.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.42 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -106.4 139.5 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.263 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.34 146.13 39.94 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 p -138.23 92.03 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.492 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.56 126.44 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.08 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.1 156.56 20.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.118 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 29.0 m -162.02 111.73 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.251 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -111.22 140.66 45.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -94.54 167.04 11.74 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.931 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -41.03 26.32 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.316 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -136.77 43.77 2.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.433 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.457 ' C ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 m 61.02 -174.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' C ' ' A' ' 28' ' ' SER . 13.2 mt -142.92 21.34 1.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -77.11 138.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.169 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.996 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.82 0.343 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.79 68.91 7.2 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.007 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 29' ' ' LEU . 1.4 tt -89.76 142.13 27.98 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 9.1 t30 -122.42 162.2 22.08 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.077 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -125.31 154.31 41.96 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.509 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.86 146.24 50.68 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp -162.7 128.42 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -173.42 170.48 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.258 -1.377 . . . . 0.0 112.678 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.413 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.29 -89.07 0.19 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.538 HG23 ' H ' ' A' ' 57' ' ' SER . 2.8 mp -82.43 145.3 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.787 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.2 p90 -139.46 -7.51 1.31 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.428 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -130.84 57.7 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.574 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 56' ' ' VAL . 5.9 p 38.05 79.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.046 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.538 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 69.26 75.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.444 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.0 -24.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.61 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER 70.49 137.55 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.051 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' N ' ' A' ' 61' ' ' SER . 79.4 t80 -90.77 172.22 8.79 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 t -57.89 117.4 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.33 -8.21 54.99 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.96 124.79 72.04 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.587 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.25 144.28 95.96 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 122.136 1.891 . . . . 0.0 112.143 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.462 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 3.0 t0 -58.26 -25.25 61.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.326 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.7 69.35 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' O ' ' NH1' ' A' ' 59' ' ' ARG . 10.0 m-85 -79.91 126.52 31.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.3 m -134.77 159.36 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.236 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.44 79.53 0.2 Allowed Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.069 -1.538 . . . . 0.0 111.297 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 8.8 t -83.3 -167.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.651 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 151.55 117.26 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.539 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -92.35 91.35 7.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.87 -75.15 0.91 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.6 p -131.65 57.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.498 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 25.9 t0 -162.62 58.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.651 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 58.2 m-85 -80.19 148.79 30.72 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 m -148.97 122.8 9.31 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.733 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 68' ' ' SER . 4.4 tt -84.68 104.56 14.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -96.12 119.98 35.59 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.309 -0.957 . . . . 0.0 111.99 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 mt -109.51 116.17 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -69.89 -24.45 63.4 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.875 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.1 mmt-85 -142.61 110.62 5.95 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.853 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -86.73 136.52 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.6 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -129.54 170.06 14.21 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.522 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -43.73 59.41 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.301 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.9 -37.67 85.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.37 -21.62 50.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.96 146.23 38.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.173 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.41 -154.58 25.19 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 92' ' ' PHE . 20.9 mt -112.41 140.55 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.125 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -104.42 150.64 24.35 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.664 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 90' ' ' ILE . 40.5 m-85 -151.08 135.18 16.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.768 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -109.11 141.12 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.857 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 9.3 p -144.23 -164.68 1.95 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.427 ' HG3' HD21 ' A' ' 29' ' ' LEU . 5.5 pm0 -159.14 165.87 32.79 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.505 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.6 p -109.2 -21.68 12.45 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.3 m -53.16 -55.26 25.53 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.359 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.429 ' CD2' HG23 ' A' ' 2' ' ' VAL . 37.9 m-70 -88.17 131.71 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.511 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 62.3 t -135.16 137.44 26.83 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.2 Cg_endo -68.27 136.71 36.4 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.539 -0.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.48 155.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.928 1.752 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.18 -64.56 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.42 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 65.58 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.869 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.01 64.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -65.95 -84.67 0.09 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.63 75.05 0.59 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.317 -1.42 . . . . 0.0 112.445 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.464 ' OG1' ' HG2' ' A' ' 6' ' ' GLN . 19.9 m -148.86 106.95 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.553 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.69 139.79 32.55 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.852 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 tt -131.67 107.27 8.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.197 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 32.89 4.16 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.162 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.421 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 66.08 163.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.96 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.587 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.051 0.453 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.44 ' N ' ' HB2' ' A' ' 26' ' ' SER . 16.9 t -63.14 155.85 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.689 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.452 ' HE1' ' SG ' ' A' ' 23' ' ' CYS . 40.5 mmm -133.46 110.44 9.98 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -80.14 147.6 31.28 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.657 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 5.3 mp0 -118.75 143.33 46.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.342 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 141.93 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.35 175.16 46.9 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.586 -1.422 . . . . 0.0 111.159 -0.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.37 -22.82 59.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 p -139.7 148.86 42.94 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 tp -126.87 78.57 73.54 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.4 102.74 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.818 1.679 . . . . 0.0 111.061 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.77 -154.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 t -147.06 154.02 40.68 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.907 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.56 87.47 0.32 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.598 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.04 -31.58 1.44 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.53 173.06 11.99 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.248 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -89.07 166.94 13.54 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.039 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.98 161.12 41.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -157.58 109.97 2.4 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.757 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' THR . 2.2 mp -101.02 118.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 t -93.7 158.43 15.68 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.155 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' SG ' ' HE1' ' A' ' 4' ' ' MET . 9.3 t -160.9 117.86 2.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.685 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -104.3 172.07 6.99 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -116.86 167.43 11.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.44 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 14.9 t -67.87 -27.18 66.45 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.39 -59.68 0.34 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.269 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.71 155.35 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.53 6.86 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.48 137.8 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 N--CA 1.488 1.461 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.277 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.583 0.23 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.578 ' H ' ' CG2' ' A' ' 97' ' ' THR . 22.6 m-85 -122.73 109.42 14.22 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.54 133.54 46.31 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.545 ' ND2' ' C ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -110.51 149.01 30.95 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.454 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 22.8 m95 -111.89 172.48 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 162.72 31.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.482 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 tp -151.25 127.13 10.32 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.37 113.36 26.84 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.852 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 -55.67 2.44 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.799 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 57' ' ' SER . 51.6 mm -124.49 137.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.043 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -113.12 -30.65 6.9 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.618 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -124.33 48.41 1.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 58' ' ' ASN . 40.8 t 56.12 103.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.376 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER 76.48 -29.37 0.18 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.566 ' N ' HD21 ' A' ' 58' ' ' ASN . 1.5 m120 -69.35 94.66 0.73 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.973 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -66.76 136.97 56.28 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.306 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -57.2 157.48 6.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.51 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -53.44 -22.73 8.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.734 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.26 31.9 6.64 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.44 125.89 27.0 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.671 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.61 149.89 73.1 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.241 1.961 . . . . 0.0 112.436 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.23 -25.46 65.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.986 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -53.95 -35.84 62.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.88 129.37 34.43 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 t -137.25 138.65 40.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -124.03 131.72 8.08 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 p -156.19 146.92 21.91 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.203 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -170.94 114.48 0.54 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -95.34 145.2 25.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.201 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.75 -101.01 0.42 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.909 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 p -131.04 21.66 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.71 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 5.9 m-20 -122.17 124.04 42.93 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 23.8 m-85 -131.47 155.3 47.61 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 25.8 m -159.49 139.57 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 6.4 tt -95.56 104.53 16.45 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.19 129.24 38.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.692 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -116.81 128.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.468 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.1 m -85.13 2.33 43.99 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.706 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.37 112.5 0.35 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.841 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.5 t -91.75 150.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.34 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -137.28 167.15 22.15 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.197 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.86 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.227 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -66.15 -29.66 69.99 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.769 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.42 -19.98 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.98 137.08 56.88 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.15 -137.71 5.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.59 106.69 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.485 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.28 130.43 36.21 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.481 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 1.2 m-85 -118.11 166.61 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.657 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 14.7 p -134.85 152.46 51.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -156.25 155.9 33.15 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -112.39 163.04 14.89 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.826 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.5 m -144.89 46.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.578 ' CG2' ' H ' ' A' ' 37' ' ' TYR . 2.1 p -124.64 -44.17 1.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -99.5 142.2 31.3 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -109.18 137.22 20.13 Favored Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.589 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.55 146.45 86.79 Favored 'Cis proline' 0 C--N 1.316 -1.173 0 C-N-CA 123.528 -1.447 . . . . 0.0 111.494 -0.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.04 125.49 15.98 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.72 1.613 . . . . 0.0 110.156 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -91.22 107.37 19.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.198 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -94.27 139.42 31.07 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.098 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -167.85 -141.05 3.06 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.363 -1.398 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 92' ' ' PHE . . . 132.58 175.19 13.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.22 79.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.1 m -149.91 107.41 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.185 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -75.9 93.61 3.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.35 83.89 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -124.96 54.97 1.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.143 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER 54.82 176.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.416 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 31.8 mtpt . . . . . 0 C--N 1.302 -1.479 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.488 ' HB ' HE22 ' A' ' 95' ' ' GLN . 69.0 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 121.029 0.442 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 t -68.61 161.0 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.659 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 25' ' ' SER . 82.0 mmm -139.25 101.46 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -91.89 103.45 15.99 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -107.35 166.31 10.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.743 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.67 170.35 8.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.583 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 12.1 Cg_endo -83.72 173.8 41.67 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.794 -1.336 . . . . 0.0 110.72 -2.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.3 mt -72.88 -16.69 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.126 -1.029 . . . . 0.0 109.626 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.0 p -154.14 136.18 14.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tp -122.72 86.32 49.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.269 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.68 116.81 4.61 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.64 1.56 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 112' ' ' LYS . 35.8 m -141.86 -172.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -114.42 145.75 41.46 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.08 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.35 89.43 0.67 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.4 -1.04 3.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -95.71 -135.17 0.22 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 167.57 21.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.706 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.06 168.79 22.88 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.196 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 19.7 p -160.38 91.72 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -78.3 125.86 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 7' ' ' THR . 32.4 t -85.57 157.4 20.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.268 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 2.0 m -161.89 106.11 1.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.161 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' NH1' ' O ' ' A' ' 74' ' ' THR . 55.7 ttm-85 -106.49 144.89 32.52 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.401 ' HA ' ' SD ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -98.91 154.8 17.77 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -63.93 -72.03 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.22 48.61 1.02 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t 67.97 176.28 0.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.509 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 55.6 mt -124.78 52.7 1.53 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.617 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.1 t -106.65 130.94 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.301 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.728 0.299 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -134.28 139.6 45.83 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.425 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.48 HD11 ' CD2' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -162.26 149.67 13.98 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.115 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.402 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 4.4 p-10 -137.72 170.89 15.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.184 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.533 ' CE3' HD21 ' A' ' 78' ' ' LEU . 70.1 m95 -131.9 164.04 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.525 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 1.5 m-85 -154.73 131.57 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.507 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.16 117.49 30.21 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.798 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 13.6 tm0? -101.42 140.2 36.05 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 5.9 tp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.42 -90.08 0.52 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.183 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.483 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.8 mp -82.66 145.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -139.36 -7.19 1.34 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tptt -139.78 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 5.8 t 76.4 -47.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.977 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -171.77 45.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.08 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.86 -36.57 11.59 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 68.31 134.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' H ' HG23 ' A' ' 63' ' ' VAL . 4.7 t80 -81.08 168.08 19.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -60.17 -33.12 71.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.02 11.38 22.27 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.756 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 65' ' ' ASP . 21.3 t -104.46 128.08 27.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.436 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.2 Cg_endo -67.17 19.34 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.119 1.879 . . . . 0.0 112.92 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 63' ' ' VAL . 15.4 t70 68.7 -37.07 0.34 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -52.72 -18.32 1.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.492 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 57.0 m-85 -87.92 92.81 9.27 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.208 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 m -109.94 158.44 18.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.042 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.04 14.95 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.574 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.6 t -148.41 168.03 23.71 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.74 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.665 ' CA ' ' CD2' ' A' ' 76' ' ' PHE . . . -173.19 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.001 -1.571 . . . . 0.0 111.524 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -92.79 51.92 1.78 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -59.53 4.27 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.72 -1.228 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.423 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 3.8 p -125.63 34.47 4.9 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.766 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.05 106.81 1.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.316 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.665 ' CD2' ' CA ' ' A' ' 71' ' ' GLY . 11.6 m-85 -128.59 145.29 51.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.395 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.6 m -149.78 170.85 17.78 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.682 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.533 HD21 ' CE3' ' A' ' 40' ' ' TRP . 4.7 tp -134.67 94.79 3.24 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.557 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -77.96 111.52 13.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.582 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.405 HG12 ' CE1' ' A' ' 67' ' ' PHE . 77.2 mt -91.54 117.98 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -92.5 89.01 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.264 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.598 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 104.09 76.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.475 1.109 . . . . 0.0 110.464 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 100.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.716 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HB2' HH12 ' A' ' 66' ' ' ARG . 50.6 mt-10 -94.67 179.03 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.19 -28.44 40.6 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.686 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.97 -51.42 70.12 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.39 -26.33 1.28 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.155 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.1 mt -56.57 144.58 31.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.36 -134.72 8.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.62 119.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.519 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.44 146.75 24.43 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.82 175.23 9.78 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.33 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.439 ' H ' ' HA3' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -160.72 159.05 29.7 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.966 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 t -151.24 178.1 9.57 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.606 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.488 HE22 ' HB ' ' A' ' 2' ' ' VAL . 0.9 OUTLIER -129.44 124.85 35.14 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.613 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.3 p -93.15 4.19 54.42 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.5 m -70.64 -57.71 4.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.733 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -91.45 94.51 9.5 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.407 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.43 ' CG2' ' HA ' ' A' ' 100' ' ' PRO . 14.7 p -74.97 139.11 72.91 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 5.4 Cg_endo -72.85 142.83 75.81 Favored 'Cis proline' 0 C--N 1.318 -1.05 0 C-N-CA 123.726 -1.364 . . . . 0.0 111.781 -0.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.25 112.32 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.863 1.709 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.2 p -72.77 84.84 1.21 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 16.8 t80 -76.83 155.04 33.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 168.17 -52.54 0.22 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 118.822 -1.656 . . . . 0.0 111.354 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.439 ' HA3' ' H ' ' A' ' 93' ' ' CYS . . . 50.19 -138.05 22.77 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.159 -1.495 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.94 85.12 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.282 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 m -152.84 109.45 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.748 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.97 97.23 9.69 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.269 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.69 84.23 5.86 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.6 57.18 0.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.456 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER 54.88 178.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.708 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 1.2 tppt? . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.1 t . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.962 0.411 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.1 150.81 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.662 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.62 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 50.7 mtp -133.5 -174.22 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.507 0.67 . . . . 0.0 109.694 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -156.55 152.06 26.83 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.557 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -140.34 150.18 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.044 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.55 166.87 15.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -74.59 178.41 34.32 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.717 -1.368 . . . . 0.0 110.846 -1.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -36.95 78.05 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.53 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.3 t -140.24 147.55 40.18 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.063 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tp -134.1 83.18 46.16 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.406 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.05 101.17 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.839 1.692 . . . . 0.0 110.241 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.74 -167.78 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.884 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -127.35 147.73 50.26 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.78 89.34 0.26 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.667 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.92 -6.8 2.36 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.65 -152.16 0.27 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -125.05 155.93 38.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.67 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.53 25.98 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.7 p -163.32 94.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.36 129.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.018 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 37.0 m -87.96 159.39 18.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.966 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.479 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 2.1 t -160.74 137.11 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.672 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.41 45.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.966 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 m -110.77 146.83 35.67 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.319 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -52.14 -38.01 56.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -133.25 167.0 21.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -63.52 137.99 58.34 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 77.2 mt -94.39 23.48 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.208 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.41 139.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 . . . . . 0 N--CA 1.488 1.472 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.704 -179.897 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.738 0.304 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.36 137.39 37.28 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.169 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 21.1 tp -172.63 151.51 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.46 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -154.72 120.71 5.22 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 29.6 m95 -87.93 149.68 23.92 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.546 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -123.7 155.68 37.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.574 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.4 tp -150.91 117.11 5.62 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.499 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -111.94 130.45 55.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.448 ' CD1' ' OD1' ' A' ' 39' ' ' ASN . 16.0 tp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.48 -88.94 0.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.241 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.82 123.05 40.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.028 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -110.48 20.17 18.01 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.374 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.44 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -172.14 143.77 1.56 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.89 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.1 t -44.09 106.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.081 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.06 71.21 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.419 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -170.71 110.65 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.359 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -77.33 139.76 39.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.847 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.427 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 68.7 t80 -69.85 160.13 32.36 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.408 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 5.3 m -40.25 -53.73 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.86 57.44 3.7 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 60' ' ' PHE . 88.9 t -144.59 113.9 5.12 Favored Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.105 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 159.77 37.45 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.966 1.778 . . . . 0.0 111.938 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -58.08 -27.46 63.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.549 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' CG ' ' HB2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -43.71 -42.12 5.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.322 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.51 124.51 30.17 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.623 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -124.63 151.86 44.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.722 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.35 155.11 25.94 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.772 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -149.78 141.83 23.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.42 128.45 4.32 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.92 -1.609 . . . . 0.0 112.094 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 m -94.73 -124.55 0.11 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.17 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.14 -55.89 1.25 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 p -125.27 20.65 8.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.972 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -132.11 143.25 49.88 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.418 ' CG ' ' C ' ' A' ' 75' ' ' ASP . 40.4 m-85 -151.13 136.42 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 m -139.37 140.92 37.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.597 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 1.8 tt -117.63 111.05 18.66 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.161 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -120.81 138.14 54.18 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.196 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.85 138.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -72.09 -36.17 69.43 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.434 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB2' ' CG ' ' A' ' 66' ' ' ARG . 3.9 mtt180 -135.25 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.058 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -65.8 111.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CD ' HH21 ' A' ' 66' ' ' ARG . 24.4 mt-10 -106.65 177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.75 39.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.16 -32.81 74.17 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -20.16 66.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.53 139.94 54.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.35 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -173.42 23.04 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.419 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.4 mp -85.25 158.56 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -131.51 148.77 52.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.693 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -147.21 165.13 30.99 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.262 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.466 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 22.8 p -132.7 102.92 5.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -83.17 164.32 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.145 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.62 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -130.38 118.2 20.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.633 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.22 22.02 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.496 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 3.9 m -89.11 -40.41 12.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.801 -0.759 . . . . 0.0 111.737 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 53.1 m-70 -119.34 152.4 36.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.673 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 68.0 t -113.86 137.76 22.46 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.61 142.3 73.96 Favored 'Cis proline' 0 C--N 1.317 -1.112 0 C-N-CA 123.589 -1.421 . . . . 0.0 111.805 -0.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.69 110.81 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.841 1.694 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -64.85 147.86 52.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.71 -74.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.69 -137.49 8.29 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.598 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.665 ' N ' ' HB3' ' A' ' 92' ' ' PHE . . . 114.0 90.6 1.8 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -151.46 8.76 0.66 Allowed Glycine 0 N--CA 1.483 1.827 0 C-N-CA 117.908 -2.091 . . . . 0.0 113.909 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.6 m -147.73 138.53 23.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.885 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -113.6 103.4 11.21 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.358 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.86 86.94 7.34 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.523 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.62 139.1 45.04 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.721 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.4 tt -55.42 158.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.714 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? . . . . . 0 N--CA 1.487 1.419 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.959 179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.019 0.438 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.95 157.09 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' A' ' 25' ' ' SER . 40.1 mmm -133.31 113.47 12.64 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -77.78 127.65 32.75 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.577 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.644 ' CD ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 tp60 -101.57 139.29 37.43 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.75 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.18 145.83 9.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.62 -179.98 28.71 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.093 -0.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.01 -29.75 49.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.498 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.88 149.63 50.33 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.261 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -142.24 83.07 12.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.877 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.07 113.97 3.02 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.853 1.702 . . . . 0.0 110.808 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.9 m -143.08 162.65 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.326 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.415 ' HG ' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -99.14 158.66 15.52 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.391 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 111' ' ' ILE . 25.5 mt -78.96 94.65 5.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.1 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 133.05 16.98 1.18 Allowed Glycine 0 N--CA 1.494 2.544 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.415 ' CG ' ' HG ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -111.99 -131.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.724 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 2.6 mt-30 -139.08 172.52 12.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.317 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.65 166.14 26.66 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.556 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -160.86 80.99 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.9 mt -90.63 124.15 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.295 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -87.15 151.88 22.81 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.927 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -160.8 111.09 1.75 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.225 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.38 170.29 8.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.821 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.425 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 2.3 t -111.36 155.25 23.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.101 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -49.04 25.88 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 28' ' ' SER . 4.0 tp-100 -97.84 -68.6 0.79 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 27' ' ' GLN . 39.3 t 167.45 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.73 20.77 7.77 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.56 119.3 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.628 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.476 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.677 0.275 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CG ' ' OG1' ' A' ' 97' ' ' THR . 12.6 m-85 -97.92 159.43 14.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.99 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 16.1 tp 179.8 151.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.343 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 m120 -137.71 149.09 46.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -120.42 157.28 29.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -147.75 172.01 14.77 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.577 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.72 120.69 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.95 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -90.18 116.88 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 17.8 ttpp . . . . . 0 C--N 1.306 -1.285 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.545 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.696 0.284 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 51' ' ' LEU . 64.9 mt -102.3 -80.1 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.167 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -105.5 138.71 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.662 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -132.06 28.58 4.45 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.659 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -178.8 68.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.434 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 57' ' ' SER . 20.5 m 19.74 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.541 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER 79.42 63.2 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.46 108.51 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.988 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.458 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 15.4 mtt85 -89.17 153.62 20.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.758 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 40.0 t80 -83.78 160.28 21.26 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.3 t -42.97 -38.55 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.029 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.08 52.42 1.09 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 75.0 t -146.12 118.93 5.11 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.8 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.36 138.07 78.5 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.159 1.906 . . . . 0.0 111.919 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -52.22 -23.78 6.17 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.474 HH21 ' CB ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -67.53 12.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.128 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 65' ' ' ASP . 12.2 m-85 -115.74 104.51 11.74 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.395 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.0 m -105.68 121.08 43.27 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.12 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.15 102.7 0.52 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 31.2 t -151.47 175.34 12.39 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.142 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 174.37 147.63 6.19 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.8 p -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.4 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.11 -102.79 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.213 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.1 p -124.55 15.45 8.84 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.111 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -115.83 125.68 53.0 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.517 ' CD2' HD23 ' A' ' 38' ' ' LEU . 4.0 m-85 -140.97 168.14 20.5 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.517 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -160.1 155.91 25.95 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.255 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.49 102.02 10.15 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.487 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -89.8 125.12 35.19 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.66 130.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.456 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 22.9 m -84.16 -18.78 35.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.877 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.474 ' CB ' HH21 ' A' ' 66' ' ' ARG . 1.1 mmt-85 -148.24 92.85 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.749 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' GLY . 86.6 t -76.36 117.95 21.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.7 -179.55 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.963 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.98 23.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 23.1 mt-10 -68.78 -23.83 64.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.487 ' HB3' ' CD2' ' A' ' 109' ' ' LEU . 3.1 m-20 -77.27 -29.65 53.96 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.42 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -51.04 142.38 12.26 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.66 -139.58 11.11 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.6 135.15 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.998 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.18 141.15 34.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.515 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 79.8 m-85 -130.21 175.44 8.92 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 25.6 p -156.68 146.41 20.83 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.537 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -149.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.612 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -155.18 145.4 21.85 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.427 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 m -107.4 -5.86 17.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.213 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.551 HG21 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -69.74 -27.09 64.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.807 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CD2' HG21 ' A' ' 97' ' ' THR . 43.4 m-70 -102.62 145.32 29.82 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.503 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 4.8 t -132.55 129.47 21.41 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.233 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.8 Cg_endo -67.24 148.48 79.95 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.795 -0.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.88 123.84 12.23 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.969 1.779 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -89.48 125.46 35.19 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.236 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 6.5 t80 -125.98 136.41 52.97 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.49 -164.67 29.77 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.24 -172.88 15.37 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.24 58.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.1 m -80.67 110.12 15.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.376 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -64.96 103.11 0.68 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -98.45 83.56 3.05 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.119 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -107.61 148.87 28.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.712 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.9 tt -52.37 168.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.43 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 13' ' ' VAL . 3.2 ttmm . . . . . 0 N--CA 1.492 1.639 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.756 0.312 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.543 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.518 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 98' ' ' HIS . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.783 0.325 . . . . 0.0 110.736 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 67' ' ' PHE . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.401 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.404 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.469 ' O ' ' NE2' ' A' ' 6' ' ' GLN . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.463 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.456 ' HG1' ' CG ' ' A' ' 95' ' ' GLN . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 24.6 tttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' CD2' ' A' ' 98' ' ' HIS . 39.2 t . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.869 0.366 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.9 t -81.68 156.25 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -136.41 105.87 6.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.619 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -78.98 134.08 36.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.11 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.95 158.24 21.17 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -75.99 177.97 37.05 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.603 -1.416 . . . . 0.0 111.248 -1.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -77.57 -27.06 51.33 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.879 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 m -143.21 149.4 37.92 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.939 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.71 88.92 10.46 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.717 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.3 117.79 5.27 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.918 1.745 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 m -142.34 -164.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 t -118.22 169.37 9.76 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.34 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.39 89.7 7.44 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.85 -25.58 2.25 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.92 -161.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.011 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.594 ' CB ' ' HA ' ' A' ' 81' ' ' SER . 2.0 pm0 -134.84 136.34 42.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.266 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.23 178.29 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.478 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -155.9 73.54 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' THR . 2.6 mp -62.54 128.49 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' THR . 21.8 t -93.26 155.29 17.52 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.304 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.619 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 81.5 m -160.86 109.65 1.62 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.09 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -108.82 150.34 27.77 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -104.17 152.36 22.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.483 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -80.34 -22.89 40.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.81 34.81 1.98 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t 58.62 -173.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.106 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.93 13.89 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.079 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.91 135.29 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 . . . . . 0 N--CA 1.488 1.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.009 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -88.21 149.88 23.61 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.16 157.57 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.478 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.8 p-10 -159.96 113.57 2.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.533 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 55.9 m95 -90.76 169.71 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.21 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.08 133.52 8.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.54 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 tp -107.52 130.51 54.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.459 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.22 125.03 39.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.781 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.895 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.96 -63.86 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.479 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 39' ' ' ASN . 43.3 mm -121.52 139.85 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.0 p90 -122.83 30.81 6.27 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.459 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -174.29 -166.59 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.422 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -82.99 22.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.122 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -44.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.647 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 1.4 m-80 -46.21 140.44 3.98 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.977 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 5.2 mtm180 -110.29 134.04 52.65 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 61' ' ' SER . 65.7 t80 -57.38 162.39 2.84 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.1 m -68.43 92.26 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.32 32.17 0.45 Allowed Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 65' ' ' ASP . 38.8 t -113.67 132.67 22.46 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.82 13.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.959 1.773 . . . . 0.0 113.12 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 63' ' ' VAL . 1.1 t70 71.46 -41.78 0.51 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -46.36 -26.86 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.085 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 80' ' ' ILE . 83.1 m-85 -80.82 123.64 28.41 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 m -138.27 101.05 4.29 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.545 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 56' ' ' VAL . . . -92.99 120.01 6.07 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.8 p -151.45 154.52 36.75 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.566 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -165.84 163.74 36.93 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -92.94 -115.35 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.719 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.1 -78.28 0.64 Allowed Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 p -111.37 18.26 19.38 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.349 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.42 131.74 53.74 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.717 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.566 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 54.3 m-85 -142.51 153.96 44.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.916 -0.713 . . . . 0.0 110.522 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 3.5 m -151.75 145.65 25.16 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.498 HD12 ' CG ' ' A' ' 40' ' ' TRP . 9.7 tp -104.45 93.61 4.88 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -81.17 118.45 22.57 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.094 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.568 HG12 ' CD1' ' A' ' 67' ' ' PHE . 23.0 mt -114.61 103.46 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.594 ' HA ' ' CB ' ' A' ' 18' ' ' GLN . 1.4 m -74.95 39.45 0.14 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.046 -1.062 . . . . 0.0 113.524 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 81' ' ' SER . 1.1 mmt85 169.63 97.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.696 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.49 99.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.54 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -177.01 3.28 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.508 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.32 -26.89 43.44 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.821 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.83 -36.21 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.964 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -43.39 98.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.91 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' CE ' ' A' ' 44' ' ' LYS . 89.3 mt -43.62 148.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.715 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.87 -155.02 20.75 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.61 142.76 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.22 144.72 43.28 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.906 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -133.59 155.79 49.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 1.8 p -136.52 102.21 4.87 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 158.89 15.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.696 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.477 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -110.65 127.9 55.47 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.604 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.9 m -83.61 -5.57 59.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.004 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -62.63 -62.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.29 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' A' ' 2' ' ' VAL . 66.7 m-70 -89.12 114.78 26.08 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.41 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 21.8 t -104.59 134.37 19.7 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.832 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.16 156.98 97.91 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.591 -1.421 . . . . 0.0 111.523 -0.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.38 139.91 85.14 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.034 1.823 . . . . 0.0 110.997 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.28 -43.93 60.13 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.315 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 t80 68.35 161.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.581 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.78 130.87 2.92 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 145.93 173.78 17.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.441 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 178.86 67.15 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 m -77.1 113.81 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.888 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -73.84 107.25 5.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.391 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.67 94.85 6.31 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.704 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.32 136.67 52.26 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -69.2 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.059 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.445 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.349 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.129 0.49 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.5 162.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.761 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.546 ' HE2' ' SG ' ' A' ' 93' ' ' CYS . 48.6 mmm -126.85 175.51 7.98 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -150.72 93.56 1.97 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.204 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.625 ' NE2' ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp60 -82.5 148.3 28.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.232 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.515 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -161.18 165.14 17.49 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.908 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -76.76 173.97 55.43 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.482 -1.466 . . . . 0.0 110.563 -1.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.96 -28.59 68.4 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.592 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -140.97 130.43 23.85 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -125.92 94.16 42.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.699 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.86 121.1 7.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.8 1.666 . . . . 0.0 110.537 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.43 -165.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -146.53 160.48 42.08 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -74.69 85.69 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' HA2' ' CD ' ' A' ' 82' ' ' ARG . . . 140.43 -22.62 2.71 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 18' ' ' GLN . 31.9 t70 -76.48 177.87 7.06 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 54.5 mt-30 -94.63 -173.76 3.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.737 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.73 157.69 39.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.544 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 p -151.52 79.94 1.29 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.27 117.75 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.906 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 7' ' ' THR . 39.4 t -85.4 155.53 21.24 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.958 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -162.13 124.38 2.84 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.605 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.17 155.99 28.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.306 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 3.8 t -112.96 154.23 26.76 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.8 p -74.37 -31.73 62.49 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -136.54 150.56 48.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.689 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.6 p -50.75 128.13 19.99 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.156 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.52 27.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 28' ' ' SER . 42.5 t -88.81 133.89 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.393 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 . . . . . 0 N--CA 1.489 1.521 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.41 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.1 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.822 0.344 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -112.37 132.72 54.86 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.24 125.85 6.91 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.957 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' N ' HD23 ' A' ' 38' ' ' LEU . 34.6 p30 -133.24 169.65 16.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.256 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 78' ' ' LEU . 36.5 m95 -125.03 150.56 46.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.11 147.59 44.13 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 tp -135.62 125.53 25.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.52 152.75 33.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.107 -1.037 . . . . 0.0 112.103 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.323 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -113.34 -71.56 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.261 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.6 mm -109.46 150.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 47.7 p90 -149.19 25.36 0.9 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.559 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' HD21 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -174.41 61.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.832 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 56' ' ' VAL . 14.6 m 30.44 97.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.09 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 72.05 46.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.859 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.489 HD21 ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -148.96 108.97 4.08 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 65' ' ' ASP . 41.7 mtm180 -79.83 153.0 29.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.906 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 61' ' ' SER . 59.9 t80 -91.14 171.78 9.01 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.546 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t -59.9 123.0 15.68 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.218 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.05 66.22 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 90.0 t -84.46 123.93 74.14 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 138.95 83.29 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.1 1.867 . . . . 0.0 112.02 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 6.1 m-20 -56.29 -18.55 10.94 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.615 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -77.61 27.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.606 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.8 m-85 -128.17 129.03 45.87 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.4 104.01 3.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' VAL . . . -110.65 108.15 2.37 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.318 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -143.0 163.37 32.97 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.686 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . -169.9 172.34 43.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.45 -151.23 0.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.632 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.91 -48.81 13.75 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -146.51 35.14 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.444 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -135.64 90.62 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.158 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.517 ' CD2' HD13 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -119.62 155.41 32.35 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.08 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.3 m -146.98 141.03 26.02 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.539 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 5.5 tt -94.02 110.33 22.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 131.39 46.95 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.018 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 57.3 mt -117.99 131.58 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.2 m -90.64 -0.5 57.71 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.72 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.494 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 tpt180 -169.05 97.32 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.88 136.66 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.999 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.89 163.8 13.81 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.812 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.63 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.28 -27.11 62.27 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -30.91 71.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.474 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.444 ' O ' ' CE ' ' A' ' 44' ' ' LYS . 85.9 mt -42.94 134.87 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.23 -154.62 25.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 mm -103.62 131.84 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.09 154.95 18.29 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.175 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.464 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 38.1 m-85 -147.45 176.88 9.68 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.082 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 4' ' ' MET . 0.6 OUTLIER -160.71 127.68 4.22 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.401 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.446 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 4.8 p -118.74 -170.24 1.87 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.324 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.04 127.39 5.81 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 m -107.12 57.73 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m -108.93 -50.3 3.03 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -87.87 -40.01 14.34 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.28 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.564 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.8 OUTLIER 64.94 141.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.315 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.564 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -67.78 158.04 84.95 Favored 'Cis proline' 0 C--N 1.319 -1.024 0 C-N-CA 123.55 -1.437 . . . . 0.0 111.362 -0.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.67 114.59 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.938 1.758 . . . . 0.0 111.532 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 p -52.95 -55.19 25.26 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.09 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.6 OUTLIER 61.95 116.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.57 100.09 0.61 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.231 -1.461 . . . . 0.0 111.547 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' A' ' 92' ' ' PHE . . . -100.62 -90.36 2.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.61 93.5 1.35 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.307 -1.425 . . . . 0.0 112.798 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -158.49 109.17 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.556 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.71 105.39 5.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.202 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.64 94.01 7.48 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.129 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 144.06 50.3 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.675 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 4.8 mt -76.81 156.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 11.9 mttm . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.213 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.409 ' H ' ' CG2' ' A' ' 102' ' ' THR . 62.9 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.25 124.99 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.195 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 81.9 mmm -120.68 102.38 8.36 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -96.1 156.7 16.22 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.311 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.561 HE21 ' H ' ' A' ' 106' ' ' GLY . 5.9 tt0 -130.39 151.48 50.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.838 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -157.82 156.55 28.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.97 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.4 176.83 42.02 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.611 -1.412 . . . . 0.0 111.328 -0.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -75.12 -18.27 60.27 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.813 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 p -156.02 140.64 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.085 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.68 91.38 33.98 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.731 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -70.47 105.72 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.97 1.78 . . . . 0.0 111.236 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.6 m -117.71 -154.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.44 159.43 39.34 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.493 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.34 88.94 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.6 -1.22 5.98 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.5 -177.76 4.19 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 179.39 5.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.107 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.44 163.93 39.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.226 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 m -155.18 95.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.335 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 77' ' ' THR . 23.2 mt -84.36 165.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.354 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' THR . 11.0 m -131.07 154.5 48.19 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.735 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.44 126.51 4.65 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.81 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -120.06 145.99 46.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.452 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 85.8 p -107.66 125.17 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.46 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -73.82 32.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.242 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.37 -85.85 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.767 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 t 171.39 146.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.753 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 46.1 mt -109.83 30.01 7.09 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.5 t -107.29 147.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.439 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.726 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' HB2' ' HG1' ' A' ' 97' ' ' THR . 90.3 m-85 -84.44 143.83 29.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 8.7 tp -165.46 146.2 7.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.851 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.468 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 2.3 m120 -135.38 156.89 48.18 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.466 ' HE1' ' CD2' ' A' ' 38' ' ' LEU . 59.5 m95 -137.33 152.66 49.97 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' TRP . 33.4 m-85 -144.56 154.46 42.88 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp -127.42 106.05 8.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.019 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -69.68 105.84 2.86 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.382 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' NZ ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.477 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.912 0.387 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 63' ' ' VAL . 1.8 mm? -82.25 -69.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.439 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mm -108.92 127.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.023 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.534 ' HH ' ' NZ ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -134.14 25.89 3.88 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.952 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.534 ' NZ ' ' HH ' ' A' ' 54' ' ' TYR . 4.7 mttt -171.24 27.9 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' ASN . 95.0 t 63.3 119.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.637 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.1 p 34.36 33.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.36 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.525 ' ND2' ' N ' ' A' ' 55' ' ' LYS . 4.3 p30 -107.33 -32.91 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 1.2 mtm-85 66.52 113.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.553 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 61' ' ' SER . 51.4 t80 -61.61 167.34 3.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.4 t -54.2 -40.58 67.72 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.86 63.91 3.46 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 65' ' ' ASP . 58.8 t -139.61 133.17 15.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.704 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -67.38 14.39 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 122.221 1.947 . . . . 0.0 112.468 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 63' ' ' VAL . 5.1 m-20 65.43 -24.18 0.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.569 HH12 ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -65.3 -11.62 43.47 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.328 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CE1' HG12 ' A' ' 80' ' ' ILE . 77.3 m-85 -95.26 132.84 39.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.412 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -147.89 85.69 1.56 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.443 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 77' ' ' THR . . . -86.08 107.09 3.13 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -76.67 163.03 27.24 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.979 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.655 ' HA2' ' CD1' ' A' ' 76' ' ' PHE . . . -142.06 96.26 0.2 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -94.36 82.91 4.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.502 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.16 -82.13 0.13 Allowed Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 p -123.31 14.87 9.7 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.791 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.95 132.02 53.97 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.26 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.655 ' CD1' ' HA2' ' A' ' 71' ' ' GLY . 24.8 m-85 -138.49 143.89 39.77 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.477 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 100.0 m -139.98 112.28 7.73 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.54 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.2 tt -80.68 100.31 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -94.93 134.3 37.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.284 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 HG12 ' CE1' ' A' ' 67' ' ' PHE . 7.6 mt -113.07 137.29 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -87.01 -44.24 11.73 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.681 -1.207 . . . . 0.0 111.947 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -124.71 102.37 7.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 69.3 t -89.44 103.6 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.569 ' CD ' HH12 ' A' ' 66' ' ' ARG . 4.0 mt-10 -102.89 177.21 4.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.249 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.16 -27.11 31.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' O ' ' NZ ' ' A' ' 44' ' ' LYS . 55.1 mm-40 -78.96 -40.23 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.532 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.07 -20.23 23.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.408 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.68 167.39 4.54 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.756 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.01 180.0 16.07 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.715 -1.231 . . . . 0.0 111.267 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.87 115.5 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 143.38 26.95 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.811 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.542 ' HA ' HE22 ' A' ' 6' ' ' GLN . 13.6 m-85 -135.48 158.76 43.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.51 156.64 46.8 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 10.5 t -150.91 -177.05 5.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -129.26 113.8 15.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.2 t -84.33 34.67 0.52 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.802 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -100.13 -72.27 0.67 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.41 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.2 m-70 -78.24 162.11 26.79 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.408 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 45.7 t -137.88 137.57 21.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.586 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.3 Cg_endo -73.46 158.58 98.39 Favored 'Cis proline' 0 C--N 1.318 -1.058 0 C-N-CA 123.568 -1.43 . . . . 0.0 111.472 -1.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.77 151.63 82.9 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.966 1.777 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 36.7 p -89.94 -61.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.048 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 3.3 t80 72.83 146.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.008 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.75 170.25 30.43 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.502 ' CA ' ' HB3' ' A' ' 6' ' ' GLN . . . 120.11 -155.38 16.19 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.841 -1.171 . . . . 0.0 111.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.561 ' H ' HE21 ' A' ' 6' ' ' GLN . . . 147.69 60.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 m -81.76 108.28 15.17 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.966 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -68.99 89.74 0.43 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.15 87.52 6.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.521 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 143.25 49.25 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 mt -88.34 146.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.932 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 mttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.809 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.435 ' HB ' HE22 ' A' ' 95' ' ' GLN . 39.1 t . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.852 0.358 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.51 169.93 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.209 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.676 ' SD ' ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -132.64 99.21 4.56 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.541 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -89.57 148.42 23.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.552 ' CB ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -141.54 153.48 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.379 -0.929 . . . . 0.0 110.824 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.525 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.29 146.27 11.62 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.726 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -82.12 176.93 35.24 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.806 -1.331 . . . . 0.0 111.342 -0.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.422 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 3.5 mm? -73.08 -27.31 61.65 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -137.72 149.62 46.63 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 tp -135.43 86.2 30.22 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.924 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.546 ' CB ' ' HA ' ' A' ' 112' ' ' LYS . 10.2 Cg_endo -72.23 101.77 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.657 1.571 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 112' ' ' LYS . 20.4 m -126.7 -178.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.34 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.2 174.53 5.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.11 86.98 6.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.37 -25.65 1.54 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.65 -166.93 0.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.024 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -114.59 138.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.53 166.37 11.98 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.843 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 p -160.95 100.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -98.94 142.53 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -103.34 141.13 36.45 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.802 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.99 94.21 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.564 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' CZ ' ' CB ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.1 163.08 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.186 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.63 166.36 13.28 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.129 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -64.93 -70.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.413 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.6 162.13 17.33 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 p -59.09 129.61 42.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.1 mt -85.02 34.73 0.56 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -96.96 114.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.126 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.676 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 -105.5 102.66 12.11 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.964 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 76' ' ' PHE . 1.4 tt -149.1 126.91 11.8 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.865 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.21 163.77 15.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.39 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.423 ' CE3' HD12 ' A' ' 78' ' ' LEU . 47.1 m95 -123.56 159.02 30.09 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -144.45 148.28 34.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.026 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.5 tp -123.14 79.84 1.71 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.57 30.94 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.45 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt . . . . . 0 N--CA 1.484 1.274 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.625 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.22 -60.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.678 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mm -113.49 131.56 64.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.99 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 55' ' ' LYS . 52.2 p90 -108.61 -13.78 14.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.83 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' SER . 1.2 mtpm? -153.93 110.13 3.29 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 57' ' ' SER . 1.2 p 43.56 -73.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 55' ' ' LYS . 16.6 t -136.67 -15.8 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.55 -1.26 . . . . 0.0 113.789 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -64.4 114.25 4.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.911 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -71.86 143.73 49.31 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.361 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.4 175.43 4.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.473 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 p -61.61 -51.38 68.73 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.579 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.54 71.11 2.98 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 65' ' ' ASP . 46.5 t -139.35 125.68 12.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.803 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 66' ' ' ARG . 1.1 Cg_endo -68.04 14.35 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.031 1.821 . . . . 0.0 111.799 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 63' ' ' VAL . 35.9 m-20 60.09 -9.38 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.979 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 64' ' ' PRO . 12.1 mtm-85 -76.96 19.63 0.29 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ASP . 89.3 m-85 -137.55 135.81 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.624 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -146.14 96.58 2.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 149.71 37.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m -154.1 113.61 3.78 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.384 -1.327 . . . . 0.0 111.577 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -146.58 135.75 5.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -88.02 -84.29 0.2 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.101 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.5 -57.17 1.47 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.643 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 36.9 p -145.85 56.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 10.4 t70 -161.18 73.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.069 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.557 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 10.3 m-85 -95.81 117.42 30.53 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -111.72 129.17 56.2 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.574 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.423 HD12 ' CE3' ' A' ' 40' ' ' TRP . 2.3 tt -85.66 94.19 9.02 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.86 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -91.39 124.63 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.255 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.441 HG22 ' CE2' ' A' ' 67' ' ' PHE . 25.2 mt -99.78 131.58 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 p -82.18 -23.19 35.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.331 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.4 ' H ' HG21 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -156.61 120.58 4.36 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.99 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.85 122.0 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -108.57 171.25 7.53 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.32 70.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.647 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -84.41 -2.3 56.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.0 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -89.15 -18.03 28.0 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.707 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 140.5 45.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.65 -140.25 7.18 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' CD1' ' A' ' 92' ' ' PHE . 1.6 mp -116.95 113.4 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.883 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.464 ' OH ' ' CE2' ' A' ' 67' ' ' PHE . 1.9 m-85 -91.94 112.79 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.739 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CE1' ' HA3' ' A' ' 106' ' ' GLY . 3.3 m-85 -119.05 -176.49 3.13 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -152.93 -179.44 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.239 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.432 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 74.9 p -171.62 144.41 1.86 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.479 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.467 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 19.2 pt20 -109.61 157.42 19.07 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.6 p -132.34 13.44 4.6 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.97 60.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.677 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -110.03 162.47 14.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 10.9 p -128.01 138.22 32.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.508 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.8 Cg_endo -71.29 158.2 95.44 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.588 -1.421 . . . . 0.0 111.845 -0.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.52 119.75 7.04 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.786 1.657 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 95' ' ' GLN . 54.6 p -91.24 134.02 34.92 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.958 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.7 138.65 55.24 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.676 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . -72.54 -159.05 4.47 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -73.14 -157.19 4.0 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 92' ' ' PHE . . . -178.23 98.75 0.12 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 m -107.36 143.75 35.22 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.527 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.92 133.75 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.282 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 89.04 2.75 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -127.6 59.78 1.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 19.6 mm 59.0 163.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.404 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.944 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.446 ' H ' ' CG2' ' A' ' 102' ' ' THR . 59.5 t . . . . . 0 C--O 1.216 -0.707 0 CA-C-O 120.66 0.267 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.74 141.76 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.655 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.21 105.95 7.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.794 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -99.03 112.66 24.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.911 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.613 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 9.4 tt0 -95.77 149.91 20.98 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.783 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.2 159.98 24.23 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.711 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -72.61 177.62 35.0 Favored 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.603 -1.415 . . . . 0.0 111.259 -0.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.1 mt -82.4 -15.47 52.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.758 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -144.5 135.41 25.02 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.545 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.85 72.0 81.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.433 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.6 106.87 1.34 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.943 1.762 . . . . 0.0 111.377 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 7.6 m -141.77 175.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.313 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.465 ' HG ' ' CG ' ' A' ' 17' ' ' ASP . 1.1 p -99.14 161.11 13.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.151 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.49 88.13 2.11 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.71 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.89 -23.03 0.91 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CG ' ' HG ' ' A' ' 14' ' ' SER . 69.2 m-20 -71.71 170.99 12.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.326 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.59 137.84 33.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.27 163.38 14.44 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -162.27 95.4 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.205 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 77' ' ' THR . 2.7 mp -81.19 167.34 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 7' ' ' THR . 23.1 t -138.92 110.43 7.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.392 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.6 t -117.28 127.6 54.24 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.068 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -116.6 150.42 38.08 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.73 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 27' ' ' GLN . 5.8 p -109.9 119.57 39.75 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.9 m -75.25 21.61 0.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.7 tt0 -149.45 2.72 0.55 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.46 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.73 150.86 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.52 28.77 8.44 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.71 115.3 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.775 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.011 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.531 0.205 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.502 ' HB3' ' CG2' ' A' ' 96' ' ' THR . 91.3 m-85 -121.65 132.81 54.86 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 1.7 tp -156.47 141.15 16.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.481 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 1.5 m120 -124.84 148.07 48.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.477 ' CE3' HD11 ' A' ' 78' ' ' LEU . 31.9 m95 -115.23 160.8 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -149.4 156.98 42.89 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp -141.99 113.72 7.9 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.856 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.84 125.91 33.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt . . . . . 0 N--CA 1.489 1.522 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.01 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.9 tp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.709 0.29 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 1.3 mm? -96.81 -71.9 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.488 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -101.54 133.48 44.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.83 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.429 ' CE1' ' ND2' ' A' ' 58' ' ' ASN . 44.9 p90 -122.48 20.23 10.39 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.954 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 1.6 tppp? -168.97 65.91 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.409 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 t 68.51 -66.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -138.64 11.78 2.72 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.749 -1.18 . . . . 0.0 113.078 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 55' ' ' LYS . 53.2 p-10 -75.18 -156.82 0.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.938 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -153.88 118.22 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.359 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.86 157.74 17.57 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.734 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 p -53.81 138.28 36.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.29 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.51 -26.0 7.66 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.29 118.78 50.22 Favored Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.028 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.0 144.55 99.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.883 1.722 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.98 -36.21 17.04 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -26.86 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -84.3 107.28 16.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t -134.61 108.44 8.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.535 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.09 170.79 21.91 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.1 t -164.22 -165.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.916 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.566 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 151.89 113.39 0.57 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.807 -1.663 . . . . 0.0 111.899 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -98.74 100.63 11.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.1 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 -115.72 4.78 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.557 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.5 p -99.22 18.63 17.05 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.402 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 3.7 m-20 -129.25 136.06 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.582 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.566 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 69.5 m-85 -139.4 151.78 46.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.404 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 43.0 m -145.73 139.35 26.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.998 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -105.1 91.79 3.95 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.403 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -86.08 116.89 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.375 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.71 129.35 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.62 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -90.48 13.15 16.48 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.27 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.4 113.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.608 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.04 143.47 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.18 179.05 4.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.11 18.84 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.256 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -55.26 -29.92 59.05 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -36.18 82.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.664 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.3 mt -48.69 134.07 16.45 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.342 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.67 -146.99 12.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.47 112.55 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.281 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -78.78 138.85 38.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.701 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.95 164.21 28.49 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.336 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.477 ' SG ' ' HA2' ' A' ' 105' ' ' GLY . 13.7 p -135.9 142.82 44.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.3 t -143.86 112.45 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 149.65 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 37' ' ' TYR . 12.1 t -123.43 26.62 7.8 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 37' ' ' TYR . 24.0 m -92.09 -23.83 19.34 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -127.88 136.52 51.5 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.715 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.4 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 50.9 t -109.69 138.37 20.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.436 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.5 Cg_endo -73.71 161.17 94.76 Favored 'Cis proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.634 -1.402 . . . . 0.0 111.757 -0.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.29 136.12 49.82 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.984 1.789 . . . . 0.0 110.75 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.446 ' CG2' ' H ' ' A' ' 2' ' ' VAL . 26.4 p -61.89 -51.05 69.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.085 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.6 t80 55.34 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.11 82.08 0.06 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.477 ' HA2' ' SG ' ' A' ' 93' ' ' CYS . . . -93.99 -126.13 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 145.41 80.69 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.805 -1.664 . . . . 0.0 112.274 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.1 m -154.5 108.39 2.94 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.629 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -79.01 149.32 32.25 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.939 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tt -154.2 88.62 1.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.42 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 111' ' ' ILE . 6.4 pt-20 -122.23 38.62 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 0.2 OUTLIER 74.95 168.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.757 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.671 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.79 124.01 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.212 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.543 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.518 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 98' ' ' HIS . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 32' ' ' SER . 58.8 t-80 -69.69 173.34 6.26 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.472 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 75.0 m -69.93 73.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 176.64 -27.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.421 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 23.57 5.94 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.82 142.77 48.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 m -113.12 129.38 56.53 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.736 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -167.31 1.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.83 77.78 2.11 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 59.56 3.73 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -163.99 1.44 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.23 124.03 74.49 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.602 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 155.98 49.91 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.849 1.699 . . . . 0.0 111.703 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -138.08 128.44 26.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.769 -0.773 . . . . 0.0 111.232 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.57 131.96 47.48 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.794 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 67' ' ' PHE . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.404 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.469 ' O ' ' NE2' ' A' ' 6' ' ' GLN . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.463 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.456 ' HG1' ' CG ' ' A' ' 95' ' ' GLN . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 24.6 tttt -88.34 145.36 25.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.346 -1.788 . . . . 0.0 110.514 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.547 ' H1 ' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.727 0.775 . . . . 0.0 110.636 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.0 t 67.52 99.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.136 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.3 t -74.76 158.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.618 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.496 ' SD ' HD23 ' A' ' 29' ' ' LEU . 84.2 mmm -122.43 101.99 7.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.986 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.91 136.95 37.42 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.321 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.545 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 34.6 tt0 -126.83 146.4 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.46 164.99 19.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.423 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 7.0 Cg_endo -75.71 176.57 43.08 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.412 -1.495 . . . . 0.0 110.99 -1.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.78 -25.15 56.16 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -140.21 143.41 36.02 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.601 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tp -134.11 70.07 74.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.279 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.04 113.16 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.936 1.757 . . . . 0.0 111.238 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.01 170.36 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.505 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -111.27 89.84 3.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.106 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 14' ' ' SER . 67.2 mt -8.69 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.079 0.862 . . . . 0.0 112.871 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.87 -35.26 0.37 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.615 -1.278 . . . . 0.0 110.774 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.77 179.11 7.88 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -92.04 161.31 14.83 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.997 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.53 165.08 16.99 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.616 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -159.6 88.8 0.86 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.152 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.3 mt -85.61 127.6 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.986 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.405 ' N ' ' O ' ' A' ' 7' ' ' THR . 24.5 t -87.4 150.2 23.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.99 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.01 132.79 4.32 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.551 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 179.64 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -109.44 157.86 18.53 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.713 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 t -68.67 -23.21 64.38 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.76 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.63 -57.14 0.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.6 137.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.496 HD23 ' SD ' ' A' ' 4' ' ' MET . 74.7 mt -88.36 -45.78 9.72 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 29' ' ' LEU . 76.2 t -36.62 125.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.879 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -64.03 169.21 4.53 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.068 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 m -49.44 -27.1 3.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.171 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.06 62.96 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.364 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.55 -131.65 2.61 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.013 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.42 179.11 5.83 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -87.9 76.48 8.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -74.09 122.84 23.32 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.187 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.404 HD22 ' O ' ' A' ' 94' ' ' SER . 0.9 OUTLIER -141.51 132.99 26.83 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.035 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 2.6 p-10 -124.95 127.01 46.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -94.44 175.07 6.82 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.514 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -160.55 168.16 25.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.88 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tp -151.89 116.69 5.14 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.77 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -93.84 132.2 38.48 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.433 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -161.31 0.83 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.124 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.37 7.67 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.53 53.89 0.52 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -103.48 135.52 44.92 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.476 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.606 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -90.97 -57.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.973 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.606 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 7.4 Cg_endo -73.59 99.86 1.19 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.623 1.548 . . . . 0.0 110.259 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.3 23.72 6.38 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.672 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -87.46 139.07 30.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.758 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 32.0 mt -125.92 -39.82 2.08 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.524 ' CD1' ' NH2' ' A' ' 59' ' ' ARG . 16.8 mm -138.83 146.19 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.3 p90 -143.66 32.58 1.29 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.206 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -177.57 55.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 57' ' ' SER . 48.3 t 36.98 83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.253 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 79.18 70.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.941 0.877 . . . . 0.0 110.342 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.05 106.08 0.2 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.373 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.596 ' CZ ' ' HB2' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -77.09 163.42 26.64 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 61' ' ' SER . 44.6 t80 -91.77 172.94 8.14 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 54.5 p -60.23 -47.04 87.64 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.434 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.75 50.92 2.91 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 119.595 -1.288 . . . . 0.0 112.321 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' CG1' HH11 ' A' ' 59' ' ' ARG . 44.3 t -141.49 122.88 8.93 Favored Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.1 164.23 32.89 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.993 1.795 . . . . 0.0 111.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' C ' ' H ' ' A' ' 67' ' ' PHE . 6.6 p-10 -69.74 -7.4 39.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -60.95 0.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.538 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 64.9 m-85 -122.68 155.98 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 t -161.61 112.05 1.65 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.51 147.11 18.31 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -161.46 -176.48 5.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.516 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 153.74 171.42 20.83 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.604 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -80.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.691 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.4 -49.16 0.06 OUTLIER Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -113.62 17.64 18.1 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.72 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.71 133.53 16.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.516 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 55.0 m-85 -147.03 168.93 20.32 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.455 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.7 m -152.76 141.76 21.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.341 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 10.4 tt -113.22 112.63 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.53 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -110.3 151.68 27.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.468 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 81' ' ' SER . 97.0 mt -124.71 139.65 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -69.63 -23.99 63.58 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.004 -179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -170.17 113.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.111 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.8 110.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.931 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.02 172.03 8.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.603 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.96 73.64 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.141 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 -13.73 59.8 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.43 -26.33 58.25 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.752 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 48.3 mt -53.74 150.19 7.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.38 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.89 178.9 17.76 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.945 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 mm -86.0 108.29 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.729 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -77.38 156.42 31.23 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -143.7 164.66 29.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 93' ' ' CYS . 30.8 p -148.55 82.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.673 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.404 ' O ' HD22 ' A' ' 38' ' ' LEU . 71.1 m -89.18 -178.35 5.63 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.007 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -135.22 157.8 45.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.0 t -127.29 45.22 2.76 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.21 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 29' ' ' LEU . 18.6 m -114.4 -52.62 2.71 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 1' ' ' ASP . 65.7 m-70 -86.86 145.68 26.49 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.475 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 47.1 t -113.82 138.64 22.81 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.853 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.475 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -70.55 164.35 81.7 Favored 'Cis proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.668 -1.388 . . . . 0.0 111.504 -0.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.81 120.16 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.522 1.481 . . . . 0.0 110.67 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.547 ' CG2' ' H1 ' ' A' ' 1' ' ' ASP . 1.4 p -91.7 112.63 24.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -84.37 151.51 24.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.73 157.9 29.79 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.579 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.475 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 134.93 -175.74 20.41 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.545 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 141.74 55.11 0.04 OUTLIER Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.161 -1.495 . . . . 0.0 111.857 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.433 ' CB ' HE21 ' A' ' 6' ' ' GLN . 16.2 m -99.06 115.23 28.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.617 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 93.97 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.123 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.9 83.07 6.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.724 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 153.97 28.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.0 132.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.869 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -63.64 157.45 23.93 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.278 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 116.43 -1.747 . . . . 0.0 110.542 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.134 0.493 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.2 t -61.61 111.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.725 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.447 ' N ' ' HB2' ' A' ' 26' ' ' SER . 46.8 t -69.0 153.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.313 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.421 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 30.1 mtp -135.06 92.8 2.92 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -79.19 121.1 24.62 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.016 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.489 ' CB ' ' H ' ' A' ' 106' ' ' GLY . 0.7 OUTLIER -97.8 129.05 44.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.721 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.31 151.56 37.2 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -74.23 -179.82 27.24 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.716 -1.368 . . . . 0.0 111.648 0.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 -33.29 53.59 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.054 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 m -130.27 153.16 48.91 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.829 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 tp -143.3 73.63 17.68 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.97 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.41 106.58 1.25 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.886 1.724 . . . . 0.0 110.645 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.3 m -132.34 170.47 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.45 150.26 22.36 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 33.9 mt -73.74 90.54 1.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.38 -21.3 1.07 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 18' ' ' GLN . 7.0 m-20 -84.54 -154.52 0.18 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.055 -0.572 . . . . 0.0 110.369 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.454 ' H ' ' HB3' ' A' ' 17' ' ' ASP . 25.8 mt-30 -125.25 164.55 20.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.555 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.97 160.95 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.011 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 m -149.94 95.39 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.48 133.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.023 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -92.07 159.51 15.66 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.504 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 3.3 m -156.47 105.92 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.865 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -100.97 124.98 47.5 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.029 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 78.0 p -87.9 147.34 25.12 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -49.03 -68.17 0.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.742 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 59.46 1.55 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 t 61.6 173.88 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.966 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 23.5 mt -131.73 21.36 4.63 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.535 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.6 t -79.89 122.72 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.512 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -66.13 179.17 0.98 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.011 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -75.73 60.92 1.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.817 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 178.87 -30.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.59 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.09 0.37 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.702 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -120.05 105.37 10.96 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.069 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 10.4 m -93.18 140.99 28.92 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.485 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 156.78 41.61 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.654 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -173.31 105.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.54 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -96.54 105.26 17.33 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.625 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.472 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 43.2 m95 -84.94 148.76 26.06 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 103' ' ' PHE . 41.0 m-85 -136.72 157.24 47.22 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 8.4 tp -136.7 110.43 8.1 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.79 121.77 37.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' CE ' ' HA ' ' A' ' 86' ' ' GLU . 7.4 tttt -90.65 173.81 7.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.27 90.31 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 45.77 38.73 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.285 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 161.7 35.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.47 144.68 99.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.263 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.11 130.1 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.899 1.732 . . . . 0.0 111.061 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -99.03 130.69 45.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 21.9 tp -85.33 135.79 33.75 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.332 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 39.4 mt -120.38 -55.56 2.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.224 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -120.11 158.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.587 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 30.1 p90 -138.17 -28.17 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.878 -1.129 . . . . 0.0 112.254 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -101.31 -51.29 3.53 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.4 p -178.31 -41.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.481 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -138.47 -31.86 0.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.837 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.11 120.05 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HB3' ' HB ' ' A' ' 63' ' ' VAL . 36.0 mtm-85 -77.54 157.65 30.27 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.295 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 85.4 t80 -73.77 160.41 31.53 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 38.2 t -62.6 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.349 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.7 -19.62 3.52 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 40.7 t -81.54 118.5 72.45 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.62 155.98 39.52 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.917 1.745 . . . . 0.0 111.993 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.87 -19.29 6.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.219 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -49.52 -26.38 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.811 -0.755 . . . . 0.0 111.284 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -100.57 128.22 46.7 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.507 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.7 p -141.8 128.59 20.49 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.259 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.36 150.53 18.4 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.63 147.54 10.38 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.217 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.596 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -166.07 125.89 1.4 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 m -95.1 67.29 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.79 -91.37 0.5 Allowed Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.114 -1.517 . . . . 0.0 112.144 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.1 p -121.9 1.55 9.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.348 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -106.16 97.81 7.57 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.954 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.596 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 73.4 m-85 -114.41 147.43 39.24 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.1 m -149.83 133.88 17.09 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.002 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 8.4 tt -92.16 112.09 23.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.194 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -107.05 129.19 54.85 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 5.1 mt -109.83 134.51 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.692 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 36.7 m -83.41 -19.14 36.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.276 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.434 ' HG2' ' O ' ' A' ' 81' ' ' SER . 4.1 mtt-85 -145.53 97.15 2.94 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.596 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 15' ' ' LEU . 51.6 t -75.68 117.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.354 -0.939 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -115.65 172.53 7.07 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.989 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.5 12.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.714 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 1.3 mt-10 -68.45 -36.72 79.41 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -59.96 -15.02 18.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.842 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.43 136.46 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.608 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -167.42 27.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.25 118.43 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.689 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -84.4 147.51 27.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.156 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 67.1 m-85 -141.1 167.28 22.57 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.817 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.476 ' N ' HE22 ' A' ' 6' ' ' GLN . 24.1 p -155.95 102.13 2.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.1 p -88.63 171.25 10.16 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.421 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 3.4 pt20 -127.76 112.0 14.3 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.1 p -81.11 55.31 2.47 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.843 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 m -128.52 -53.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -100.31 177.49 5.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.179 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.44 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 96.7 t -145.9 135.51 11.57 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.495 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.44 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -70.87 139.61 58.9 Favored 'Cis proline' 0 C--N 1.317 -1.1 0 C-N-CA 123.558 -1.434 . . . . 0.0 111.462 -0.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.75 118.48 5.52 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.717 1.611 . . . . 0.0 110.933 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.4 p -66.45 160.57 24.65 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.946 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -112.39 38.2 2.8 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.736 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.68 -178.93 31.29 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.464 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -90.83 -50.53 2.86 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.489 ' H ' ' CB ' ' A' ' 6' ' ' GLN . . . 127.57 95.4 0.88 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.056 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.8 m -100.37 120.77 40.46 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.11 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -78.5 118.43 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tt -113.16 100.54 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.77 159.28 23.28 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 tt -65.14 168.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.558 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.52 ' HZ2' ' C ' ' A' ' 113' ' ' ARG . 6.1 tmtt? -81.74 152.89 26.81 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.956 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.52 ' C ' ' HZ2' ' A' ' 112' ' ' LYS . 3.2 tpt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.351 -1.785 . . . . 0.0 110.529 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.358 0.599 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t -140.3 135.49 36.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.587 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.92 132.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.278 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 54.5 mmm -125.46 93.5 3.88 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 m -78.71 116.08 18.83 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.606 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 1.2 mp0 -101.83 148.9 24.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.927 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.58 163.12 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.501 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -77.41 177.29 40.04 Favored 'Cis proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.59 -1.421 . . . . 0.0 110.711 -1.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.9 -26.61 63.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 95.7 p -145.43 146.64 31.6 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.701 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.19 78.19 75.02 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.375 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.93 108.53 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.862 1.708 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 12.5 m -144.52 153.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.249 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.93 152.18 26.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.3 mt -69.89 88.76 0.57 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.031 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.65 -27.81 0.6 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.82 171.25 15.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 26.5 mt-30 -87.16 134.25 33.55 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.331 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -107.01 155.18 20.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 m -149.09 97.76 2.73 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.406 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.6 mt -84.17 161.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.786 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.6 t -122.17 146.22 47.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.692 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.606 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.9 m -150.34 104.92 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -112.14 134.68 53.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.801 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.465 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 54.5 p -98.51 152.29 19.71 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.297 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 p -73.02 -35.12 66.72 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 28' ' ' SER . 7.3 tp60 -121.12 148.72 43.81 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.454 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -50.3 142.91 9.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.26 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 69.1 mt -108.55 43.35 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.048 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -102.14 135.5 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' A' ' 32' ' ' SER . 4.3 t-80 -81.53 -161.01 0.39 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.796 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.586 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 61.4 m -78.61 34.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 31' ' ' HIS . 50.4 p-10 -166.98 -158.03 0.28 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.35 52.62 2.11 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.442 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -140.1 145.2 37.31 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.259 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 17.2 m -123.35 120.4 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.977 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.458 ' CD1' ' N ' ' A' ' 37' ' ' TYR . 6.3 m-30 -86.65 72.86 10.15 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 tt -119.34 132.59 55.89 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.532 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -126.14 165.48 18.8 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.524 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.593 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 50.9 m95 -114.52 154.32 28.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.0 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.21 163.5 29.47 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.632 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.6 tp -155.66 136.99 13.95 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.821 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -115.92 123.29 47.72 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.575 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 17.7 tptp -88.31 155.89 19.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.643 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' N ' ' HG3' ' A' ' 44' ' ' LYS . . . -62.11 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.709 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 52.51 25.73 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.578 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 1.1 tp-100 -142.82 -167.11 2.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.204 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 p -92.7 112.84 57.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.0 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.19 158.13 56.28 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.666 1.577 . . . . 0.0 111.669 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -144.77 165.76 27.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 140.14 30.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.52 -72.41 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.986 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.2 mm -120.28 164.67 16.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.479 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 35.5 p90 -155.69 156.44 34.93 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 13.6 mttm 48.25 22.33 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.923 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' TYR . 78.4 t 63.89 127.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.568 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p 41.94 56.86 3.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.834 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 9.8 m120 -127.67 -21.73 3.71 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.358 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.469 ' NH1' ' CG ' ' A' ' 65' ' ' ASP . 3.8 mtt180 54.47 101.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.97 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -60.25 160.21 8.76 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.638 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p -56.27 112.51 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.621 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.23 7.64 20.77 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -112.05 104.57 56.12 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.152 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 66' ' ' ARG . 4.5 Cg_exo -59.37 155.08 43.0 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.002 1.801 . . . . 0.0 112.078 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.16 -15.81 0.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.789 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -51.98 -34.96 44.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.774 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -95.15 129.28 42.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.881 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.86 93.28 3.28 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.7 106.27 2.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.628 -1.272 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.6 m -113.68 -176.64 2.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.047 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.624 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 154.14 117.8 0.65 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.9 t -98.1 67.76 1.92 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.144 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.76 -109.51 1.48 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.549 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 65.3 p -101.95 9.65 40.36 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.662 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 8.2 p-10 -113.73 139.49 49.05 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.624 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 96.7 m-85 -147.82 156.27 42.54 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 28.7 m -150.04 152.75 35.34 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.752 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.41 HD13 ' CD2' ' A' ' 40' ' ' TRP . 6.8 tt -115.96 92.74 3.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 6.1 mttt -92.23 126.89 37.5 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.006 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 18.7 mt -114.42 132.44 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.059 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -60.16 -73.64 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.275 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.671 HH12 ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -123.39 100.44 6.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.526 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.3 t -54.33 145.89 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.983 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.671 ' CG ' HH12 ' A' ' 82' ' ' ARG . 2.4 mm-40 -126.48 172.84 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.478 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.73 -29.67 54.15 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.49 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -66.19 -41.1 90.68 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.98 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -33.06 41.02 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.083 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.81 130.87 38.46 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.7 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.47 8.75 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 3.9 mp -125.64 116.58 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.272 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -88.53 153.71 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.159 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -154.76 179.96 8.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.215 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.1 p -165.22 163.36 20.23 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.942 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.471 ' CB ' ' CD2' ' A' ' 103' ' ' PHE . 8.4 t -147.03 -173.32 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.834 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -136.54 108.12 6.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -82.84 43.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.047 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.17 -58.16 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.849 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -88.76 171.78 9.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.297 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 57.4 t -139.17 138.72 21.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -71.39 148.8 90.88 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.276 -1.552 . . . . 0.0 111.336 -1.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.62 113.4 1.94 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.762 1.641 . . . . 0.0 110.084 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 87.39 4.56 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 94' ' ' SER . 1.5 t80 -83.5 111.46 19.08 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.882 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.89 152.21 6.61 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -167.34 -128.18 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.06 100.27 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 C-N-CA 117.641 -2.218 . . . . 0.0 113.632 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.7 m -158.35 104.17 1.83 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.82 156.19 18.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.396 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 93.89 3.15 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.816 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -106.82 31.94 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.696 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER 61.91 170.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.9 tttm -77.41 138.72 39.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.018 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.427 -1.749 . . . . 0.0 110.618 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.688 0.756 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.429 HG23 ' CD2' ' A' ' 98' ' ' HIS . 64.1 t 62.07 99.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.553 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.06 116.27 17.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mtp -93.94 89.76 6.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.054 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -77.08 112.23 13.5 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.64 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.701 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 38.1 tt0 -100.05 154.95 17.99 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -161.45 161.4 22.91 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.307 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -77.03 178.12 36.68 Favored 'Cis proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.522 -1.449 . . . . 0.0 110.314 -2.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.26 -21.56 66.32 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.469 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 p -154.83 152.38 29.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.607 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -129.59 77.51 77.02 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.019 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.43 102.75 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.699 1.599 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.17 -167.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.805 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.22 153.0 34.61 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' HG ' ' CD1' ' A' ' 111' ' ' ILE . 63.9 mt -75.46 87.03 2.6 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.443 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.64 -26.34 0.52 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.58 -170.65 2.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.42 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -106.4 139.5 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.263 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -113.34 146.13 39.94 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.397 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 p -138.23 92.03 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.492 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.56 126.44 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.08 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.1 156.56 20.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.118 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 29.0 m -162.02 111.73 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.251 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -111.22 140.66 45.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -94.54 167.04 11.74 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.931 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -41.03 26.32 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.316 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -136.77 43.77 2.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.433 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.457 ' C ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 m 61.02 -174.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.457 ' HG ' ' C ' ' A' ' 28' ' ' SER . 13.2 mt -142.92 21.34 1.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -77.11 138.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.169 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -64.92 170.88 3.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.996 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -51.02 -35.27 33.33 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.37 39.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -128.38 -129.4 3.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.4 -159.15 0.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.201 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.9 m -109.51 96.57 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.409 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.79 68.91 7.2 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.007 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 29' ' ' LEU . 1.4 tt -89.76 142.13 27.98 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 9.1 t30 -122.42 162.2 22.08 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.077 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.504 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -125.31 154.31 41.96 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.509 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.86 146.24 50.68 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp -162.7 128.42 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -173.42 170.48 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.258 -1.377 . . . . 0.0 112.678 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HG3' ' H ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -111.37 -158.66 0.65 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.413 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' H ' ' HG3' ' A' ' 44' ' ' LYS . . . -55.98 -19.99 14.67 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.211 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.24 83.79 0.04 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.84 -72.52 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 38.5 p -86.94 161.48 46.97 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.117 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 3.3 Cg_exo -62.66 172.24 4.82 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.734 1.622 . . . . 0.0 110.385 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.26 65.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.439 -0.904 . . . . 0.0 112.192 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.2 tp -172.54 97.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.29 -89.07 0.19 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.538 HG23 ' H ' ' A' ' 57' ' ' SER . 2.8 mp -82.43 145.3 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.787 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.2 p90 -139.46 -7.51 1.31 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.428 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -130.84 57.7 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.574 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 56' ' ' VAL . 5.9 p 38.05 79.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.046 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.538 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 69.26 75.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.444 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -151.0 -24.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.61 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER 70.49 137.55 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.051 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' N ' ' A' ' 61' ' ' SER . 79.4 t80 -90.77 172.22 8.79 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 t -57.89 117.4 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.33 -8.21 54.99 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.8 t -84.96 124.79 72.04 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.587 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.25 144.28 95.96 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 122.136 1.891 . . . . 0.0 112.143 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.462 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 3.0 t0 -58.26 -25.25 61.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.326 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.7 69.35 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' O ' ' NH1' ' A' ' 59' ' ' ARG . 10.0 m-85 -79.91 126.52 31.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.3 m -134.77 159.36 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.236 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.44 79.53 0.2 Allowed Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.069 -1.538 . . . . 0.0 111.297 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.485 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 8.8 t -83.3 -167.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.651 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 151.55 117.26 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.539 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -92.35 91.35 7.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.87 -75.15 0.91 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.6 p -131.65 57.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.498 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 25.9 t0 -162.62 58.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.651 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 58.2 m-85 -80.19 148.79 30.72 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 m -148.97 122.8 9.31 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.733 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 68' ' ' SER . 4.4 tt -84.68 104.56 14.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -96.12 119.98 35.59 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.309 -0.957 . . . . 0.0 111.99 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 7.8 mt -109.51 116.17 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.352 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -69.89 -24.45 63.4 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.875 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.1 mmt-85 -142.61 110.62 5.95 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.853 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -86.73 136.52 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.6 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -129.54 170.06 14.21 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.522 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -43.73 59.41 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.301 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.9 -37.67 85.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.37 -21.62 50.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.6 mt -58.96 146.23 38.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.173 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.41 -154.58 25.19 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 92' ' ' PHE . 20.9 mt -112.41 140.55 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.125 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -104.42 150.64 24.35 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.664 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 90' ' ' ILE . 40.5 m-85 -151.08 135.18 16.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.768 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -109.11 141.12 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.857 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 9.3 p -144.23 -164.68 1.95 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.427 ' HG3' HD21 ' A' ' 29' ' ' LEU . 5.5 pm0 -159.14 165.87 32.79 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.505 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.6 p -109.2 -21.68 12.45 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.3 m -53.16 -55.26 25.53 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.359 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.429 ' CD2' HG23 ' A' ' 2' ' ' VAL . 37.9 m-70 -88.17 131.71 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.511 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 62.3 t -135.16 137.44 26.83 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.511 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.2 Cg_endo -68.27 136.71 36.4 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.539 -0.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.48 155.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.928 1.752 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.18 -64.56 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.42 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 65.58 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.869 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.01 64.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.434 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -65.95 -84.67 0.09 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.63 75.05 0.59 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.317 -1.42 . . . . 0.0 112.445 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.464 ' OG1' ' HG2' ' A' ' 6' ' ' GLN . 19.9 m -148.86 106.95 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.553 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.69 139.79 32.55 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.852 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 7.6 tt -131.67 107.27 8.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.197 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.33 32.89 4.16 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.162 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.421 ' CD1' ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 66.08 163.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.96 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.96 57.9 4.33 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.587 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 116.254 -1.832 . . . . 0.0 111.049 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.949 0.404 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t -69.65 94.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.869 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.44 ' N ' ' HB2' ' A' ' 26' ' ' SER . 16.9 t -63.14 155.85 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.689 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.452 ' HE1' ' SG ' ' A' ' 23' ' ' CYS . 40.5 mmm -133.46 110.44 9.98 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.697 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -80.14 147.6 31.28 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.657 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 5.3 mp0 -118.75 143.33 46.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.342 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 141.93 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -79.35 175.16 46.9 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.586 -1.422 . . . . 0.0 111.159 -0.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.37 -22.82 59.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 p -139.7 148.86 42.94 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.6 tp -126.87 78.57 73.54 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.991 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.4 102.74 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.818 1.679 . . . . 0.0 111.061 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.6 m -132.77 -154.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.3 t -147.06 154.02 40.68 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.907 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.6 mt -68.56 87.47 0.32 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.598 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.04 -31.58 1.44 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.53 173.06 11.99 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.248 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -89.07 166.94 13.54 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.039 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.98 161.12 41.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.218 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -157.58 109.97 2.4 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.757 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' THR . 2.2 mp -101.02 118.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 t -93.7 158.43 15.68 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.155 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' SG ' ' HE1' ' A' ' 4' ' ' MET . 9.3 t -160.9 117.86 2.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.685 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -104.3 172.07 6.99 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.8 t -116.86 167.43 11.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.164 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.44 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 14.9 t -67.87 -27.18 66.45 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.39 -59.68 0.34 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.269 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.71 155.35 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 83.6 mt -114.53 6.86 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.48 137.8 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.42 ' HB3' ' H ' ' A' ' 32' ' ' SER . 5.5 t-80 -66.32 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.277 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.42 ' H ' ' HB3' ' A' ' 31' ' ' HIS . 33.2 t -91.0 -57.39 2.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.51 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -175.84 41.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.59 -53.12 0.14 Allowed Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.223 -1.465 . . . . 0.0 111.006 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -76.96 132.98 39.31 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.698 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -132.26 137.57 47.56 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.793 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.578 ' H ' ' CG2' ' A' ' 97' ' ' THR . 22.6 m-85 -122.73 109.42 14.22 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.54 133.54 46.31 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.947 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' ND2' ' C ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -110.51 149.01 30.95 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.454 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 22.8 m95 -111.89 172.48 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 162.72 31.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.482 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.7 tp -151.25 127.13 10.32 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.37 113.36 26.84 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.852 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.72 167.76 21.26 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.134 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.38 84.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.904 -0.719 . . . . 0.0 112.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LYS . . . 68.99 33.23 74.2 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.7 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 1.1 tt0 -123.6 167.44 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.267 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 t -60.87 121.3 60.78 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.987 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.56 151.94 80.44 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.028 1.819 . . . . 0.0 111.394 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -134.82 152.39 51.71 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tp -95.36 139.45 31.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.97 -55.67 2.44 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.799 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.454 HG22 ' N ' ' A' ' 57' ' ' SER . 51.6 mm -124.49 137.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.043 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -113.12 -30.65 6.9 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.618 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -124.33 48.41 1.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.485 ' C ' ' H ' ' A' ' 58' ' ' ASN . 40.8 t 56.12 103.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.376 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.459 ' HA ' ' H ' ' A' ' 69' ' ' GLY . 0.7 OUTLIER 76.48 -29.37 0.18 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.566 ' N ' HD21 ' A' ' 58' ' ' ASN . 1.5 m120 -69.35 94.66 0.73 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.973 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -66.76 136.97 56.28 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.306 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -57.2 157.48 6.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.51 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -53.44 -22.73 8.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.734 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.26 31.9 6.64 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.44 125.89 27.0 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.671 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.61 149.89 73.1 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.241 1.961 . . . . 0.0 112.436 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.23 -25.46 65.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.986 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.507 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -53.95 -35.84 62.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.88 129.37 34.43 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 t -137.25 138.65 40.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -124.03 131.72 8.08 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 p -156.19 146.92 21.91 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.203 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -170.94 114.48 0.54 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -95.34 145.2 25.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.201 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.75 -101.01 0.42 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.909 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 p -131.04 21.66 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.71 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 5.9 m-20 -122.17 124.04 42.93 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 23.8 m-85 -131.47 155.3 47.61 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 25.8 m -159.49 139.57 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.447 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 6.4 tt -95.56 104.53 16.45 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.19 129.24 38.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.692 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -116.81 128.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.468 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.1 m -85.13 2.33 43.99 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.706 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.37 112.5 0.35 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.841 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.5 t -91.75 150.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.34 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -137.28 167.15 22.15 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.197 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.86 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.227 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -66.15 -29.66 69.99 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.769 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.42 -19.98 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 78.8 mt -65.98 137.08 56.88 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.855 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.15 -137.71 5.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.59 106.69 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.485 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -78.28 130.43 36.21 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.311 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.481 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 1.2 m-85 -118.11 166.61 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.657 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 14.7 p -134.85 152.46 51.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -156.25 155.9 33.15 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -112.39 163.04 14.89 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.826 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.5 m -144.89 46.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.578 ' CG2' ' H ' ' A' ' 37' ' ' TYR . 2.1 p -124.64 -44.17 1.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -99.5 142.2 31.3 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -109.18 137.22 20.13 Favored Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.589 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -74.55 146.45 86.79 Favored 'Cis proline' 0 C--N 1.316 -1.173 0 C-N-CA 123.528 -1.447 . . . . 0.0 111.494 -0.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.04 125.49 15.98 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.72 1.613 . . . . 0.0 110.156 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.432 ' CG2' ' HB2' ' A' ' 1' ' ' ASP . 38.3 p -91.22 107.37 19.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -94.27 139.42 31.07 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.098 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -167.85 -141.05 3.06 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.363 -1.398 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 92' ' ' PHE . . . 132.58 175.19 13.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.22 79.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.1 m -149.91 107.41 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.185 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -75.9 93.61 3.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 5.0 tt -89.35 83.89 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -124.96 54.97 1.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.143 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER 54.82 176.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.416 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 31.8 mtpt -71.0 124.06 23.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.869 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.499 ' HA ' ' NH2' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 116.402 -1.761 . . . . 0.0 110.702 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.999 0.428 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.488 ' HB ' HE22 ' A' ' 95' ' ' GLN . 69.0 t -53.74 110.82 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 t -68.61 161.0 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.659 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.401 ' SD ' ' HA ' ' A' ' 25' ' ' SER . 82.0 mmm -139.25 101.46 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -91.89 103.45 15.99 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -107.35 166.31 10.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.743 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.499 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.67 170.35 8.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.583 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 12.1 Cg_endo -83.72 173.8 41.67 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.794 -1.336 . . . . 0.0 110.72 -2.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.3 mt -72.88 -16.69 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.126 -1.029 . . . . 0.0 109.626 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.0 p -154.14 136.18 14.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tp -122.72 86.32 49.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.269 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.68 116.81 4.61 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.64 1.56 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 112' ' ' LYS . 35.8 m -141.86 -172.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -114.42 145.75 41.46 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.08 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.6 mt -70.35 89.43 0.67 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.537 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.4 -1.04 3.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -95.71 -135.17 0.22 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 167.57 21.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.706 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.06 168.79 22.88 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.196 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 19.7 p -160.38 91.72 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -78.3 125.86 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.153 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 7' ' ' THR . 32.4 t -85.57 157.4 20.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.268 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 2.0 m -161.89 106.11 1.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.161 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' NH1' ' O ' ' A' ' 74' ' ' THR . 55.7 ttm-85 -106.49 144.89 32.52 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.401 ' HA ' ' SD ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -98.91 154.8 17.77 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -63.93 -72.03 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.22 48.61 1.02 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t 67.97 176.28 0.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.509 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 55.6 mt -124.78 52.7 1.53 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.617 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 35.1 t -106.65 130.94 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.483 ' C ' ' H ' ' A' ' 33' ' ' ASN . 45.2 t-80 -82.44 171.69 13.87 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.301 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.441 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 58.3 m -77.1 37.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.568 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' H ' ' C ' ' A' ' 31' ' ' HIS . 4.0 p30 175.27 -28.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.324 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -78.16 -131.04 0.6 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.636 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -158.86 -67.78 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.688 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -157.16 126.5 6.01 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.761 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -134.28 139.6 45.83 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.425 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.48 HD11 ' CD2' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -162.26 149.67 13.98 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.115 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.402 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 4.4 p-10 -137.72 170.89 15.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.184 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.533 ' CE3' HD21 ' A' ' 78' ' ' LEU . 70.1 m95 -131.9 164.04 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.525 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.404 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 1.5 m-85 -154.73 131.57 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.507 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 5.4 tp -116.16 117.49 30.21 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.798 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 49' ' ' PRO . 13.6 tm0? -101.42 140.2 36.05 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.865 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.04 165.06 13.01 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.493 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.81 111.03 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.844 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.68 46.16 13.02 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -135.39 154.06 51.6 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.171 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.0 p -61.92 122.48 72.27 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.231 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 43' ' ' GLN . 5.6 Cg_exo -58.56 113.97 1.78 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.674 1.583 . . . . 0.0 111.472 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.27 156.72 31.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.959 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.404 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . 5.9 tp -114.53 139.3 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.354 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 17.5 mt -113.42 -90.08 0.52 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.183 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.483 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 2.8 mp -82.66 145.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -139.36 -7.19 1.34 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.414 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tptt -139.78 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 5.8 t 76.4 -47.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.977 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -171.77 45.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.08 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.86 -36.57 11.59 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 68.31 134.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' H ' HG23 ' A' ' 63' ' ' VAL . 4.7 t80 -81.08 168.08 19.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -60.17 -33.12 71.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.02 11.38 22.27 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.756 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 ' C ' ' H ' ' A' ' 65' ' ' ASP . 21.3 t -104.46 128.08 27.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.436 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.2 Cg_endo -67.17 19.34 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.119 1.879 . . . . 0.0 112.92 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 63' ' ' VAL . 15.4 t70 68.7 -37.07 0.34 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -52.72 -18.32 1.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.492 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.432 ' CE2' ' HD2' ' A' ' 66' ' ' ARG . 57.0 m-85 -87.92 92.81 9.27 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.208 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 m -109.94 158.44 18.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.042 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.04 14.95 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.574 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.6 t -148.41 168.03 23.71 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.74 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.665 ' CA ' ' CD2' ' A' ' 76' ' ' PHE . . . -173.19 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.001 -1.571 . . . . 0.0 111.524 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -92.79 51.92 1.78 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -59.53 4.27 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.72 -1.228 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.423 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 3.8 p -125.63 34.47 4.9 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.766 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.05 106.81 1.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.316 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.665 ' CD2' ' CA ' ' A' ' 71' ' ' GLY . 11.6 m-85 -128.59 145.29 51.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.395 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 19.6 m -149.78 170.85 17.78 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.682 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.533 HD21 ' CE3' ' A' ' 40' ' ' TRP . 4.7 tp -134.67 94.79 3.24 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.557 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -77.96 111.52 13.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.582 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.405 HG12 ' CE1' ' A' ' 67' ' ' PHE . 77.2 mt -91.54 117.98 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -92.5 89.01 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.264 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.598 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 104.09 76.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.475 1.109 . . . . 0.0 110.464 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 72.2 t -67.59 100.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.716 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.408 ' HB2' HH12 ' A' ' 66' ' ' ARG . 50.6 mt-10 -94.67 179.03 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.19 -28.44 40.6 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.686 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.97 -51.42 70.12 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -47.39 -26.33 1.28 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.155 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 51.1 mt -56.57 144.58 31.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.85 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.36 -134.72 8.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -133.62 119.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.519 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.44 146.75 24.43 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.78 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.82 175.23 9.78 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.33 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.439 ' H ' ' HA3' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -160.72 159.05 29.7 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.966 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 t -151.24 178.1 9.57 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.606 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.488 HE22 ' HB ' ' A' ' 2' ' ' VAL . 0.9 OUTLIER -129.44 124.85 35.14 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.613 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.3 p -93.15 4.19 54.42 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 99.5 m -70.64 -57.71 4.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.733 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -91.45 94.51 9.5 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.407 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.43 ' CG2' ' HA ' ' A' ' 100' ' ' PRO . 14.7 p -74.97 139.11 72.91 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 5.4 Cg_endo -72.85 142.83 75.81 Favored 'Cis proline' 0 C--N 1.318 -1.05 0 C-N-CA 123.726 -1.364 . . . . 0.0 111.781 -0.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.25 112.32 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.863 1.709 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.2 p -72.77 84.84 1.21 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 16.8 t80 -76.83 155.04 33.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 168.17 -52.54 0.22 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 118.822 -1.656 . . . . 0.0 111.354 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' HA3' ' H ' ' A' ' 93' ' ' CYS . . . 50.19 -138.05 22.77 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.159 -1.495 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.94 85.12 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.282 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.3 m -152.84 109.45 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.748 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.97 97.23 9.69 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.269 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.69 84.23 5.86 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.6 57.18 0.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.456 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.498 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER 54.88 178.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.708 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 1.2 tppt? -80.15 147.94 31.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.078 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.409 HH11 ' CG ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 116.387 -1.768 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.068 0.461 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.1 t -69.91 120.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.999 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.1 150.81 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.662 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.62 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 50.7 mtp -133.5 -174.22 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.507 0.67 . . . . 0.0 109.694 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -156.55 152.06 26.83 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.557 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -140.34 150.18 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.044 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.55 166.87 15.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -74.59 178.41 34.32 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.717 -1.368 . . . . 0.0 110.846 -1.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -36.95 78.05 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.53 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.3 t -140.24 147.55 40.18 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.063 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tp -134.1 83.18 46.16 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.406 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -68.05 101.17 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.839 1.692 . . . . 0.0 110.241 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.74 -167.78 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.884 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -127.35 147.73 50.26 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.7 mt -67.78 89.34 0.26 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.667 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.92 -6.8 2.36 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.65 -152.16 0.27 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -125.05 155.93 38.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.67 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.53 25.98 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.7 p -163.32 94.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mp -91.36 129.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.018 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 37.0 m -87.96 159.39 18.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.966 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.479 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 2.1 t -160.74 137.11 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.672 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.41 45.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.966 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 m -110.77 146.83 35.67 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.319 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -52.14 -38.01 56.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -133.25 167.0 21.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -63.52 137.99 58.34 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.466 ' HB3' ' HG1' ' A' ' 97' ' ' THR . 77.2 mt -94.39 23.48 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.208 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.41 139.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.45 ' CG ' ' H ' ' A' ' 32' ' ' SER . 7.9 t-80 -88.43 -140.4 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.704 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.45 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 17.8 p -68.01 -74.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.408 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.95 124.31 27.56 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.588 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.79 20.65 1.25 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.115 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -106.28 91.05 3.55 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.607 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.2 m -101.93 152.79 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.36 137.39 37.28 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.169 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 21.1 tp -172.63 151.51 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.46 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -154.72 120.71 5.22 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 29.6 m95 -87.93 149.68 23.92 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.546 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' HB3' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -123.7 155.68 37.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.574 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 49' ' ' PRO . 6.4 tp -150.91 117.11 5.62 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.499 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -111.94 130.45 55.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.9 167.11 22.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.63 -34.86 27.84 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.181 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.7 48.33 0.54 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.543 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -144.42 158.76 43.59 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.88 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.6 p -61.68 138.09 95.16 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.5 Cg_endo -65.83 113.25 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.806 1.671 . . . . 0.0 111.235 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -90.53 133.11 35.3 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.069 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.448 ' CD1' ' OD1' ' A' ' 39' ' ' ASN . 16.0 tp -71.32 124.7 25.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 33.2 mt -95.48 -88.94 0.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.241 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 44.0 mm -88.82 123.05 40.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.028 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.0 p90 -110.48 20.17 18.01 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.374 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.44 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 0.1 OUTLIER -172.14 143.77 1.56 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.89 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 43.1 t -44.09 106.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.081 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.06 71.21 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.419 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -170.71 110.65 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.359 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.6 mtm-85 -77.33 139.76 39.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.847 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.427 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 68.7 t80 -69.85 160.13 32.36 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.408 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 5.3 m -40.25 -53.73 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.86 57.44 3.7 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG2' ' HB3' ' A' ' 60' ' ' PHE . 88.9 t -144.59 113.9 5.12 Favored Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.105 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 159.77 37.45 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.966 1.778 . . . . 0.0 111.938 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -58.08 -27.46 63.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.549 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' CG ' ' HB2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -43.71 -42.12 5.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.322 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -82.51 124.51 30.17 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.623 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -124.63 151.86 44.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.722 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.35 155.11 25.94 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.772 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -149.78 141.83 23.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -137.42 128.45 4.32 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.92 -1.609 . . . . 0.0 112.094 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 m -94.73 -124.55 0.11 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.17 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.14 -55.89 1.25 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 p -125.27 20.65 8.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.972 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -132.11 143.25 49.88 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.418 ' CG ' ' C ' ' A' ' 75' ' ' ASP . 40.4 m-85 -151.13 136.42 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 m -139.37 140.92 37.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.597 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 1.8 tt -117.63 111.05 18.66 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.161 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -120.81 138.14 54.18 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.196 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.8 mp -105.85 138.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.616 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -72.09 -36.17 69.43 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.434 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' HB2' ' CG ' ' A' ' 66' ' ' ARG . 3.9 mtt180 -135.25 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.058 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 58.1 t -65.8 111.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.387 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' CD ' HH21 ' A' ' 66' ' ' ARG . 24.4 mt-10 -106.65 177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.75 -31.75 39.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.139 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.16 -32.81 74.17 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -20.16 66.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 72.9 mt -58.53 139.94 54.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.35 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -173.42 23.04 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.419 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.4 mp -85.25 158.56 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.794 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -131.51 148.77 52.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.945 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.693 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -147.21 165.13 30.99 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.262 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.466 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 22.8 p -132.7 102.92 5.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.2 m -83.17 164.32 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.145 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.62 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -130.38 118.2 20.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.633 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.22 22.02 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.496 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 3.9 m -89.11 -40.41 12.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.801 -0.759 . . . . 0.0 111.737 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.496 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 53.1 m-70 -119.34 152.4 36.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.673 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.425 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 68.0 t -113.86 137.76 22.46 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.61 142.3 73.96 Favored 'Cis proline' 0 C--N 1.317 -1.112 0 C-N-CA 123.589 -1.421 . . . . 0.0 111.805 -0.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.69 110.81 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.841 1.694 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -64.85 147.86 52.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.71 -74.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.69 -137.49 8.29 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.598 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.665 ' N ' ' HB3' ' A' ' 92' ' ' PHE . . . 114.0 90.6 1.8 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.557 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -151.46 8.76 0.66 Allowed Glycine 0 N--CA 1.483 1.827 0 C-N-CA 117.908 -2.091 . . . . 0.0 113.909 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.6 m -147.73 138.53 23.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.885 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -113.6 103.4 11.21 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.358 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.86 86.94 7.34 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.523 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.62 139.1 45.04 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.721 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.4 tt -55.42 158.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.714 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -87.33 108.94 19.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.495 ' NE ' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.667 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.947 0.403 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.3 t -85.26 83.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.86 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.1 t -66.95 157.09 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.403 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.425 ' SD ' ' HB2' ' A' ' 25' ' ' SER . 40.1 mmm -133.31 113.47 12.64 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -77.78 127.65 32.75 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.577 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.644 ' CD ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 tp60 -101.57 139.29 37.43 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.75 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.18 145.83 9.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.841 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -78.62 -179.98 28.71 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.093 -0.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.01 -29.75 49.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.498 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.88 149.63 50.33 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.261 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -142.24 83.07 12.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.877 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.07 113.97 3.02 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.853 1.702 . . . . 0.0 110.808 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.9 m -143.08 162.65 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.326 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.415 ' HG ' ' CG ' ' A' ' 17' ' ' ASP . 0.0 OUTLIER -99.14 158.66 15.52 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.391 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.423 ' HG ' ' CD1' ' A' ' 111' ' ' ILE . 25.5 mt -78.96 94.65 5.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.1 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 133.05 16.98 1.18 Allowed Glycine 0 N--CA 1.494 2.544 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.415 ' CG ' ' HG ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -111.99 -131.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.724 179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.456 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 2.6 mt-30 -139.08 172.52 12.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.317 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.65 166.14 26.66 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.556 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -160.86 80.99 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.9 mt -90.63 124.15 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.295 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -87.15 151.88 22.81 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.927 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -160.8 111.09 1.75 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.225 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.38 170.29 8.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.821 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.425 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 2.3 t -111.36 155.25 23.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.101 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -49.04 25.88 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 28' ' ' SER . 4.0 tp-100 -97.84 -68.6 0.79 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 27' ' ' GLN . 39.3 t 167.45 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.73 20.77 7.77 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.56 119.3 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.628 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.546 ' O ' ' C ' ' A' ' 32' ' ' SER . 15.3 t-80 -60.11 158.38 11.33 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.476 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' HIS . 23.4 t -12.41 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.994 0.809 . . . . 0.0 112.786 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.72 52.82 0.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.78 -125.58 3.45 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -114.39 175.99 5.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -79.35 121.44 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.478 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CG ' ' OG1' ' A' ' 97' ' ' THR . 12.6 m-85 -97.92 159.43 14.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.99 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.546 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 16.1 tp 179.8 151.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.343 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 m120 -137.71 149.09 46.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -120.42 157.28 29.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.97 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -147.75 172.01 14.77 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.577 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tp -160.72 120.69 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.95 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -90.18 116.88 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG2' ' H ' ' A' ' 45' ' ' ALA . 17.8 ttpp -148.55 168.61 22.3 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' H ' ' HG2' ' A' ' 44' ' ' LYS . . . -56.42 103.74 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.52 14.66 74.92 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.131 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' CG ' ' HD2' ' A' ' 50' ' ' LYS . 3.0 tt0 -125.97 5.45 7.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.498 ' C ' ' H ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -57.04 -51.29 82.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.713 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' CD ' ' N ' ' A' ' 48' ' ' SER . 4.7 Cg_endo -71.3 19.84 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.592 1.528 . . . . 0.0 112.027 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' H ' ' C ' ' A' ' 48' ' ' SER . 1.8 ttmm -104.95 126.76 52.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -105.97 149.67 26.41 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.35 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 51' ' ' LEU . 64.9 mt -102.3 -80.1 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.167 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.3 mm -105.5 138.71 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.662 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -132.06 28.58 4.45 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.659 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -178.8 68.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.434 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.555 ' O ' ' CB ' ' A' ' 57' ' ' SER . 20.5 m 19.74 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.541 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER 79.42 63.2 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -171.46 108.51 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.988 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.458 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 15.4 mtt85 -89.17 153.62 20.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.758 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 40.0 t80 -83.78 160.28 21.26 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.3 t -42.97 -38.55 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.029 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.08 52.42 1.09 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 75.0 t -146.12 118.93 5.11 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.8 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -60.36 138.07 78.5 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.159 1.906 . . . . 0.0 111.919 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 67' ' ' PHE . 0.5 OUTLIER -52.22 -23.78 6.17 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.474 HH21 ' CB ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -67.53 12.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.128 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.485 ' H ' ' C ' ' A' ' 65' ' ' ASP . 12.2 m-85 -115.74 104.51 11.74 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.395 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.0 m -105.68 121.08 43.27 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.12 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -131.15 102.7 0.52 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 31.2 t -151.47 175.34 12.39 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.142 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 174.37 147.63 6.19 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.8 p -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.4 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.11 -102.79 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.213 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.1 p -124.55 15.45 8.84 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.111 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -115.83 125.68 53.0 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.517 ' CD2' HD23 ' A' ' 38' ' ' LEU . 4.0 m-85 -140.97 168.14 20.5 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.517 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -160.1 155.91 25.95 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.255 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.3 tt -112.49 102.02 10.15 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.487 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -89.8 125.12 35.19 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 68.8 mt -110.66 130.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.824 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.456 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 22.9 m -84.16 -18.78 35.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.877 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.474 ' CB ' HH21 ' A' ' 66' ' ' ARG . 1.1 mmt-85 -148.24 92.85 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.749 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' GLY . 86.6 t -76.36 117.95 21.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.7 -179.55 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.963 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.98 23.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.419 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 23.1 mt-10 -68.78 -23.83 64.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.487 ' HB3' ' CD2' ' A' ' 109' ' ' LEU . 3.1 m-20 -77.27 -29.65 53.96 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.42 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -51.04 142.38 12.26 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.66 -139.58 11.11 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.6 135.15 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.998 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -101.18 141.15 34.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.515 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.417 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 79.8 m-85 -130.21 175.44 8.92 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 25.6 p -156.68 146.41 20.83 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.537 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -149.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.612 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -155.18 145.4 21.85 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.427 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 m -107.4 -5.86 17.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.213 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.551 HG21 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -69.74 -27.09 64.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.807 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CD2' HG21 ' A' ' 97' ' ' THR . 43.4 m-70 -102.62 145.32 29.82 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.503 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 4.8 t -132.55 129.47 21.41 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.233 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.503 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.8 Cg_endo -67.24 148.48 79.95 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.795 -0.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.88 123.84 12.23 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.969 1.779 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -89.48 125.46 35.19 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.236 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 6.5 t80 -125.98 136.41 52.97 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.49 -164.67 29.77 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.24 -172.88 15.37 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.24 58.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 82.1 m -80.67 110.12 15.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.376 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -64.96 103.11 0.68 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.487 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -98.45 83.56 3.05 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.119 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -107.61 148.87 28.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.712 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 1.9 tt -52.37 168.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.43 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 13' ' ' VAL . 3.2 ttmm -50.94 -56.37 12.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.429 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.114 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.6 t -66.79 124.01 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.212 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.543 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.518 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 98' ' ' HIS . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 32' ' ' SER . 58.8 t-80 -69.69 173.34 6.26 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.472 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 75.0 m -69.93 73.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 176.64 -27.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.421 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 23.57 5.94 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.82 142.77 48.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 21.7 m -113.12 129.38 56.53 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.736 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.473 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 -167.31 1.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.83 77.78 2.11 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 59.56 3.73 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.18 -163.99 1.44 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.23 124.03 74.49 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.602 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 155.98 49.91 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.849 1.699 . . . . 0.0 111.703 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -138.08 128.44 26.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.769 -0.773 . . . . 0.0 111.232 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.8 tp -101.57 131.96 47.48 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.794 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.418 ' HG ' ' CD2' ' A' ' 67' ' ' PHE . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.45 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 63' ' ' VAL . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.46 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.401 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.404 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.404 ' HA ' ' HA3' ' A' ' 71' ' ' GLY . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.469 ' O ' ' NE2' ' A' ' 6' ' ' GLN . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.416 HG23 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.463 ' NE2' ' HA ' ' A' ' 29' ' ' LEU . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.451 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.456 ' HG1' ' CG ' ' A' ' 95' ' ' GLN . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.462 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 24.6 tttt -88.34 145.36 25.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.346 -1.788 . . . . 0.0 110.514 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.402 ' H1 ' ' CG ' ' A' ' 98' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.138 0.495 . . . . 0.0 109.849 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' CD2' ' A' ' 98' ' ' HIS . 39.2 t -137.33 143.57 34.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.9 t -81.68 156.25 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.027 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -136.41 105.87 6.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.271 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.619 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -78.98 134.08 36.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.11 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.95 158.24 21.17 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -75.99 177.97 37.05 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.603 -1.416 . . . . 0.0 111.248 -1.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.414 ' CD2' ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -77.57 -27.06 51.33 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.879 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 m -143.21 149.4 37.92 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.939 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.3 tp -140.71 88.92 10.46 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.717 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.3 117.79 5.27 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.918 1.745 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 m -142.34 -164.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 t -118.22 169.37 9.76 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.34 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.39 89.7 7.44 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.85 -25.58 2.25 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.92 -161.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.011 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.594 ' CB ' ' HA ' ' A' ' 81' ' ' SER . 2.0 pm0 -134.84 136.34 42.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.266 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -103.23 178.29 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.478 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -155.9 73.54 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' THR . 2.6 mp -62.54 128.49 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' THR . 21.8 t -93.26 155.29 17.52 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.304 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.619 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 81.5 m -160.86 109.65 1.62 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.09 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -108.82 150.34 27.77 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -104.17 152.36 22.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.483 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -80.34 -22.89 40.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.81 34.81 1.98 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.2 t 58.62 -173.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.106 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 12.4 mt -139.93 13.89 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.079 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.91 135.29 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.447 ' CG ' ' H ' ' A' ' 32' ' ' SER . 17.8 t-80 -79.73 -176.55 5.44 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.447 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 72.0 p -54.92 -39.46 68.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.134 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -102.51 -170.6 1.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.83 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.32 72.56 1.66 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -141.57 123.21 15.13 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.945 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -116.96 100.27 7.64 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.307 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -88.21 149.88 23.61 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.16 157.57 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.478 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' ILE . 7.8 p-10 -159.96 113.57 2.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.533 ' CH2' ' SG ' ' A' ' 23' ' ' CYS . 55.9 m95 -90.76 169.71 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.21 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.08 133.52 8.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.54 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 14.2 tp -107.52 130.51 54.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.459 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -95.22 125.03 39.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.781 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CG ' ' H ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -128.58 -166.85 1.69 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.895 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.562 ' H ' ' CG ' ' A' ' 44' ' ' LYS . . . -76.69 -36.73 57.08 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 39.73 1.26 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -132.65 -3.91 3.29 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.491 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -42.16 -56.63 5.13 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.336 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 3.8 Cg_endo -67.02 79.67 0.38 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.444 1.429 . . . . 0.0 110.234 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.515 ' CG ' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -162.77 -154.92 0.32 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.0 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.515 ' H ' ' CG ' ' A' ' 50' ' ' LYS . 19.8 tp -171.74 139.57 1.21 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.064 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.96 -63.86 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.479 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.448 ' O ' ' HA ' ' A' ' 39' ' ' ASN . 43.3 mm -121.52 139.85 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 58' ' ' ASN . 50.0 p90 -122.83 30.81 6.27 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.459 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -174.29 -166.59 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.422 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -82.99 22.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.122 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -44.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.647 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 1.4 m-80 -46.21 140.44 3.98 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.977 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 5.2 mtm180 -110.29 134.04 52.65 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.468 ' CG ' ' N ' ' A' ' 61' ' ' SER . 65.7 t80 -57.38 162.39 2.84 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.1 m -68.43 92.26 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.32 32.17 0.45 Allowed Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 65' ' ' ASP . 38.8 t -113.67 132.67 22.46 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.82 13.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.959 1.773 . . . . 0.0 113.12 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 63' ' ' VAL . 1.1 t70 71.46 -41.78 0.51 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -46.36 -26.86 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.085 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.568 ' CD1' HG12 ' A' ' 80' ' ' ILE . 83.1 m-85 -80.82 123.64 28.41 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 m -138.27 101.05 4.29 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.545 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 56' ' ' VAL . . . -92.99 120.01 6.07 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.8 p -151.45 154.52 36.75 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.566 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -165.84 163.74 36.93 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -92.94 -115.35 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.719 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.1 -78.28 0.64 Allowed Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 53.0 p -111.37 18.26 19.38 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.349 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.42 131.74 53.74 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.717 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.566 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 54.3 m-85 -142.51 153.96 44.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.916 -0.713 . . . . 0.0 110.522 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 3.5 m -151.75 145.65 25.16 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.498 HD12 ' CG ' ' A' ' 40' ' ' TRP . 9.7 tp -104.45 93.61 4.88 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -81.17 118.45 22.57 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.094 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.568 HG12 ' CD1' ' A' ' 67' ' ' PHE . 23.0 mt -114.61 103.46 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.594 ' HA ' ' CB ' ' A' ' 18' ' ' GLN . 1.4 m -74.95 39.45 0.14 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.046 -1.062 . . . . 0.0 113.524 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 81' ' ' SER . 1.1 mmt85 169.63 97.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.696 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.4 t -93.49 99.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.54 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -177.01 3.28 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.508 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.32 -26.89 43.44 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.821 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.83 -36.21 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.964 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.9 -43.39 98.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.91 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' ' CE ' ' A' ' 44' ' ' LYS . 89.3 mt -43.62 148.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.715 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.87 -155.02 20.75 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.61 142.76 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -115.22 144.72 43.28 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.906 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -133.59 155.79 49.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.478 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 1.8 p -136.52 102.21 4.87 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 158.89 15.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.696 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.477 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -110.65 127.9 55.47 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.604 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 17.9 m -83.61 -5.57 59.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.004 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 53.3 m -62.63 -62.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.29 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' A' ' 2' ' ' VAL . 66.7 m-70 -89.12 114.78 26.08 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.41 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 21.8 t -104.59 134.37 19.7 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.832 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.16 156.98 97.91 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.591 -1.421 . . . . 0.0 111.523 -0.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.38 139.91 85.14 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.034 1.823 . . . . 0.0 110.997 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.28 -43.93 60.13 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.315 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 t80 68.35 161.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.581 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.78 130.87 2.92 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 145.93 173.78 17.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 178.86 67.15 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 44.8 m -77.1 113.81 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.888 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -73.84 107.25 5.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.391 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.67 94.85 6.31 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.704 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.32 136.67 52.26 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.454 HG21 ' N ' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -69.2 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.059 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -69.94 155.37 40.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.349 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 116.38 -1.772 . . . . 0.0 110.624 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.123 0.487 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.2 t -65.66 102.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.797 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.5 162.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.761 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.546 ' HE2' ' SG ' ' A' ' 93' ' ' CYS . 48.6 mmm -126.85 175.51 7.98 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -150.72 93.56 1.97 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.204 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.625 ' NE2' ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp60 -82.5 148.3 28.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.232 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.515 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -161.18 165.14 17.49 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.908 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -76.76 173.97 55.43 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.482 -1.466 . . . . 0.0 110.563 -1.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.96 -28.59 68.4 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.592 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -140.97 130.43 23.85 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -125.92 94.16 42.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.699 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.86 121.1 7.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.8 1.666 . . . . 0.0 110.537 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 24.9 m -134.43 -165.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.442 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -146.53 160.48 42.08 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -74.69 85.69 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' HA2' ' CD ' ' A' ' 82' ' ' ARG . . . 140.43 -22.62 2.71 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 18' ' ' GLN . 31.9 t70 -76.48 177.87 7.06 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.467 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 54.5 mt-30 -94.63 -173.76 3.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.737 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -153.73 157.69 39.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.544 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 p -151.52 79.94 1.29 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 8.8 mt -81.27 117.75 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.906 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 7' ' ' THR . 39.4 t -85.4 155.53 21.24 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.958 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -162.13 124.38 2.84 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.605 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.17 155.99 28.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.306 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.471 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 3.8 t -112.96 154.23 26.76 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.8 p -74.37 -31.73 62.49 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -136.54 150.56 48.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.689 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 30' ' ' VAL . 4.6 p -50.75 128.13 19.99 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.156 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 85.8 mt -80.52 27.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 28' ' ' SER . 42.5 t -88.81 133.89 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.393 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.504 ' CG ' ' H ' ' A' ' 32' ' ' SER . 6.2 t-80 -82.05 -170.15 2.73 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.504 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 4.5 p -79.8 18.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.997 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 31' ' ' HIS . 0.2 OUTLIER -149.76 -171.47 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.492 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.6 52.72 4.18 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.689 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -143.96 145.18 32.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.1 m -141.01 137.21 32.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.46 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -112.37 132.72 54.86 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.522 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -155.24 125.85 6.91 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.957 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' N ' HD23 ' A' ' 38' ' ' LEU . 34.6 p30 -133.24 169.65 16.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.256 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ3' ' HB2' ' A' ' 78' ' ' LEU . 36.5 m95 -125.03 150.56 46.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' CD2' ' HB2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -138.11 147.59 44.13 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.906 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 tp -135.62 125.53 25.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.52 152.75 33.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.107 -1.037 . . . . 0.0 112.103 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.95 -164.6 1.15 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.48 82.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.33 42.4 96.12 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.597 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -124.47 166.33 16.21 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.11 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -58.86 118.78 31.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.434 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HB2' ' CD2' ' A' ' 41' ' ' TYR . 1.9 Cg_endo -63.09 148.58 93.17 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.838 1.692 . . . . 0.0 112.114 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -104.07 155.22 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp -103.2 135.27 45.16 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -113.34 -71.56 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.261 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.6 mm -109.46 150.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.87 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.41 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 47.7 p90 -149.19 25.36 0.9 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.559 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' HD21 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -174.41 61.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.832 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 56' ' ' VAL . 14.6 m 30.44 97.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.09 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 72.05 46.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.859 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.489 HD21 ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -148.96 108.97 4.08 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 65' ' ' ASP . 41.7 mtm180 -79.83 153.0 29.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.906 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 61' ' ' SER . 59.9 t80 -91.14 171.78 9.01 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.546 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t -59.9 123.0 15.68 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.218 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.05 66.22 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 90.0 t -84.46 123.93 74.14 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -55.83 138.95 83.29 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.1 1.867 . . . . 0.0 112.02 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 6.1 m-20 -56.29 -18.55 10.94 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.615 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -77.61 27.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.606 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 65' ' ' ASP . 4.8 m-85 -128.17 129.03 45.87 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.4 104.01 3.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' VAL . . . -110.65 108.15 2.37 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.318 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -143.0 163.37 32.97 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.686 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . -169.9 172.34 43.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.45 -151.23 0.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.632 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.91 -48.81 13.75 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -146.51 35.14 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -135.64 90.62 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.158 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.517 ' CD2' HD13 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -119.62 155.41 32.35 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.08 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.3 m -146.98 141.03 26.02 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.539 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HB2' ' CZ3' ' A' ' 40' ' ' TRP . 5.5 tt -94.02 110.33 22.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 131.39 46.95 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.018 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 57.3 mt -117.99 131.58 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.2 m -90.64 -0.5 57.71 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.72 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.494 ' CD ' ' HA2' ' A' ' 16' ' ' GLY . 1.5 tpt180 -169.05 97.32 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 99.0 t -74.88 136.66 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.999 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.89 163.8 13.81 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.812 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.63 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.28 -27.11 62.27 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -30.91 71.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.474 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.444 ' O ' ' CE ' ' A' ' 44' ' ' LYS . 85.9 mt -42.94 134.87 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.23 -154.62 25.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 mm -103.62 131.84 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.09 154.95 18.29 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.175 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.464 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 38.1 m-85 -147.45 176.88 9.68 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.082 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.546 ' SG ' ' HE2' ' A' ' 4' ' ' MET . 0.6 OUTLIER -160.71 127.68 4.22 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.401 179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.446 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 4.8 p -118.74 -170.24 1.87 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.324 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -158.04 127.39 5.81 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.154 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 m -107.12 57.73 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 54.6 m -108.93 -50.3 3.03 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.868 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -87.87 -40.01 14.34 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.28 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.564 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.8 OUTLIER 64.94 141.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.315 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.564 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -67.78 158.04 84.95 Favored 'Cis proline' 0 C--N 1.319 -1.024 0 C-N-CA 123.55 -1.437 . . . . 0.0 111.362 -0.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.67 114.59 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.938 1.758 . . . . 0.0 111.532 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 p -52.95 -55.19 25.26 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.09 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.6 OUTLIER 61.95 116.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.57 100.09 0.61 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.231 -1.461 . . . . 0.0 111.547 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.464 ' H ' ' HB3' ' A' ' 92' ' ' PHE . . . -100.62 -90.36 2.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.61 93.5 1.35 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.307 -1.425 . . . . 0.0 112.798 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.3 m -158.49 109.17 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.556 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.71 105.39 5.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.202 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.64 94.01 7.48 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.129 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 144.06 50.3 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.675 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.431 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 4.8 mt -76.81 156.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 11.9 mttm -73.11 115.72 12.78 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.213 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.327 -1.797 . . . . 0.0 110.771 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 121.05 0.452 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' H ' ' CG2' ' A' ' 102' ' ' THR . 62.9 t -106.5 111.81 36.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.097 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.25 124.99 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.195 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.452 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 81.9 mmm -120.68 102.38 8.36 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -96.1 156.7 16.22 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.311 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.561 HE21 ' H ' ' A' ' 106' ' ' GLY . 5.9 tt0 -130.39 151.48 50.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.838 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -157.82 156.55 28.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.97 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.4 176.83 42.02 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.611 -1.412 . . . . 0.0 111.328 -0.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -75.12 -18.27 60.27 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.813 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 p -156.02 140.64 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.085 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.68 91.38 33.98 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.731 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -70.47 105.72 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.97 1.78 . . . . 0.0 111.236 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.6 m -117.71 -154.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.904 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.44 159.43 39.34 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.493 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -75.34 88.94 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.6 -1.22 5.98 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.5 -177.76 4.19 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 179.39 5.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.107 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -154.44 163.93 39.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.226 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 m -155.18 95.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.335 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' O ' ' CG2' ' A' ' 77' ' ' THR . 23.2 mt -84.36 165.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.354 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' THR . 11.0 m -131.07 154.5 48.19 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.735 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.44 126.51 4.65 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.81 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -120.06 145.99 46.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.452 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 85.8 p -107.66 125.17 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.46 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -73.82 32.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.242 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.37 -85.85 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.767 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 t 171.39 146.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.753 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.43 HD11 ' CZ ' ' A' ' 76' ' ' PHE . 46.1 mt -109.83 30.01 7.09 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.5 t -107.29 147.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.439 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.29 166.34 10.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.726 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.32 -31.26 3.75 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.27 30.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.111 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.12 -123.92 5.28 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.026 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -157.69 -97.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.627 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 m -149.17 94.85 2.29 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.733 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' HB2' ' HG1' ' A' ' 97' ' ' THR . 90.3 m-85 -84.44 143.83 29.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.468 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 8.7 tp -165.46 146.2 7.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.851 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.468 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 2.3 m120 -135.38 156.89 48.18 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.466 ' HE1' ' CD2' ' A' ' 38' ' ' LEU . 59.5 m95 -137.33 152.66 49.97 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' TRP . 33.4 m-85 -144.56 154.46 42.88 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.9 tp -127.42 106.05 8.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.019 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -69.68 105.84 2.86 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.382 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HG3' ' H ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -113.61 -163.67 0.87 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.477 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' H ' ' HG3' ' A' ' 44' ' ' LYS . . . -79.06 -121.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.165 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.03 50.41 4.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -89.99 149.83 22.39 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.515 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -91.06 -56.7 0.25 Allowed Pre-proline 0 N--CA 1.489 1.499 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.041 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 3.4 Cg_exo -60.92 145.05 99.62 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.491 1.46 . . . . 0.0 111.309 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.09 57.87 0.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.716 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 34.8 tp -166.21 96.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.974 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.446 ' O ' HG22 ' A' ' 63' ' ' VAL . 1.8 mm? -82.25 -69.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.439 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mm -108.92 127.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.023 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.534 ' HH ' ' NZ ' ' A' ' 55' ' ' LYS . 0.9 OUTLIER -134.14 25.89 3.88 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.952 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.534 ' NZ ' ' HH ' ' A' ' 54' ' ' TYR . 4.7 mttt -171.24 27.9 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' ASN . 95.0 t 63.3 119.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.637 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.1 p 34.36 33.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.36 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.525 ' ND2' ' N ' ' A' ' 55' ' ' LYS . 4.3 p30 -107.33 -32.91 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 1.2 mtm-85 66.52 113.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.553 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 61' ' ' SER . 51.4 t80 -61.61 167.34 3.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.4 t -54.2 -40.58 67.72 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.86 63.91 3.46 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 65' ' ' ASP . 58.8 t -139.61 133.17 15.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.704 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -67.38 14.39 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 122.221 1.947 . . . . 0.0 112.468 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' H ' ' C ' ' A' ' 63' ' ' VAL . 5.1 m-20 65.43 -24.18 0.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.569 HH12 ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -65.3 -11.62 43.47 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.328 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.456 ' CE1' HG12 ' A' ' 80' ' ' ILE . 77.3 m-85 -95.26 132.84 39.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.412 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -147.89 85.69 1.56 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.443 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 77' ' ' THR . . . -86.08 107.09 3.13 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -76.67 163.03 27.24 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.979 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.655 ' HA2' ' CD1' ' A' ' 76' ' ' PHE . . . -142.06 96.26 0.2 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -94.36 82.91 4.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.502 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.16 -82.13 0.13 Allowed Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 18.6 p -123.31 14.87 9.7 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.791 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.95 132.02 53.97 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.26 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.655 ' CD1' ' HA2' ' A' ' 71' ' ' GLY . 24.8 m-85 -138.49 143.89 39.77 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.477 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.484 ' O ' ' HA2' ' A' ' 69' ' ' GLY . 100.0 m -139.98 112.28 7.73 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.54 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.2 tt -80.68 100.31 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.203 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -94.93 134.3 37.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.284 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.456 HG12 ' CE1' ' A' ' 67' ' ' PHE . 7.6 mt -113.07 137.29 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -87.01 -44.24 11.73 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.681 -1.207 . . . . 0.0 111.947 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -124.71 102.37 7.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 69.3 t -89.44 103.6 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.913 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.569 ' CD ' HH12 ' A' ' 66' ' ' ARG . 4.0 mt-10 -102.89 177.21 4.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.249 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.16 -27.11 31.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' O ' ' NZ ' ' A' ' 44' ' ' LYS . 55.1 mm-40 -78.96 -40.23 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.532 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.07 -20.23 23.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.408 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.68 167.39 4.54 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.756 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.01 180.0 16.07 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.715 -1.231 . . . . 0.0 111.267 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.87 115.5 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 143.38 26.95 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.811 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.542 ' HA ' HE22 ' A' ' 6' ' ' GLN . 13.6 m-85 -135.48 158.76 43.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.51 156.64 46.8 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.469 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 10.5 t -150.91 -177.05 5.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -129.26 113.8 15.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.391 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.2 t -84.33 34.67 0.52 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.802 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 0.2 OUTLIER -100.13 -72.27 0.67 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.41 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.2 m-70 -78.24 162.11 26.79 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.408 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 45.7 t -137.88 137.57 21.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.586 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.3 Cg_endo -73.46 158.58 98.39 Favored 'Cis proline' 0 C--N 1.318 -1.058 0 C-N-CA 123.568 -1.43 . . . . 0.0 111.472 -1.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.77 151.63 82.9 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.966 1.777 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.435 ' O ' ' CB ' ' A' ' 103' ' ' PHE . 36.7 p -89.94 -61.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.048 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 3.3 t80 72.83 146.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.008 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.75 170.25 30.43 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.502 ' CA ' ' HB3' ' A' ' 6' ' ' GLN . . . 120.11 -155.38 16.19 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.841 -1.171 . . . . 0.0 111.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.561 ' H ' HE21 ' A' ' 6' ' ' GLN . . . 147.69 60.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 52.4 m -81.76 108.28 15.17 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.966 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -68.99 89.74 0.43 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.15 87.52 6.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.521 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -121.24 143.25 49.25 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 8.3 mt -88.34 146.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.932 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -68.38 103.07 1.54 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.809 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.959 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.435 ' HB ' HE22 ' A' ' 95' ' ' GLN . 39.1 t -62.05 113.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.7 t -74.51 169.93 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.209 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.676 ' SD ' ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -132.64 99.21 4.56 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.541 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -89.57 148.42 23.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.552 ' CB ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -141.54 153.48 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.379 -0.929 . . . . 0.0 110.824 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.525 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.29 146.27 11.62 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.726 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -82.12 176.93 35.24 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.806 -1.331 . . . . 0.0 111.342 -0.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.422 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 3.5 mm? -73.08 -27.31 61.65 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -137.72 149.62 46.63 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.6 tp -135.43 86.2 30.22 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.924 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.546 ' CB ' ' HA ' ' A' ' 112' ' ' LYS . 10.2 Cg_endo -72.23 101.77 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.657 1.571 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 112' ' ' LYS . 20.4 m -126.7 -178.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.34 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.2 174.53 5.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -90.11 86.98 6.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.118 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.37 -25.65 1.54 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.65 -166.93 0.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.024 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -114.59 138.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.53 166.37 11.98 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.843 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 p -160.95 100.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.4 mt -98.94 142.53 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.598 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -103.34 141.13 36.45 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.802 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.99 94.21 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.564 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' CZ ' ' CB ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.1 163.08 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.186 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.63 166.36 13.28 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.129 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -64.93 -70.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.413 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.6 162.13 17.33 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 p -59.09 129.61 42.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 89.1 mt -85.02 34.73 0.56 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.693 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -96.96 114.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.126 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 32' ' ' SER . 55.5 t-80 -66.58 170.3 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.451 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 10.5 t -59.88 -17.73 39.2 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -86.18 -5.75 59.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.94 -18.05 58.08 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.775 -1.203 . . . . 0.0 111.622 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -78.78 128.51 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.358 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 126.18 30.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.862 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.5 m-30 -105.5 102.66 12.11 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.964 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.477 HD11 ' CD1' ' A' ' 76' ' ' PHE . 1.4 tt -149.1 126.91 11.8 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.865 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.21 163.77 15.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.39 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.423 ' CE3' HD12 ' A' ' 78' ' ' LEU . 47.1 m95 -123.56 159.02 30.09 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -144.45 148.28 34.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.026 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.5 tp -123.14 79.84 1.71 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.57 30.94 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.45 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.5 ttmt -129.26 170.72 13.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.625 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.45 94.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.668 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.73 50.42 64.25 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.403 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -138.9 -174.68 3.91 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.589 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 t -91.8 115.24 64.21 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.958 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.18 140.75 60.41 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.742 1.628 . . . . 0.0 111.16 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -110.97 140.0 45.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.287 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 29.5 tp -101.46 120.36 40.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.092 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.22 -60.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.678 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mm -113.49 131.56 64.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.99 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.409 ' CD2' ' HB2' ' A' ' 55' ' ' LYS . 52.2 p90 -108.61 -13.78 14.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.83 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' SER . 1.2 mtpm? -153.93 110.13 3.29 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG12 ' H ' ' A' ' 57' ' ' SER . 1.2 p 43.56 -73.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 55' ' ' LYS . 16.6 t -136.67 -15.8 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.55 -1.26 . . . . 0.0 113.789 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.49 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -64.4 114.25 4.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.911 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -71.86 143.73 49.31 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.361 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.4 175.43 4.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.473 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 p -61.61 -51.38 68.73 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.579 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.54 71.11 2.98 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 65' ' ' ASP . 46.5 t -139.35 125.68 12.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.803 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.531 ' C ' ' H ' ' A' ' 66' ' ' ARG . 1.1 Cg_endo -68.04 14.35 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.031 1.821 . . . . 0.0 111.799 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' H ' ' C ' ' A' ' 63' ' ' VAL . 35.9 m-20 60.09 -9.38 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.979 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 64' ' ' PRO . 12.1 mtm-85 -76.96 19.63 0.29 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.475 ' H ' ' C ' ' A' ' 65' ' ' ASP . 89.3 m-85 -137.55 135.81 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.624 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -146.14 96.58 2.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 149.71 37.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m -154.1 113.61 3.78 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.384 -1.327 . . . . 0.0 111.577 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -146.58 135.75 5.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -88.02 -84.29 0.2 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.101 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.5 -57.17 1.47 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.643 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 36.9 p -145.85 56.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 10.4 t70 -161.18 73.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.069 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.557 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 10.3 m-85 -95.81 117.42 30.53 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 m -111.72 129.17 56.2 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.574 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.423 HD12 ' CE3' ' A' ' 40' ' ' TRP . 2.3 tt -85.66 94.19 9.02 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.86 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -91.39 124.63 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.255 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.441 HG22 ' CE2' ' A' ' 67' ' ' PHE . 25.2 mt -99.78 131.58 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 p -82.18 -23.19 35.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.331 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.4 ' H ' HG21 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -156.61 120.58 4.36 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.99 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 53.6 t -87.85 122.0 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -108.57 171.25 7.53 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.32 70.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.647 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -84.41 -2.3 56.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.0 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -89.15 -18.03 28.0 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.707 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 140.5 45.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.65 -140.25 7.18 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.452 ' CG2' ' CD1' ' A' ' 92' ' ' PHE . 1.6 mp -116.95 113.4 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.883 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.464 ' OH ' ' CE2' ' A' ' 67' ' ' PHE . 1.9 m-85 -91.94 112.79 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.739 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.485 ' CE1' ' HA3' ' A' ' 106' ' ' GLY . 3.3 m-85 -119.05 -176.49 3.13 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -152.93 -179.44 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.239 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.432 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 74.9 p -171.62 144.41 1.86 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.479 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.467 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 19.2 pt20 -109.61 157.42 19.07 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.6 p -132.34 13.44 4.6 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.36 -36.97 60.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.677 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -110.03 162.47 14.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.085 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 10.9 p -128.01 138.22 32.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.508 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.457 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.8 Cg_endo -71.29 158.2 95.44 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.588 -1.421 . . . . 0.0 111.845 -0.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.52 119.75 7.04 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.786 1.657 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 95' ' ' GLN . 54.6 p -91.24 134.02 34.92 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.958 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.7 138.65 55.24 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.676 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . -72.54 -159.05 4.47 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.552 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -73.14 -157.19 4.0 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.485 ' HA3' ' CE1' ' A' ' 92' ' ' PHE . . . -178.23 98.75 0.12 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 m -107.36 143.75 35.22 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.527 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.92 133.75 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.282 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 1.2 tp -129.94 89.04 2.75 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -127.6 59.78 1.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 112' ' ' LYS . 19.6 mm 59.0 163.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' CG ' ' O ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -86.08 106.54 17.3 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.944 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.433 ' HD3' ' N ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.1 0.476 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.446 ' H ' ' CG2' ' A' ' 102' ' ' THR . 59.5 t -121.5 132.67 70.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.307 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.74 141.76 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.655 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.21 105.95 7.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.794 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -99.03 112.66 24.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.911 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.613 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 9.4 tt0 -95.77 149.91 20.98 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.783 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.493 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.2 159.98 24.23 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.711 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -72.61 177.62 35.0 Favored 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.603 -1.415 . . . . 0.0 111.259 -0.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.1 mt -82.4 -15.47 52.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.758 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -144.5 135.41 25.02 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.545 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.85 72.0 81.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.433 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.6 106.87 1.34 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.943 1.762 . . . . 0.0 111.377 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 7.6 m -141.77 175.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.313 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.465 ' HG ' ' CG ' ' A' ' 17' ' ' ASP . 1.1 p -99.14 161.11 13.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.151 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.6 mt -74.49 88.13 2.11 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.71 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.89 -23.03 0.91 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.465 ' CG ' ' HG ' ' A' ' 14' ' ' SER . 69.2 m-20 -71.71 170.99 12.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.326 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.59 137.84 33.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.27 163.38 14.44 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -162.27 95.4 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.205 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 77' ' ' THR . 2.7 mp -81.19 167.34 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.493 ' N ' ' O ' ' A' ' 7' ' ' THR . 23.1 t -138.92 110.43 7.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.392 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.6 t -117.28 127.6 54.24 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.068 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -116.6 150.42 38.08 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.73 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.448 ' C ' ' H ' ' A' ' 27' ' ' GLN . 5.8 p -109.9 119.57 39.75 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.9 m -75.25 21.61 0.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.7 tt0 -149.45 2.72 0.55 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.46 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 67.73 150.86 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.827 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 80.3 mt -115.52 28.77 8.44 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.264 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 65.3 t -94.71 115.3 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.775 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 33' ' ' ASN . 10.6 t-80 -61.5 175.44 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.011 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -41.68 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' HIS . 1.6 p-10 39.16 52.0 2.05 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.47 -113.21 1.51 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -111.84 -179.99 3.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 20.1 m -113.78 139.08 49.42 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.702 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.502 ' HB3' ' CG2' ' A' ' 96' ' ' THR . 91.3 m-85 -121.65 132.81 54.86 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.481 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 1.7 tp -156.47 141.15 16.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.481 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 1.5 m120 -124.84 148.07 48.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.477 ' CE3' HD11 ' A' ' 78' ' ' LEU . 31.9 m95 -115.23 160.8 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -149.4 156.98 42.89 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp -141.99 113.72 7.9 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.856 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.84 125.91 33.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -92.43 -170.93 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 87.52 0.4 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.76 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 49.91 73.46 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.565 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.31 -157.44 0.82 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.829 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.5 p -90.4 147.86 37.63 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.111 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.49 112.33 1.56 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.972 1.782 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -79.58 131.56 36.04 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 25.9 tp -98.14 121.64 40.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.502 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 52' ' ' LEU . 1.3 mm? -96.81 -71.9 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.488 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -101.54 133.48 44.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.83 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.429 ' CE1' ' ND2' ' A' ' 58' ' ' ASN . 44.9 p90 -122.48 20.23 10.39 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.954 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 1.6 tppp? -168.97 65.91 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.409 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 t 68.51 -66.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -138.64 11.78 2.72 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.749 -1.18 . . . . 0.0 113.078 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 55' ' ' LYS . 53.2 p-10 -75.18 -156.82 0.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.938 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -153.88 118.22 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.359 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.86 157.74 17.57 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.734 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 p -53.81 138.28 36.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.29 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.51 -26.0 7.66 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.5 t -64.29 118.78 50.22 Favored Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.028 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.0 144.55 99.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.883 1.722 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.98 -36.21 17.04 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -26.86 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -84.3 107.28 16.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t -134.61 108.44 8.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.535 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.09 170.79 21.91 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.1 t -164.22 -165.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.916 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.566 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 151.89 113.39 0.57 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.807 -1.663 . . . . 0.0 111.899 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -98.74 100.63 11.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.1 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 -115.72 4.78 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.557 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 35.5 p -99.22 18.63 17.05 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.402 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 3.7 m-20 -129.25 136.06 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.582 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.566 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 69.5 m-85 -139.4 151.78 46.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.404 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 21' ' ' ILE . 43.0 m -145.73 139.35 26.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.998 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -105.1 91.79 3.95 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.403 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -86.08 116.89 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.375 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.0 mt -105.71 129.35 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.62 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -90.48 13.15 16.48 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.27 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.4 113.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.608 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 65.6 t -99.04 143.47 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.18 179.05 4.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.11 18.84 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.256 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -55.26 -29.92 59.05 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.52 -36.18 82.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.664 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 31.3 mt -48.69 134.07 16.45 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.342 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.67 -146.99 12.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.47 112.55 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.281 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -78.78 138.85 38.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.701 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.95 164.21 28.49 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.336 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.477 ' SG ' ' HA2' ' A' ' 105' ' ' GLY . 13.7 p -135.9 142.82 44.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.3 t -143.86 112.45 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.79 149.65 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.676 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 37' ' ' TYR . 12.1 t -123.43 26.62 7.8 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 37' ' ' TYR . 24.0 m -92.09 -23.83 19.34 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -127.88 136.52 51.5 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.715 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.4 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 50.9 t -109.69 138.37 20.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.436 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.5 Cg_endo -73.71 161.17 94.76 Favored 'Cis proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.634 -1.402 . . . . 0.0 111.757 -0.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.29 136.12 49.82 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.984 1.789 . . . . 0.0 110.75 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.446 ' CG2' ' H ' ' A' ' 2' ' ' VAL . 26.4 p -61.89 -51.05 69.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.085 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.6 t80 55.34 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.11 82.08 0.06 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.477 ' HA2' ' SG ' ' A' ' 93' ' ' CYS . . . -93.99 -126.13 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 145.41 80.69 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.805 -1.664 . . . . 0.0 112.274 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 97.1 m -154.5 108.39 2.94 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.629 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -79.01 149.32 32.25 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.939 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.2 tt -154.2 88.62 1.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.42 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 111' ' ' ILE . 6.4 pt-20 -122.23 38.62 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.47 ' CG2' ' H ' ' A' ' 113' ' ' ARG . 0.2 OUTLIER 74.95 168.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.757 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.401 ' N ' HG22 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -47.92 -41.24 24.14 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.671 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.47 ' H ' ' CG2' ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 116.568 -1.682 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.756 0.312 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.783 0.325 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.509 HG21 ' CE1' ' A' ' 98' ' ' HIS . 2.0 t . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 4' ' ' MET . 16.3 t -74.76 158.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.618 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 29' ' ' LEU . 84.2 mmm -122.43 101.99 7.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.986 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.91 136.95 37.42 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.321 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.487 ' CB ' ' HA2' ' A' ' 105' ' ' GLY . 6.5 tt0 -126.83 146.4 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.46 164.99 19.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.423 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 11' ' ' LEU . 7.0 Cg_endo -75.71 176.57 43.08 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.412 -1.495 . . . . 0.0 110.99 -1.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.78 -25.15 56.16 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -140.21 143.41 36.02 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.601 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 8' ' ' PRO . 1.7 tp -134.11 70.07 74.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.279 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.04 113.16 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.936 1.757 . . . . 0.0 111.238 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.01 170.36 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.505 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -111.27 89.84 3.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.106 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 14' ' ' SER . 67.2 mt -8.69 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.079 0.862 . . . . 0.0 112.871 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.87 -35.26 0.37 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.615 -1.278 . . . . 0.0 110.774 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.77 179.11 7.88 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -92.04 161.31 14.83 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.997 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.53 165.08 16.99 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.616 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -159.6 88.8 0.86 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.152 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 78' ' ' LEU . 7.3 mt -85.61 127.6 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.986 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -87.4 150.2 23.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.99 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.409 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -163.01 132.79 4.32 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 179.64 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -109.44 157.86 18.53 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.713 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 t -68.67 -23.21 64.38 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.76 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.63 -57.14 0.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.6 137.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.729 ' O ' HG21 ' A' ' 97' ' ' THR . 74.7 mt -88.36 -45.78 9.72 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 29' ' ' LEU . 76.2 t -36.62 125.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.879 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.068 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.578 ' HD2' HG23 ' A' ' 97' ' ' THR . 15.3 m-85 -74.09 122.84 23.32 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -141.51 132.99 26.83 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.035 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.609 ' N ' HD23 ' A' ' 38' ' ' LEU . 2.6 p-10 -124.95 127.01 46.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -94.44 175.07 6.82 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.514 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -160.55 168.16 25.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.88 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.7 tp -151.89 116.69 5.14 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.77 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.423 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 tt0 -93.84 132.2 38.48 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.433 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.124 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.827 0.346 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 63' ' ' VAL . 32.0 mt -125.92 -39.82 2.08 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.01 HD11 ' NH2' ' A' ' 59' ' ' ARG . 16.8 mm -138.83 146.19 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.3 p90 -143.66 32.58 1.29 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.206 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -177.57 55.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 57' ' ' SER . 48.3 t 36.98 83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.253 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 79.18 70.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.941 0.877 . . . . 0.0 110.342 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -172.05 106.08 0.2 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.373 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 1.01 ' NH2' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.09 163.42 26.64 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 61' ' ' SER . 44.6 t80 -91.77 172.94 8.14 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 54.5 p -60.23 -47.04 87.64 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.434 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.75 50.92 2.91 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 119.595 -1.288 . . . . 0.0 112.321 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' NH1' ' A' ' 59' ' ' ARG . 44.3 t -141.49 122.88 8.93 Favored Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.1 164.23 32.89 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.993 1.795 . . . . 0.0 111.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 67' ' ' PHE . 6.6 p-10 -69.74 -7.4 39.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 8.1 mmt-85 -60.95 0.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.538 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 64.9 m-85 -122.68 155.98 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 t -161.61 112.05 1.65 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.51 147.11 18.31 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -161.46 -176.48 5.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 153.74 171.42 20.83 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.604 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -80.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.691 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.4 -49.16 0.06 OUTLIER Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -113.62 17.64 18.1 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.72 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.71 133.53 16.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 55.0 m-85 -147.03 168.93 20.32 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.455 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.7 m -152.76 141.76 21.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.341 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 78' ' ' LEU . 10.4 tt -113.22 112.63 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -110.3 151.68 27.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.468 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.835 HG22 ' H ' ' A' ' 82' ' ' ARG . 97.0 mt -124.71 139.65 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -23.99 63.58 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.004 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.835 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.9 ptm180 -170.17 113.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.8 110.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.931 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.02 172.03 8.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.603 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.96 73.64 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.141 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 -13.73 59.8 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.43 -26.33 58.25 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.752 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 15' ' ' LEU . 48.3 mt -53.74 150.19 7.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.89 178.9 17.76 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.945 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 mm -86.0 108.29 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.729 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.7 m-85 -77.38 156.42 31.23 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.617 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -143.7 164.66 29.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 93' ' ' CYS . 30.8 p -148.55 82.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.673 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -89.18 -178.35 5.63 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.007 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -135.22 157.8 45.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 96' ' ' THR . 8.0 t -127.29 45.22 2.76 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.729 HG21 ' O ' ' A' ' 29' ' ' LEU . 18.6 m -114.4 -52.62 2.71 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.509 ' CE1' HG21 ' A' ' 2' ' ' VAL . 65.7 m-70 -86.86 145.68 26.49 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.501 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 47.1 t -113.82 138.64 22.81 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.853 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -70.55 164.35 81.7 Favored 'Cis proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.668 -1.388 . . . . 0.0 111.504 -0.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.81 120.16 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.522 1.481 . . . . 0.0 110.67 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -91.7 112.63 24.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.242 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -84.37 151.51 24.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.73 157.9 29.79 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.579 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 134.93 -175.74 20.41 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.74 55.11 0.04 OUTLIER Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.161 -1.495 . . . . 0.0 111.857 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.2 m -99.06 115.23 28.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.617 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 93.97 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.123 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.9 83.07 6.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.724 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 153.97 28.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.0 132.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.869 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.1 tttm . . . . . 0 C--N 1.303 -1.453 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.278 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 98' ' ' HIS . 88.2 t . . . . . 0 C--O 1.214 -0.797 0 CA-C-O 120.876 0.37 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' N ' ' HB2' ' A' ' 26' ' ' SER . 46.8 t -69.0 153.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.313 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.403 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 30.1 mtp -135.06 92.8 2.92 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -79.19 121.1 24.62 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.016 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.54 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -97.8 129.05 44.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.721 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.31 151.56 37.2 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 107' ' ' THR . 8.1 Cg_endo -74.23 -179.82 27.24 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.716 -1.368 . . . . 0.0 111.648 0.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 -33.29 53.59 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.054 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 m -130.27 153.16 48.91 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.829 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 tp -143.3 73.63 17.68 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.97 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.41 106.58 1.25 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.886 1.724 . . . . 0.0 110.645 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.3 m -132.34 170.47 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.45 150.26 22.36 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD22 ' C ' ' A' ' 84' ' ' GLU . 33.9 mt -73.74 90.54 1.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.38 -21.3 1.07 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 18' ' ' GLN . 7.0 m-20 -84.54 -154.52 0.18 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.055 -0.572 . . . . 0.0 110.369 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 81' ' ' SER . 25.8 mt-30 -125.25 164.55 20.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.555 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.97 160.95 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.011 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 m -149.94 95.39 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mp -91.48 133.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.023 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -92.07 159.51 15.66 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.504 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 3.3 m -156.47 105.92 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.865 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -100.97 124.98 47.5 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.029 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 78.0 p -87.9 147.34 25.12 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.431 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -49.03 -68.17 0.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.742 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 59.46 1.55 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.59 ' CA ' HG22 ' A' ' 74' ' ' THR . 19.9 t 61.6 173.88 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.966 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD21 ' OE1' ' A' ' 95' ' ' GLN . 23.5 mt -131.73 21.36 4.63 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.535 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.562 HG22 ' OG1' ' A' ' 36' ' ' THR . 45.6 t -79.89 122.72 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.512 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.011 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.562 ' OG1' HG22 ' A' ' 30' ' ' VAL . 10.4 m . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.71 0.291 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 156.78 41.61 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.654 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.552 HD22 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -173.31 105.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.54 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -96.54 105.26 17.33 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.625 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' NE1' HD22 ' A' ' 38' ' ' LEU . 43.2 m95 -84.94 148.76 26.06 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 103' ' ' PHE . 41.0 m-85 -136.72 157.24 47.22 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 91' ' ' TYR . 8.4 tp -136.7 110.43 8.1 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.79 121.77 37.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' CE ' ' HA ' ' A' ' 86' ' ' GLU . 7.4 tttt . . . . . 0 C--N 1.303 -1.421 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.195 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 40' ' ' TRP . 21.9 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.889 0.376 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 63' ' ' VAL . 39.4 mt -120.38 -55.56 2.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 59' ' ' ARG . 41.5 mm -120.11 158.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 30.1 p90 -138.17 -28.17 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.878 -1.129 . . . . 0.0 112.254 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -101.31 -51.29 3.53 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 57' ' ' SER . 7.4 p -178.31 -41.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.481 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.543 ' N ' HG13 ' A' ' 56' ' ' VAL . 8.9 t -138.47 -31.86 0.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.11 120.05 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 36.0 mtm-85 -77.54 157.65 30.27 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.295 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 85.4 t80 -73.77 160.41 31.53 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 38.2 t -62.6 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.349 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.7 -19.62 3.52 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 52' ' ' LEU . 40.7 t -81.54 118.5 72.45 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.62 155.98 39.52 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.917 1.745 . . . . 0.0 111.993 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.87 -19.29 6.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.219 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -49.52 -26.38 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.811 -0.755 . . . . 0.0 111.284 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD2' HD13 ' A' ' 52' ' ' LEU . 60.9 m-85 -100.57 128.22 46.7 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.507 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.7 p -141.8 128.59 20.49 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.259 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.36 150.53 18.4 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.63 147.54 10.38 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.217 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -166.07 125.89 1.4 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 m -95.1 67.29 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.79 -91.37 0.5 Allowed Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.114 -1.517 . . . . 0.0 112.144 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 28' ' ' SER . 37.1 p -121.9 1.55 9.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.348 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -106.16 97.81 7.57 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.954 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.604 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 73.4 m-85 -114.41 147.43 39.24 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 21' ' ' ILE . 17.1 m -149.83 133.88 17.09 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.002 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 8.4 tt -92.16 112.09 23.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.194 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -107.05 129.19 54.85 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 82' ' ' ARG . 5.1 mt -109.83 134.51 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.692 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 36.7 m -83.41 -19.14 36.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.276 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.1 mtt-85 -145.53 97.15 2.94 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.596 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 15' ' ' LEU . 51.6 t -75.68 117.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.354 -0.939 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.539 ' C ' HD22 ' A' ' 15' ' ' LEU . 7.6 mm-40 -115.65 172.53 7.07 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.989 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.5 12.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.714 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 1.3 mt-10 -68.45 -36.72 79.41 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -59.96 -15.02 18.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.842 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.43 136.46 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.608 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -167.42 27.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.25 118.43 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.689 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.716 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.1 m-85 -84.4 147.51 27.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.156 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -141.1 167.28 22.57 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.817 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.512 ' N ' HE22 ' A' ' 6' ' ' GLN . 24.1 p -155.95 102.13 2.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.1 p -88.63 171.25 10.16 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.516 ' OE1' HD21 ' A' ' 29' ' ' LEU . 3.4 pt20 -127.76 112.0 14.3 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.1 p -81.11 55.31 2.47 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.843 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 m -128.52 -53.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 2' ' ' VAL . 34.9 m-70 -100.31 177.49 5.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.179 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.456 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 96.7 t -145.9 135.51 11.57 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.495 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -70.87 139.61 58.9 Favored 'Cis proline' 0 C--N 1.317 -1.1 0 C-N-CA 123.558 -1.434 . . . . 0.0 111.462 -0.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 100' ' ' PRO . 1.1 Cg_endo -65.75 118.48 5.52 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.717 1.611 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.4 p -66.45 160.57 24.65 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.946 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -112.39 38.2 2.8 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.736 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.68 -178.93 31.29 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.464 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -90.83 -50.53 2.86 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 6' ' ' GLN . . . 127.57 95.4 0.88 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.056 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' PRO . 93.8 m -100.37 120.77 40.46 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.11 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -78.5 118.43 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tt -113.16 100.54 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.77 159.28 23.28 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 tt -65.14 168.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.558 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tmtt? . . . . . 0 N--CA 1.489 1.479 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.956 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.403 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t . . . . . 0 C--O 1.215 -0.744 0 CA-C-O 120.73 0.3 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.92 132.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.278 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 54.5 mmm -125.46 93.5 3.88 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 m -78.71 116.08 18.83 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.616 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 1.2 mp0 -101.83 148.9 24.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.927 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.58 163.12 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.501 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.716 ' HG2' HD12 ' A' ' 11' ' ' LEU . 8.2 Cg_endo -77.41 177.29 40.04 Favored 'Cis proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.59 -1.421 . . . . 0.0 110.711 -1.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.9 -26.61 63.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 95.7 p -145.43 146.64 31.6 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.701 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.716 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -130.19 78.19 75.02 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.93 108.53 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.862 1.708 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 12.5 m -144.52 153.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.249 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.93 152.18 26.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.616 ' HG ' HD11 ' A' ' 111' ' ' ILE . 62.3 mt -69.89 88.76 0.57 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.65 -27.81 0.6 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.82 171.25 15.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 95.4 mt-30 -87.16 134.25 33.55 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.331 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -107.01 155.18 20.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.404 ' H ' HD21 ' A' ' 11' ' ' LEU . 25.6 m -149.09 97.76 2.73 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.992 HG23 HG21 ' A' ' 107' ' ' THR . 26.6 mt -84.17 161.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.786 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.6 t -122.17 146.22 47.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.692 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.616 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.9 m -150.34 104.92 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -112.14 134.68 53.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.801 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 29' ' ' LEU . 54.5 p -98.51 152.29 19.71 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.297 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 p -73.02 -35.12 66.72 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 28' ' ' SER . 7.3 tp60 -121.12 148.72 43.81 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.623 ' HA ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -50.3 142.91 9.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.26 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 25' ' ' SER . 69.1 mt -108.55 43.35 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -102.14 135.5 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.796 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 29' ' ' LEU . 17.2 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' A' ' 97' ' ' THR . 6.3 m-30 -86.65 72.86 10.15 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG ' ' A' ' 76' ' ' PHE . 4.0 tt -119.34 132.59 55.89 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.532 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' HB2' HD11 ' A' ' 51' ' ' LEU . 5.1 p30 -126.14 165.48 18.8 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.524 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.731 ' CE3' HD12 ' A' ' 78' ' ' LEU . 50.9 m95 -114.52 154.32 28.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.0 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.21 163.5 29.47 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.632 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 91' ' ' TYR . 18.6 tp -155.66 136.99 13.95 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -115.92 123.29 47.72 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.575 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 17.7 tptp . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.643 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.609 HD23 ' CG ' ' A' ' 60' ' ' PHE . 34.7 tp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.614 ' O ' HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -96.52 -72.41 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.986 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 54' ' ' TYR . 30.2 mm -120.28 164.67 16.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.479 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' N ' HG22 ' A' ' 53' ' ' ILE . 35.5 p90 -155.69 156.44 34.93 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 13.6 mttm 48.25 22.33 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.923 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' TYR . 78.4 t 63.89 127.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.568 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p 41.94 56.86 3.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.834 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 9.8 m120 -127.67 -21.73 3.71 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.358 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HA ' HD13 ' A' ' 53' ' ' ILE . 3.8 mtt180 54.47 101.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.97 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' HD23 ' A' ' 51' ' ' LEU . 35.0 t80 -60.25 160.21 8.76 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.638 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p -56.27 112.51 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.621 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.23 7.64 20.77 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 52' ' ' LEU . 78.7 t -112.05 104.57 56.12 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.37 155.08 43.0 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.002 1.801 . . . . 0.0 112.078 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.16 -15.81 0.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.789 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -51.98 -34.96 44.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.774 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HD2' HD21 ' A' ' 78' ' ' LEU . 90.3 m-85 -95.15 129.28 42.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.881 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.86 93.28 3.28 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.7 106.27 2.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.628 -1.272 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.6 m -113.68 -176.64 2.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.047 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 154.14 117.8 0.65 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.9 t -98.1 67.76 1.92 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.144 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.76 -109.51 1.48 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.549 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 28' ' ' SER . 65.3 p -101.95 9.65 40.36 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 8.2 p-10 -113.73 139.49 49.05 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 96.7 m-85 -147.82 156.27 42.54 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 21' ' ' ILE . 28.7 m -150.04 152.75 35.34 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.752 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.731 HD12 ' CE3' ' A' ' 40' ' ' TRP . 6.8 tt -115.96 92.74 3.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 6.1 mttt -92.23 126.89 37.5 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.006 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 19' ' ' ALA . 18.7 mt -114.42 132.44 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.059 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -60.16 -73.64 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.275 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.693 HH12 ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -123.39 100.44 6.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.526 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 87' ' ' ASP . 72.3 t -54.33 145.89 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.983 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.693 ' CG ' HH12 ' A' ' 82' ' ' ARG . 2.4 mm-40 -126.48 172.84 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.478 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.73 -29.67 54.15 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.49 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 15.3 mm-40 -66.19 -41.1 90.68 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' CB ' HG13 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -52.33 -33.06 41.02 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.083 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 111' ' ' ILE . 39.8 mt -53.81 130.87 38.46 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.7 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.47 8.75 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.9 mp -125.64 116.58 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.644 ' CE2' HD13 ' A' ' 42' ' ' LEU . 3.4 m-85 -88.53 153.71 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.159 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' HG22 ' A' ' 90' ' ' ILE . 61.2 m-85 -154.76 179.96 8.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.215 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.1 p -165.22 163.36 20.23 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.942 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.471 ' CB ' ' CD2' ' A' ' 103' ' ' PHE . 8.4 t -147.03 -173.32 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.834 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 2.7 pt20 -136.54 108.12 6.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.123 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -82.84 43.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.047 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -114.17 -58.16 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.849 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.403 ' CG ' HG21 ' A' ' 2' ' ' VAL . 78.9 m-70 -88.76 171.78 9.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.297 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 100' ' ' PRO . 57.4 t -139.17 138.72 21.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.1 Cg_endo -71.39 148.8 90.88 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.276 -1.552 . . . . 0.0 111.336 -1.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.62 113.4 1.94 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.762 1.641 . . . . 0.0 110.084 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 87.39 4.56 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 94' ' ' SER . 1.5 t80 -83.5 111.46 19.08 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.882 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.89 152.21 6.61 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -167.34 -128.18 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.06 100.27 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 C-N-CA 117.641 -2.218 . . . . 0.0 113.632 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.992 HG21 HG23 ' A' ' 21' ' ' ILE . 96.7 m -158.35 104.17 1.83 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -89.82 156.19 18.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.396 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 93.89 3.15 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.816 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 111' ' ' ILE . 17.3 pt-20 -106.82 31.94 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.696 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.616 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER 61.91 170.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 111' ' ' ILE . 3.9 tttm . . . . . 0 N--CA 1.49 1.544 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.018 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 29' ' ' LEU . 64.1 t . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.4 0.619 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.06 116.27 17.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mtp -93.94 89.76 6.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.054 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -77.08 112.23 13.5 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.64 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.698 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 38.1 tt0 -100.05 154.95 17.99 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -161.45 161.4 22.91 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.307 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 107' ' ' THR . 6.7 Cg_endo -77.03 178.12 36.68 Favored 'Cis proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.522 -1.449 . . . . 0.0 110.314 -2.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 9' ' ' LEU . 4.4 mm? -63.26 -21.56 66.32 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.469 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 p -154.83 152.38 29.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.607 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 3.5 tp -129.59 77.51 77.02 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.019 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.43 102.75 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.699 1.599 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 34.3 m -137.17 -167.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.805 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.22 153.0 34.61 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 111' ' ' ILE . 63.9 mt -75.46 87.03 2.6 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.443 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.64 -26.34 0.52 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.58 -170.65 2.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.42 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -106.4 139.5 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.263 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -113.34 146.13 39.94 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.397 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 p -138.23 92.03 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.492 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.518 HG23 HG21 ' A' ' 107' ' ' THR . 4.8 mt -89.56 126.44 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.08 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.1 156.56 20.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.118 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 29.0 m -162.02 111.73 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.251 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -111.22 140.66 45.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -94.54 167.04 11.74 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.931 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -41.03 26.32 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.316 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -136.77 43.77 2.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.433 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.471 ' C ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 m 61.02 -174.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.849 ' CD1' HD12 ' A' ' 38' ' ' LEU . 13.2 mt -142.92 21.34 1.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -77.11 138.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.169 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.996 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 29' ' ' LEU . 11.9 m . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.82 0.343 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.79 68.91 7.2 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.007 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 29' ' ' LEU . 1.4 tt -89.76 142.13 27.98 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.666 ' OD1' HD12 ' A' ' 51' ' ' LEU . 9.1 t30 -122.42 162.2 22.08 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.077 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.741 ' CD2' HD12 ' A' ' 78' ' ' LEU . 50.6 m95 -125.31 154.31 41.96 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.509 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.86 146.24 50.68 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp -162.7 128.42 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -173.42 170.48 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.258 -1.377 . . . . 0.0 112.678 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.413 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.666 HD12 ' OD1' ' A' ' 39' ' ' ASN . 1.2 tp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.29 -89.07 0.19 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.664 HG21 ' H ' ' A' ' 57' ' ' SER . 2.8 mp -82.43 145.3 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.787 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.513 ' CZ ' ' ND2' ' A' ' 58' ' ' ASN . 42.2 p90 -139.46 -7.51 1.31 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.428 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -130.84 57.7 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.574 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 56' ' ' VAL . 5.9 p 38.05 79.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.046 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.664 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 69.26 75.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.444 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.513 ' ND2' ' CZ ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -151.0 -24.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER 70.49 137.55 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.051 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' N ' ' A' ' 61' ' ' SER . 79.4 t80 -90.77 172.22 8.79 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 t -57.89 117.4 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.33 -8.21 54.99 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG21 ' H ' ' A' ' 60' ' ' PHE . 94.8 t -84.96 124.79 72.04 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.25 144.28 95.96 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 122.136 1.891 . . . . 0.0 112.143 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 3.0 t0 -58.26 -25.25 61.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.326 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.7 69.35 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' O ' ' NH1' ' A' ' 59' ' ' ARG . 10.0 m-85 -79.91 126.52 31.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.3 m -134.77 159.36 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.236 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -152.44 79.53 0.2 Allowed Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.069 -1.538 . . . . 0.0 111.297 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 8.8 t -83.3 -167.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 151.55 117.26 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.539 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -92.35 91.35 7.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.87 -75.15 0.91 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.6 p -131.65 57.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.525 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 25.9 t0 -162.62 58.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.659 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 58.2 m-85 -80.19 148.79 30.72 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 m -148.97 122.8 9.31 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.733 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 40' ' ' TRP . 4.4 tt -84.68 104.56 14.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -96.12 119.98 35.59 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.309 -0.957 . . . . 0.0 111.99 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.502 HG13 HD23 ' A' ' 78' ' ' LEU . 7.8 mt -109.51 116.17 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.352 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -69.89 -24.45 63.4 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.875 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.1 mmt-85 -142.61 110.62 5.95 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.853 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -86.73 136.52 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.6 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' C ' HD22 ' A' ' 15' ' ' LEU . 2.9 mt-10 -129.54 170.06 14.21 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.522 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -43.73 59.41 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.301 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.9 -37.67 85.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.37 -21.62 50.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 109' ' ' LEU . 78.6 mt -58.96 146.23 38.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.173 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.41 -154.58 25.19 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 92' ' ' PHE . 20.9 mt -112.41 140.55 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.125 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -104.42 150.64 24.35 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.664 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 90' ' ' ILE . 40.5 m-85 -151.08 135.18 16.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.768 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -109.11 141.12 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.857 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 9.3 p -144.23 -164.68 1.95 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 29' ' ' LEU . 5.5 pm0 -159.14 165.87 32.79 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.505 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.6 p -109.2 -21.68 12.45 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' LEU . 10.3 m -53.16 -55.26 25.53 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.359 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CG ' HG21 ' A' ' 2' ' ' VAL . 37.9 m-70 -88.17 131.71 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.529 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 62.3 t -135.16 137.44 26.83 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.2 Cg_endo -68.27 136.71 36.4 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.539 -0.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.48 155.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.928 1.752 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.18 -64.56 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 65.58 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.869 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.01 64.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -65.95 -84.67 0.09 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.63 75.05 0.59 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.317 -1.42 . . . . 0.0 112.445 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.518 HG21 HG23 ' A' ' 21' ' ' ILE . 19.9 m -148.86 106.95 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.553 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.69 139.79 32.55 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.852 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 88' ' ' LEU . 7.6 tt -131.67 107.27 8.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.197 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -131.33 32.89 4.16 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.162 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.742 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 66.08 163.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.96 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.587 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG12 ' OG ' ' A' ' 25' ' ' SER . 11.6 t . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.051 0.453 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' N ' ' HB2' ' A' ' 26' ' ' SER . 16.9 t -63.14 155.85 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.689 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.5 mmm -133.46 110.44 9.98 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.697 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -80.14 147.6 31.28 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.657 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 5.3 mp0 -118.75 143.33 46.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.342 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 141.93 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 11' ' ' LEU . 9.6 Cg_endo -79.35 175.16 46.9 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.586 -1.422 . . . . 0.0 111.159 -0.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.37 -22.82 59.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 p -139.7 148.86 42.94 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 21' ' ' ILE . 4.6 tp -126.87 78.57 73.54 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.4 102.74 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.818 1.679 . . . . 0.0 111.061 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 14' ' ' SER . 8.6 m -132.77 -154.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 13' ' ' VAL . 3.3 t -147.06 154.02 40.68 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.907 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 84' ' ' GLU . 14.6 mt -68.56 87.47 0.32 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 82' ' ' ARG . . . 147.04 -31.58 1.44 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.53 173.06 11.99 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.248 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -89.07 166.94 13.54 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.039 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -147.98 161.12 41.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.218 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -157.58 109.97 2.4 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.757 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.565 HG13 HD22 ' A' ' 11' ' ' LEU . 2.2 mp -101.02 118.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 t -93.7 158.43 15.68 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.155 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.3 t -160.9 117.86 2.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -104.3 172.07 6.99 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.422 ' OG ' HG12 ' A' ' 2' ' ' VAL . 1.8 t -116.86 167.43 11.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 14.9 t -67.87 -27.18 66.45 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.39 -59.68 0.34 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.269 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.71 155.35 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.676 ' O ' HG21 ' A' ' 97' ' ' THR . 83.6 mt -114.53 6.86 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.48 137.8 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 N--CA 1.488 1.461 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.277 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.583 0.23 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' H ' ' CG2' ' A' ' 97' ' ' THR . 22.6 m-85 -122.73 109.42 14.22 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -130.54 133.54 46.31 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.854 ' ND2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -110.51 149.01 30.95 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.454 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.584 ' O ' HD12 ' A' ' 51' ' ' LEU . 22.8 m95 -111.89 172.48 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 162.72 31.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.482 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 91' ' ' TYR . 19.7 tp -151.25 127.13 10.32 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.37 113.36 26.84 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.852 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.854 HD13 ' ND2' ' A' ' 39' ' ' ASN . 9.1 tp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -101.97 -55.67 2.44 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.799 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.756 HG21 ' H ' ' A' ' 57' ' ' SER . 51.6 mm -124.49 137.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.043 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.704 ' HB3' HD21 ' A' ' 51' ' ' LEU . 37.2 p90 -113.12 -30.65 6.9 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.618 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -124.33 48.41 1.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 58' ' ' ASN . 40.8 t 56.12 103.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.376 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.756 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.7 OUTLIER 76.48 -29.37 0.18 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 56' ' ' VAL . 12.3 m-20 -69.35 94.66 0.73 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.973 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 53' ' ' ILE . 4.1 mtm180 -66.76 136.97 56.28 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' VAL . 25.8 t80 -57.2 157.48 6.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -53.44 -22.73 8.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.734 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.26 31.9 6.64 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 60' ' ' PHE . 38.8 t -120.44 125.89 27.0 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.671 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.61 149.89 73.1 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.241 1.961 . . . . 0.0 112.436 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.23 -25.46 65.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.986 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -53.95 -35.84 62.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.88 129.37 34.43 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 t -137.25 138.65 40.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.546 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -124.03 131.72 8.08 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 p -156.19 146.92 21.91 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.203 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -170.94 114.48 0.54 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -95.34 145.2 25.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.201 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.75 -101.01 0.42 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.909 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 p -131.04 21.66 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.71 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 5.9 m-20 -122.17 124.04 42.93 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 23.8 m-85 -131.47 155.3 47.61 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 25.8 m -159.49 139.57 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.578 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.4 tt -95.56 104.53 16.45 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.19 129.24 38.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.692 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.721 HG22 ' H ' ' A' ' 82' ' ' ARG . 32.1 mt -116.81 128.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.468 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.1 m -85.13 2.33 43.99 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.706 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -171.37 112.5 0.35 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.841 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.5 t -91.75 150.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.34 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.53 ' C ' HD22 ' A' ' 15' ' ' LEU . 4.3 mt-10 -137.28 167.15 22.15 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.197 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.86 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.227 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -66.15 -29.66 69.99 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.769 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.42 -19.98 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 109' ' ' LEU . 78.8 mt -65.98 137.08 56.88 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.855 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.15 -137.71 5.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.59 106.69 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.485 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.477 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.28 130.43 36.21 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.311 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 1.2 m-85 -118.11 166.61 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.657 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 14.7 p -134.85 152.46 51.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -156.25 155.9 33.15 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.536 ' CB ' HD22 ' A' ' 29' ' ' LEU . 4.0 pt20 -112.39 163.04 14.89 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.5 m -144.89 46.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.676 HG21 ' O ' ' A' ' 29' ' ' LEU . 2.1 p -124.64 -44.17 1.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -99.5 142.2 31.3 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.5 p -109.18 137.22 20.13 Favored Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 6.1 Cg_endo -74.55 146.45 86.79 Favored 'Cis proline' 0 C--N 1.316 -1.173 0 C-N-CA 123.528 -1.447 . . . . 0.0 111.494 -0.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.04 125.49 15.98 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.72 1.613 . . . . 0.0 110.156 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -91.22 107.37 19.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.198 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -94.27 139.42 31.07 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.098 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -167.85 -141.05 3.06 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.363 -1.398 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 92' ' ' PHE . . . 132.58 175.19 13.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.22 79.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.48 HG21 HG23 ' A' ' 21' ' ' ILE . 93.1 m -149.91 107.41 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.185 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -75.9 93.61 3.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 88' ' ' LEU . 5.0 tt -89.35 83.89 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.3 tt0 -124.96 54.97 1.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.143 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.671 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER 54.82 176.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.416 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 111' ' ' ILE . 31.8 mtpt . . . . . 0 C--N 1.302 -1.479 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CG ' ' A' ' 98' ' ' HIS . 69.0 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 121.029 0.442 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 4' ' ' MET . 17.1 t -68.61 161.0 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.659 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.472 ' N ' HG12 ' A' ' 3' ' ' VAL . 82.0 mmm -139.25 101.46 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -91.89 103.45 15.99 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -107.35 166.31 10.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.743 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.67 170.35 8.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.583 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 12.1 Cg_endo -83.72 173.8 41.67 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.794 -1.336 . . . . 0.0 110.72 -2.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.3 mt -72.88 -16.69 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.126 -1.029 . . . . 0.0 109.626 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.0 p -154.14 136.18 14.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tp -122.72 86.32 49.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.269 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.68 116.81 4.61 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.64 1.56 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.579 HG21 HG11 ' A' ' 83' ' ' VAL . 35.8 m -141.86 -172.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -114.42 145.75 41.46 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.08 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 111' ' ' ILE . 38.6 mt -70.35 89.43 0.67 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.4 -1.04 3.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -95.71 -135.17 0.22 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 167.57 21.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.706 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -150.06 168.79 22.88 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 19.7 p -160.38 91.72 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mt -78.3 125.86 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 7' ' ' THR . 32.4 t -85.57 157.4 20.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.268 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 2.0 m -161.89 106.11 1.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.161 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' NH1' ' O ' ' A' ' 74' ' ' THR . 55.7 ttm-85 -106.49 144.89 32.52 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.91 154.8 17.77 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -63.93 -72.03 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.22 48.61 1.02 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t 67.97 176.28 0.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.77 ' C ' HG21 ' A' ' 97' ' ' THR . 55.6 mt -124.78 52.7 1.53 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.617 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.443 ' N ' HG21 ' A' ' 97' ' ' THR . 35.1 t -106.65 130.94 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.301 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.728 0.299 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -134.28 139.6 45.83 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.425 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.683 HD13 ' CG ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -162.26 149.67 13.98 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.115 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 4.4 p-10 -137.72 170.89 15.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.184 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE2' HD13 ' A' ' 78' ' ' LEU . 70.1 m95 -131.9 164.04 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.525 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 1.5 m-85 -154.73 131.57 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.507 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.66 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 5.4 tp -116.16 117.49 30.21 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.798 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 42' ' ' LEU . 13.6 tm0? -101.42 140.2 36.05 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.865 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.493 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 52' ' ' LEU . 5.9 tp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 67' ' ' PHE . 17.5 mt -113.42 -90.08 0.52 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.183 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.748 HD13 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -82.66 145.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -139.36 -7.19 1.34 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tptt -139.78 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 5.8 t 76.4 -47.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.977 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -171.77 45.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.08 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.86 -36.57 11.59 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 68.31 134.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' H ' HG21 ' A' ' 63' ' ' VAL . 4.7 t80 -81.08 168.08 19.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -60.17 -33.12 71.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.02 11.38 22.27 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.756 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.583 HG21 ' H ' ' A' ' 60' ' ' PHE . 21.3 t -104.46 128.08 27.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.436 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.2 Cg_endo -67.17 19.34 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.119 1.879 . . . . 0.0 112.92 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 63' ' ' VAL . 15.4 t70 68.7 -37.07 0.34 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -52.72 -18.32 1.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.492 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.605 ' O ' HD11 ' A' ' 53' ' ' ILE . 57.0 m-85 -87.92 92.81 9.27 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.208 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 m -109.94 158.44 18.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.042 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.04 14.95 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.574 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.6 t -148.41 168.03 23.71 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.74 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.665 ' CA ' ' CD2' ' A' ' 76' ' ' PHE . . . -173.19 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.001 -1.571 . . . . 0.0 111.524 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -92.79 51.92 1.78 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -59.53 4.27 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.72 -1.228 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.423 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 3.8 p -125.63 34.47 4.9 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.766 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.05 106.81 1.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.316 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 11.6 m-85 -128.59 145.29 51.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.395 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 78' ' ' LEU . 19.6 m -149.78 170.85 17.78 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.682 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.748 HD11 HD13 ' A' ' 53' ' ' ILE . 4.7 tp -134.67 94.79 3.24 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.557 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -77.96 111.52 13.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.582 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' ALA . 77.2 mt -91.54 117.98 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -92.5 89.01 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.264 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.598 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 104.09 76.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.475 1.109 . . . . 0.0 110.464 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 13' ' ' VAL . 72.2 t -67.59 100.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' HH12 ' A' ' 66' ' ' ARG . 50.6 mt-10 -94.67 179.03 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.19 -28.44 40.6 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.686 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.97 -51.42 70.12 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' OD2' HD13 ' A' ' 80' ' ' ILE . 4.4 m-20 -47.39 -26.33 1.28 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 111' ' ' ILE . 51.1 mt -56.57 144.58 31.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.36 -134.72 8.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -133.62 119.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.519 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 3.8 m-85 -89.44 146.75 24.43 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.78 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.82 175.23 9.78 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.33 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.456 ' H ' ' HA3' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -160.72 159.05 29.7 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.966 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 t -151.24 178.1 9.57 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.606 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.563 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -129.44 124.85 35.14 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.613 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.3 p -93.15 4.19 54.42 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.77 HG21 ' C ' ' A' ' 29' ' ' LEU . 99.5 m -70.64 -57.71 4.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CG ' HG21 ' A' ' 2' ' ' VAL . 75.7 m-70 -91.45 94.51 9.5 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.407 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 100' ' ' PRO . 14.7 p -74.97 139.11 72.91 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' A' ' 99' ' ' VAL . 5.4 Cg_endo -72.85 142.83 75.81 Favored 'Cis proline' 0 C--N 1.318 -1.05 0 C-N-CA 123.726 -1.364 . . . . 0.0 111.781 -0.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.25 112.32 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.863 1.709 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.2 p -72.77 84.84 1.21 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 16.8 t80 -76.83 155.04 33.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 168.17 -52.54 0.22 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 118.822 -1.656 . . . . 0.0 111.354 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 93' ' ' CYS . . . 50.19 -138.05 22.77 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.159 -1.495 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.94 85.12 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.282 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 21' ' ' ILE . 17.3 m -152.84 109.45 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.748 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.97 97.23 9.69 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.269 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -90.69 84.23 5.86 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.161 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.6 57.18 0.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.456 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.693 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER 54.88 178.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.708 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.693 ' N ' HG23 ' A' ' 111' ' ' ILE . 1.2 tppt? . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 98' ' ' HIS . 65.1 t . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.962 0.411 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.1 150.81 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.662 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.63 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 50.7 mtp -133.5 -174.22 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.507 0.67 . . . . 0.0 109.694 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -156.55 152.06 26.83 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -140.34 150.18 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.044 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.55 166.87 15.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 5.0 Cg_endo -74.59 178.41 34.32 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.717 -1.368 . . . . 0.0 110.846 -1.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -36.95 78.05 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.53 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.3 t -140.24 147.55 40.18 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.063 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tp -134.1 83.18 46.16 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.406 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' C ' ' HG3' ' A' ' 112' ' ' LYS . 2.0 Cg_endo -68.05 101.17 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.839 1.692 . . . . 0.0 110.241 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.74 -167.78 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.884 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -127.35 147.73 50.26 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 85' ' ' ALA . 17.7 mt -67.78 89.34 0.26 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.667 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.92 -6.8 2.36 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.65 -152.16 0.27 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -125.05 155.93 38.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.67 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HB2' HG21 ' A' ' 83' ' ' VAL . . . -129.75 163.53 25.98 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.449 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.7 p -163.32 94.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.423 HG23 ' OG1' ' A' ' 107' ' ' THR . 2.7 mp -91.36 129.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.018 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 37.0 m -87.96 159.39 18.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.966 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 2.1 t -160.74 137.11 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.672 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.41 45.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.966 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 m -110.77 146.83 35.67 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.319 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -52.14 -38.01 56.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -133.25 167.0 21.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -63.52 137.99 58.34 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 29' ' ' LEU . 77.2 mt -94.39 23.48 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.208 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.41 139.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 . . . . . 0 N--CA 1.488 1.472 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.704 -179.897 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.738 0.304 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.36 137.39 37.28 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.169 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 21.1 tp -172.63 151.51 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -154.72 120.71 5.22 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 29.6 m95 -87.93 149.68 23.92 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.546 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HB3' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -123.7 155.68 37.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.574 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.662 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 6.4 tp -150.91 117.11 5.62 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.499 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -111.94 130.45 55.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 54' ' ' TYR . 16.0 tp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 67' ' ' PHE . 33.2 mt -95.48 -88.94 0.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.241 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 59' ' ' ARG . 44.0 mm -88.82 123.05 40.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.028 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' A' ' 51' ' ' LEU . 36.0 p90 -110.48 20.17 18.01 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.374 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.14 143.77 1.56 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.89 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.626 HG13 ' H ' ' A' ' 71' ' ' GLY . 43.1 t -44.09 106.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.06 71.21 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.419 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.491 ' ND2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -170.71 110.65 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.359 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HA ' HD13 ' A' ' 53' ' ' ILE . 24.6 mtm-85 -77.33 139.76 39.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.847 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 68.7 t80 -69.85 160.13 32.36 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.408 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 5.3 m -40.25 -53.73 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.86 57.44 3.7 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 60' ' ' PHE . 88.9 t -144.59 113.9 5.12 Favored Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.105 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 159.77 37.45 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.966 1.778 . . . . 0.0 111.938 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -58.08 -27.46 63.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.549 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' CG ' ' HB2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -43.71 -42.12 5.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.322 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 52' ' ' LEU . 64.7 m-85 -82.51 124.51 30.17 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.623 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -124.63 151.86 44.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.722 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.35 155.11 25.94 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.772 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -149.78 141.83 23.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' H ' HG13 ' A' ' 56' ' ' VAL . . . -137.42 128.45 4.32 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.92 -1.609 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 m -94.73 -124.55 0.11 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.17 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.14 -55.89 1.25 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 p -125.27 20.65 8.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.972 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -132.11 143.25 49.88 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CD1' HD22 ' A' ' 38' ' ' LEU . 40.4 m-85 -151.13 136.42 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 m -139.37 140.92 37.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.597 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 1.8 tt -117.63 111.05 18.66 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.161 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -120.81 138.14 54.18 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.196 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 19' ' ' ALA . 2.8 mp -105.85 138.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -72.09 -36.17 69.43 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.434 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HB2' ' CG ' ' A' ' 66' ' ' ARG . 3.9 mtt180 -135.25 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.058 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 19' ' ' ALA . 58.1 t -65.8 111.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.387 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 66' ' ' ARG . 24.4 mt-10 -106.65 177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 15' ' ' LEU . . . -52.75 -31.75 39.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.16 -32.81 74.17 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -20.16 66.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 109' ' ' LEU . 72.9 mt -58.53 139.94 54.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -173.42 23.04 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.419 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 90' ' ' ILE . 5.4 mp -85.25 158.56 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.662 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 13.2 m-85 -131.51 148.77 52.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.693 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -147.21 165.13 30.99 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.262 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 22.8 p -132.7 102.92 5.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 38' ' ' LEU . 5.2 m -83.17 164.32 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.145 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -130.38 118.2 20.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.633 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.22 22.02 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.9 m -89.11 -40.41 12.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.801 -0.759 . . . . 0.0 111.737 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CE1' HG21 ' A' ' 2' ' ' VAL . 32.8 m80 -119.34 152.4 36.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.673 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 68.0 t -113.86 137.76 22.46 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.61 142.3 73.96 Favored 'Cis proline' 0 C--N 1.317 -1.112 0 C-N-CA 123.589 -1.421 . . . . 0.0 111.805 -0.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.69 110.81 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.841 1.694 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -64.85 147.86 52.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.71 -74.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.69 -137.49 8.29 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.598 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.679 ' N ' ' HB3' ' A' ' 92' ' ' PHE . . . 114.0 90.6 1.8 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -151.46 8.76 0.66 Allowed Glycine 0 N--CA 1.483 1.827 0 C-N-CA 117.908 -2.091 . . . . 0.0 113.909 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 91' ' ' TYR . 30.6 m -147.73 138.53 23.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.885 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -113.6 103.4 11.21 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.358 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -85.86 86.94 7.34 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.62 139.1 45.04 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.721 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.4 tt -55.42 158.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.714 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HG3' ' C ' ' A' ' 12' ' ' PRO . 3.8 mtmp? . . . . . 0 N--CA 1.487 1.419 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG21 ' CG ' ' A' ' 98' ' ' HIS . 4.3 t . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.019 0.438 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 30.1 t -66.95 157.09 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.438 ' CG ' HE22 ' A' ' 95' ' ' GLN . 40.1 mmm -133.31 113.47 12.64 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -77.78 127.65 32.75 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.577 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.644 ' CD ' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -101.57 139.29 37.43 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.75 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.18 145.83 9.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.841 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 107' ' ' THR . 9.1 Cg_endo -78.62 -179.98 28.71 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.093 -0.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.01 -29.75 49.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.498 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.88 149.63 50.33 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.261 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -142.24 83.07 12.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.877 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.07 113.97 3.02 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.853 1.702 . . . . 0.0 110.808 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 26.9 m -143.08 162.65 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.326 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.14 158.66 15.52 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' ' 111' ' ' ILE . 25.5 mt -78.96 94.65 5.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.1 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 133.05 16.98 1.18 Allowed Glycine 0 N--CA 1.494 2.544 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.99 -131.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 2.6 mt-30 -139.08 172.52 12.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.317 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.761 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -145.65 166.14 26.66 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.556 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -160.86 80.99 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.755 HG23 HG21 ' A' ' 107' ' ' THR . 2.9 mt -90.63 124.15 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.295 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -87.15 151.88 22.81 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.927 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -160.8 111.09 1.75 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.225 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.38 170.29 8.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.821 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.419 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 2.3 t -111.36 155.25 23.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.101 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -49.04 25.88 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 28' ' ' SER . 4.0 tp-100 -97.84 -68.6 0.79 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 74' ' ' THR . 39.3 t 167.45 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.73 20.77 7.77 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.56 119.3 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.628 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.476 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.677 0.275 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CG ' ' OG1' ' A' ' 97' ' ' THR . 12.6 m-85 -97.92 159.43 14.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.99 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 76' ' ' PHE . 16.1 tp 179.8 151.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.343 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.555 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 m120 -137.71 149.09 46.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD2' HD12 ' A' ' 78' ' ' LEU . 39.0 m95 -120.42 157.28 29.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.97 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -147.75 172.01 14.77 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.577 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 91' ' ' TYR . 1.1 tp -160.72 120.69 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.95 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -90.18 116.88 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 17.8 ttpp . . . . . 0 C--N 1.306 -1.285 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.545 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.696 0.284 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 51' ' ' LEU . 64.9 mt -102.3 -80.1 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.167 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 69' ' ' GLY . 3.3 mm -105.5 138.71 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.474 ' HB3' HD21 ' A' ' 51' ' ' LEU . 32.4 p90 -132.06 28.58 4.45 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.659 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -178.8 68.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.434 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 56' ' ' VAL . 20.5 m 19.74 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.541 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER 79.42 63.2 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.452 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -171.46 108.51 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.988 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 15.4 mtt85 -89.17 153.62 20.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.758 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 40.0 t80 -83.78 160.28 21.26 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.3 t -42.97 -38.55 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.029 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.08 52.42 1.09 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 75.0 t -146.12 118.93 5.11 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.8 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 4.2 Cg_exo -60.36 138.07 78.5 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.159 1.906 . . . . 0.0 111.919 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.486 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -52.22 -23.78 6.17 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' CB ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -67.53 12.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.128 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' HD1' HD21 ' A' ' 78' ' ' LEU . 12.2 m-85 -115.74 104.51 11.74 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.395 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.0 m -105.68 121.08 43.27 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.12 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' O ' HG21 ' A' ' 53' ' ' ILE . . . -131.15 102.7 0.52 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 31.2 t -151.47 175.34 12.39 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.142 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 174.37 147.63 6.19 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.8 p -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.4 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.11 -102.79 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.213 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.772 HG22 ' HA ' ' A' ' 28' ' ' SER . 59.1 p -124.55 15.45 8.84 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.111 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -115.83 125.68 53.0 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CD2' HD22 ' A' ' 38' ' ' LEU . 4.0 m-85 -140.97 168.14 20.5 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.517 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -160.1 155.91 25.95 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.255 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 40' ' ' TRP . 5.3 tt -112.49 102.02 10.15 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.487 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -89.8 125.12 35.19 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.761 HD12 ' HB3' ' A' ' 19' ' ' ALA . 68.8 mt -110.66 130.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 22.9 m -84.16 -18.78 35.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.877 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' CB ' HH21 ' A' ' 66' ' ' ARG . 1.1 mmt-85 -148.24 92.85 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.749 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' GLY . 86.6 t -76.36 117.95 21.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' LEU . 1.5 mp0 -116.7 -179.55 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.98 23.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 23.1 mt-10 -68.78 -23.83 64.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' ' CD2' ' A' ' 109' ' ' LEU . 3.1 m-20 -77.27 -29.65 53.96 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.42 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -51.04 142.38 12.26 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.66 -139.58 11.11 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.4 mp -124.6 135.15 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.998 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 42' ' ' LEU . 1.1 m-85 -101.18 141.15 34.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.515 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -130.21 175.44 8.92 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.597 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.6 p -156.68 146.41 20.83 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.537 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -149.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.612 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.438 HE22 ' CG ' ' A' ' 4' ' ' MET . 5.3 pm0 -155.18 145.4 21.85 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.427 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 m -107.4 -5.86 17.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.213 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.694 HG22 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -69.74 -27.09 64.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.807 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.694 ' CD2' HG22 ' A' ' 97' ' ' THR . 43.4 m-70 -102.62 145.32 29.82 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 4.8 t -132.55 129.47 21.41 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.233 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.8 Cg_endo -67.24 148.48 79.95 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.795 -0.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.88 123.84 12.23 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.969 1.779 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -89.48 125.46 35.19 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.236 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 6.5 t80 -125.98 136.41 52.97 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.49 -164.67 29.77 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' NE2' ' A' ' 6' ' ' GLN . . . 111.24 -172.88 15.37 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.734 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.24 58.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.755 HG21 HG23 ' A' ' 21' ' ' ILE . 82.1 m -80.67 110.12 15.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -64.96 103.11 0.68 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -98.45 83.56 3.05 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.119 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -107.61 148.87 28.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.712 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.6 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.9 tt -52.37 168.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.43 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 13' ' ' VAL . 3.2 ttmm . . . . . 0 N--CA 1.492 1.639 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.756 0.312 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.783 0.325 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.485 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 39.2 t . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.869 0.366 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 47.9 t -81.68 156.25 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.428 ' CE ' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -136.41 105.87 6.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.271 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.627 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -78.98 134.08 36.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.11 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.95 158.24 21.17 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -75.99 177.97 37.05 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.603 -1.416 . . . . 0.0 111.248 -1.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -77.57 -27.06 51.33 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.879 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 m -143.21 149.4 37.92 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.939 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 8.3 tp -140.71 88.92 10.46 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.717 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.3 117.79 5.27 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.918 1.745 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 m -142.34 -164.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 t -118.22 169.37 9.76 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.34 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.39 89.7 7.44 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.85 -25.58 2.25 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.92 -161.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.011 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -134.84 136.34 42.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.266 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -103.23 178.29 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.478 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -155.9 73.54 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 107' ' ' THR . 2.6 mp -62.54 128.49 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' THR . 21.8 t -93.26 155.29 17.52 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.304 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 81.5 m -160.86 109.65 1.62 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.09 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -108.82 150.34 27.77 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -104.17 152.36 22.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.483 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -80.34 -22.89 40.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.81 34.81 1.98 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.429 ' N ' HG22 ' A' ' 74' ' ' THR . 24.2 t 58.62 -173.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.106 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.615 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 12.4 mt -139.93 13.89 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.079 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.91 135.29 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 . . . . . 0 N--CA 1.488 1.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.009 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -88.21 149.88 23.61 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -168.16 157.57 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.578 ' H ' HD23 ' A' ' 38' ' ' LEU . 3.5 p30 -159.96 113.57 2.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.952 ' CD2' HD13 ' A' ' 78' ' ' LEU . 55.9 m95 -90.76 169.71 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.21 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.08 133.52 8.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.54 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 14.2 tp -107.52 130.51 54.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.459 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 42' ' ' LEU . 38.1 tt0 -95.22 125.03 39.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.781 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' NZ ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.895 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 54' ' ' TYR . 19.8 tp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.96 -63.86 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.479 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 58' ' ' ASN . 43.3 mm -121.52 139.85 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.731 ' HB3' HD21 ' A' ' 51' ' ' LEU . 50.0 p90 -122.83 30.81 6.27 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.459 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.8 mmtp -174.29 -166.59 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.422 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.419 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.99 22.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.122 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -44.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.647 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.579 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.4 m-80 -46.21 140.44 3.98 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.977 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 5.2 mtm180 -110.29 134.04 52.65 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 65.7 t80 -57.38 162.39 2.84 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.1 m -68.43 92.26 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.32 32.17 0.45 Allowed Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 65' ' ' ASP . 38.8 t -113.67 132.67 22.46 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.82 13.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.959 1.773 . . . . 0.0 113.12 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 63' ' ' VAL . 1.1 t70 71.46 -41.78 0.51 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -46.36 -26.86 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.085 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CD1' HG12 ' A' ' 80' ' ' ILE . 83.1 m-85 -80.82 123.64 28.41 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 m -138.27 101.05 4.29 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.545 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' CA ' HD12 ' A' ' 78' ' ' LEU . . . -92.99 120.01 6.07 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.8 p -151.45 154.52 36.75 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -165.84 163.74 36.93 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -92.94 -115.35 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.719 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.1 -78.28 0.64 Allowed Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 28' ' ' SER . 53.0 p -111.37 18.26 19.38 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.349 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.42 131.74 53.74 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.717 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 54.3 m-85 -142.51 153.96 44.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.916 -0.713 . . . . 0.0 110.522 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 3.5 m -151.75 145.65 25.16 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.952 HD13 ' CD2' ' A' ' 40' ' ' TRP . 9.7 tp -104.45 93.61 4.88 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -81.17 118.45 22.57 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.094 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.761 HG21 ' OD2' ' A' ' 87' ' ' ASP . 23.0 mt -114.61 103.46 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 18' ' ' GLN . 1.4 m -74.95 39.45 0.14 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.046 -1.062 . . . . 0.0 113.524 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 81' ' ' SER . 1.1 mmt85 169.63 97.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.696 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 87' ' ' ASP . 88.4 t -93.49 99.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -177.01 3.28 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.508 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.32 -26.89 43.44 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.821 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.83 -36.21 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.964 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.761 ' OD2' HG21 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.9 -43.39 98.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.91 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.773 HD21 ' CD1' ' A' ' 111' ' ' ILE . 89.3 mt -43.62 148.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.715 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.87 -155.02 20.75 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.61 142.76 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.646 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 14.0 m-85 -115.22 144.72 43.28 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.906 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -133.59 155.79 49.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 1.8 p -136.52 102.21 4.87 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 158.89 15.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.696 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -110.65 127.9 55.47 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.604 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 96' ' ' THR . 17.9 m -83.61 -5.57 59.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.004 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 29' ' ' LEU . 53.3 m -62.63 -62.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.29 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -89.12 114.78 26.08 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.43 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 21.8 t -104.59 134.37 19.7 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.832 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.16 156.98 97.91 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.591 -1.421 . . . . 0.0 111.523 -0.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.38 139.91 85.14 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.034 1.823 . . . . 0.0 110.997 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.28 -43.93 60.13 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.315 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 t80 68.35 161.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.581 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.78 130.87 2.92 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 145.93 173.78 17.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.441 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 178.86 67.15 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 21' ' ' ILE . 44.8 m -77.1 113.81 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.888 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -73.84 107.25 5.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.391 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -100.67 94.85 6.31 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.704 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.32 136.67 52.26 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.773 ' CD1' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -69.2 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.059 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.445 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.349 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' HG21 ' A' ' 102' ' ' THR . 25.2 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.129 0.49 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 4' ' ' MET . 15.6 t -69.5 162.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.761 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 25' ' ' SER . 48.6 mmm -126.85 175.51 7.98 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -150.72 93.56 1.97 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.204 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.625 ' NE2' ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp60 -82.5 148.3 28.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.232 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -161.18 165.14 17.49 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.908 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 9.1 Cg_endo -76.76 173.97 55.43 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.482 -1.466 . . . . 0.0 110.563 -1.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.96 -28.59 68.4 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.592 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -140.97 130.43 23.85 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -125.92 94.16 42.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.699 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.86 121.1 7.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.8 1.666 . . . . 0.0 110.537 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 83' ' ' VAL . 24.9 m -134.43 -165.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.442 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -146.53 160.48 42.08 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -74.69 85.69 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 82' ' ' ARG . . . 140.43 -22.62 2.71 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 18' ' ' GLN . 31.9 t70 -76.48 177.87 7.06 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.416 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 54.5 mt-30 -94.63 -173.76 3.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.737 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -153.73 157.69 39.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 p -151.52 79.94 1.29 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.002 HG23 HG21 ' A' ' 107' ' ' THR . 8.8 mt -81.27 117.75 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.906 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 7' ' ' THR . 39.4 t -85.4 155.53 21.24 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.958 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -162.13 124.38 2.84 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.605 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.17 155.99 28.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.306 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 3.8 t -112.96 154.23 26.76 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.8 p -74.37 -31.73 62.49 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 2' ' ' VAL . 4.9 tt0 -136.54 150.56 48.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.689 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 p -50.75 128.13 19.99 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.66 ' C ' HG21 ' A' ' 97' ' ' THR . 85.8 mt -80.52 27.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.89 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.81 133.89 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.393 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 . . . . . 0 N--CA 1.489 1.521 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.41 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' LEU . 84.1 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.822 0.344 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -112.37 132.72 54.86 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' CG ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -155.24 125.85 6.91 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.957 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 38' ' ' LEU . 34.6 p30 -133.24 169.65 16.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.256 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 78' ' ' LEU . 36.5 m95 -125.03 150.56 46.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.11 147.59 44.13 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 tp -135.62 125.53 25.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.52 152.75 33.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.107 -1.037 . . . . 0.0 112.103 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.323 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -113.34 -71.56 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.261 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 59' ' ' ARG . 31.6 mm -109.46 150.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.87 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 47.7 p90 -149.19 25.36 0.9 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.559 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.41 61.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.832 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.6 m 30.44 97.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.09 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 72.05 46.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.859 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.502 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -148.96 108.97 4.08 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 65' ' ' ASP . 41.7 mtm180 -79.83 153.0 29.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.906 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 61' ' ' SER . 59.9 t80 -91.14 171.78 9.01 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.546 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t -59.9 123.0 15.68 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.218 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.05 66.22 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 90.0 t -84.46 123.93 74.14 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -55.83 138.95 83.29 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.1 1.867 . . . . 0.0 112.02 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 6.1 m-20 -56.29 -18.55 10.94 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.615 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -77.61 27.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.606 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.576 ' CE2' HD21 ' A' ' 78' ' ' LEU . 4.8 m-85 -128.17 129.03 45.87 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.4 104.01 3.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' VAL . . . -110.65 108.15 2.37 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.318 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -143.0 163.37 32.97 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.686 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . -169.9 172.34 43.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.45 -151.23 0.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.632 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.91 -48.81 13.75 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -146.51 35.14 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.444 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -135.64 90.62 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.158 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CG ' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -119.62 155.41 32.35 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.08 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.3 m -146.98 141.03 26.02 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.539 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CE2' ' A' ' 67' ' ' PHE . 5.5 tt -94.02 110.33 22.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 131.39 46.95 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.018 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 82' ' ' ARG . 57.3 mt -117.99 131.58 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.2 m -90.64 -0.5 57.71 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.72 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.779 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.5 tpt180 -169.05 97.32 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 13' ' ' VAL . 99.0 t -74.88 136.66 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.89 163.8 13.81 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.812 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.63 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.28 -27.11 62.27 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -30.91 71.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.474 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 111' ' ' ILE . 85.9 mt -42.94 134.87 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.23 -154.62 25.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 mm -103.62 131.84 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.09 154.95 18.29 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.175 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 38.1 m-85 -147.45 176.88 9.68 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.082 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.71 127.68 4.22 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.401 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 4.8 p -118.74 -170.24 1.87 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.324 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.44 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -158.04 127.39 5.81 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 m -107.12 57.73 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.66 HG21 ' C ' ' A' ' 29' ' ' LEU . 54.6 m -108.93 -50.3 3.03 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.868 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -87.87 -40.01 14.34 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.28 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.597 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.8 OUTLIER 64.94 141.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.315 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -67.78 158.04 84.95 Favored 'Cis proline' 0 C--N 1.319 -1.024 0 C-N-CA 123.55 -1.437 . . . . 0.0 111.362 -0.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.67 114.59 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.938 1.758 . . . . 0.0 111.532 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 2' ' ' VAL . 14.2 p -52.95 -55.19 25.26 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.09 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.6 OUTLIER 61.95 116.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.57 100.09 0.61 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.231 -1.461 . . . . 0.0 111.547 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.505 ' H ' ' HB3' ' A' ' 92' ' ' PHE . . . -100.62 -90.36 2.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.61 93.5 1.35 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.307 -1.425 . . . . 0.0 112.798 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.002 HG21 HG23 ' A' ' 21' ' ' ILE . 2.3 m -158.49 109.17 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.556 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.71 105.39 5.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.202 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.64 94.01 7.48 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.129 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 144.06 50.3 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.675 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.551 HD12 HD21 ' A' ' 88' ' ' LEU . 4.8 mt -76.81 156.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 11.9 mttm . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.213 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.691 ' O ' HG21 ' A' ' 102' ' ' THR . 62.9 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.25 124.99 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.195 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 81.9 mmm -120.68 102.38 8.36 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -96.1 156.7 16.22 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.311 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.731 HE21 ' CG2' ' A' ' 21' ' ' ILE . 23.2 tt0 -130.39 151.48 50.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.838 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -157.82 156.55 28.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.97 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.4 176.83 42.02 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.611 -1.412 . . . . 0.0 111.328 -0.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -75.12 -18.27 60.27 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.813 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 p -156.02 140.64 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.085 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.68 91.38 33.98 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.731 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -70.47 105.72 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.97 1.78 . . . . 0.0 111.236 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 83' ' ' VAL . 8.6 m -117.71 -154.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.509 ' HA ' HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -132.44 159.43 39.34 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.493 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 111' ' ' ILE . 19.0 mt -75.34 88.94 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.6 -1.22 5.98 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.5 -177.76 4.19 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 179.39 5.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.107 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -154.44 163.93 39.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 m -155.18 95.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.335 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.731 ' CG2' HE21 ' A' ' 6' ' ' GLN . 23.2 mt -84.36 165.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.354 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 21' ' ' ILE . 11.0 m -131.07 154.5 48.19 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.735 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.44 126.51 4.65 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.81 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -120.06 145.99 46.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.476 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 85.8 p -107.66 125.17 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.46 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -73.82 32.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.242 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.543 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -160.37 -85.85 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.767 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.755 ' HA ' HG22 ' A' ' 74' ' ' THR . 3.3 t 171.39 146.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.753 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.826 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 46.1 mt -109.83 30.01 7.09 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.5 t -107.29 147.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.439 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.726 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.667 ' HB2' HG23 ' A' ' 97' ' ' THR . 90.3 m-85 -84.44 143.83 29.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.843 HD21 ' HE1' ' A' ' 40' ' ' TRP . 8.7 tp -165.46 146.2 7.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.851 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 2.3 m120 -135.38 156.89 48.18 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.843 ' HE1' HD21 ' A' ' 38' ' ' LEU . 59.5 m95 -137.33 152.66 49.97 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' TRP . 33.4 m-85 -144.56 154.46 42.88 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 10.9 tp -127.42 106.05 8.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.019 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -69.68 105.84 2.86 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.382 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.477 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 51' ' ' LEU . 34.8 tp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.912 0.387 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.8 mm? -82.25 -69.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.439 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 53' ' ' ILE . 16.7 mm -108.92 127.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.023 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.612 ' HD1' HD22 ' A' ' 58' ' ' ASN . 0.9 OUTLIER -134.14 25.89 3.88 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.952 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -171.24 27.9 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.891 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' ASN . 95.0 t 63.3 119.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.637 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.1 p 34.36 33.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.36 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.612 HD22 ' HD1' ' A' ' 54' ' ' TYR . 6.6 p-10 -107.33 -32.91 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 1.2 mtm-85 66.52 113.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.553 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 61' ' ' SER . 51.4 t80 -61.61 167.34 3.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.4 t -54.2 -40.58 67.72 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.86 63.91 3.46 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 65' ' ' ASP . 58.8 t -139.61 133.17 15.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.704 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HG2' ' HE ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -67.38 14.39 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 122.221 1.947 . . . . 0.0 112.468 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 5.1 m-20 65.43 -24.18 0.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.59 HH12 ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -65.3 -11.62 43.47 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.328 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HD1' HD21 ' A' ' 78' ' ' LEU . 77.3 m-85 -95.26 132.84 39.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.412 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -147.89 85.69 1.56 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.443 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' THR . . . -86.08 107.09 3.13 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -76.67 163.03 27.24 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.979 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.687 ' HA2' ' CD1' ' A' ' 76' ' ' PHE . . . -142.06 96.26 0.2 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -94.36 82.91 4.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.502 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.16 -82.13 0.13 Allowed Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 28' ' ' SER . 18.6 p -123.31 14.87 9.7 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.791 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.95 132.02 53.97 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.26 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.826 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 24.8 m-85 -138.49 143.89 39.77 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.477 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 21' ' ' ILE . 100.0 m -139.98 112.28 7.73 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.54 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 78' ' ' LEU . 10.2 tt -80.68 100.31 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -94.93 134.3 37.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.284 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 19' ' ' ALA . 7.6 mt -113.07 137.29 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 12.0 t -87.01 -44.24 11.73 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.681 -1.207 . . . . 0.0 111.947 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -124.71 102.37 7.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 HG21 ' A' ' 13' ' ' VAL . 69.3 t -89.44 103.6 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' CD ' HH12 ' A' ' 66' ' ' ARG . 4.0 mt-10 -102.89 177.21 4.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.249 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.16 -27.11 31.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -78.96 -40.23 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.532 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.07 -20.23 23.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.408 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' CD1' ' A' ' 111' ' ' ILE . 97.7 mt -62.68 167.39 4.54 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.756 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.01 180.0 16.07 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.715 -1.231 . . . . 0.0 111.267 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.87 115.5 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.449 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -88.76 143.38 26.95 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.811 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -135.48 158.76 43.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.158 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.51 156.64 46.8 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 10.5 t -150.91 -177.05 5.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.546 ' HB2' HD22 ' A' ' 29' ' ' LEU . 1.8 pt20 -129.26 113.8 15.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 37' ' ' TYR . 10.2 t -84.33 34.67 0.52 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.667 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -100.13 -72.27 0.67 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.2 m-70 -78.24 162.11 26.79 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.424 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 45.7 t -137.88 137.57 21.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.586 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.3 Cg_endo -73.46 158.58 98.39 Favored 'Cis proline' 0 C--N 1.318 -1.058 0 C-N-CA 123.568 -1.43 . . . . 0.0 111.472 -1.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.77 151.63 82.9 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.966 1.777 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 2' ' ' VAL . 36.7 p -89.94 -61.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.048 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 3.3 t80 72.83 146.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.008 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.75 170.25 30.43 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' CA ' ' HB3' ' A' ' 6' ' ' GLN . . . 120.11 -155.38 16.19 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.841 -1.171 . . . . 0.0 111.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.69 60.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 21' ' ' ILE . 52.4 m -81.76 108.28 15.17 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -68.99 89.74 0.43 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.15 87.52 6.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.521 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -121.24 143.25 49.25 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.183 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.93 HD13 ' HG ' ' A' ' 15' ' ' LEU . 8.3 mt -88.34 146.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 mttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.809 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.913 HG13 ' H ' ' A' ' 27' ' ' GLN . 39.1 t . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.852 0.358 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 4' ' ' MET . 6.7 t -74.51 169.93 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.697 ' SD ' ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -132.64 99.21 4.56 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.541 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -89.57 148.42 23.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.581 ' CB ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -141.54 153.48 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.379 -0.929 . . . . 0.0 110.824 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.29 146.27 11.62 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.726 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HG2' HD12 ' A' ' 11' ' ' LEU . 11.0 Cg_endo -82.12 176.93 35.24 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.806 -1.331 . . . . 0.0 111.342 -0.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 -27.31 61.65 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.043 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -137.72 149.62 46.63 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.879 ' HB3' HD12 ' A' ' 109' ' ' LEU . 3.6 tp -135.43 86.2 30.22 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.924 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CB ' ' HA ' ' A' ' 112' ' ' LYS . 10.2 Cg_endo -72.23 101.77 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.657 1.571 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 112' ' ' LYS . 20.4 m -126.7 -178.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.34 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.2 174.53 5.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 83' ' ' VAL . 21.4 mt -90.11 86.98 6.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.37 -25.65 1.54 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.65 -166.93 0.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.024 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -114.59 138.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -115.53 166.37 11.98 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 p -160.95 100.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' THR . 69.4 mt -98.94 142.53 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -103.34 141.13 36.45 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.802 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.99 94.21 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.564 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' CZ ' ' CB ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.1 163.08 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.186 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.63 166.36 13.28 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.129 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -64.93 -70.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.913 ' H ' HG13 ' A' ' 2' ' ' VAL . 1.8 tt0 -87.6 162.13 17.33 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.994 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 p -59.09 129.61 42.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 76' ' ' PHE . 89.1 mt -85.02 34.73 0.56 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.693 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -96.96 114.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.126 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.676 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 97' ' ' THR . 21.5 m-30 -105.5 102.66 12.11 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.964 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 76' ' ' PHE . 1.4 tt -149.1 126.91 11.8 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.865 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -116.21 163.77 15.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.39 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.496 ' CE3' HD13 ' A' ' 78' ' ' LEU . 47.1 m95 -123.56 159.02 30.09 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.447 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 14.6 m-85 -144.45 148.28 34.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.026 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD22 ' OH ' ' A' ' 91' ' ' TYR . 24.5 tp -123.14 79.84 1.71 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.57 30.94 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.45 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt . . . . . 0 N--CA 1.484 1.274 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.625 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 54' ' ' TYR . 29.5 tp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.22 -60.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.678 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mm -113.49 131.56 64.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.99 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HB3' HD21 ' A' ' 51' ' ' LEU . 52.2 p90 -108.61 -13.78 14.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.83 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' SER . 1.2 mtpm? -153.93 110.13 3.29 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 57' ' ' SER . 1.2 p 43.56 -73.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.596 ' H ' HG13 ' A' ' 56' ' ' VAL . 16.6 t -136.67 -15.8 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.55 -1.26 . . . . 0.0 113.789 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.59 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -64.4 114.25 4.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.911 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -71.86 143.73 49.31 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.361 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.4 175.43 4.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.473 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 p -61.61 -51.38 68.73 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.579 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.54 71.11 2.98 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 65' ' ' ASP . 46.5 t -139.35 125.68 12.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.803 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 66' ' ' ARG . 1.1 Cg_endo -68.04 14.35 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.031 1.821 . . . . 0.0 111.799 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 35.9 m-20 60.09 -9.38 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.979 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 64' ' ' PRO . 12.1 mtm-85 -76.96 19.63 0.29 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' OH ' ' A' ' 91' ' ' TYR . 89.3 m-85 -137.55 135.81 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.624 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -146.14 96.58 2.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 149.71 37.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m -154.1 113.61 3.78 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.384 -1.327 . . . . 0.0 111.577 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -146.58 135.75 5.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -88.02 -84.29 0.2 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.101 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.5 -57.17 1.47 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.643 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 36.9 p -145.85 56.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 10.4 t70 -161.18 73.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.069 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.722 ' CD1' HD13 ' A' ' 38' ' ' LEU . 10.3 m-85 -95.81 117.42 30.53 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 m -111.72 129.17 56.2 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.574 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' CE3' ' A' ' 40' ' ' TRP . 2.3 tt -85.66 94.19 9.02 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.86 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -91.39 124.63 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.255 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 19' ' ' ALA . 25.2 mt -99.78 131.58 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 p -82.18 -23.19 35.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.331 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -156.61 120.58 4.36 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.99 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.592 HG13 ' OD2' ' A' ' 87' ' ' ASP . 53.6 t -87.85 122.0 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -108.57 171.25 7.53 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.32 70.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.647 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -84.41 -2.3 56.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.0 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.592 ' OD2' HG13 ' A' ' 83' ' ' VAL . 3.0 t70 -89.15 -18.03 28.0 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.707 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 109' ' ' LEU . 13.4 mt -73.92 140.5 45.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.487 ' C ' HD12 ' A' ' 90' ' ' ILE . . . 155.65 -140.25 7.18 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 89' ' ' GLY . 1.6 mp -116.95 113.4 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.883 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' CE2' ' A' ' 67' ' ' PHE . 1.9 m-85 -91.94 112.79 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.739 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' A' ' 106' ' ' GLY . 3.3 m-85 -119.05 -176.49 3.13 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -152.93 -179.44 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.239 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.436 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 74.9 p -171.62 144.41 1.86 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.479 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.461 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 6.8 pt20 -109.61 157.42 19.07 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.6 p -132.34 13.44 4.6 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -75.36 -36.97 60.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.677 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CE1' HG21 ' A' ' 2' ' ' VAL . 70.8 m80 -110.03 162.47 14.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.085 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 10.9 p -128.01 138.22 32.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.508 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.8 Cg_endo -71.29 158.2 95.44 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.588 -1.421 . . . . 0.0 111.845 -0.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.52 119.75 7.04 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.786 1.657 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 p -91.24 134.02 34.92 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.958 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.7 138.65 55.24 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.697 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . -72.54 -159.05 4.47 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -73.14 -157.19 4.0 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 92' ' ' PHE . . . -178.23 98.75 0.12 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 8' ' ' PRO . 21.5 m -107.36 143.75 35.22 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.92 133.75 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.282 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.879 HD12 ' HB3' ' A' ' 11' ' ' LEU . 1.2 tp -129.94 89.04 2.75 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -127.6 59.78 1.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.59 HG22 ' N ' ' A' ' 112' ' ' LYS . 19.6 mm 59.0 163.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.404 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.944 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.76 ' O ' HG21 ' A' ' 102' ' ' THR . 59.5 t . . . . . 0 C--O 1.216 -0.707 0 CA-C-O 120.66 0.267 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.74 141.76 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.655 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.21 105.95 7.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.794 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -99.03 112.66 24.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.911 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 9.4 tt0 -95.77 149.91 20.98 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.783 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.2 159.98 24.23 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.711 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HA ' HG22 ' A' ' 7' ' ' THR . 4.4 Cg_endo -72.61 177.62 35.0 Favored 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.603 -1.415 . . . . 0.0 111.259 -0.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.1 mt -82.4 -15.47 52.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.758 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -144.5 135.41 25.02 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.545 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.554 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -128.85 72.0 81.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.433 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.6 106.87 1.34 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.943 1.762 . . . . 0.0 111.377 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 7.6 m -141.77 175.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.313 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 p -99.14 161.11 13.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 111' ' ' ILE . 24.6 mt -74.49 88.13 2.11 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.89 -23.03 0.91 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -71.71 170.99 12.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.326 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.59 137.84 33.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.27 163.38 14.44 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -162.27 95.4 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.205 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.824 ' O ' HG23 ' A' ' 77' ' ' THR . 2.7 mp -81.19 167.34 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 23.1 t -138.92 110.43 7.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.392 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.6 t -117.28 127.6 54.24 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.068 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -116.6 150.42 38.08 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.73 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' HG11 ' A' ' 2' ' ' VAL . 5.8 p -109.9 119.57 39.75 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.9 m -75.25 21.61 0.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' ' 2' ' ' VAL . 1.7 tt0 -149.45 2.72 0.55 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.46 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.459 ' CA ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER 67.73 150.86 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.827 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 80.3 mt -115.52 28.77 8.44 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG22 ' OG1' ' A' ' 36' ' ' THR . 65.3 t -94.71 115.3 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.775 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.011 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 30' ' ' VAL . 20.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.531 0.205 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.779 ' HB3' HG23 ' A' ' 96' ' ' THR . 91.3 m-85 -121.65 132.81 54.86 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 76' ' ' PHE . 1.7 tp -156.47 141.15 16.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 1.5 m120 -124.84 148.07 48.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.471 ' O ' HD12 ' A' ' 51' ' ' LEU . 31.9 m95 -115.23 160.8 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -149.4 156.98 42.89 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp -141.99 113.72 7.9 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.856 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.84 125.91 33.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt . . . . . 0 N--CA 1.489 1.522 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.01 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 54' ' ' TYR . 25.9 tp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.709 0.29 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.3 mm? -96.81 -71.9 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.488 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -101.54 133.48 44.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.83 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' HB3' HD21 ' A' ' 51' ' ' LEU . 44.9 p90 -122.48 20.23 10.39 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.954 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 1.6 tppp? -168.97 65.91 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.409 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 t 68.51 -66.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -138.64 11.78 2.72 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.749 -1.18 . . . . 0.0 113.078 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 55' ' ' LYS . 53.2 p-10 -75.18 -156.82 0.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.938 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -153.88 118.22 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.359 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.86 157.74 17.57 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.734 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 p -53.81 138.28 36.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.29 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.51 -26.0 7.66 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 52' ' ' LEU . 60.5 t -64.29 118.78 50.22 Favored Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.028 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.0 144.55 99.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.883 1.722 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.98 -36.21 17.04 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -26.86 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -84.3 107.28 16.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t -134.61 108.44 8.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.535 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.09 170.79 21.91 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.1 t -164.22 -165.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.916 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 151.89 113.39 0.57 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.807 -1.663 . . . . 0.0 111.899 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -98.74 100.63 11.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.1 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 -115.72 4.78 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.557 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 28' ' ' SER . 35.5 p -99.22 18.63 17.05 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.402 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 3.7 m-20 -129.25 136.06 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.582 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 69.5 m-85 -139.4 151.78 46.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.404 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ILE . 43.0 m -145.73 139.35 26.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.998 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -105.1 91.79 3.95 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.403 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -86.08 116.89 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.375 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.647 HG22 ' H ' ' A' ' 82' ' ' ARG . 37.0 mt -105.71 129.35 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.62 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -90.48 13.15 16.48 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.27 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -176.4 113.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.608 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 87' ' ' ASP . 65.6 t -99.04 143.47 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 15' ' ' LEU . 58.8 mt-10 -123.18 179.05 4.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.834 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.11 18.84 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.256 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -55.26 -29.92 59.05 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -63.52 -36.18 82.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.664 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 111' ' ' ILE . 31.3 mt -48.69 134.07 16.45 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.67 -146.99 12.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.47 112.55 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.281 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -78.78 138.85 38.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.701 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.95 164.21 28.49 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.336 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 105' ' ' GLY . 13.7 p -135.9 142.82 44.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.3 t -143.86 112.45 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.486 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -65.79 149.65 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.676 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.779 HG23 ' HB3' ' A' ' 37' ' ' TYR . 12.1 t -123.43 26.62 7.8 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 37' ' ' TYR . 24.0 m -92.09 -23.83 19.34 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.486 ' H ' HE22 ' A' ' 95' ' ' GLN . 59.2 m80 -127.88 136.52 51.5 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.715 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 100' ' ' PRO . 50.9 t -109.69 138.37 20.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.436 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HA ' HG13 ' A' ' 99' ' ' VAL . 5.5 Cg_endo -73.71 161.17 94.76 Favored 'Cis proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.634 -1.402 . . . . 0.0 111.757 -0.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.29 136.12 49.82 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.984 1.789 . . . . 0.0 110.75 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 2' ' ' VAL . 26.4 p -61.89 -51.05 69.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.085 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.6 t80 55.34 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.11 82.08 0.06 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 93' ' ' CYS . . . -93.99 -126.13 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.664 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 145.41 80.69 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.805 -1.664 . . . . 0.0 112.274 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' PRO . 97.1 m -154.5 108.39 2.94 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.629 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -79.01 149.32 32.25 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.939 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' CD2' HD23 ' A' ' 88' ' ' LEU . 4.2 tt -154.2 88.62 1.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 111' ' ' ILE . 6.4 pt-20 -122.23 38.62 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 74.95 168.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.757 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.671 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t -66.79 124.01 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.212 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 32' ' ' SER . 58.8 t-80 -69.69 173.34 6.26 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.472 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 75.0 m -69.93 73.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 176.64 -27.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.421 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 23.57 5.94 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.82 142.77 48.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m -113.12 129.38 56.53 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.736 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -97.6 -167.31 1.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.83 77.78 2.11 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 59.56 3.73 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -134.18 -163.99 1.44 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.699 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.23 124.03 74.49 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.602 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 155.98 49.91 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.849 1.699 . . . . 0.0 111.703 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -138.08 128.44 26.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.769 -0.773 . . . . 0.0 111.232 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp -101.57 131.96 47.48 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.794 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt -88.34 145.36 25.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.346 -1.788 . . . . 0.0 110.514 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.701 ' O ' HG21 ' A' ' 102' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.727 0.775 . . . . 0.0 110.636 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.546 HG23 ' C ' ' A' ' 1' ' ' ASP . 2.0 t 67.52 99.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 4' ' ' MET . 16.3 t -74.76 158.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.618 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 29' ' ' LEU . 84.2 mmm -122.43 101.99 7.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.986 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.91 136.95 37.42 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.321 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.487 ' CB ' ' HA2' ' A' ' 105' ' ' GLY . 6.5 tt0 -126.83 146.4 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.46 164.99 19.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.423 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 11' ' ' LEU . 7.0 Cg_endo -75.71 176.57 43.08 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.412 -1.495 . . . . 0.0 110.99 -1.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.78 -25.15 56.16 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -140.21 143.41 36.02 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.601 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 8' ' ' PRO . 1.7 tp -134.11 70.07 74.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.279 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.04 113.16 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.936 1.757 . . . . 0.0 111.238 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.01 170.36 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.505 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -111.27 89.84 3.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.106 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 14' ' ' SER . 67.2 mt -8.69 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.079 0.862 . . . . 0.0 112.871 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.87 -35.26 0.37 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.615 -1.278 . . . . 0.0 110.774 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.77 179.11 7.88 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -92.04 161.31 14.83 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.997 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.53 165.08 16.99 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.616 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -159.6 88.8 0.86 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.152 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 78' ' ' LEU . 7.3 mt -85.61 127.6 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.986 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -87.4 150.2 23.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.99 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.409 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -163.01 132.79 4.32 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.551 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 179.64 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -109.44 157.86 18.53 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.713 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 t -68.67 -23.21 64.38 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.76 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.63 -57.14 0.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.6 137.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.729 ' O ' HG21 ' A' ' 97' ' ' THR . 74.7 mt -88.36 -45.78 9.72 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 29' ' ' LEU . 76.2 t -36.62 125.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.879 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -64.03 169.21 4.53 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.068 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 m -49.44 -27.1 3.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.171 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.06 62.96 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.364 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.55 -131.65 2.61 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.013 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -128.42 179.11 5.83 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.134 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -87.9 76.48 8.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.578 ' HD2' HG23 ' A' ' 97' ' ' THR . 15.3 m-85 -74.09 122.84 23.32 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -141.51 132.99 26.83 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.035 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.609 ' N ' HD23 ' A' ' 38' ' ' LEU . 2.6 p-10 -124.95 127.01 46.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -94.44 175.07 6.82 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.514 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -160.55 168.16 25.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.88 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.7 tp -151.89 116.69 5.14 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.77 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 tt0 -93.84 132.2 38.48 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.433 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -161.31 0.83 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.124 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.37 7.67 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.53 53.89 0.52 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -103.48 135.52 44.92 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.476 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.618 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -90.97 -57.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.973 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 7.4 Cg_endo -73.59 99.86 1.19 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.623 1.548 . . . . 0.0 110.259 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -127.3 23.72 6.38 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.672 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -87.46 139.07 30.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.758 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 63' ' ' VAL . 32.0 mt -125.92 -39.82 2.08 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.01 HD11 ' NH2' ' A' ' 59' ' ' ARG . 16.8 mm -138.83 146.19 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.3 p90 -143.66 32.58 1.29 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.206 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -177.57 55.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 57' ' ' SER . 48.3 t 36.98 83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.253 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 79.18 70.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.941 0.877 . . . . 0.0 110.342 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -172.05 106.08 0.2 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.373 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 1.01 ' NH2' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.09 163.42 26.64 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 61' ' ' SER . 44.6 t80 -91.77 172.94 8.14 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 54.5 p -60.23 -47.04 87.64 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.434 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.75 50.92 2.91 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 119.595 -1.288 . . . . 0.0 112.321 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' NH1' ' A' ' 59' ' ' ARG . 44.3 t -141.49 122.88 8.93 Favored Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.1 164.23 32.89 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.993 1.795 . . . . 0.0 111.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 67' ' ' PHE . 6.6 p-10 -69.74 -7.4 39.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 8.1 mmt-85 -60.95 0.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.538 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 64.9 m-85 -122.68 155.98 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 t -161.61 112.05 1.65 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.51 147.11 18.31 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -161.46 -176.48 5.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 153.74 171.42 20.83 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.604 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -80.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.691 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.4 -49.16 0.06 OUTLIER Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -113.62 17.64 18.1 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.72 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.71 133.53 16.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 55.0 m-85 -147.03 168.93 20.32 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.455 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.7 m -152.76 141.76 21.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.341 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.552 HD23 ' C ' ' A' ' 78' ' ' LEU . 10.4 tt -113.22 112.63 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -110.3 151.68 27.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.468 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.835 HG22 ' H ' ' A' ' 82' ' ' ARG . 97.0 mt -124.71 139.65 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -23.99 63.58 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.004 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.835 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.9 ptm180 -170.17 113.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.8 110.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.931 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.02 172.03 8.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.603 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.96 73.64 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.141 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 -13.73 59.8 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.43 -26.33 58.25 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.752 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 15' ' ' LEU . 48.3 mt -53.74 150.19 7.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.89 178.9 17.76 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.945 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 mm -86.0 108.29 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.729 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.7 m-85 -77.38 156.42 31.23 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.617 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -143.7 164.66 29.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 93' ' ' CYS . 30.8 p -148.55 82.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.673 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -89.18 -178.35 5.63 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.007 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -135.22 157.8 45.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 96' ' ' THR . 8.0 t -127.29 45.22 2.76 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.729 HG21 ' O ' ' A' ' 29' ' ' LEU . 18.6 m -114.4 -52.62 2.71 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.509 ' CE1' HG21 ' A' ' 2' ' ' VAL . 65.7 m-70 -86.86 145.68 26.49 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.501 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 47.1 t -113.82 138.64 22.81 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.853 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -70.55 164.35 81.7 Favored 'Cis proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.668 -1.388 . . . . 0.0 111.504 -0.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.81 120.16 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.522 1.481 . . . . 0.0 110.67 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 1' ' ' ASP . 1.4 p -91.7 112.63 24.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -84.37 151.51 24.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.73 157.9 29.79 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.579 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 134.93 -175.74 20.41 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 141.74 55.11 0.04 OUTLIER Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.161 -1.495 . . . . 0.0 111.857 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.2 m -99.06 115.23 28.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.617 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 93.97 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.123 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.9 83.07 6.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.724 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 153.97 28.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.0 132.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.869 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -63.64 157.45 23.93 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.278 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 116.43 -1.747 . . . . 0.0 110.542 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.134 0.493 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 98' ' ' HIS . 88.2 t -61.61 111.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.725 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' N ' ' HB2' ' A' ' 26' ' ' SER . 46.8 t -69.0 153.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.313 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.403 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 30.1 mtp -135.06 92.8 2.92 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -79.19 121.1 24.62 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.016 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.54 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -97.8 129.05 44.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.721 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.31 151.56 37.2 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 107' ' ' THR . 8.1 Cg_endo -74.23 -179.82 27.24 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.716 -1.368 . . . . 0.0 111.648 0.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 -33.29 53.59 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.054 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 m -130.27 153.16 48.91 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.829 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 tp -143.3 73.63 17.68 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.97 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.41 106.58 1.25 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.886 1.724 . . . . 0.0 110.645 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.3 m -132.34 170.47 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.45 150.26 22.36 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD22 ' C ' ' A' ' 84' ' ' GLU . 33.9 mt -73.74 90.54 1.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.38 -21.3 1.07 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 18' ' ' GLN . 7.0 m-20 -84.54 -154.52 0.18 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.055 -0.572 . . . . 0.0 110.369 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 81' ' ' SER . 25.8 mt-30 -125.25 164.55 20.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.555 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.97 160.95 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.011 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 m -149.94 95.39 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mp -91.48 133.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.023 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -92.07 159.51 15.66 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.504 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 3.3 m -156.47 105.92 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.865 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -100.97 124.98 47.5 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.029 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 78.0 p -87.9 147.34 25.12 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.431 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -49.03 -68.17 0.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.742 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 59.46 1.55 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.59 ' CA ' HG22 ' A' ' 74' ' ' THR . 19.9 t 61.6 173.88 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.966 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD21 ' OE1' ' A' ' 95' ' ' GLN . 23.5 mt -131.73 21.36 4.63 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.535 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG22 ' OG1' ' A' ' 36' ' ' THR . 45.6 t -79.89 122.72 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.512 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.626 ' HB3' HD22 ' A' ' 33' ' ' ASN . 17.1 t-80 -66.13 179.17 0.98 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.011 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -75.73 60.92 1.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.817 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.626 HD22 ' HB3' ' A' ' 31' ' ' HIS . 2.9 p30 178.87 -30.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.59 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.09 0.37 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.702 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -120.05 105.37 10.96 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.069 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.562 ' OG1' HG22 ' A' ' 30' ' ' VAL . 10.4 m -93.18 140.99 28.92 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.485 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 156.78 41.61 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.654 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.552 HD22 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -173.31 105.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.54 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -96.54 105.26 17.33 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.625 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' NE1' HD22 ' A' ' 38' ' ' LEU . 43.2 m95 -84.94 148.76 26.06 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 103' ' ' PHE . 41.0 m-85 -136.72 157.24 47.22 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 91' ' ' TYR . 8.4 tp -136.7 110.43 8.1 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.79 121.77 37.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' CE ' ' HA ' ' A' ' 86' ' ' GLU . 7.4 tttt -90.65 173.81 7.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.27 90.31 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 45.77 38.73 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.285 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 161.7 35.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.47 144.68 99.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.263 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.11 130.1 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.899 1.732 . . . . 0.0 111.061 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -99.03 130.69 45.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 40' ' ' TRP . 21.9 tp -85.33 135.79 33.75 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 63' ' ' VAL . 39.4 mt -120.38 -55.56 2.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 59' ' ' ARG . 41.5 mm -120.11 158.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 30.1 p90 -138.17 -28.17 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.878 -1.129 . . . . 0.0 112.254 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -101.31 -51.29 3.53 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 57' ' ' SER . 7.4 p -178.31 -41.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.481 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.543 ' N ' HG13 ' A' ' 56' ' ' VAL . 8.9 t -138.47 -31.86 0.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.11 120.05 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 36.0 mtm-85 -77.54 157.65 30.27 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.295 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 85.4 t80 -73.77 160.41 31.53 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 38.2 t -62.6 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.349 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.7 -19.62 3.52 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 52' ' ' LEU . 40.7 t -81.54 118.5 72.45 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.62 155.98 39.52 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.917 1.745 . . . . 0.0 111.993 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.87 -19.29 6.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.219 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -49.52 -26.38 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.811 -0.755 . . . . 0.0 111.284 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD2' HD13 ' A' ' 52' ' ' LEU . 60.9 m-85 -100.57 128.22 46.7 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.507 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.7 p -141.8 128.59 20.49 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.259 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.36 150.53 18.4 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.63 147.54 10.38 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.217 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -166.07 125.89 1.4 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 m -95.1 67.29 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.79 -91.37 0.5 Allowed Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.114 -1.517 . . . . 0.0 112.144 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 28' ' ' SER . 37.1 p -121.9 1.55 9.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.348 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -106.16 97.81 7.57 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.954 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.604 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 73.4 m-85 -114.41 147.43 39.24 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 21' ' ' ILE . 17.1 m -149.83 133.88 17.09 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.002 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 8.4 tt -92.16 112.09 23.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.194 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -107.05 129.19 54.85 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 82' ' ' ARG . 5.1 mt -109.83 134.51 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.692 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 36.7 m -83.41 -19.14 36.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.276 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.1 mtt-85 -145.53 97.15 2.94 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.596 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 15' ' ' LEU . 51.6 t -75.68 117.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.354 -0.939 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.539 ' C ' HD22 ' A' ' 15' ' ' LEU . 7.6 mm-40 -115.65 172.53 7.07 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.989 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.5 12.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.714 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 1.3 mt-10 -68.45 -36.72 79.41 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -59.96 -15.02 18.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.842 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.43 136.46 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.608 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -167.42 27.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.25 118.43 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.689 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.716 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.1 m-85 -84.4 147.51 27.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.156 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -141.1 167.28 22.57 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.817 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.512 ' N ' HE22 ' A' ' 6' ' ' GLN . 24.1 p -155.95 102.13 2.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.1 p -88.63 171.25 10.16 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.516 ' OE1' HD21 ' A' ' 29' ' ' LEU . 3.4 pt20 -127.76 112.0 14.3 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.1 p -81.11 55.31 2.47 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.843 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 m -128.52 -53.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 2' ' ' VAL . 34.9 m-70 -100.31 177.49 5.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.179 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.456 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 96.7 t -145.9 135.51 11.57 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.495 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -70.87 139.61 58.9 Favored 'Cis proline' 0 C--N 1.317 -1.1 0 C-N-CA 123.558 -1.434 . . . . 0.0 111.462 -0.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 100' ' ' PRO . 1.1 Cg_endo -65.75 118.48 5.52 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.717 1.611 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.4 p -66.45 160.57 24.65 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.946 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -112.39 38.2 2.8 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.736 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.68 -178.93 31.29 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.464 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -90.83 -50.53 2.86 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 6' ' ' GLN . . . 127.57 95.4 0.88 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.056 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' PRO . 93.8 m -100.37 120.77 40.46 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.11 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -78.5 118.43 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tt -113.16 100.54 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.77 159.28 23.28 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 tt -65.14 168.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.558 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tmtt? -81.74 152.89 26.81 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.956 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.351 -1.785 . . . . 0.0 110.529 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.358 0.599 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.403 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t -140.3 135.49 36.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.92 132.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.278 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 54.5 mmm -125.46 93.5 3.88 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 m -78.71 116.08 18.83 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.616 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 1.2 mp0 -101.83 148.9 24.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.927 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.58 163.12 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.501 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.716 ' HG2' HD12 ' A' ' 11' ' ' LEU . 8.2 Cg_endo -77.41 177.29 40.04 Favored 'Cis proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.59 -1.421 . . . . 0.0 110.711 -1.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.9 -26.61 63.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 95.7 p -145.43 146.64 31.6 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.701 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.716 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -130.19 78.19 75.02 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.93 108.53 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.862 1.708 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 12.5 m -144.52 153.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.249 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.93 152.18 26.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.616 ' HG ' HD11 ' A' ' 111' ' ' ILE . 62.3 mt -69.89 88.76 0.57 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.65 -27.81 0.6 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.82 171.25 15.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 95.4 mt-30 -87.16 134.25 33.55 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.331 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -107.01 155.18 20.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.404 ' H ' HD21 ' A' ' 11' ' ' LEU . 25.6 m -149.09 97.76 2.73 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.992 HG23 HG21 ' A' ' 107' ' ' THR . 26.6 mt -84.17 161.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.786 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.6 t -122.17 146.22 47.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.692 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.616 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.9 m -150.34 104.92 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -112.14 134.68 53.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.801 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 29' ' ' LEU . 54.5 p -98.51 152.29 19.71 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.297 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 p -73.02 -35.12 66.72 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 28' ' ' SER . 7.3 tp60 -121.12 148.72 43.81 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HA ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -50.3 142.91 9.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.26 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 25' ' ' SER . 69.1 mt -108.55 43.35 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -102.14 135.5 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CG ' ' H ' ' A' ' 32' ' ' SER . 4.3 t-80 -81.53 -161.01 0.39 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.796 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.542 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 61.4 m -78.61 34.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 31' ' ' HIS . 50.4 p-10 -166.98 -158.03 0.28 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.35 52.62 2.11 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.442 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -140.1 145.2 37.31 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.259 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 29' ' ' LEU . 17.2 m -123.35 120.4 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.977 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' A' ' 97' ' ' THR . 6.3 m-30 -86.65 72.86 10.15 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG ' ' A' ' 76' ' ' PHE . 4.0 tt -119.34 132.59 55.89 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.532 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' HB2' HD11 ' A' ' 51' ' ' LEU . 5.1 p30 -126.14 165.48 18.8 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.524 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.731 ' CE3' HD12 ' A' ' 78' ' ' LEU . 50.9 m95 -114.52 154.32 28.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.0 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.21 163.5 29.47 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.632 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 91' ' ' TYR . 18.6 tp -155.66 136.99 13.95 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -115.92 123.29 47.72 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.575 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 17.7 tptp -88.31 155.89 19.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.643 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' N ' ' HG3' ' A' ' 44' ' ' LYS . . . -62.11 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.709 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 52.51 25.73 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.578 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 1.1 tp-100 -142.82 -167.11 2.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.204 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 p -92.7 112.84 57.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.0 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.19 158.13 56.28 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.666 1.577 . . . . 0.0 111.669 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -144.77 165.76 27.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.609 HD23 ' CG ' ' A' ' 60' ' ' PHE . 34.7 tp -86.77 140.14 30.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.614 ' O ' HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -96.52 -72.41 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.986 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 54' ' ' TYR . 30.2 mm -120.28 164.67 16.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.479 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' N ' HG22 ' A' ' 53' ' ' ILE . 35.5 p90 -155.69 156.44 34.93 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 13.6 mttm 48.25 22.33 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.923 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' TYR . 78.4 t 63.89 127.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.568 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p 41.94 56.86 3.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.834 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 9.8 m120 -127.67 -21.73 3.71 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.358 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HA ' HD13 ' A' ' 53' ' ' ILE . 3.8 mtt180 54.47 101.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.97 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' HD23 ' A' ' 51' ' ' LEU . 35.0 t80 -60.25 160.21 8.76 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.638 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p -56.27 112.51 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.621 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.23 7.64 20.77 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 52' ' ' LEU . 78.7 t -112.05 104.57 56.12 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.37 155.08 43.0 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.002 1.801 . . . . 0.0 112.078 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.16 -15.81 0.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.789 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -51.98 -34.96 44.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.774 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HD2' HD21 ' A' ' 78' ' ' LEU . 90.3 m-85 -95.15 129.28 42.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.881 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.86 93.28 3.28 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.7 106.27 2.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.628 -1.272 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.6 m -113.68 -176.64 2.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.047 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 154.14 117.8 0.65 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.9 t -98.1 67.76 1.92 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.144 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.76 -109.51 1.48 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.549 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 28' ' ' SER . 65.3 p -101.95 9.65 40.36 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 8.2 p-10 -113.73 139.49 49.05 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 96.7 m-85 -147.82 156.27 42.54 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 21' ' ' ILE . 28.7 m -150.04 152.75 35.34 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.752 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.731 HD12 ' CE3' ' A' ' 40' ' ' TRP . 6.8 tt -115.96 92.74 3.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 6.1 mttt -92.23 126.89 37.5 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.006 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 19' ' ' ALA . 18.7 mt -114.42 132.44 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.059 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -60.16 -73.64 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.275 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.693 HH12 ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -123.39 100.44 6.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.526 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 87' ' ' ASP . 72.3 t -54.33 145.89 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.983 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.693 ' CG ' HH12 ' A' ' 82' ' ' ARG . 2.4 mm-40 -126.48 172.84 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.478 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.73 -29.67 54.15 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.49 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 15.3 mm-40 -66.19 -41.1 90.68 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' CB ' HG13 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -52.33 -33.06 41.02 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.083 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 111' ' ' ILE . 39.8 mt -53.81 130.87 38.46 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.7 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.47 8.75 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.9 mp -125.64 116.58 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.644 ' CE2' HD13 ' A' ' 42' ' ' LEU . 3.4 m-85 -88.53 153.71 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.159 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' HG22 ' A' ' 90' ' ' ILE . 61.2 m-85 -154.76 179.96 8.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.215 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.1 p -165.22 163.36 20.23 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.942 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.471 ' CB ' ' CD2' ' A' ' 103' ' ' PHE . 8.4 t -147.03 -173.32 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.834 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 2.7 pt20 -136.54 108.12 6.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.123 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -82.84 43.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.047 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -114.17 -58.16 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.849 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.403 ' CG ' HG21 ' A' ' 2' ' ' VAL . 78.9 m-70 -88.76 171.78 9.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.297 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 100' ' ' PRO . 57.4 t -139.17 138.72 21.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.1 Cg_endo -71.39 148.8 90.88 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.276 -1.552 . . . . 0.0 111.336 -1.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.62 113.4 1.94 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.762 1.641 . . . . 0.0 110.084 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 87.39 4.56 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 94' ' ' SER . 1.5 t80 -83.5 111.46 19.08 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.882 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.89 152.21 6.61 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -167.34 -128.18 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.06 100.27 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 C-N-CA 117.641 -2.218 . . . . 0.0 113.632 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.992 HG21 HG23 ' A' ' 21' ' ' ILE . 96.7 m -158.35 104.17 1.83 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -89.82 156.19 18.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.396 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 93.89 3.15 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.816 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 111' ' ' ILE . 17.3 pt-20 -106.82 31.94 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.696 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.616 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER 61.91 170.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 111' ' ' ILE . 3.9 tttm -77.41 138.72 39.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.018 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.427 -1.749 . . . . 0.0 110.618 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.688 0.756 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 29' ' ' LEU . 64.1 t 62.07 99.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.553 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.06 116.27 17.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mtp -93.94 89.76 6.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.054 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -77.08 112.23 13.5 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.64 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.698 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 38.1 tt0 -100.05 154.95 17.99 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -161.45 161.4 22.91 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.307 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 107' ' ' THR . 6.7 Cg_endo -77.03 178.12 36.68 Favored 'Cis proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.522 -1.449 . . . . 0.0 110.314 -2.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 9' ' ' LEU . 4.4 mm? -63.26 -21.56 66.32 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.469 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 p -154.83 152.38 29.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.607 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 3.5 tp -129.59 77.51 77.02 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.019 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.43 102.75 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.699 1.599 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 34.3 m -137.17 -167.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.805 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.22 153.0 34.61 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 111' ' ' ILE . 63.9 mt -75.46 87.03 2.6 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.443 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.64 -26.34 0.52 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.58 -170.65 2.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.42 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -106.4 139.5 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.263 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -113.34 146.13 39.94 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.397 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 p -138.23 92.03 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.492 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.518 HG23 HG21 ' A' ' 107' ' ' THR . 4.8 mt -89.56 126.44 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.08 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.1 156.56 20.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.118 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 29.0 m -162.02 111.73 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.251 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -111.22 140.66 45.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -94.54 167.04 11.74 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.931 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -41.03 26.32 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.316 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -136.77 43.77 2.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.433 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.471 ' C ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 m 61.02 -174.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.849 ' CD1' HD12 ' A' ' 38' ' ' LEU . 13.2 mt -142.92 21.34 1.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -77.11 138.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.169 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -64.92 170.88 3.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.996 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -51.02 -35.27 33.33 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -158.37 39.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -128.38 -129.4 3.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -122.4 -159.15 0.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.201 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 29' ' ' LEU . 11.9 m -109.51 96.57 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.409 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.79 68.91 7.2 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.007 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 29' ' ' LEU . 1.4 tt -89.76 142.13 27.98 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.666 ' OD1' HD12 ' A' ' 51' ' ' LEU . 9.1 t30 -122.42 162.2 22.08 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.077 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.741 ' CD2' HD12 ' A' ' 78' ' ' LEU . 50.6 m95 -125.31 154.31 41.96 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.509 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.86 146.24 50.68 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp -162.7 128.42 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -173.42 170.48 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.258 -1.377 . . . . 0.0 112.678 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -111.37 -158.66 0.65 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.413 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' H ' ' HG3' ' A' ' 44' ' ' LYS . . . -55.98 -19.99 14.67 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.211 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.24 83.79 0.04 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.84 -72.52 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 38.5 p -86.94 161.48 46.97 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.117 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 3.3 Cg_exo -62.66 172.24 4.82 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.734 1.622 . . . . 0.0 110.385 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -124.26 65.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.439 -0.904 . . . . 0.0 112.192 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.666 HD12 ' OD1' ' A' ' 39' ' ' ASN . 1.2 tp -172.54 97.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.907 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.29 -89.07 0.19 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.664 HG21 ' H ' ' A' ' 57' ' ' SER . 2.8 mp -82.43 145.3 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.787 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.513 ' CZ ' ' ND2' ' A' ' 58' ' ' ASN . 42.2 p90 -139.46 -7.51 1.31 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.428 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -130.84 57.7 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.574 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 56' ' ' VAL . 5.9 p 38.05 79.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.046 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.664 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 69.26 75.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.444 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.513 ' ND2' ' CZ ' ' A' ' 54' ' ' TYR . 0.4 OUTLIER -151.0 -24.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER 70.49 137.55 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.051 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' N ' ' A' ' 61' ' ' SER . 79.4 t80 -90.77 172.22 8.79 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 t -57.89 117.4 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.33 -8.21 54.99 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG21 ' H ' ' A' ' 60' ' ' PHE . 94.8 t -84.96 124.79 72.04 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.25 144.28 95.96 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 122.136 1.891 . . . . 0.0 112.143 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 3.0 t0 -58.26 -25.25 61.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.326 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.7 69.35 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' O ' ' NH1' ' A' ' 59' ' ' ARG . 10.0 m-85 -79.91 126.52 31.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.3 m -134.77 159.36 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.236 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -152.44 79.53 0.2 Allowed Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.069 -1.538 . . . . 0.0 111.297 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 8.8 t -83.3 -167.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 151.55 117.26 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.539 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -92.35 91.35 7.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.87 -75.15 0.91 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.6 p -131.65 57.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.525 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 25.9 t0 -162.62 58.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.659 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 58.2 m-85 -80.19 148.79 30.72 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 m -148.97 122.8 9.31 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.733 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 40' ' ' TRP . 4.4 tt -84.68 104.56 14.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -96.12 119.98 35.59 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.309 -0.957 . . . . 0.0 111.99 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.502 HG13 HD23 ' A' ' 78' ' ' LEU . 7.8 mt -109.51 116.17 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.352 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -69.89 -24.45 63.4 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.875 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.1 mmt-85 -142.61 110.62 5.95 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.853 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -86.73 136.52 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.6 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' C ' HD22 ' A' ' 15' ' ' LEU . 2.9 mt-10 -129.54 170.06 14.21 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.522 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -43.73 59.41 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.301 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.9 -37.67 85.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.37 -21.62 50.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 109' ' ' LEU . 78.6 mt -58.96 146.23 38.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.173 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.41 -154.58 25.19 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 92' ' ' PHE . 20.9 mt -112.41 140.55 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.125 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -104.42 150.64 24.35 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.664 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 90' ' ' ILE . 40.5 m-85 -151.08 135.18 16.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.768 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -109.11 141.12 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.857 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 9.3 p -144.23 -164.68 1.95 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 29' ' ' LEU . 5.5 pm0 -159.14 165.87 32.79 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.505 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.6 p -109.2 -21.68 12.45 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' LEU . 10.3 m -53.16 -55.26 25.53 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.359 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CG ' HG21 ' A' ' 2' ' ' VAL . 37.9 m-70 -88.17 131.71 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.529 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 62.3 t -135.16 137.44 26.83 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.2 Cg_endo -68.27 136.71 36.4 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.539 -0.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.48 155.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.928 1.752 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.18 -64.56 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 65.58 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.869 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.01 64.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -65.95 -84.67 0.09 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.63 75.05 0.59 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.317 -1.42 . . . . 0.0 112.445 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.518 HG21 HG23 ' A' ' 21' ' ' ILE . 19.9 m -148.86 106.95 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.553 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.69 139.79 32.55 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.852 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 88' ' ' LEU . 7.6 tt -131.67 107.27 8.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.197 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -131.33 32.89 4.16 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.162 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.742 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 66.08 163.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.96 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -88.96 57.9 4.33 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.587 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 116.254 -1.832 . . . . 0.0 111.049 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.451 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.949 0.404 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG12 ' OG ' ' A' ' 25' ' ' SER . 11.6 t -69.65 94.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' N ' ' HB2' ' A' ' 26' ' ' SER . 16.9 t -63.14 155.85 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.689 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.5 mmm -133.46 110.44 9.98 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.697 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -80.14 147.6 31.28 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.657 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 5.3 mp0 -118.75 143.33 46.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.342 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 141.93 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 11' ' ' LEU . 9.6 Cg_endo -79.35 175.16 46.9 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.586 -1.422 . . . . 0.0 111.159 -0.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.37 -22.82 59.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 p -139.7 148.86 42.94 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 21' ' ' ILE . 4.6 tp -126.87 78.57 73.54 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.4 102.74 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.818 1.679 . . . . 0.0 111.061 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 14' ' ' SER . 8.6 m -132.77 -154.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 13' ' ' VAL . 3.3 t -147.06 154.02 40.68 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.907 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 84' ' ' GLU . 14.6 mt -68.56 87.47 0.32 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 82' ' ' ARG . . . 147.04 -31.58 1.44 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.53 173.06 11.99 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.248 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -89.07 166.94 13.54 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.039 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -147.98 161.12 41.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.218 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -157.58 109.97 2.4 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.757 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.565 HG13 HD22 ' A' ' 11' ' ' LEU . 2.2 mp -101.02 118.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 t -93.7 158.43 15.68 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.155 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.3 t -160.9 117.86 2.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -104.3 172.07 6.99 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.422 ' OG ' HG12 ' A' ' 2' ' ' VAL . 1.8 t -116.86 167.43 11.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 14.9 t -67.87 -27.18 66.45 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.39 -59.68 0.34 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.269 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.71 155.35 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.676 ' O ' HG21 ' A' ' 97' ' ' THR . 83.6 mt -114.53 6.86 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.48 137.8 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -66.32 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.277 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -91.0 -57.39 2.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.51 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -175.84 41.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.59 -53.12 0.14 Allowed Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.223 -1.465 . . . . 0.0 111.006 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -76.96 132.98 39.31 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.698 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -132.26 137.57 47.56 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.793 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' H ' ' CG2' ' A' ' 97' ' ' THR . 22.6 m-85 -122.73 109.42 14.22 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -130.54 133.54 46.31 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.854 ' ND2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -110.51 149.01 30.95 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.454 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.584 ' O ' HD12 ' A' ' 51' ' ' LEU . 22.8 m95 -111.89 172.48 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 162.72 31.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.482 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 91' ' ' TYR . 19.7 tp -151.25 127.13 10.32 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.37 113.36 26.84 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.852 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.72 167.76 21.26 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.134 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.38 84.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.904 -0.719 . . . . 0.0 112.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LYS . . . 68.99 33.23 74.2 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.7 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 1.1 tt0 -123.6 167.44 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.267 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 t -60.87 121.3 60.78 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.987 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.56 151.94 80.44 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.028 1.819 . . . . 0.0 111.394 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -134.82 152.39 51.71 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.854 HD13 ' ND2' ' A' ' 39' ' ' ASN . 9.1 tp -95.36 139.45 31.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.839 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -101.97 -55.67 2.44 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.799 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.756 HG21 ' H ' ' A' ' 57' ' ' SER . 51.6 mm -124.49 137.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.043 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.704 ' HB3' HD21 ' A' ' 51' ' ' LEU . 37.2 p90 -113.12 -30.65 6.9 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.618 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -124.33 48.41 1.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 58' ' ' ASN . 40.8 t 56.12 103.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.376 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.756 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.7 OUTLIER 76.48 -29.37 0.18 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 56' ' ' VAL . 12.3 m-20 -69.35 94.66 0.73 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.973 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 53' ' ' ILE . 4.1 mtm180 -66.76 136.97 56.28 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' VAL . 25.8 t80 -57.2 157.48 6.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -53.44 -22.73 8.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.734 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.26 31.9 6.64 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 60' ' ' PHE . 38.8 t -120.44 125.89 27.0 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.671 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.61 149.89 73.1 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.241 1.961 . . . . 0.0 112.436 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.23 -25.46 65.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.986 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -53.95 -35.84 62.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.88 129.37 34.43 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 t -137.25 138.65 40.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.546 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -124.03 131.72 8.08 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 p -156.19 146.92 21.91 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.203 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -170.94 114.48 0.54 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -95.34 145.2 25.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.201 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.75 -101.01 0.42 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.909 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 p -131.04 21.66 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.71 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 5.9 m-20 -122.17 124.04 42.93 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 23.8 m-85 -131.47 155.3 47.61 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 25.8 m -159.49 139.57 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.578 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.4 tt -95.56 104.53 16.45 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.19 129.24 38.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.692 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.721 HG22 ' H ' ' A' ' 82' ' ' ARG . 32.1 mt -116.81 128.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.468 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.1 m -85.13 2.33 43.99 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.706 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -171.37 112.5 0.35 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.841 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.5 t -91.75 150.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.34 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' C ' HD22 ' A' ' 15' ' ' LEU . 4.3 mt-10 -137.28 167.15 22.15 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.197 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.86 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.227 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -66.15 -29.66 69.99 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.769 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.42 -19.98 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 109' ' ' LEU . 78.8 mt -65.98 137.08 56.88 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.855 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.15 -137.71 5.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.59 106.69 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.485 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.477 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.28 130.43 36.21 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.311 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 1.2 m-85 -118.11 166.61 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.657 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 14.7 p -134.85 152.46 51.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -156.25 155.9 33.15 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.536 ' CB ' HD22 ' A' ' 29' ' ' LEU . 4.0 pt20 -112.39 163.04 14.89 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.5 m -144.89 46.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.676 HG21 ' O ' ' A' ' 29' ' ' LEU . 2.1 p -124.64 -44.17 1.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -99.5 142.2 31.3 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.5 p -109.18 137.22 20.13 Favored Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 6.1 Cg_endo -74.55 146.45 86.79 Favored 'Cis proline' 0 C--N 1.316 -1.173 0 C-N-CA 123.528 -1.447 . . . . 0.0 111.494 -0.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.04 125.49 15.98 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.72 1.613 . . . . 0.0 110.156 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.451 ' CG2' ' HB2' ' A' ' 1' ' ' ASP . 38.3 p -91.22 107.37 19.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -94.27 139.42 31.07 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.098 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -167.85 -141.05 3.06 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.363 -1.398 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 92' ' ' PHE . . . 132.58 175.19 13.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.22 79.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.48 HG21 HG23 ' A' ' 21' ' ' ILE . 93.1 m -149.91 107.41 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.185 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -75.9 93.61 3.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 88' ' ' LEU . 5.0 tt -89.35 83.89 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.3 tt0 -124.96 54.97 1.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.143 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.671 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER 54.82 176.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.416 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 111' ' ' ILE . 31.8 mtpt -71.0 124.06 23.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.869 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.539 HH12 HG22 ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 116.402 -1.761 . . . . 0.0 110.702 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.999 0.428 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CG ' ' A' ' 98' ' ' HIS . 69.0 t -53.74 110.82 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 4' ' ' MET . 17.1 t -68.61 161.0 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.659 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.472 ' N ' HG12 ' A' ' 3' ' ' VAL . 82.0 mmm -139.25 101.46 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -91.89 103.45 15.99 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -107.35 166.31 10.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.743 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.67 170.35 8.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.583 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 12.1 Cg_endo -83.72 173.8 41.67 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.794 -1.336 . . . . 0.0 110.72 -2.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.3 mt -72.88 -16.69 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.126 -1.029 . . . . 0.0 109.626 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.0 p -154.14 136.18 14.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tp -122.72 86.32 49.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.269 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.68 116.81 4.61 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.64 1.56 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.579 HG21 HG11 ' A' ' 83' ' ' VAL . 35.8 m -141.86 -172.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -114.42 145.75 41.46 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.08 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 111' ' ' ILE . 38.6 mt -70.35 89.43 0.67 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.4 -1.04 3.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -95.71 -135.17 0.22 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 167.57 21.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.706 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -150.06 168.79 22.88 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 19.7 p -160.38 91.72 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mt -78.3 125.86 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 7' ' ' THR . 32.4 t -85.57 157.4 20.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.268 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 2.0 m -161.89 106.11 1.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.161 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' NH1' ' O ' ' A' ' 74' ' ' THR . 55.7 ttm-85 -106.49 144.89 32.52 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.91 154.8 17.77 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -63.93 -72.03 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.22 48.61 1.02 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t 67.97 176.28 0.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.77 ' C ' HG21 ' A' ' 97' ' ' THR . 55.6 mt -124.78 52.7 1.53 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.617 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 35' ' ' ASN . 35.1 t -106.65 130.94 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.474 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 45.2 t-80 -82.44 171.69 13.87 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.301 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.441 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 58.3 m -77.1 37.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.568 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' HIS . 4.0 p30 175.27 -28.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.324 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' H ' ' HB3' ' A' ' 31' ' ' HIS . . . -78.16 -131.04 0.6 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.636 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.805 ' O ' HG22 ' A' ' 30' ' ' VAL . 6.2 m-80 -158.86 -67.78 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.688 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -157.16 126.5 6.01 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.761 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -134.28 139.6 45.83 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.425 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.683 HD13 ' CG ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -162.26 149.67 13.98 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.115 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 4.4 p-10 -137.72 170.89 15.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.184 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE2' HD13 ' A' ' 78' ' ' LEU . 70.1 m95 -131.9 164.04 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.525 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 1.5 m-85 -154.73 131.57 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.507 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.755 HD23 ' HD3' ' A' ' 50' ' ' LYS . 5.4 tp -116.16 117.49 30.21 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.798 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 42' ' ' LEU . 13.6 tm0? -101.42 140.2 36.05 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.865 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -114.04 165.06 13.01 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.493 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.81 111.03 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.844 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.68 46.16 13.02 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 29.9 tt0 -135.39 154.06 51.6 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.171 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.0 p -61.92 122.48 72.27 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.231 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.56 113.97 1.78 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.674 1.583 . . . . 0.0 111.472 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.755 ' HD3' HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -77.27 156.72 31.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.959 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 52' ' ' LEU . 5.9 tp -114.53 139.3 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.354 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 67' ' ' PHE . 17.5 mt -113.42 -90.08 0.52 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.183 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.748 HD13 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -82.66 145.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -139.36 -7.19 1.34 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tptt -139.78 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 5.8 t 76.4 -47.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.977 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -171.77 45.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.08 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.86 -36.57 11.59 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 68.31 134.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' H ' HG21 ' A' ' 63' ' ' VAL . 4.7 t80 -81.08 168.08 19.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -60.17 -33.12 71.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.02 11.38 22.27 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.756 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.583 HG21 ' H ' ' A' ' 60' ' ' PHE . 21.3 t -104.46 128.08 27.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.436 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.2 Cg_endo -67.17 19.34 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.119 1.879 . . . . 0.0 112.92 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 63' ' ' VAL . 15.4 t70 68.7 -37.07 0.34 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -52.72 -18.32 1.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.492 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.605 ' O ' HD11 ' A' ' 53' ' ' ILE . 57.0 m-85 -87.92 92.81 9.27 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.208 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 m -109.94 158.44 18.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.042 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.04 14.95 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.574 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.6 t -148.41 168.03 23.71 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.74 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.665 ' CA ' ' CD2' ' A' ' 76' ' ' PHE . . . -173.19 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.001 -1.571 . . . . 0.0 111.524 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -92.79 51.92 1.78 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -59.53 4.27 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.72 -1.228 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.423 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 3.8 p -125.63 34.47 4.9 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.766 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.05 106.81 1.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.316 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 11.6 m-85 -128.59 145.29 51.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.395 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 78' ' ' LEU . 19.6 m -149.78 170.85 17.78 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.682 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.748 HD11 HD13 ' A' ' 53' ' ' ILE . 4.7 tp -134.67 94.79 3.24 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.557 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -77.96 111.52 13.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.582 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' ALA . 77.2 mt -91.54 117.98 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -92.5 89.01 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.264 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.598 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 104.09 76.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.475 1.109 . . . . 0.0 110.464 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 13' ' ' VAL . 72.2 t -67.59 100.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' HH12 ' A' ' 66' ' ' ARG . 50.6 mt-10 -94.67 179.03 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.19 -28.44 40.6 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.686 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.97 -51.42 70.12 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' OD2' HD13 ' A' ' 80' ' ' ILE . 4.4 m-20 -47.39 -26.33 1.28 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 111' ' ' ILE . 51.1 mt -56.57 144.58 31.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.36 -134.72 8.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -133.62 119.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.519 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 3.8 m-85 -89.44 146.75 24.43 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.78 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.82 175.23 9.78 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.33 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.456 ' H ' ' HA3' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -160.72 159.05 29.7 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.966 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 t -151.24 178.1 9.57 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.606 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.563 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -129.44 124.85 35.14 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.613 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.3 p -93.15 4.19 54.42 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.77 HG21 ' C ' ' A' ' 29' ' ' LEU . 99.5 m -70.64 -57.71 4.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CG ' HG21 ' A' ' 2' ' ' VAL . 75.7 m-70 -91.45 94.51 9.5 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.407 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 100' ' ' PRO . 14.7 p -74.97 139.11 72.91 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' A' ' 99' ' ' VAL . 5.4 Cg_endo -72.85 142.83 75.81 Favored 'Cis proline' 0 C--N 1.318 -1.05 0 C-N-CA 123.726 -1.364 . . . . 0.0 111.781 -0.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.25 112.32 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.863 1.709 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.2 p -72.77 84.84 1.21 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 16.8 t80 -76.83 155.04 33.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 168.17 -52.54 0.22 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 118.822 -1.656 . . . . 0.0 111.354 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 93' ' ' CYS . . . 50.19 -138.05 22.77 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.159 -1.495 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.94 85.12 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.282 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 21' ' ' ILE . 17.3 m -152.84 109.45 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.748 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.97 97.23 9.69 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.269 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -90.69 84.23 5.86 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.161 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.6 57.18 0.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.456 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.693 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER 54.88 178.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.708 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.693 ' N ' HG23 ' A' ' 111' ' ' ILE . 1.2 tppt? -80.15 147.94 31.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.078 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.417 HH11 ' CG ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 116.387 -1.768 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.068 0.461 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 98' ' ' HIS . 65.1 t -69.91 120.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.999 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.1 150.81 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.662 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.63 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 50.7 mtp -133.5 -174.22 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.507 0.67 . . . . 0.0 109.694 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -156.55 152.06 26.83 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -140.34 150.18 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.044 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.55 166.87 15.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 5.0 Cg_endo -74.59 178.41 34.32 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.717 -1.368 . . . . 0.0 110.846 -1.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -36.95 78.05 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.53 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.3 t -140.24 147.55 40.18 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.063 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tp -134.1 83.18 46.16 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.406 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' C ' ' HG3' ' A' ' 112' ' ' LYS . 2.0 Cg_endo -68.05 101.17 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.839 1.692 . . . . 0.0 110.241 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.74 -167.78 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.884 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -127.35 147.73 50.26 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 85' ' ' ALA . 17.7 mt -67.78 89.34 0.26 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.667 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.92 -6.8 2.36 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.65 -152.16 0.27 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -125.05 155.93 38.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.67 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HB2' HG21 ' A' ' 83' ' ' VAL . . . -129.75 163.53 25.98 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.449 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.7 p -163.32 94.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.423 HG23 ' OG1' ' A' ' 107' ' ' THR . 2.7 mp -91.36 129.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.018 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 37.0 m -87.96 159.39 18.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.966 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 2.1 t -160.74 137.11 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.672 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.41 45.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.966 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 m -110.77 146.83 35.67 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.319 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -52.14 -38.01 56.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -133.25 167.0 21.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -63.52 137.99 58.34 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 29' ' ' LEU . 77.2 mt -94.39 23.48 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.208 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.41 139.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 7.9 t-80 -88.43 -140.4 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.704 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.405 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 17.8 p -68.01 -74.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.408 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -132.95 124.31 27.56 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.588 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.79 20.65 1.25 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.115 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 8.4 m-80 -106.28 91.05 3.55 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.607 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.2 m -101.93 152.79 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.36 137.39 37.28 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.169 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 21.1 tp -172.63 151.51 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -154.72 120.71 5.22 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 29.6 m95 -87.93 149.68 23.92 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.546 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HB3' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -123.7 155.68 37.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.574 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.662 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 6.4 tp -150.91 117.11 5.62 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.499 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -111.94 130.45 55.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -77.9 167.11 22.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.63 -34.86 27.84 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.181 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.7 48.33 0.54 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.543 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 30.7 tt0 -144.42 158.76 43.59 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.6 p -61.68 138.09 95.16 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.5 Cg_endo -65.83 113.25 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.806 1.671 . . . . 0.0 111.235 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -90.53 133.11 35.3 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.069 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 54' ' ' TYR . 16.0 tp -71.32 124.7 25.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 67' ' ' PHE . 33.2 mt -95.48 -88.94 0.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.241 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 59' ' ' ARG . 44.0 mm -88.82 123.05 40.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.028 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' A' ' 51' ' ' LEU . 36.0 p90 -110.48 20.17 18.01 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.374 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.14 143.77 1.56 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.89 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.626 HG13 ' H ' ' A' ' 71' ' ' GLY . 43.1 t -44.09 106.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.06 71.21 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.419 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.491 ' ND2' ' CE2' ' A' ' 54' ' ' TYR . 0.1 OUTLIER -170.71 110.65 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.359 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HA ' HD13 ' A' ' 53' ' ' ILE . 24.6 mtm-85 -77.33 139.76 39.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.847 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 68.7 t80 -69.85 160.13 32.36 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.408 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 5.3 m -40.25 -53.73 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.86 57.44 3.7 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 60' ' ' PHE . 88.9 t -144.59 113.9 5.12 Favored Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.105 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 159.77 37.45 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.966 1.778 . . . . 0.0 111.938 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -58.08 -27.46 63.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.549 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' CG ' ' HB2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -43.71 -42.12 5.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.322 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 52' ' ' LEU . 64.7 m-85 -82.51 124.51 30.17 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.623 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -124.63 151.86 44.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.722 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.35 155.11 25.94 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.772 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -149.78 141.83 23.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' H ' HG13 ' A' ' 56' ' ' VAL . . . -137.42 128.45 4.32 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.92 -1.609 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 m -94.73 -124.55 0.11 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.17 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.14 -55.89 1.25 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 p -125.27 20.65 8.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.972 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -132.11 143.25 49.88 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CD1' HD22 ' A' ' 38' ' ' LEU . 40.4 m-85 -151.13 136.42 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 m -139.37 140.92 37.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.597 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 1.8 tt -117.63 111.05 18.66 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.161 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -120.81 138.14 54.18 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.196 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 19' ' ' ALA . 2.8 mp -105.85 138.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -72.09 -36.17 69.43 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.434 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HB2' ' CG ' ' A' ' 66' ' ' ARG . 3.9 mtt180 -135.25 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.058 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 19' ' ' ALA . 58.1 t -65.8 111.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.387 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 66' ' ' ARG . 24.4 mt-10 -106.65 177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 15' ' ' LEU . . . -52.75 -31.75 39.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.16 -32.81 74.17 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -20.16 66.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 109' ' ' LEU . 72.9 mt -58.53 139.94 54.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -173.42 23.04 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.419 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 90' ' ' ILE . 5.4 mp -85.25 158.56 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.662 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 13.2 m-85 -131.51 148.77 52.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.693 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -147.21 165.13 30.99 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.262 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 22.8 p -132.7 102.92 5.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 38' ' ' LEU . 5.2 m -83.17 164.32 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.145 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -130.38 118.2 20.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.633 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.22 22.02 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.9 m -89.11 -40.41 12.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.801 -0.759 . . . . 0.0 111.737 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.557 ' CE1' HG21 ' A' ' 2' ' ' VAL . 32.8 m80 -119.34 152.4 36.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.673 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 68.0 t -113.86 137.76 22.46 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.61 142.3 73.96 Favored 'Cis proline' 0 C--N 1.317 -1.112 0 C-N-CA 123.589 -1.421 . . . . 0.0 111.805 -0.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.69 110.81 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.841 1.694 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -64.85 147.86 52.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.71 -74.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.69 -137.49 8.29 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.598 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.679 ' N ' ' HB3' ' A' ' 92' ' ' PHE . . . 114.0 90.6 1.8 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -151.46 8.76 0.66 Allowed Glycine 0 N--CA 1.483 1.827 0 C-N-CA 117.908 -2.091 . . . . 0.0 113.909 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 91' ' ' TYR . 30.6 m -147.73 138.53 23.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.885 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -113.6 103.4 11.21 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.358 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -85.86 86.94 7.34 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.62 139.1 45.04 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.721 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.4 tt -55.42 158.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.714 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HG3' ' C ' ' A' ' 12' ' ' PRO . 3.8 mtmp? -87.33 108.94 19.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.959 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.549 ' NE ' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.667 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.947 0.403 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG21 ' CG ' ' A' ' 98' ' ' HIS . 4.3 t -85.26 83.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 30.1 t -66.95 157.09 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.438 ' CG ' HE22 ' A' ' 95' ' ' GLN . 40.1 mmm -133.31 113.47 12.64 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -77.78 127.65 32.75 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.577 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.644 ' CD ' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -101.57 139.29 37.43 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.75 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.18 145.83 9.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.841 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 107' ' ' THR . 9.1 Cg_endo -78.62 -179.98 28.71 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.093 -0.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.01 -29.75 49.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.498 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.88 149.63 50.33 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.261 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -142.24 83.07 12.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.877 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.07 113.97 3.02 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.853 1.702 . . . . 0.0 110.808 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 26.9 m -143.08 162.65 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.326 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.14 158.66 15.52 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' ' 111' ' ' ILE . 25.5 mt -78.96 94.65 5.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.1 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 133.05 16.98 1.18 Allowed Glycine 0 N--CA 1.494 2.544 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.99 -131.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 2.6 mt-30 -139.08 172.52 12.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.317 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.761 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -145.65 166.14 26.66 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.556 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -160.86 80.99 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.755 HG23 HG21 ' A' ' 107' ' ' THR . 2.9 mt -90.63 124.15 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.295 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -87.15 151.88 22.81 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.927 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -160.8 111.09 1.75 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.225 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.38 170.29 8.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.821 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.419 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 2.3 t -111.36 155.25 23.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.101 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -49.04 25.88 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 28' ' ' SER . 4.0 tp-100 -97.84 -68.6 0.79 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 74' ' ' THR . 39.3 t 167.45 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.73 20.77 7.77 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.56 119.3 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.628 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.546 ' O ' ' C ' ' A' ' 32' ' ' SER . 15.3 t-80 -60.11 158.38 11.33 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.476 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' HIS . 23.4 t -12.41 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.994 0.809 . . . . 0.0 112.786 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.72 52.82 0.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.78 -125.58 3.45 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -114.39 175.99 5.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -79.35 121.44 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.478 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CG ' ' OG1' ' A' ' 97' ' ' THR . 12.6 m-85 -97.92 159.43 14.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.99 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 76' ' ' PHE . 16.1 tp 179.8 151.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.343 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.555 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 m120 -137.71 149.09 46.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD2' HD12 ' A' ' 78' ' ' LEU . 39.0 m95 -120.42 157.28 29.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.97 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -147.75 172.01 14.77 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.577 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 91' ' ' TYR . 1.1 tp -160.72 120.69 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.95 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -90.18 116.88 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 17.8 ttpp -148.55 168.61 22.3 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' H ' ' HG2' ' A' ' 44' ' ' LYS . . . -56.42 103.74 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.52 14.66 74.92 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.131 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 3.0 tt0 -125.97 5.45 7.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.487 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.04 -51.29 82.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.713 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 4.7 Cg_endo -71.3 19.84 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.592 1.528 . . . . 0.0 112.027 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 48' ' ' SER . 1.8 ttmm -104.95 126.76 52.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -105.97 149.67 26.41 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.35 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 51' ' ' LEU . 64.9 mt -102.3 -80.1 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.167 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 69' ' ' GLY . 3.3 mm -105.5 138.71 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.474 ' HB3' HD21 ' A' ' 51' ' ' LEU . 32.4 p90 -132.06 28.58 4.45 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.659 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -178.8 68.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.434 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.748 ' O ' HG23 ' A' ' 56' ' ' VAL . 20.5 m 19.74 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.541 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER 79.42 63.2 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.452 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -171.46 108.51 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.988 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 15.4 mtt85 -89.17 153.62 20.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.758 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 40.0 t80 -83.78 160.28 21.26 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.3 t -42.97 -38.55 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.029 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.08 52.42 1.09 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 75.0 t -146.12 118.93 5.11 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.8 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 4.2 Cg_exo -60.36 138.07 78.5 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.159 1.906 . . . . 0.0 111.919 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -52.22 -23.78 6.17 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' CB ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -67.53 12.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.128 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' HD1' HD21 ' A' ' 78' ' ' LEU . 12.2 m-85 -115.74 104.51 11.74 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.395 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.0 m -105.68 121.08 43.27 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.12 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' O ' HG21 ' A' ' 53' ' ' ILE . . . -131.15 102.7 0.52 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 31.2 t -151.47 175.34 12.39 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.142 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 174.37 147.63 6.19 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.8 p -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.4 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.11 -102.79 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.213 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.772 HG22 ' HA ' ' A' ' 28' ' ' SER . 59.1 p -124.55 15.45 8.84 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.111 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -115.83 125.68 53.0 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CD2' HD22 ' A' ' 38' ' ' LEU . 4.0 m-85 -140.97 168.14 20.5 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.517 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -160.1 155.91 25.95 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.255 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 40' ' ' TRP . 5.3 tt -112.49 102.02 10.15 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.487 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -89.8 125.12 35.19 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.761 HD12 ' HB3' ' A' ' 19' ' ' ALA . 68.8 mt -110.66 130.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 22.9 m -84.16 -18.78 35.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.877 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' CB ' HH21 ' A' ' 66' ' ' ARG . 1.1 mmt-85 -148.24 92.85 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.749 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' GLY . 86.6 t -76.36 117.95 21.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' LEU . 1.5 mp0 -116.7 -179.55 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.98 23.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 23.1 mt-10 -68.78 -23.83 64.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' ' CD2' ' A' ' 109' ' ' LEU . 3.1 m-20 -77.27 -29.65 53.96 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.42 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -51.04 142.38 12.26 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.66 -139.58 11.11 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.4 mp -124.6 135.15 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.998 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 42' ' ' LEU . 1.1 m-85 -101.18 141.15 34.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.515 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -130.21 175.44 8.92 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.618 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.597 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 25.6 p -156.68 146.41 20.83 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.537 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -149.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.612 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.438 HE22 ' CG ' ' A' ' 4' ' ' MET . 5.3 pm0 -155.18 145.4 21.85 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.427 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 m -107.4 -5.86 17.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.213 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.694 HG22 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -69.74 -27.09 64.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.807 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.694 ' CD2' HG22 ' A' ' 97' ' ' THR . 43.4 m-70 -102.62 145.32 29.82 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 4.8 t -132.55 129.47 21.41 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.233 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.8 Cg_endo -67.24 148.48 79.95 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.795 -0.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.88 123.84 12.23 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.969 1.779 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -89.48 125.46 35.19 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.236 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 6.5 t80 -125.98 136.41 52.97 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.49 -164.67 29.77 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.447 ' HA3' ' NE2' ' A' ' 6' ' ' GLN . . . 111.24 -172.88 15.37 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.734 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.24 58.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.755 HG21 HG23 ' A' ' 21' ' ' ILE . 82.1 m -80.67 110.12 15.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -64.96 103.11 0.68 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -98.45 83.56 3.05 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.119 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -107.61 148.87 28.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.712 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.6 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.9 tt -52.37 168.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.43 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 13' ' ' VAL . 3.2 ttmm -50.94 -56.37 12.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.429 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.114 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t -66.79 124.01 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.212 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 32' ' ' SER . 58.8 t-80 -69.69 173.34 6.26 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.472 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 75.0 m -69.93 73.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 176.64 -27.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.421 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 23.57 5.94 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.82 142.77 48.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m -113.12 129.38 56.53 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.736 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -97.6 -167.31 1.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.83 77.78 2.11 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 59.56 3.73 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -134.18 -163.99 1.44 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.699 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.23 124.03 74.49 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.602 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 155.98 49.91 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.849 1.699 . . . . 0.0 111.703 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -138.08 128.44 26.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.769 -0.773 . . . . 0.0 111.232 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp -101.57 131.96 47.48 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.794 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt -88.34 145.36 25.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.346 -1.788 . . . . 0.0 110.514 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.138 0.495 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' CD2' ' A' ' 98' ' ' HIS . 39.2 t -137.33 143.57 34.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 47.9 t -81.68 156.25 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.428 ' CE ' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -136.41 105.87 6.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.271 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.627 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -78.98 134.08 36.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.11 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.95 158.24 21.17 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -75.99 177.97 37.05 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.603 -1.416 . . . . 0.0 111.248 -1.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -77.57 -27.06 51.33 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.879 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 m -143.21 149.4 37.92 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.939 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 8.3 tp -140.71 88.92 10.46 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.717 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.3 117.79 5.27 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.918 1.745 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 m -142.34 -164.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 t -118.22 169.37 9.76 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.34 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.39 89.7 7.44 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.85 -25.58 2.25 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.92 -161.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.011 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 81' ' ' SER . 0.0 OUTLIER -134.84 136.34 42.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.266 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -103.23 178.29 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.478 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -155.9 73.54 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 107' ' ' THR . 2.6 mp -62.54 128.49 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' THR . 21.8 t -93.26 155.29 17.52 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.304 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 81.5 m -160.86 109.65 1.62 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.09 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -108.82 150.34 27.77 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -104.17 152.36 22.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.483 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -80.34 -22.89 40.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.81 34.81 1.98 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.429 ' N ' HG22 ' A' ' 74' ' ' THR . 24.2 t 58.62 -173.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.106 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.615 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 12.4 mt -139.93 13.89 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.079 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.91 135.29 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 32' ' ' SER . 17.8 t-80 -79.73 -176.55 5.44 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.412 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 72.0 p -54.92 -39.46 68.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.134 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -102.51 -170.6 1.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.83 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.32 72.56 1.66 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -141.57 123.21 15.13 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.945 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -116.96 100.27 7.64 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.307 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -88.21 149.88 23.61 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -168.16 157.57 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.578 ' H ' HD23 ' A' ' 38' ' ' LEU . 3.5 p30 -159.96 113.57 2.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.952 ' CD2' HD13 ' A' ' 78' ' ' LEU . 55.9 m95 -90.76 169.71 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.21 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.08 133.52 8.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.54 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 14.2 tp -107.52 130.51 54.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.459 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 42' ' ' LEU . 38.1 tt0 -95.22 125.03 39.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.781 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' NZ ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -128.58 -166.85 1.69 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.895 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' H ' ' CG ' ' A' ' 44' ' ' LYS . . . -76.69 -36.73 57.08 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 39.73 1.26 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -132.65 -3.91 3.29 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -42.16 -56.63 5.13 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.336 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 3.8 Cg_endo -67.02 79.67 0.38 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.444 1.429 . . . . 0.0 110.234 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' CG ' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -162.77 -154.92 0.32 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.0 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 54' ' ' TYR . 19.8 tp -171.74 139.57 1.21 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.064 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.96 -63.86 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.479 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 58' ' ' ASN . 43.3 mm -121.52 139.85 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.731 ' HB3' HD21 ' A' ' 51' ' ' LEU . 50.0 p90 -122.83 30.81 6.27 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.459 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.8 mmtp -174.29 -166.59 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.422 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.99 22.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.122 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -44.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.647 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.579 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.4 m-80 -46.21 140.44 3.98 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.977 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 5.2 mtm180 -110.29 134.04 52.65 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 65.7 t80 -57.38 162.39 2.84 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.1 m -68.43 92.26 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.32 32.17 0.45 Allowed Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 65' ' ' ASP . 38.8 t -113.67 132.67 22.46 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.82 13.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.959 1.773 . . . . 0.0 113.12 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 63' ' ' VAL . 1.1 t70 71.46 -41.78 0.51 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -46.36 -26.86 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.085 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CD1' HG12 ' A' ' 80' ' ' ILE . 83.1 m-85 -80.82 123.64 28.41 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 m -138.27 101.05 4.29 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.545 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' CA ' HD12 ' A' ' 78' ' ' LEU . . . -92.99 120.01 6.07 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.8 p -151.45 154.52 36.75 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -165.84 163.74 36.93 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -92.94 -115.35 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.719 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.1 -78.28 0.64 Allowed Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 28' ' ' SER . 53.0 p -111.37 18.26 19.38 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.349 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.42 131.74 53.74 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.717 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 54.3 m-85 -142.51 153.96 44.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.916 -0.713 . . . . 0.0 110.522 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 3.5 m -151.75 145.65 25.16 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.952 HD13 ' CD2' ' A' ' 40' ' ' TRP . 9.7 tp -104.45 93.61 4.88 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -81.17 118.45 22.57 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.094 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.761 HG21 ' OD2' ' A' ' 87' ' ' ASP . 23.0 mt -114.61 103.46 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 18' ' ' GLN . 1.4 m -74.95 39.45 0.14 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.046 -1.062 . . . . 0.0 113.524 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 81' ' ' SER . 1.1 mmt85 169.63 97.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.696 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 87' ' ' ASP . 88.4 t -93.49 99.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -177.01 3.28 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.508 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.32 -26.89 43.44 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.821 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.83 -36.21 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.964 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.761 ' OD2' HG21 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.9 -43.39 98.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.91 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.773 HD21 ' CD1' ' A' ' 111' ' ' ILE . 89.3 mt -43.62 148.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.715 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.87 -155.02 20.75 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.61 142.76 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.646 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 14.0 m-85 -115.22 144.72 43.28 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.906 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -133.59 155.79 49.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 1.8 p -136.52 102.21 4.87 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 158.89 15.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.696 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -110.65 127.9 55.47 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.604 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' HG22 ' A' ' 96' ' ' THR . 17.9 m -83.61 -5.57 59.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.004 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 29' ' ' LEU . 53.3 m -62.63 -62.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.29 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' A' ' 2' ' ' VAL . 66.7 m-70 -89.12 114.78 26.08 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.43 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 21.8 t -104.59 134.37 19.7 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.832 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.16 156.98 97.91 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.591 -1.421 . . . . 0.0 111.523 -0.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.38 139.91 85.14 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.034 1.823 . . . . 0.0 110.997 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.28 -43.93 60.13 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.315 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 t80 68.35 161.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.581 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.78 130.87 2.92 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 145.93 173.78 17.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 178.86 67.15 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 21' ' ' ILE . 44.8 m -77.1 113.81 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.888 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -73.84 107.25 5.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.391 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -100.67 94.85 6.31 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.704 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.32 136.67 52.26 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.773 ' CD1' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -69.2 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.059 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -69.94 155.37 40.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.349 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 116.38 -1.772 . . . . 0.0 110.624 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.123 0.487 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' HG21 ' A' ' 102' ' ' THR . 25.2 t -65.66 102.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.797 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 4' ' ' MET . 15.6 t -69.5 162.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.761 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 25' ' ' SER . 48.6 mmm -126.85 175.51 7.98 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -150.72 93.56 1.97 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.204 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.625 ' NE2' ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp60 -82.5 148.3 28.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.232 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -161.18 165.14 17.49 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.908 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 9.1 Cg_endo -76.76 173.97 55.43 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.482 -1.466 . . . . 0.0 110.563 -1.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.96 -28.59 68.4 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.592 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -140.97 130.43 23.85 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -125.92 94.16 42.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.699 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.86 121.1 7.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.8 1.666 . . . . 0.0 110.537 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 83' ' ' VAL . 24.9 m -134.43 -165.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.442 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -146.53 160.48 42.08 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -74.69 85.69 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 82' ' ' ARG . . . 140.43 -22.62 2.71 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 18' ' ' GLN . 31.9 t70 -76.48 177.87 7.06 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 54.5 mt-30 -94.63 -173.76 3.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.737 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -153.73 157.69 39.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 p -151.52 79.94 1.29 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.002 HG23 HG21 ' A' ' 107' ' ' THR . 8.8 mt -81.27 117.75 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.906 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 7' ' ' THR . 39.4 t -85.4 155.53 21.24 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.958 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -162.13 124.38 2.84 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.605 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.17 155.99 28.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.306 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 3.8 t -112.96 154.23 26.76 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.8 p -74.37 -31.73 62.49 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 2' ' ' VAL . 4.9 tt0 -136.54 150.56 48.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.689 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 p -50.75 128.13 19.99 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.66 ' C ' HG21 ' A' ' 97' ' ' THR . 85.8 mt -80.52 27.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.89 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.81 133.89 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.393 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.464 ' CG ' ' H ' ' A' ' 32' ' ' SER . 6.2 t-80 -82.05 -170.15 2.73 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.464 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 4.5 p -79.8 18.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.997 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.76 -171.47 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.492 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.6 52.72 4.18 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.689 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -143.96 145.18 32.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' LEU . 84.1 m -141.01 137.21 32.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.46 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -112.37 132.72 54.86 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' CG ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -155.24 125.85 6.91 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.957 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 38' ' ' LEU . 34.6 p30 -133.24 169.65 16.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.256 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 78' ' ' LEU . 36.5 m95 -125.03 150.56 46.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' CD2' ' HB2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -138.11 147.59 44.13 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.906 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 tp -135.62 125.53 25.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.52 152.75 33.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.107 -1.037 . . . . 0.0 112.103 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.95 -164.6 1.15 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.48 82.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.33 42.4 96.12 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.597 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -124.47 166.33 16.21 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.11 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -58.86 118.78 31.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.434 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HB2' ' CD2' ' A' ' 41' ' ' TYR . 1.9 Cg_endo -63.09 148.58 93.17 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.838 1.692 . . . . 0.0 112.114 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -104.07 155.22 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp -103.2 135.27 45.16 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -113.34 -71.56 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.261 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 59' ' ' ARG . 31.6 mm -109.46 150.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.87 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 47.7 p90 -149.19 25.36 0.9 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.559 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.41 61.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.832 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.718 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.6 m 30.44 97.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.09 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 72.05 46.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.859 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.502 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -148.96 108.97 4.08 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 65' ' ' ASP . 41.7 mtm180 -79.83 153.0 29.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.906 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 61' ' ' SER . 59.9 t80 -91.14 171.78 9.01 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.546 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t -59.9 123.0 15.68 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.218 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.05 66.22 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 90.0 t -84.46 123.93 74.14 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -55.83 138.95 83.29 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.1 1.867 . . . . 0.0 112.02 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 6.1 m-20 -56.29 -18.55 10.94 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.615 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -77.61 27.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.606 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.576 ' CE2' HD21 ' A' ' 78' ' ' LEU . 4.8 m-85 -128.17 129.03 45.87 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.4 104.01 3.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' VAL . . . -110.65 108.15 2.37 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.318 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -143.0 163.37 32.97 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.686 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . -169.9 172.34 43.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.45 -151.23 0.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.632 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.91 -48.81 13.75 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -146.51 35.14 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -135.64 90.62 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.158 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CG ' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -119.62 155.41 32.35 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.08 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.3 m -146.98 141.03 26.02 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.539 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CE2' ' A' ' 67' ' ' PHE . 5.5 tt -94.02 110.33 22.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 131.39 46.95 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.018 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 82' ' ' ARG . 57.3 mt -117.99 131.58 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.2 m -90.64 -0.5 57.71 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.72 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.779 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.5 tpt180 -169.05 97.32 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 13' ' ' VAL . 99.0 t -74.88 136.66 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.89 163.8 13.81 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.812 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.63 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.28 -27.11 62.27 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -30.91 71.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.474 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 111' ' ' ILE . 85.9 mt -42.94 134.87 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.23 -154.62 25.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 mm -103.62 131.84 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.09 154.95 18.29 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.175 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 38.1 m-85 -147.45 176.88 9.68 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.082 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.71 127.68 4.22 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.401 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 4.8 p -118.74 -170.24 1.87 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.324 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.44 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -158.04 127.39 5.81 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 m -107.12 57.73 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.66 HG21 ' C ' ' A' ' 29' ' ' LEU . 54.6 m -108.93 -50.3 3.03 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.868 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -87.87 -40.01 14.34 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.28 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.597 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.8 OUTLIER 64.94 141.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.315 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -67.78 158.04 84.95 Favored 'Cis proline' 0 C--N 1.319 -1.024 0 C-N-CA 123.55 -1.437 . . . . 0.0 111.362 -0.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.67 114.59 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.938 1.758 . . . . 0.0 111.532 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 2' ' ' VAL . 14.2 p -52.95 -55.19 25.26 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.09 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.6 OUTLIER 61.95 116.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.57 100.09 0.61 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.231 -1.461 . . . . 0.0 111.547 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.505 ' H ' ' HB3' ' A' ' 92' ' ' PHE . . . -100.62 -90.36 2.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.61 93.5 1.35 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.307 -1.425 . . . . 0.0 112.798 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.002 HG21 HG23 ' A' ' 21' ' ' ILE . 2.3 m -158.49 109.17 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.556 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.71 105.39 5.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.202 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.64 94.01 7.48 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.129 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 144.06 50.3 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.675 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.551 HD12 HD21 ' A' ' 88' ' ' LEU . 4.8 mt -76.81 156.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 11.9 mttm -73.11 115.72 12.78 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.213 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.327 -1.797 . . . . 0.0 110.771 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 121.05 0.452 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.691 ' O ' HG21 ' A' ' 102' ' ' THR . 62.9 t -106.5 111.81 36.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.097 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.25 124.99 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.195 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 81.9 mmm -120.68 102.38 8.36 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -96.1 156.7 16.22 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.311 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.731 HE21 ' CG2' ' A' ' 21' ' ' ILE . 23.2 tt0 -130.39 151.48 50.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.838 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -157.82 156.55 28.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.97 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.4 176.83 42.02 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.611 -1.412 . . . . 0.0 111.328 -0.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -75.12 -18.27 60.27 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.813 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 p -156.02 140.64 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.085 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.68 91.38 33.98 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.731 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -70.47 105.72 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.97 1.78 . . . . 0.0 111.236 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 83' ' ' VAL . 8.6 m -117.71 -154.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.509 ' HA ' HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -132.44 159.43 39.34 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.493 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 111' ' ' ILE . 19.0 mt -75.34 88.94 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.6 -1.22 5.98 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.5 -177.76 4.19 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 179.39 5.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.107 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -154.44 163.93 39.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 m -155.18 95.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.335 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.731 ' CG2' HE21 ' A' ' 6' ' ' GLN . 23.2 mt -84.36 165.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.354 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 21' ' ' ILE . 11.0 m -131.07 154.5 48.19 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.735 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.44 126.51 4.65 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.81 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -120.06 145.99 46.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.476 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 85.8 p -107.66 125.17 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.46 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -73.82 32.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.242 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.543 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -160.37 -85.85 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.767 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.755 ' HA ' HG22 ' A' ' 74' ' ' THR . 3.3 t 171.39 146.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.753 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.826 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 46.1 mt -109.83 30.01 7.09 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 35' ' ' ASN . 48.5 t -107.29 147.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.439 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.29 166.34 10.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.726 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.32 -31.26 3.75 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.27 30.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.111 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.12 -123.92 5.28 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.026 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.625 ' O ' HG22 ' A' ' 30' ' ' VAL . 23.3 m-20 -157.69 -97.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.627 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 m -149.17 94.85 2.29 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.733 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.667 ' HB2' HG23 ' A' ' 97' ' ' THR . 90.3 m-85 -84.44 143.83 29.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.843 HD21 ' HE1' ' A' ' 40' ' ' TRP . 8.7 tp -165.46 146.2 7.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.851 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 2.3 m120 -135.38 156.89 48.18 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.843 ' HE1' HD21 ' A' ' 38' ' ' LEU . 59.5 m95 -137.33 152.66 49.97 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' TRP . 33.4 m-85 -144.56 154.46 42.88 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 10.9 tp -127.42 106.05 8.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.019 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -69.68 105.84 2.86 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.382 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -113.61 -163.67 0.87 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.477 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' H ' ' HG3' ' A' ' 44' ' ' LYS . . . -79.06 -121.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.165 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.03 50.41 4.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -89.99 149.83 22.39 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.54 ' H ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -91.06 -56.7 0.25 Allowed Pre-proline 0 N--CA 1.489 1.499 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.041 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 48' ' ' SER . 3.4 Cg_exo -60.92 145.05 99.62 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.491 1.46 . . . . 0.0 111.309 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.09 57.87 0.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.716 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 51' ' ' LEU . 34.8 tp -166.21 96.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.8 mm? -82.25 -69.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.439 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 53' ' ' ILE . 16.7 mm -108.92 127.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.023 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.612 ' HD1' HD22 ' A' ' 58' ' ' ASN . 0.9 OUTLIER -134.14 25.89 3.88 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.952 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.7 mttt -171.24 27.9 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.891 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' ASN . 95.0 t 63.3 119.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.637 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.1 p 34.36 33.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.36 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.612 HD22 ' HD1' ' A' ' 54' ' ' TYR . 6.6 p-10 -107.33 -32.91 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 1.2 mtm-85 66.52 113.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.553 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 61' ' ' SER . 51.4 t80 -61.61 167.34 3.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.4 t -54.2 -40.58 67.72 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.86 63.91 3.46 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 65' ' ' ASP . 58.8 t -139.61 133.17 15.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.704 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HG2' ' HE ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -67.38 14.39 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 122.221 1.947 . . . . 0.0 112.468 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 5.1 m-20 65.43 -24.18 0.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.59 HH12 ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -65.3 -11.62 43.47 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.328 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HD1' HD21 ' A' ' 78' ' ' LEU . 77.3 m-85 -95.26 132.84 39.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.412 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -147.89 85.69 1.56 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.443 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' THR . . . -86.08 107.09 3.13 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -76.67 163.03 27.24 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.979 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.687 ' HA2' ' CD1' ' A' ' 76' ' ' PHE . . . -142.06 96.26 0.2 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -94.36 82.91 4.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.502 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.16 -82.13 0.13 Allowed Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 28' ' ' SER . 18.6 p -123.31 14.87 9.7 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.791 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.95 132.02 53.97 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.26 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.826 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 24.8 m-85 -138.49 143.89 39.77 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.477 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 21' ' ' ILE . 100.0 m -139.98 112.28 7.73 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.54 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 78' ' ' LEU . 10.2 tt -80.68 100.31 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -94.93 134.3 37.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.284 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 19' ' ' ALA . 7.6 mt -113.07 137.29 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 12.0 t -87.01 -44.24 11.73 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.681 -1.207 . . . . 0.0 111.947 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -124.71 102.37 7.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 HG21 ' A' ' 13' ' ' VAL . 69.3 t -89.44 103.6 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' CD ' HH12 ' A' ' 66' ' ' ARG . 4.0 mt-10 -102.89 177.21 4.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.249 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.16 -27.11 31.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -78.96 -40.23 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.532 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.07 -20.23 23.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.408 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' CD1' ' A' ' 111' ' ' ILE . 97.7 mt -62.68 167.39 4.54 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.756 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.01 180.0 16.07 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.715 -1.231 . . . . 0.0 111.267 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.87 115.5 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.449 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -88.76 143.38 26.95 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.811 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -135.48 158.76 43.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.158 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.51 156.64 46.8 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 10.5 t -150.91 -177.05 5.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.546 ' HB2' HD22 ' A' ' 29' ' ' LEU . 1.8 pt20 -129.26 113.8 15.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 37' ' ' TYR . 10.2 t -84.33 34.67 0.52 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.667 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -100.13 -72.27 0.67 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.2 m-70 -78.24 162.11 26.79 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.424 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 45.7 t -137.88 137.57 21.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.586 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.3 Cg_endo -73.46 158.58 98.39 Favored 'Cis proline' 0 C--N 1.318 -1.058 0 C-N-CA 123.568 -1.43 . . . . 0.0 111.472 -1.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.77 151.63 82.9 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.966 1.777 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 2' ' ' VAL . 36.7 p -89.94 -61.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.048 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 3.3 t80 72.83 146.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.008 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.75 170.25 30.43 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' CA ' ' HB3' ' A' ' 6' ' ' GLN . . . 120.11 -155.38 16.19 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.841 -1.171 . . . . 0.0 111.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 147.69 60.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 21' ' ' ILE . 52.4 m -81.76 108.28 15.17 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -68.99 89.74 0.43 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.15 87.52 6.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.521 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -121.24 143.25 49.25 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.183 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.93 HD13 ' HG ' ' A' ' 15' ' ' LEU . 8.3 mt -88.34 146.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -68.38 103.07 1.54 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.809 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.959 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.913 HG13 ' H ' ' A' ' 27' ' ' GLN . 39.1 t -62.05 113.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 4' ' ' MET . 6.7 t -74.51 169.93 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.697 ' SD ' ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -132.64 99.21 4.56 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.541 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -89.57 148.42 23.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.581 ' CB ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -141.54 153.48 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.379 -0.929 . . . . 0.0 110.824 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.29 146.27 11.62 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.726 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HG2' HD12 ' A' ' 11' ' ' LEU . 11.0 Cg_endo -82.12 176.93 35.24 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.806 -1.331 . . . . 0.0 111.342 -0.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -73.08 -27.31 61.65 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.043 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -137.72 149.62 46.63 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.879 ' HB3' HD12 ' A' ' 109' ' ' LEU . 3.6 tp -135.43 86.2 30.22 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.924 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CB ' ' HA ' ' A' ' 112' ' ' LYS . 10.2 Cg_endo -72.23 101.77 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.657 1.571 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 112' ' ' LYS . 20.4 m -126.7 -178.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.34 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.2 174.53 5.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 83' ' ' VAL . 21.4 mt -90.11 86.98 6.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.37 -25.65 1.54 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.65 -166.93 0.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.024 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -114.59 138.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -115.53 166.37 11.98 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 p -160.95 100.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' THR . 69.4 mt -98.94 142.53 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -103.34 141.13 36.45 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.802 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.99 94.21 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.564 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' CZ ' ' CB ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.1 163.08 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.186 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.63 166.36 13.28 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.129 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -64.93 -70.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.913 ' H ' HG13 ' A' ' 2' ' ' VAL . 1.8 tt0 -87.6 162.13 17.33 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.994 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 p -59.09 129.61 42.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 76' ' ' PHE . 89.1 mt -85.02 34.73 0.56 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.693 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -96.96 114.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.126 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 32' ' ' SER . 55.5 t-80 -66.58 170.3 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.451 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 10.5 t -59.88 -17.73 39.2 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -86.18 -5.75 59.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.94 -18.05 58.08 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.775 -1.203 . . . . 0.0 111.622 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -78.78 128.51 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.358 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 126.18 30.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.862 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 97' ' ' THR . 21.5 m-30 -105.5 102.66 12.11 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.964 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 76' ' ' PHE . 1.4 tt -149.1 126.91 11.8 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.865 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -116.21 163.77 15.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.39 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.496 ' CE3' HD13 ' A' ' 78' ' ' LEU . 47.1 m95 -123.56 159.02 30.09 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.447 ' CE2' ' ND2' ' A' ' 39' ' ' ASN . 14.6 m-85 -144.45 148.28 34.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.026 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD22 ' OH ' ' A' ' 91' ' ' TYR . 24.5 tp -123.14 79.84 1.71 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.57 30.94 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.45 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.5 ttmt -129.26 170.72 13.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.625 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.45 94.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.668 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.73 50.42 64.25 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -138.9 -174.68 3.91 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.589 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 t -91.8 115.24 64.21 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.958 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.18 140.75 60.41 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.742 1.628 . . . . 0.0 111.16 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -110.97 140.0 45.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.287 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 54' ' ' TYR . 29.5 tp -101.46 120.36 40.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.092 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.22 -60.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.678 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mm -113.49 131.56 64.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.99 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HB3' HD21 ' A' ' 51' ' ' LEU . 52.2 p90 -108.61 -13.78 14.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.83 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' SER . 1.2 mtpm? -153.93 110.13 3.29 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 57' ' ' SER . 1.2 p 43.56 -73.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.596 ' H ' HG13 ' A' ' 56' ' ' VAL . 16.6 t -136.67 -15.8 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.55 -1.26 . . . . 0.0 113.789 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.59 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -64.4 114.25 4.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.911 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -71.86 143.73 49.31 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.361 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.4 175.43 4.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.473 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 p -61.61 -51.38 68.73 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.579 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.54 71.11 2.98 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 65' ' ' ASP . 46.5 t -139.35 125.68 12.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.803 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 66' ' ' ARG . 1.1 Cg_endo -68.04 14.35 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.031 1.821 . . . . 0.0 111.799 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 35.9 m-20 60.09 -9.38 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.979 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 64' ' ' PRO . 12.1 mtm-85 -76.96 19.63 0.29 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' OH ' ' A' ' 91' ' ' TYR . 89.3 m-85 -137.55 135.81 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.624 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -146.14 96.58 2.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 149.71 37.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m -154.1 113.61 3.78 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.384 -1.327 . . . . 0.0 111.577 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -146.58 135.75 5.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -88.02 -84.29 0.2 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.101 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.5 -57.17 1.47 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.643 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 36.9 p -145.85 56.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 10.4 t70 -161.18 73.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.069 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.722 ' CD1' HD13 ' A' ' 38' ' ' LEU . 10.3 m-85 -95.81 117.42 30.53 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 m -111.72 129.17 56.2 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.574 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' CE3' ' A' ' 40' ' ' TRP . 2.3 tt -85.66 94.19 9.02 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.86 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -91.39 124.63 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.255 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 19' ' ' ALA . 25.2 mt -99.78 131.58 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 p -82.18 -23.19 35.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.331 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -156.61 120.58 4.36 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.99 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.592 HG13 ' OD2' ' A' ' 87' ' ' ASP . 53.6 t -87.85 122.0 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -108.57 171.25 7.53 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.32 70.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.647 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -84.41 -2.3 56.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.0 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.592 ' OD2' HG13 ' A' ' 83' ' ' VAL . 3.0 t70 -89.15 -18.03 28.0 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.707 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 109' ' ' LEU . 13.4 mt -73.92 140.5 45.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.487 ' C ' HD12 ' A' ' 90' ' ' ILE . . . 155.65 -140.25 7.18 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 89' ' ' GLY . 1.6 mp -116.95 113.4 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.883 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' CE2' ' A' ' 67' ' ' PHE . 1.9 m-85 -91.94 112.79 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.739 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' A' ' 106' ' ' GLY . 3.3 m-85 -119.05 -176.49 3.13 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -152.93 -179.44 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.239 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.436 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 74.9 p -171.62 144.41 1.86 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.479 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.461 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 6.8 pt20 -109.61 157.42 19.07 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.6 p -132.34 13.44 4.6 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -75.36 -36.97 60.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.677 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.575 ' CE1' HG21 ' A' ' 2' ' ' VAL . 70.8 m80 -110.03 162.47 14.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.085 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 10.9 p -128.01 138.22 32.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.508 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.8 Cg_endo -71.29 158.2 95.44 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.588 -1.421 . . . . 0.0 111.845 -0.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.52 119.75 7.04 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.786 1.657 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.6 p -91.24 134.02 34.92 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.958 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.7 138.65 55.24 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.697 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . -72.54 -159.05 4.47 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -73.14 -157.19 4.0 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 92' ' ' PHE . . . -178.23 98.75 0.12 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 8' ' ' PRO . 21.5 m -107.36 143.75 35.22 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.92 133.75 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.282 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.879 HD12 ' HB3' ' A' ' 11' ' ' LEU . 1.2 tp -129.94 89.04 2.75 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -127.6 59.78 1.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.59 HG22 ' N ' ' A' ' 112' ' ' LYS . 19.6 mm 59.0 163.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -86.08 106.54 17.3 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.944 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.514 ' HD3' ' H ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.1 0.476 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.76 ' O ' HG21 ' A' ' 102' ' ' THR . 59.5 t -121.5 132.67 70.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.307 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.74 141.76 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.655 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.21 105.95 7.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.794 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -99.03 112.66 24.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.911 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 9.4 tt0 -95.77 149.91 20.98 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.783 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.2 159.98 24.23 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.711 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HA ' HG22 ' A' ' 7' ' ' THR . 4.4 Cg_endo -72.61 177.62 35.0 Favored 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.603 -1.415 . . . . 0.0 111.259 -0.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.1 mt -82.4 -15.47 52.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.758 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -144.5 135.41 25.02 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.545 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.554 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -128.85 72.0 81.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.433 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.6 106.87 1.34 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.943 1.762 . . . . 0.0 111.377 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 7.6 m -141.77 175.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.313 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 p -99.14 161.11 13.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 111' ' ' ILE . 24.6 mt -74.49 88.13 2.11 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.89 -23.03 0.91 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -71.71 170.99 12.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.326 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.59 137.84 33.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.27 163.38 14.44 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -162.27 95.4 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.205 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.824 ' O ' HG23 ' A' ' 77' ' ' THR . 2.7 mp -81.19 167.34 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 23.1 t -138.92 110.43 7.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.392 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.6 t -117.28 127.6 54.24 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.068 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -116.6 150.42 38.08 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.73 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' HG11 ' A' ' 2' ' ' VAL . 5.8 p -109.9 119.57 39.75 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.9 m -75.25 21.61 0.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -149.45 2.72 0.55 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.46 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.459 ' CA ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER 67.73 150.86 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.827 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 80.3 mt -115.52 28.77 8.44 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG22 ' OG1' ' A' ' 36' ' ' THR . 65.3 t -94.71 115.3 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.775 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 33' ' ' ASN . 10.6 t-80 -61.5 175.44 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.011 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -41.68 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' HIS . 1.6 p-10 39.16 52.0 2.05 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.47 -113.21 1.51 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -111.84 -179.99 3.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 30' ' ' VAL . 20.1 m -113.78 139.08 49.42 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.702 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.779 ' HB3' HG23 ' A' ' 96' ' ' THR . 91.3 m-85 -121.65 132.81 54.86 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 76' ' ' PHE . 1.7 tp -156.47 141.15 16.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 1.5 m120 -124.84 148.07 48.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.471 ' O ' HD12 ' A' ' 51' ' ' LEU . 31.9 m95 -115.23 160.8 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -149.4 156.98 42.89 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp -141.99 113.72 7.9 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.856 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.84 125.91 33.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -92.43 -170.93 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 87.52 0.4 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.76 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 49.91 73.46 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.565 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.31 -157.44 0.82 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.829 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.5 p -90.4 147.86 37.63 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.111 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.49 112.33 1.56 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.972 1.782 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -79.58 131.56 36.04 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 54' ' ' TYR . 25.9 tp -98.14 121.64 40.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.502 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.3 mm? -96.81 -71.9 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.488 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -101.54 133.48 44.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.83 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' HB3' HD21 ' A' ' 51' ' ' LEU . 44.9 p90 -122.48 20.23 10.39 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.954 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 1.6 tppp? -168.97 65.91 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.409 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 t 68.51 -66.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -138.64 11.78 2.72 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.749 -1.18 . . . . 0.0 113.078 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 55' ' ' LYS . 53.2 p-10 -75.18 -156.82 0.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.938 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -153.88 118.22 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.359 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.86 157.74 17.57 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.734 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 p -53.81 138.28 36.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.29 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.51 -26.0 7.66 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 52' ' ' LEU . 60.5 t -64.29 118.78 50.22 Favored Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.028 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.0 144.55 99.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.883 1.722 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.98 -36.21 17.04 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -26.86 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -84.3 107.28 16.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t -134.61 108.44 8.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.535 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.09 170.79 21.91 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.1 t -164.22 -165.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.916 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 151.89 113.39 0.57 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.807 -1.663 . . . . 0.0 111.899 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -98.74 100.63 11.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.1 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 -115.72 4.78 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.557 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 28' ' ' SER . 35.5 p -99.22 18.63 17.05 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.402 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 3.7 m-20 -129.25 136.06 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.582 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 69.5 m-85 -139.4 151.78 46.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.404 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ILE . 43.0 m -145.73 139.35 26.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.998 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -105.1 91.79 3.95 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.403 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -86.08 116.89 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.375 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.647 HG22 ' H ' ' A' ' 82' ' ' ARG . 37.0 mt -105.71 129.35 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.62 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -90.48 13.15 16.48 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.27 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -176.4 113.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.608 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 87' ' ' ASP . 65.6 t -99.04 143.47 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 15' ' ' LEU . 58.8 mt-10 -123.18 179.05 4.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.834 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.11 18.84 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.256 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -55.26 -29.92 59.05 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -63.52 -36.18 82.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.664 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 111' ' ' ILE . 31.3 mt -48.69 134.07 16.45 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.67 -146.99 12.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.47 112.55 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.281 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -78.78 138.85 38.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.701 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.95 164.21 28.49 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.336 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 105' ' ' GLY . 13.7 p -135.9 142.82 44.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.3 t -143.86 112.45 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.486 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -65.79 149.65 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.676 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.779 HG23 ' HB3' ' A' ' 37' ' ' TYR . 12.1 t -123.43 26.62 7.8 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 37' ' ' TYR . 24.0 m -92.09 -23.83 19.34 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.486 ' H ' HE22 ' A' ' 95' ' ' GLN . 59.2 m80 -127.88 136.52 51.5 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.715 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 100' ' ' PRO . 50.9 t -109.69 138.37 20.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.436 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HA ' HG13 ' A' ' 99' ' ' VAL . 5.5 Cg_endo -73.71 161.17 94.76 Favored 'Cis proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.634 -1.402 . . . . 0.0 111.757 -0.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.29 136.12 49.82 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.984 1.789 . . . . 0.0 110.75 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 2' ' ' VAL . 26.4 p -61.89 -51.05 69.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.085 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.6 t80 55.34 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.11 82.08 0.06 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 93' ' ' CYS . . . -93.99 -126.13 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.664 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 145.41 80.69 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.805 -1.664 . . . . 0.0 112.274 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' PRO . 97.1 m -154.5 108.39 2.94 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.629 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -79.01 149.32 32.25 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.939 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' CD2' HD23 ' A' ' 88' ' ' LEU . 4.2 tt -154.2 88.62 1.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 111' ' ' ILE . 6.4 pt-20 -122.23 38.62 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 74.95 168.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.757 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -47.92 -41.24 24.14 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.671 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.545 ' H ' HG23 ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 116.568 -1.682 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.756 0.312 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.783 0.325 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.509 HG21 ' CE1' ' A' ' 98' ' ' HIS . 2.0 t . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 121.008 0.432 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 4' ' ' MET . 16.3 t -74.76 158.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.618 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 29' ' ' LEU . 84.2 mmm -122.43 101.99 7.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.986 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.91 136.95 37.42 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.321 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.594 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 34.6 tt0 -126.83 146.4 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.46 164.99 19.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.423 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 11' ' ' LEU . 7.0 Cg_endo -75.71 176.57 43.08 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.412 -1.495 . . . . 0.0 110.99 -1.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.78 -25.15 56.16 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -140.21 143.41 36.02 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.601 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 8' ' ' PRO . 1.7 tp -134.11 70.07 74.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.279 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.04 113.16 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.936 1.757 . . . . 0.0 111.238 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.01 170.36 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.505 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -111.27 89.84 3.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.106 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 14' ' ' SER . 67.2 mt -8.69 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.079 0.862 . . . . 0.0 112.871 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.87 -35.26 0.37 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.615 -1.278 . . . . 0.0 110.774 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.77 179.11 7.88 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -92.04 161.31 14.83 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.997 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.53 165.08 16.99 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.616 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -159.6 88.8 0.86 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.152 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 78' ' ' LEU . 7.3 mt -85.61 127.6 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.986 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -87.4 150.2 23.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.99 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.01 132.79 4.32 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.551 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 179.64 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -109.44 157.86 18.53 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.713 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 t -68.67 -23.21 64.38 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.76 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.63 -57.14 0.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.6 137.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.729 ' O ' HG21 ' A' ' 97' ' ' THR . 74.7 mt -88.36 -45.78 9.72 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 29' ' ' LEU . 76.2 t -36.62 125.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.879 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 . . . . . 0 N--CA 1.488 1.431 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.068 -179.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.903 0.382 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.578 ' HD2' HG23 ' A' ' 97' ' ' THR . 15.3 m-85 -74.09 122.84 23.32 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -141.51 132.99 26.83 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.035 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.609 ' N ' HD23 ' A' ' 38' ' ' LEU . 2.6 p-10 -124.95 127.01 46.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -94.44 175.07 6.82 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.514 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -160.55 168.16 25.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.88 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.7 tp -151.89 116.69 5.14 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.77 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.423 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 tt0 -93.84 132.2 38.48 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.433 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.124 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 120.827 0.346 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 63' ' ' VAL . 32.0 mt -125.92 -39.82 2.08 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.01 HD11 ' NH2' ' A' ' 59' ' ' ARG . 16.8 mm -138.83 146.19 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.3 p90 -143.66 32.58 1.29 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.206 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -177.57 55.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 57' ' ' SER . 48.3 t 36.98 83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.253 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 79.18 70.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.941 0.877 . . . . 0.0 110.342 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.05 106.08 0.2 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.373 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 1.01 ' NH2' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.09 163.42 26.64 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 61' ' ' SER . 44.6 t80 -91.77 172.94 8.14 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 54.5 p -60.23 -47.04 87.64 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.434 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.75 50.92 2.91 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 119.595 -1.288 . . . . 0.0 112.321 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' NH1' ' A' ' 59' ' ' ARG . 44.3 t -141.49 122.88 8.93 Favored Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.1 164.23 32.89 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.993 1.795 . . . . 0.0 111.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 67' ' ' PHE . 6.6 p-10 -69.74 -7.4 39.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 8.1 mmt-85 -60.95 0.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.538 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 64.9 m-85 -122.68 155.98 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 t -161.61 112.05 1.65 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.51 147.11 18.31 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -161.46 -176.48 5.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 153.74 171.42 20.83 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.604 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -80.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.691 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.4 -49.16 0.06 OUTLIER Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -113.62 17.64 18.1 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.72 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.71 133.53 16.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 55.0 m-85 -147.03 168.93 20.32 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.455 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.7 m -152.76 141.76 21.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.341 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 78' ' ' LEU . 10.4 tt -113.22 112.63 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -110.3 151.68 27.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.468 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.835 HG22 ' H ' ' A' ' 82' ' ' ARG . 97.0 mt -124.71 139.65 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -23.99 63.58 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.004 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.835 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.9 ptm180 -170.17 113.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.8 110.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.931 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.02 172.03 8.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.603 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.96 73.64 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.141 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 -13.73 59.8 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.43 -26.33 58.25 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.752 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 15' ' ' LEU . 48.3 mt -53.74 150.19 7.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.89 178.9 17.76 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.945 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 mm -86.0 108.29 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.729 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.7 m-85 -77.38 156.42 31.23 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.617 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -143.7 164.66 29.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 93' ' ' CYS . 30.8 p -148.55 82.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.673 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -89.18 -178.35 5.63 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.007 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -135.22 157.8 45.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 96' ' ' THR . 8.0 t -127.29 45.22 2.76 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.729 HG21 ' O ' ' A' ' 29' ' ' LEU . 18.6 m -114.4 -52.62 2.71 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.509 ' CE1' HG21 ' A' ' 2' ' ' VAL . 65.7 m-70 -86.86 145.68 26.49 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.501 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 47.1 t -113.82 138.64 22.81 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.853 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -70.55 164.35 81.7 Favored 'Cis proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.668 -1.388 . . . . 0.0 111.504 -0.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.81 120.16 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.522 1.481 . . . . 0.0 110.67 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 p -91.7 112.63 24.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.242 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -84.37 151.51 24.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.73 157.9 29.79 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.579 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 134.93 -175.74 20.41 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.594 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 141.74 55.11 0.04 OUTLIER Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.161 -1.495 . . . . 0.0 111.857 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.467 ' CB ' HE21 ' A' ' 6' ' ' GLN . 16.2 m -99.06 115.23 28.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.617 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 93.97 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.123 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.9 83.07 6.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.724 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 153.97 28.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.0 132.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.869 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.1 tttm . . . . . 0 C--N 1.303 -1.453 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.278 -179.948 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 98' ' ' HIS . 88.2 t . . . . . 0 C--O 1.214 -0.797 0 CA-C-O 120.876 0.37 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' N ' ' HB2' ' A' ' 26' ' ' SER . 46.8 t -69.0 153.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.313 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.403 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 30.1 mtp -135.06 92.8 2.92 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -79.19 121.1 24.62 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.016 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.54 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -97.8 129.05 44.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.721 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.31 151.56 37.2 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 107' ' ' THR . 8.1 Cg_endo -74.23 -179.82 27.24 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.716 -1.368 . . . . 0.0 111.648 0.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 -33.29 53.59 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.054 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 m -130.27 153.16 48.91 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.829 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 tp -143.3 73.63 17.68 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.97 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.41 106.58 1.25 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.886 1.724 . . . . 0.0 110.645 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.3 m -132.34 170.47 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.45 150.26 22.36 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD22 ' C ' ' A' ' 84' ' ' GLU . 33.9 mt -73.74 90.54 1.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.38 -21.3 1.07 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 18' ' ' GLN . 7.0 m-20 -84.54 -154.52 0.18 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.055 -0.572 . . . . 0.0 110.369 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 81' ' ' SER . 25.8 mt-30 -125.25 164.55 20.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.555 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.97 160.95 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.011 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 m -149.94 95.39 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mp -91.48 133.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.023 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -92.07 159.51 15.66 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.504 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 3.3 m -156.47 105.92 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.865 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -100.97 124.98 47.5 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.029 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 78.0 p -87.9 147.34 25.12 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.431 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -49.03 -68.17 0.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.742 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 59.46 1.55 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.59 ' CA ' HG22 ' A' ' 74' ' ' THR . 19.9 t 61.6 173.88 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.966 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.516 HD21 ' OE1' ' A' ' 95' ' ' GLN . 23.5 mt -131.73 21.36 4.63 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.535 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.562 HG22 ' OG1' ' A' ' 36' ' ' THR . 45.6 t -79.89 122.72 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.512 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.011 179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.562 ' OG1' HG22 ' A' ' 30' ' ' VAL . 10.4 m . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.71 0.291 . . . . 0.0 110.485 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 156.78 41.61 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.654 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.552 HD22 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -173.31 105.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.54 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -96.54 105.26 17.33 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.625 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' NE1' HD22 ' A' ' 38' ' ' LEU . 43.2 m95 -84.94 148.76 26.06 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 103' ' ' PHE . 41.0 m-85 -136.72 157.24 47.22 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 91' ' ' TYR . 8.4 tp -136.7 110.43 8.1 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.79 121.77 37.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' CE ' ' HA ' ' A' ' 86' ' ' GLU . 7.4 tttt . . . . . 0 C--N 1.303 -1.421 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.195 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 40' ' ' TRP . 21.9 tp . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.889 0.376 . . . . 0.0 110.332 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 63' ' ' VAL . 39.4 mt -120.38 -55.56 2.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 59' ' ' ARG . 41.5 mm -120.11 158.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 30.1 p90 -138.17 -28.17 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.878 -1.129 . . . . 0.0 112.254 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -101.31 -51.29 3.53 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 57' ' ' SER . 7.4 p -178.31 -41.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.481 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.543 ' N ' HG13 ' A' ' 56' ' ' VAL . 8.9 t -138.47 -31.86 0.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.11 120.05 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 36.0 mtm-85 -77.54 157.65 30.27 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.295 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 85.4 t80 -73.77 160.41 31.53 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 38.2 t -62.6 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.349 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.7 -19.62 3.52 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 52' ' ' LEU . 40.7 t -81.54 118.5 72.45 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.62 155.98 39.52 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.917 1.745 . . . . 0.0 111.993 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.87 -19.29 6.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.219 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -49.52 -26.38 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.811 -0.755 . . . . 0.0 111.284 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD2' HD13 ' A' ' 52' ' ' LEU . 60.9 m-85 -100.57 128.22 46.7 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.507 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.7 p -141.8 128.59 20.49 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.259 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.36 150.53 18.4 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.63 147.54 10.38 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.217 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -166.07 125.89 1.4 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 m -95.1 67.29 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.79 -91.37 0.5 Allowed Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.114 -1.517 . . . . 0.0 112.144 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 28' ' ' SER . 37.1 p -121.9 1.55 9.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.348 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -106.16 97.81 7.57 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.954 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.604 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 73.4 m-85 -114.41 147.43 39.24 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 21' ' ' ILE . 17.1 m -149.83 133.88 17.09 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.002 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 8.4 tt -92.16 112.09 23.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.194 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -107.05 129.19 54.85 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 82' ' ' ARG . 5.1 mt -109.83 134.51 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.692 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 36.7 m -83.41 -19.14 36.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.276 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.518 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.1 mtt-85 -145.53 97.15 2.94 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.596 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 15' ' ' LEU . 51.6 t -75.68 117.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.354 -0.939 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.539 ' C ' HD22 ' A' ' 15' ' ' LEU . 7.6 mm-40 -115.65 172.53 7.07 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.989 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.5 12.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.714 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 1.3 mt-10 -68.45 -36.72 79.41 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -59.96 -15.02 18.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.842 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.43 136.46 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.608 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -167.42 27.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.25 118.43 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.689 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.716 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.1 m-85 -84.4 147.51 27.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.156 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -141.1 167.28 22.57 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.817 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.512 ' N ' HE22 ' A' ' 6' ' ' GLN . 24.1 p -155.95 102.13 2.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.1 p -88.63 171.25 10.16 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.516 ' OE1' HD21 ' A' ' 29' ' ' LEU . 3.4 pt20 -127.76 112.0 14.3 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.1 p -81.11 55.31 2.47 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.843 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 m -128.52 -53.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 2' ' ' VAL . 34.9 m-70 -100.31 177.49 5.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.179 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.456 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 96.7 t -145.9 135.51 11.57 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.495 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -70.87 139.61 58.9 Favored 'Cis proline' 0 C--N 1.317 -1.1 0 C-N-CA 123.558 -1.434 . . . . 0.0 111.462 -0.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 100' ' ' PRO . 1.1 Cg_endo -65.75 118.48 5.52 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.717 1.611 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.4 p -66.45 160.57 24.65 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.946 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -112.39 38.2 2.8 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.736 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.68 -178.93 31.29 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.464 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -90.83 -50.53 2.86 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 6' ' ' GLN . . . 127.57 95.4 0.88 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.056 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' PRO . 93.8 m -100.37 120.77 40.46 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.11 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -78.5 118.43 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tt -113.16 100.54 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.77 159.28 23.28 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 tt -65.14 168.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.558 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tmtt? . . . . . 0 N--CA 1.489 1.479 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.956 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.403 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t . . . . . 0 C--O 1.215 -0.744 0 CA-C-O 120.73 0.3 . . . . 0.0 110.587 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.92 132.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.278 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 54.5 mmm -125.46 93.5 3.88 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 m -78.71 116.08 18.83 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.616 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 1.2 mp0 -101.83 148.9 24.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.927 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.58 163.12 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.501 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.716 ' HG2' HD12 ' A' ' 11' ' ' LEU . 8.2 Cg_endo -77.41 177.29 40.04 Favored 'Cis proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.59 -1.421 . . . . 0.0 110.711 -1.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.9 -26.61 63.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 95.7 p -145.43 146.64 31.6 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.701 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.716 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -130.19 78.19 75.02 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.93 108.53 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.862 1.708 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 12.5 m -144.52 153.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.249 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.93 152.18 26.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.616 ' HG ' HD11 ' A' ' 111' ' ' ILE . 62.3 mt -69.89 88.76 0.57 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.65 -27.81 0.6 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.82 171.25 15.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 26.5 mt-30 -87.16 134.25 33.55 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.331 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -107.01 155.18 20.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.404 ' H ' HD21 ' A' ' 11' ' ' LEU . 25.6 m -149.09 97.76 2.73 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.992 HG23 HG21 ' A' ' 107' ' ' THR . 26.6 mt -84.17 161.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.786 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.6 t -122.17 146.22 47.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.692 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.616 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.9 m -150.34 104.92 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -112.14 134.68 53.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.801 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 29' ' ' LEU . 54.5 p -98.51 152.29 19.71 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.297 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 p -73.02 -35.12 66.72 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 28' ' ' SER . 7.3 tp60 -121.12 148.72 43.81 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.623 ' HA ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -50.3 142.91 9.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.26 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 25' ' ' SER . 69.1 mt -108.55 43.35 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -102.14 135.5 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t-80 . . . . . 0 N--CA 1.488 1.468 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.796 -179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 29' ' ' LEU . 17.2 m . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' A' ' 97' ' ' THR . 6.3 m-30 -86.65 72.86 10.15 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG ' ' A' ' 76' ' ' PHE . 4.0 tt -119.34 132.59 55.89 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.532 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.456 ' HB2' HD11 ' A' ' 51' ' ' LEU . 5.1 p30 -126.14 165.48 18.8 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.524 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.731 ' CE3' HD12 ' A' ' 78' ' ' LEU . 50.9 m95 -114.52 154.32 28.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.0 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.21 163.5 29.47 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.632 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 91' ' ' TYR . 18.6 tp -155.66 136.99 13.95 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -115.92 123.29 47.72 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.575 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.432 ' HE2' ' HA ' ' A' ' 86' ' ' GLU . 17.7 tptp . . . . . 0 N--CA 1.485 1.324 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.643 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.609 HD23 ' CG ' ' A' ' 60' ' ' PHE . 34.7 tp . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.614 ' O ' HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -96.52 -72.41 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.986 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 54' ' ' TYR . 30.2 mm -120.28 164.67 16.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.479 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' N ' HG22 ' A' ' 53' ' ' ILE . 35.5 p90 -155.69 156.44 34.93 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 13.6 mttm 48.25 22.33 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.923 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' TYR . 78.4 t 63.89 127.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.568 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p 41.94 56.86 3.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.834 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 9.8 m120 -127.67 -21.73 3.71 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.358 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HA ' HD13 ' A' ' 53' ' ' ILE . 3.8 mtt180 54.47 101.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.97 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' HD23 ' A' ' 51' ' ' LEU . 35.0 t80 -60.25 160.21 8.76 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.638 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p -56.27 112.51 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.621 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.23 7.64 20.77 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 52' ' ' LEU . 78.7 t -112.05 104.57 56.12 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.37 155.08 43.0 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.002 1.801 . . . . 0.0 112.078 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.469 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.16 -15.81 0.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.789 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -51.98 -34.96 44.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.774 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HD2' HD21 ' A' ' 78' ' ' LEU . 90.3 m-85 -95.15 129.28 42.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.881 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.86 93.28 3.28 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.7 106.27 2.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.628 -1.272 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.6 m -113.68 -176.64 2.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.047 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 154.14 117.8 0.65 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.9 t -98.1 67.76 1.92 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.144 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.76 -109.51 1.48 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.549 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 28' ' ' SER . 65.3 p -101.95 9.65 40.36 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 8.2 p-10 -113.73 139.49 49.05 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 96.7 m-85 -147.82 156.27 42.54 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 21' ' ' ILE . 28.7 m -150.04 152.75 35.34 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.752 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.731 HD12 ' CE3' ' A' ' 40' ' ' TRP . 6.8 tt -115.96 92.74 3.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 6.1 mttt -92.23 126.89 37.5 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.006 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 19' ' ' ALA . 18.7 mt -114.42 132.44 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.059 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -60.16 -73.64 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.275 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.693 HH12 ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -123.39 100.44 6.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.526 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 87' ' ' ASP . 72.3 t -54.33 145.89 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.983 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.693 ' CG ' HH12 ' A' ' 82' ' ' ARG . 2.4 mm-40 -126.48 172.84 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.478 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.73 -29.67 54.15 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.49 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 15.3 mm-40 -66.19 -41.1 90.68 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.454 ' CB ' HG13 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -52.33 -33.06 41.02 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.083 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 111' ' ' ILE . 39.8 mt -53.81 130.87 38.46 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.7 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.47 8.75 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.9 mp -125.64 116.58 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.644 ' CE2' HD13 ' A' ' 42' ' ' LEU . 3.4 m-85 -88.53 153.71 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.159 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' HG22 ' A' ' 90' ' ' ILE . 61.2 m-85 -154.76 179.96 8.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.215 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.1 p -165.22 163.36 20.23 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.942 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.471 ' CB ' ' CD2' ' A' ' 103' ' ' PHE . 8.4 t -147.03 -173.32 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.834 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 2.7 pt20 -136.54 108.12 6.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.123 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -82.84 43.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.047 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -114.17 -58.16 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.849 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.403 ' CG ' HG21 ' A' ' 2' ' ' VAL . 78.9 m-70 -88.76 171.78 9.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.297 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 100' ' ' PRO . 57.4 t -139.17 138.72 21.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.1 Cg_endo -71.39 148.8 90.88 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.276 -1.552 . . . . 0.0 111.336 -1.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.62 113.4 1.94 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.762 1.641 . . . . 0.0 110.084 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 87.39 4.56 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 94' ' ' SER . 1.5 t80 -83.5 111.46 19.08 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.882 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.89 152.21 6.61 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -167.34 -128.18 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.06 100.27 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 C-N-CA 117.641 -2.218 . . . . 0.0 113.632 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.992 HG21 HG23 ' A' ' 21' ' ' ILE . 96.7 m -158.35 104.17 1.83 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -89.82 156.19 18.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.396 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 93.89 3.15 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.816 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 111' ' ' ILE . 17.3 pt-20 -106.82 31.94 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.696 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.616 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER 61.91 170.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 111' ' ' ILE . 3.9 tttm . . . . . 0 N--CA 1.49 1.544 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.018 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 29' ' ' LEU . 64.1 t . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 121.4 0.619 . . . . 0.0 111.553 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.06 116.27 17.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mtp -93.94 89.76 6.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.054 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -77.08 112.23 13.5 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.64 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.698 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 38.1 tt0 -100.05 154.95 17.99 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -161.45 161.4 22.91 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.307 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 107' ' ' THR . 6.7 Cg_endo -77.03 178.12 36.68 Favored 'Cis proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.522 -1.449 . . . . 0.0 110.314 -2.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 9' ' ' LEU . 4.4 mm? -63.26 -21.56 66.32 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.469 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 p -154.83 152.38 29.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.607 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 3.5 tp -129.59 77.51 77.02 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.019 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.43 102.75 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.699 1.599 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 34.3 m -137.17 -167.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.805 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.22 153.0 34.61 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 111' ' ' ILE . 63.9 mt -75.46 87.03 2.6 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.443 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.64 -26.34 0.52 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.58 -170.65 2.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.42 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -106.4 139.5 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.263 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -113.34 146.13 39.94 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.397 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 p -138.23 92.03 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.492 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.518 HG23 HG21 ' A' ' 107' ' ' THR . 4.8 mt -89.56 126.44 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.08 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.1 156.56 20.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.118 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 29.0 m -162.02 111.73 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.251 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -111.22 140.66 45.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -94.54 167.04 11.74 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.931 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -41.03 26.32 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.316 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -136.77 43.77 2.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.433 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.471 ' C ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 m 61.02 -174.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.849 ' CD1' HD12 ' A' ' 38' ' ' LEU . 13.2 mt -142.92 21.34 1.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -77.11 138.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.169 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.996 179.998 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 29' ' ' LEU . 11.9 m . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.82 0.343 . . . . 0.0 111.409 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.79 68.91 7.2 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.007 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 29' ' ' LEU . 1.4 tt -89.76 142.13 27.98 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.666 ' OD1' HD12 ' A' ' 51' ' ' LEU . 9.1 t30 -122.42 162.2 22.08 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.077 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.741 ' CD2' HD12 ' A' ' 78' ' ' LEU . 50.6 m95 -125.31 154.31 41.96 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.509 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.86 146.24 50.68 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp -162.7 128.42 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -173.42 170.48 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.258 -1.377 . . . . 0.0 112.678 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.309 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.413 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.666 HD12 ' OD1' ' A' ' 39' ' ' ASN . 1.2 tp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.908 0.385 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.29 -89.07 0.19 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.664 HG21 ' H ' ' A' ' 57' ' ' SER . 2.8 mp -82.43 145.3 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.787 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.2 p90 -139.46 -7.51 1.31 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.428 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 2.7 tmtt? -130.84 57.7 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.574 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 56' ' ' VAL . 5.9 p 38.05 79.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.046 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.664 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 69.26 75.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.444 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -151.0 -24.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER 70.49 137.55 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.051 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' N ' ' A' ' 61' ' ' SER . 79.4 t80 -90.77 172.22 8.79 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 t -57.89 117.4 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.33 -8.21 54.99 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.488 HG21 ' H ' ' A' ' 60' ' ' PHE . 94.8 t -84.96 124.79 72.04 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.25 144.28 95.96 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 122.136 1.891 . . . . 0.0 112.143 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 3.0 t0 -58.26 -25.25 61.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.326 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.7 69.35 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.441 ' O ' ' NH1' ' A' ' 59' ' ' ARG . 10.0 m-85 -79.91 126.52 31.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.3 m -134.77 159.36 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.236 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -152.44 79.53 0.2 Allowed Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.069 -1.538 . . . . 0.0 111.297 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 8.8 t -83.3 -167.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 151.55 117.26 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.539 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -92.35 91.35 7.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.87 -75.15 0.91 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.6 p -131.65 57.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.525 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 25.9 t0 -162.62 58.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.659 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 58.2 m-85 -80.19 148.79 30.72 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 m -148.97 122.8 9.31 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.733 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 40' ' ' TRP . 4.4 tt -84.68 104.56 14.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -96.12 119.98 35.59 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.309 -0.957 . . . . 0.0 111.99 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.502 HG13 HD23 ' A' ' 78' ' ' LEU . 7.8 mt -109.51 116.17 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.352 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -69.89 -24.45 63.4 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.875 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.1 mmt-85 -142.61 110.62 5.95 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.853 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -86.73 136.52 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.6 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.624 ' C ' HD22 ' A' ' 15' ' ' LEU . 2.9 mt-10 -129.54 170.06 14.21 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.522 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -43.73 59.41 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.301 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.9 -37.67 85.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.37 -21.62 50.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 109' ' ' LEU . 78.6 mt -58.96 146.23 38.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.173 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.41 -154.58 25.19 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 92' ' ' PHE . 20.9 mt -112.41 140.55 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.125 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -104.42 150.64 24.35 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.664 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 90' ' ' ILE . 40.5 m-85 -151.08 135.18 16.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.768 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -109.11 141.12 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.857 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 9.3 p -144.23 -164.68 1.95 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 29' ' ' LEU . 5.5 pm0 -159.14 165.87 32.79 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.505 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.6 p -109.2 -21.68 12.45 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' LEU . 10.3 m -53.16 -55.26 25.53 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.359 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CG ' HG21 ' A' ' 2' ' ' VAL . 37.9 m-70 -88.17 131.71 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.529 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 62.3 t -135.16 137.44 26.83 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.2 Cg_endo -68.27 136.71 36.4 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.539 -0.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.48 155.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.928 1.752 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.18 -64.56 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 65.58 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.869 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.01 64.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -65.95 -84.67 0.09 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.63 75.05 0.59 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.317 -1.42 . . . . 0.0 112.445 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.518 HG21 HG23 ' A' ' 21' ' ' ILE . 19.9 m -148.86 106.95 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.553 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.69 139.79 32.55 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.852 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 88' ' ' LEU . 7.6 tt -131.67 107.27 8.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.197 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -131.33 32.89 4.16 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.162 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.742 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 66.08 163.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.96 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.587 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.422 HG12 ' OG ' ' A' ' 25' ' ' SER . 11.6 t . . . . . 0 N--CA 1.475 0.779 0 CA-C-O 121.051 0.453 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' N ' ' HB2' ' A' ' 26' ' ' SER . 16.9 t -63.14 155.85 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.689 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.5 mmm -133.46 110.44 9.98 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.697 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -80.14 147.6 31.28 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.657 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 5.3 mp0 -118.75 143.33 46.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.342 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 141.93 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 11' ' ' LEU . 9.6 Cg_endo -79.35 175.16 46.9 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.586 -1.422 . . . . 0.0 111.159 -0.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.37 -22.82 59.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 p -139.7 148.86 42.94 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 21' ' ' ILE . 4.6 tp -126.87 78.57 73.54 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.4 102.74 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.818 1.679 . . . . 0.0 111.061 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 14' ' ' SER . 8.6 m -132.77 -154.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 13' ' ' VAL . 3.3 t -147.06 154.02 40.68 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.907 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 84' ' ' GLU . 14.6 mt -68.56 87.47 0.32 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 82' ' ' ARG . . . 147.04 -31.58 1.44 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.53 173.06 11.99 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.248 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' A' ' 81' ' ' SER . 2.2 mt-30 -89.07 166.94 13.54 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.039 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -147.98 161.12 41.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.218 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -157.58 109.97 2.4 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.757 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.565 HG13 HD22 ' A' ' 11' ' ' LEU . 2.2 mp -101.02 118.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 t -93.7 158.43 15.68 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.155 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.3 t -160.9 117.86 2.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -104.3 172.07 6.99 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.422 ' OG ' HG12 ' A' ' 2' ' ' VAL . 1.8 t -116.86 167.43 11.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 14.9 t -67.87 -27.18 66.45 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.39 -59.68 0.34 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.269 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.71 155.35 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.676 ' O ' HG21 ' A' ' 97' ' ' THR . 83.6 mt -114.53 6.86 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.48 137.8 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 . . . . . 0 N--CA 1.488 1.461 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.277 -179.911 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 120.583 0.23 . . . . 0.0 110.793 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.642 ' H ' ' CG2' ' A' ' 97' ' ' THR . 22.6 m-85 -122.73 109.42 14.22 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -130.54 133.54 46.31 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.699 ' OD1' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.51 149.01 30.95 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.454 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.584 ' O ' HD12 ' A' ' 51' ' ' LEU . 22.8 m95 -111.89 172.48 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 162.72 31.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.482 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 91' ' ' TYR . 19.7 tp -151.25 127.13 10.32 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.37 113.36 26.84 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.852 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.306 -1.295 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 54' ' ' TYR . 9.1 tp . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 120.843 0.354 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -101.97 -55.67 2.44 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.799 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.756 HG21 ' H ' ' A' ' 57' ' ' SER . 51.6 mm -124.49 137.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.043 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.704 ' HB3' HD21 ' A' ' 51' ' ' LEU . 37.2 p90 -113.12 -30.65 6.9 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.618 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -124.33 48.41 1.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 58' ' ' ASN . 40.8 t 56.12 103.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.376 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.756 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.7 OUTLIER 76.48 -29.37 0.18 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 58' ' ' ASN . 1.5 m120 -69.35 94.66 0.73 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.973 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 53' ' ' ILE . 4.1 mtm180 -66.76 136.97 56.28 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' VAL . 25.8 t80 -57.2 157.48 6.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -53.44 -22.73 8.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.734 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.26 31.9 6.64 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 60' ' ' PHE . 38.8 t -120.44 125.89 27.0 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.671 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.61 149.89 73.1 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.241 1.961 . . . . 0.0 112.436 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.23 -25.46 65.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.986 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -53.95 -35.84 62.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.88 129.37 34.43 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 t -137.25 138.65 40.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.546 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -124.03 131.72 8.08 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 p -156.19 146.92 21.91 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.203 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -170.94 114.48 0.54 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -95.34 145.2 25.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.201 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.75 -101.01 0.42 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.909 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 p -131.04 21.66 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.71 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 5.9 m-20 -122.17 124.04 42.93 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 23.8 m-85 -131.47 155.3 47.61 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 25.8 m -159.49 139.57 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.578 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.4 tt -95.56 104.53 16.45 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.19 129.24 38.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.692 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.721 HG22 ' H ' ' A' ' 82' ' ' ARG . 32.1 mt -116.81 128.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.468 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HA ' HE21 ' A' ' 18' ' ' GLN . 8.1 m -85.13 2.33 43.99 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.706 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -171.37 112.5 0.35 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.841 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.5 t -91.75 150.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.34 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.53 ' C ' HD22 ' A' ' 15' ' ' LEU . 4.3 mt-10 -137.28 167.15 22.15 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.197 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.86 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.227 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -66.15 -29.66 69.99 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.769 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.42 -19.98 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 109' ' ' LEU . 78.8 mt -65.98 137.08 56.88 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.855 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.15 -137.71 5.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.59 106.69 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.485 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.477 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.28 130.43 36.21 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.311 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 1.2 m-85 -118.11 166.61 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.657 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 14.7 p -134.85 152.46 51.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -156.25 155.9 33.15 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.536 ' CB ' HD22 ' A' ' 29' ' ' LEU . 4.0 pt20 -112.39 163.04 14.89 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.5 m -144.89 46.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.676 HG21 ' O ' ' A' ' 29' ' ' LEU . 2.1 p -124.64 -44.17 1.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -99.5 142.2 31.3 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.5 p -109.18 137.22 20.13 Favored Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 6.1 Cg_endo -74.55 146.45 86.79 Favored 'Cis proline' 0 C--N 1.316 -1.173 0 C-N-CA 123.528 -1.447 . . . . 0.0 111.494 -0.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.04 125.49 15.98 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.72 1.613 . . . . 0.0 110.156 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.3 p -91.22 107.37 19.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.198 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -94.27 139.42 31.07 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.098 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -167.85 -141.05 3.06 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.363 -1.398 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 92' ' ' PHE . . . 132.58 175.19 13.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.22 79.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.48 HG21 HG23 ' A' ' 21' ' ' ILE . 93.1 m -149.91 107.41 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.185 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -75.9 93.61 3.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 88' ' ' LEU . 5.0 tt -89.35 83.89 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.3 tt0 -124.96 54.97 1.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.143 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.671 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER 54.82 176.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.416 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 111' ' ' ILE . 31.8 mtpt . . . . . 0 C--N 1.302 -1.479 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.869 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CG ' ' A' ' 98' ' ' HIS . 69.0 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 121.029 0.442 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 4' ' ' MET . 17.1 t -68.61 161.0 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.659 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.472 ' N ' HG12 ' A' ' 3' ' ' VAL . 82.0 mmm -139.25 101.46 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -91.89 103.45 15.99 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -107.35 166.31 10.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.743 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.67 170.35 8.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.583 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 12.1 Cg_endo -83.72 173.8 41.67 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.794 -1.336 . . . . 0.0 110.72 -2.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.3 mt -72.88 -16.69 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.126 -1.029 . . . . 0.0 109.626 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.0 p -154.14 136.18 14.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tp -122.72 86.32 49.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.269 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.68 116.81 4.61 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.64 1.56 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.579 HG21 HG11 ' A' ' 83' ' ' VAL . 35.8 m -141.86 -172.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -114.42 145.75 41.46 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.08 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 111' ' ' ILE . 38.6 mt -70.35 89.43 0.67 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.4 -1.04 3.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -95.71 -135.17 0.22 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 167.57 21.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.706 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -150.06 168.79 22.88 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 19.7 p -160.38 91.72 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mt -78.3 125.86 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 7' ' ' THR . 32.4 t -85.57 157.4 20.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.268 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 2.0 m -161.89 106.11 1.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.161 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' NH1' ' O ' ' A' ' 74' ' ' THR . 55.7 ttm-85 -106.49 144.89 32.52 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.91 154.8 17.77 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -63.93 -72.03 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.22 48.61 1.02 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t 67.97 176.28 0.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.77 ' C ' HG21 ' A' ' 97' ' ' THR . 55.6 mt -124.78 52.7 1.53 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.617 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.443 ' N ' HG21 ' A' ' 97' ' ' THR . 35.1 t -106.65 130.94 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 . . . . . 0 C--N 1.305 -1.36 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.301 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 120.728 0.299 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -134.28 139.6 45.83 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.425 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.683 HD13 ' CG ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -162.26 149.67 13.98 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.115 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.409 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 4.4 p-10 -137.72 170.89 15.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.184 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE2' HD13 ' A' ' 78' ' ' LEU . 70.1 m95 -131.9 164.04 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.525 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 1.5 m-85 -154.73 131.57 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.507 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.66 HD22 ' CZ ' ' A' ' 91' ' ' TYR . 5.4 tp -116.16 117.49 30.21 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.798 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 42' ' ' LEU . 13.6 tm0? -101.42 140.2 36.05 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.865 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.493 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 52' ' ' LEU . 5.9 tp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.045 0.45 . . . . 0.0 111.354 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 67' ' ' PHE . 17.5 mt -113.42 -90.08 0.52 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.183 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.748 HD13 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -82.66 145.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -139.36 -7.19 1.34 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tptt -139.78 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 5.8 t 76.4 -47.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.977 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -171.77 45.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.08 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.86 -36.57 11.59 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 68.31 134.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' H ' HG21 ' A' ' 63' ' ' VAL . 4.7 t80 -81.08 168.08 19.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -60.17 -33.12 71.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.02 11.38 22.27 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.756 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.583 HG21 ' H ' ' A' ' 60' ' ' PHE . 21.3 t -104.46 128.08 27.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.436 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.2 Cg_endo -67.17 19.34 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.119 1.879 . . . . 0.0 112.92 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 63' ' ' VAL . 15.4 t70 68.7 -37.07 0.34 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -52.72 -18.32 1.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.492 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.605 ' O ' HD11 ' A' ' 53' ' ' ILE . 57.0 m-85 -87.92 92.81 9.27 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.208 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 m -109.94 158.44 18.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.042 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.04 14.95 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.574 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.6 t -148.41 168.03 23.71 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.74 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.665 ' CA ' ' CD2' ' A' ' 76' ' ' PHE . . . -173.19 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.001 -1.571 . . . . 0.0 111.524 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -92.79 51.92 1.78 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -59.53 4.27 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.72 -1.228 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.423 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 3.8 p -125.63 34.47 4.9 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.766 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.05 106.81 1.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.316 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 11.6 m-85 -128.59 145.29 51.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.395 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 78' ' ' LEU . 19.6 m -149.78 170.85 17.78 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.682 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.748 HD11 HD13 ' A' ' 53' ' ' ILE . 4.7 tp -134.67 94.79 3.24 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.557 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -77.96 111.52 13.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.582 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' ALA . 77.2 mt -91.54 117.98 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -92.5 89.01 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.264 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.598 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 104.09 76.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.475 1.109 . . . . 0.0 110.464 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 13' ' ' VAL . 72.2 t -67.59 100.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' HH12 ' A' ' 66' ' ' ARG . 50.6 mt-10 -94.67 179.03 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.19 -28.44 40.6 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.686 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.97 -51.42 70.12 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' OD2' HD13 ' A' ' 80' ' ' ILE . 4.4 m-20 -47.39 -26.33 1.28 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 111' ' ' ILE . 51.1 mt -56.57 144.58 31.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.36 -134.72 8.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -133.62 119.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.519 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 3.8 m-85 -89.44 146.75 24.43 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.78 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.82 175.23 9.78 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.33 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.456 ' H ' ' HA3' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -160.72 159.05 29.7 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.966 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 t -151.24 178.1 9.57 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.606 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.563 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -129.44 124.85 35.14 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.613 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.3 p -93.15 4.19 54.42 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.77 HG21 ' C ' ' A' ' 29' ' ' LEU . 99.5 m -70.64 -57.71 4.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CG ' HG21 ' A' ' 2' ' ' VAL . 75.7 m-70 -91.45 94.51 9.5 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.407 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 100' ' ' PRO . 14.7 p -74.97 139.11 72.91 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' A' ' 99' ' ' VAL . 5.4 Cg_endo -72.85 142.83 75.81 Favored 'Cis proline' 0 C--N 1.318 -1.05 0 C-N-CA 123.726 -1.364 . . . . 0.0 111.781 -0.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.25 112.32 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.863 1.709 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.2 p -72.77 84.84 1.21 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 16.8 t80 -76.83 155.04 33.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 168.17 -52.54 0.22 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 118.822 -1.656 . . . . 0.0 111.354 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 93' ' ' CYS . . . 50.19 -138.05 22.77 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.159 -1.495 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.94 85.12 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.282 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 21' ' ' ILE . 17.3 m -152.84 109.45 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.748 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.97 97.23 9.69 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.269 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -90.69 84.23 5.86 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.161 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.6 57.18 0.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.456 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.693 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER 54.88 178.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.708 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.693 ' N ' HG23 ' A' ' 111' ' ' ILE . 1.2 tppt? . . . . . 0 N--CA 1.49 1.551 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.078 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 98' ' ' HIS . 65.1 t . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 120.962 0.411 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.1 150.81 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.662 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.63 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 50.7 mtp -133.5 -174.22 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.507 0.67 . . . . 0.0 109.694 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -156.55 152.06 26.83 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -140.34 150.18 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.044 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.55 166.87 15.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 5.0 Cg_endo -74.59 178.41 34.32 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.717 -1.368 . . . . 0.0 110.846 -1.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -36.95 78.05 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.53 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.3 t -140.24 147.55 40.18 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.063 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tp -134.1 83.18 46.16 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.406 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.413 ' C ' ' HG3' ' A' ' 112' ' ' LYS . 2.0 Cg_endo -68.05 101.17 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.839 1.692 . . . . 0.0 110.241 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.74 -167.78 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.884 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -127.35 147.73 50.26 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 85' ' ' ALA . 17.7 mt -67.78 89.34 0.26 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.667 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.92 -6.8 2.36 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.65 -152.16 0.27 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -125.05 155.93 38.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.67 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HB2' HG21 ' A' ' 83' ' ' VAL . . . -129.75 163.53 25.98 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.449 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.7 p -163.32 94.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.423 HG23 ' OG1' ' A' ' 107' ' ' THR . 2.7 mp -91.36 129.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.018 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 37.0 m -87.96 159.39 18.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.966 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 2.1 t -160.74 137.11 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.672 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.41 45.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.966 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 m -110.77 146.83 35.67 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.319 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -52.14 -38.01 56.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -133.25 167.0 21.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -63.52 137.99 58.34 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 29' ' ' LEU . 77.2 mt -94.39 23.48 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.208 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.41 139.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.9 t-80 . . . . . 0 N--CA 1.488 1.472 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.704 -179.897 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.738 0.304 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.36 137.39 37.28 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.169 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 21.1 tp -172.63 151.51 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -154.72 120.71 5.22 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 29.6 m95 -87.93 149.68 23.92 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.546 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HB3' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -123.7 155.68 37.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.574 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.662 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 6.4 tp -150.91 117.11 5.62 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.499 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -111.94 130.45 55.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 54' ' ' TYR . 16.0 tp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.853 0.358 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 67' ' ' PHE . 33.2 mt -95.48 -88.94 0.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.241 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 59' ' ' ARG . 44.0 mm -88.82 123.05 40.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.028 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' A' ' 51' ' ' LEU . 36.0 p90 -110.48 20.17 18.01 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.374 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.14 143.77 1.56 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.89 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.626 HG13 ' H ' ' A' ' 71' ' ' GLY . 43.1 t -44.09 106.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.06 71.21 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.419 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -170.71 110.65 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.359 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HA ' HD13 ' A' ' 53' ' ' ILE . 24.6 mtm-85 -77.33 139.76 39.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.847 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 68.7 t80 -69.85 160.13 32.36 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.408 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 5.3 m -40.25 -53.73 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.86 57.44 3.7 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 60' ' ' PHE . 88.9 t -144.59 113.9 5.12 Favored Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.105 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 159.77 37.45 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.966 1.778 . . . . 0.0 111.938 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -58.08 -27.46 63.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.549 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.502 ' CG ' ' HB2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -43.71 -42.12 5.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.322 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 52' ' ' LEU . 64.7 m-85 -82.51 124.51 30.17 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.623 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -124.63 151.86 44.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.722 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.35 155.11 25.94 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.772 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -149.78 141.83 23.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' H ' HG13 ' A' ' 56' ' ' VAL . . . -137.42 128.45 4.32 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.92 -1.609 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 m -94.73 -124.55 0.11 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.17 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.14 -55.89 1.25 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 p -125.27 20.65 8.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.972 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -132.11 143.25 49.88 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CD1' HD22 ' A' ' 38' ' ' LEU . 40.4 m-85 -151.13 136.42 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 m -139.37 140.92 37.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.597 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 1.8 tt -117.63 111.05 18.66 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.161 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -120.81 138.14 54.18 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.196 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 19' ' ' ALA . 2.8 mp -105.85 138.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -72.09 -36.17 69.43 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.434 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HB2' ' CG ' ' A' ' 66' ' ' ARG . 3.9 mtt180 -135.25 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.058 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 19' ' ' ALA . 58.1 t -65.8 111.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.387 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 66' ' ' ARG . 24.4 mt-10 -106.65 177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 15' ' ' LEU . . . -52.75 -31.75 39.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.16 -32.81 74.17 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -20.16 66.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 109' ' ' LEU . 72.9 mt -58.53 139.94 54.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -173.42 23.04 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.419 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 90' ' ' ILE . 5.4 mp -85.25 158.56 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.662 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 13.2 m-85 -131.51 148.77 52.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -147.21 165.13 30.99 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.262 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 22.8 p -132.7 102.92 5.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 38' ' ' LEU . 5.2 m -83.17 164.32 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.145 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -130.38 118.2 20.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.633 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.22 22.02 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.538 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 3.9 m -89.11 -40.41 12.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.801 -0.759 . . . . 0.0 111.737 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.538 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 53.1 m-70 -119.34 152.4 36.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.673 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 68.0 t -113.86 137.76 22.46 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.61 142.3 73.96 Favored 'Cis proline' 0 C--N 1.317 -1.112 0 C-N-CA 123.589 -1.421 . . . . 0.0 111.805 -0.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.69 110.81 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.841 1.694 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -64.85 147.86 52.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.71 -74.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.69 -137.49 8.29 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.598 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.679 ' N ' ' HB3' ' A' ' 92' ' ' PHE . . . 114.0 90.6 1.8 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -151.46 8.76 0.66 Allowed Glycine 0 N--CA 1.483 1.827 0 C-N-CA 117.908 -2.091 . . . . 0.0 113.909 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 91' ' ' TYR . 30.6 m -147.73 138.53 23.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.885 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -113.6 103.4 11.21 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.358 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -85.86 86.94 7.34 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.62 139.1 45.04 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.721 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.4 tt -55.42 158.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.714 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HG3' ' C ' ' A' ' 12' ' ' PRO . 3.8 mtmp? . . . . . 0 N--CA 1.487 1.419 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG21 ' CG ' ' A' ' 98' ' ' HIS . 4.3 t . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 121.019 0.438 . . . . 0.0 110.86 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 30.1 t -66.95 157.09 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.438 ' CG ' HE22 ' A' ' 95' ' ' GLN . 40.1 mmm -133.31 113.47 12.64 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -77.78 127.65 32.75 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.577 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.644 ' CD ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 tp60 -101.57 139.29 37.43 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.75 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.18 145.83 9.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.841 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 107' ' ' THR . 9.1 Cg_endo -78.62 -179.98 28.71 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.093 -0.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.01 -29.75 49.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.498 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.88 149.63 50.33 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.261 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -142.24 83.07 12.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.877 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.07 113.97 3.02 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.853 1.702 . . . . 0.0 110.808 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 26.9 m -143.08 162.65 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.326 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.14 158.66 15.52 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' ' 111' ' ' ILE . 25.5 mt -78.96 94.65 5.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.1 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 133.05 16.98 1.18 Allowed Glycine 0 N--CA 1.494 2.544 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.99 -131.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 2.6 mt-30 -139.08 172.52 12.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.317 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.761 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -145.65 166.14 26.66 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.556 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -160.86 80.99 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.755 HG23 HG21 ' A' ' 107' ' ' THR . 2.9 mt -90.63 124.15 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.295 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -87.15 151.88 22.81 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.927 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -160.8 111.09 1.75 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.225 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.38 170.29 8.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.821 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.419 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 2.3 t -111.36 155.25 23.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.101 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -49.04 25.88 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 28' ' ' SER . 4.0 tp-100 -97.84 -68.6 0.79 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 74' ' ' THR . 39.3 t 167.45 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.73 20.77 7.77 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.56 119.3 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.628 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.3 t-80 . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.476 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 120.677 0.275 . . . . 0.0 110.478 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CG ' ' OG1' ' A' ' 97' ' ' THR . 12.6 m-85 -97.92 159.43 14.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.99 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 76' ' ' PHE . 16.1 tp 179.8 151.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.343 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.555 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 m120 -137.71 149.09 46.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD2' HD12 ' A' ' 78' ' ' LEU . 39.0 m95 -120.42 157.28 29.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.97 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -147.75 172.01 14.77 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.577 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 91' ' ' TYR . 1.1 tp -160.72 120.69 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.95 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -90.18 116.88 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HD3' ' O ' ' A' ' 86' ' ' GLU . 17.8 ttpp . . . . . 0 C--N 1.306 -1.285 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.545 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.696 0.284 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 51' ' ' LEU . 64.9 mt -102.3 -80.1 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.167 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 69' ' ' GLY . 3.3 mm -105.5 138.71 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.474 ' HB3' HD21 ' A' ' 51' ' ' LEU . 32.4 p90 -132.06 28.58 4.45 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.659 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -178.8 68.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.434 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 56' ' ' VAL . 20.5 m 19.74 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.541 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER 79.42 63.2 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.452 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -171.46 108.51 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.988 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 15.4 mtt85 -89.17 153.62 20.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.758 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 40.0 t80 -83.78 160.28 21.26 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.3 t -42.97 -38.55 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.029 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.08 52.42 1.09 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 75.0 t -146.12 118.93 5.11 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.8 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 4.2 Cg_exo -60.36 138.07 78.5 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.159 1.906 . . . . 0.0 111.919 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.486 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -52.22 -23.78 6.17 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' CB ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -67.53 12.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.128 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.511 ' HD1' HD21 ' A' ' 78' ' ' LEU . 12.2 m-85 -115.74 104.51 11.74 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.395 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.0 m -105.68 121.08 43.27 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.12 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' O ' HG21 ' A' ' 53' ' ' ILE . . . -131.15 102.7 0.52 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 31.2 t -151.47 175.34 12.39 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.142 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 174.37 147.63 6.19 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.8 p -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.4 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.11 -102.79 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.213 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.772 HG22 ' HA ' ' A' ' 28' ' ' SER . 59.1 p -124.55 15.45 8.84 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.111 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -115.83 125.68 53.0 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CD2' HD22 ' A' ' 38' ' ' LEU . 4.0 m-85 -140.97 168.14 20.5 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.517 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -160.1 155.91 25.95 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.255 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 40' ' ' TRP . 5.3 tt -112.49 102.02 10.15 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.487 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -89.8 125.12 35.19 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.761 HD12 ' HB3' ' A' ' 19' ' ' ALA . 68.8 mt -110.66 130.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 22.9 m -84.16 -18.78 35.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.877 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.492 ' CB ' HH21 ' A' ' 66' ' ' ARG . 1.1 mmt-85 -148.24 92.85 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.749 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' GLY . 86.6 t -76.36 117.95 21.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' LEU . 1.5 mp0 -116.7 -179.55 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.98 23.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 23.1 mt-10 -68.78 -23.83 64.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' ' CD2' ' A' ' 109' ' ' LEU . 3.1 m-20 -77.27 -29.65 53.96 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.42 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -51.04 142.38 12.26 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.66 -139.58 11.11 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.4 mp -124.6 135.15 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.998 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 42' ' ' LEU . 1.1 m-85 -101.18 141.15 34.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.515 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.423 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 79.8 m-85 -130.21 175.44 8.92 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 25.6 p -156.68 146.41 20.83 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.537 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -149.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.612 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.438 HE22 ' CG ' ' A' ' 4' ' ' MET . 5.3 pm0 -155.18 145.4 21.85 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.427 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 m -107.4 -5.86 17.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.213 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.694 HG22 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -69.74 -27.09 64.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.807 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.694 ' CD2' HG22 ' A' ' 97' ' ' THR . 43.4 m-70 -102.62 145.32 29.82 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 4.8 t -132.55 129.47 21.41 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.233 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.8 Cg_endo -67.24 148.48 79.95 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.795 -0.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.88 123.84 12.23 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.969 1.779 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -89.48 125.46 35.19 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.236 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 6.5 t80 -125.98 136.41 52.97 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.49 -164.67 29.77 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.24 -172.88 15.37 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.24 58.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.755 HG21 HG23 ' A' ' 21' ' ' ILE . 82.1 m -80.67 110.12 15.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -64.96 103.11 0.68 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -98.45 83.56 3.05 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.119 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -107.61 148.87 28.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.712 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.6 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.9 tt -52.37 168.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.43 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 13' ' ' VAL . 3.2 ttmm . . . . . 0 N--CA 1.492 1.639 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.429 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t . . . . . 0 N--CA 1.474 0.745 0 CA-C-O 120.756 0.312 . . . . 0.0 111.212 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.783 0.325 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt . . . . . 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' CD2' ' A' ' 98' ' ' HIS . 39.2 t . . . . . 0 N--CA 1.475 0.817 0 CA-C-O 120.869 0.366 . . . . 0.0 111.273 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 47.9 t -81.68 156.25 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.428 ' CE ' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -136.41 105.87 6.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.271 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.627 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -78.98 134.08 36.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.11 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.95 158.24 21.17 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -75.99 177.97 37.05 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.603 -1.416 . . . . 0.0 111.248 -1.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -77.57 -27.06 51.33 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.879 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 m -143.21 149.4 37.92 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.939 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 8.3 tp -140.71 88.92 10.46 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.717 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.3 117.79 5.27 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.918 1.745 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 m -142.34 -164.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 t -118.22 169.37 9.76 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.34 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.39 89.7 7.44 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.85 -25.58 2.25 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.92 -161.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.011 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 81' ' ' SER . 2.0 pm0 -134.84 136.34 42.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.266 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -103.23 178.29 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.478 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -155.9 73.54 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 107' ' ' THR . 2.6 mp -62.54 128.49 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' THR . 21.8 t -93.26 155.29 17.52 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.304 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 81.5 m -160.86 109.65 1.62 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.09 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -108.82 150.34 27.77 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -104.17 152.36 22.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.483 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -80.34 -22.89 40.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.81 34.81 1.98 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.429 ' N ' HG22 ' A' ' 74' ' ' THR . 24.2 t 58.62 -173.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.106 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.615 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 12.4 mt -139.93 13.89 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.079 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.91 135.29 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 . . . . . 0 N--CA 1.488 1.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.009 179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.838 0.352 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -88.21 149.88 23.61 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -168.16 157.57 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.578 ' H ' HD23 ' A' ' 38' ' ' LEU . 7.8 p-10 -159.96 113.57 2.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.952 ' CD2' HD13 ' A' ' 78' ' ' LEU . 55.9 m95 -90.76 169.71 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.21 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.08 133.52 8.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.54 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 14.2 tp -107.52 130.51 54.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.459 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 42' ' ' LEU . 38.1 tt0 -95.22 125.03 39.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.781 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.549 ' NZ ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.895 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 54' ' ' TYR . 19.8 tp . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.96 -63.86 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.479 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 58' ' ' ASN . 43.3 mm -121.52 139.85 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.731 ' HB3' HD21 ' A' ' 51' ' ' LEU . 50.0 p90 -122.83 30.81 6.27 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.459 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.8 mmtp -174.29 -166.59 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.422 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.419 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.99 22.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.122 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -44.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.647 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.579 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.4 m-80 -46.21 140.44 3.98 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.977 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 5.2 mtm180 -110.29 134.04 52.65 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 65.7 t80 -57.38 162.39 2.84 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.1 m -68.43 92.26 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.32 32.17 0.45 Allowed Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 65' ' ' ASP . 38.8 t -113.67 132.67 22.46 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.82 13.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.959 1.773 . . . . 0.0 113.12 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 63' ' ' VAL . 1.1 t70 71.46 -41.78 0.51 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -46.36 -26.86 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.085 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CD1' HG12 ' A' ' 80' ' ' ILE . 83.1 m-85 -80.82 123.64 28.41 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 m -138.27 101.05 4.29 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.545 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' CA ' HD12 ' A' ' 78' ' ' LEU . . . -92.99 120.01 6.07 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.8 p -151.45 154.52 36.75 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -165.84 163.74 36.93 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -92.94 -115.35 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.719 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.1 -78.28 0.64 Allowed Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 28' ' ' SER . 53.0 p -111.37 18.26 19.38 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.349 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.42 131.74 53.74 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.717 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 54.3 m-85 -142.51 153.96 44.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.916 -0.713 . . . . 0.0 110.522 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 3.5 m -151.75 145.65 25.16 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.952 HD13 ' CD2' ' A' ' 40' ' ' TRP . 9.7 tp -104.45 93.61 4.88 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -81.17 118.45 22.57 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.094 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.761 HG21 ' OD2' ' A' ' 87' ' ' ASP . 23.0 mt -114.61 103.46 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 18' ' ' GLN . 1.4 m -74.95 39.45 0.14 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.046 -1.062 . . . . 0.0 113.524 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 81' ' ' SER . 1.1 mmt85 169.63 97.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.696 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 87' ' ' ASP . 88.4 t -93.49 99.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -177.01 3.28 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.508 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.32 -26.89 43.44 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.821 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.83 -36.21 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.964 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.761 ' OD2' HG21 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.9 -43.39 98.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.91 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.773 HD21 ' CD1' ' A' ' 111' ' ' ILE . 89.3 mt -43.62 148.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.715 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.87 -155.02 20.75 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.61 142.76 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.646 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 14.0 m-85 -115.22 144.72 43.28 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.906 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -133.59 155.79 49.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 1.8 p -136.52 102.21 4.87 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 158.89 15.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.696 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.485 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -110.65 127.9 55.47 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.604 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 96' ' ' THR . 17.9 m -83.61 -5.57 59.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.004 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 29' ' ' LEU . 53.3 m -62.63 -62.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.29 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' A' ' 2' ' ' VAL . 66.7 m-70 -89.12 114.78 26.08 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.43 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 21.8 t -104.59 134.37 19.7 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.832 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.16 156.98 97.91 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.591 -1.421 . . . . 0.0 111.523 -0.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.38 139.91 85.14 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.034 1.823 . . . . 0.0 110.997 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.28 -43.93 60.13 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.315 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 t80 68.35 161.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.581 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.78 130.87 2.92 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 145.93 173.78 17.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.441 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 178.86 67.15 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 21' ' ' ILE . 44.8 m -77.1 113.81 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.888 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -73.84 107.25 5.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.391 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -100.67 94.85 6.31 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.704 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.32 136.67 52.26 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.773 ' CD1' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -69.2 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.059 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.303 -1.445 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.349 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' HG21 ' A' ' 102' ' ' THR . 25.2 t . . . . . 0 N--CA 1.476 0.847 0 CA-C-O 121.129 0.49 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 4' ' ' MET . 15.6 t -69.5 162.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.761 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 25' ' ' SER . 48.6 mmm -126.85 175.51 7.98 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -150.72 93.56 1.97 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.204 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.625 ' NE2' ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp60 -82.5 148.3 28.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.232 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -161.18 165.14 17.49 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.908 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 9.1 Cg_endo -76.76 173.97 55.43 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.482 -1.466 . . . . 0.0 110.563 -1.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.96 -28.59 68.4 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.592 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -140.97 130.43 23.85 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -125.92 94.16 42.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.699 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.86 121.1 7.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.8 1.666 . . . . 0.0 110.537 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 83' ' ' VAL . 24.9 m -134.43 -165.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.442 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -146.53 160.48 42.08 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -74.69 85.69 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 82' ' ' ARG . . . 140.43 -22.62 2.71 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 18' ' ' GLN . 31.9 t70 -76.48 177.87 7.06 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.416 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 54.5 mt-30 -94.63 -173.76 3.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.737 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -153.73 157.69 39.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 p -151.52 79.94 1.29 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.002 HG23 HG21 ' A' ' 107' ' ' THR . 8.8 mt -81.27 117.75 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.906 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 7' ' ' THR . 39.4 t -85.4 155.53 21.24 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.958 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -162.13 124.38 2.84 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.605 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.17 155.99 28.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.306 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 3.8 t -112.96 154.23 26.76 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.8 p -74.37 -31.73 62.49 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 2' ' ' VAL . 4.9 tt0 -136.54 150.56 48.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.689 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 p -50.75 128.13 19.99 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.66 ' C ' HG21 ' A' ' 97' ' ' THR . 85.8 mt -80.52 27.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.89 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.81 133.89 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.393 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 . . . . . 0 N--CA 1.489 1.521 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.41 -179.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' LEU . 84.1 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 120.822 0.344 . . . . 0.0 110.46 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -112.37 132.72 54.86 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' CG ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -155.24 125.85 6.91 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.957 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 38' ' ' LEU . 34.6 p30 -133.24 169.65 16.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.256 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 78' ' ' LEU . 36.5 m95 -125.03 150.56 46.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.11 147.59 44.13 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.906 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 tp -135.62 125.53 25.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.52 152.75 33.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.107 -1.037 . . . . 0.0 112.103 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.444 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.323 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.042 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -113.34 -71.56 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.261 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 59' ' ' ARG . 31.6 mm -109.46 150.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.87 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 47.7 p90 -149.19 25.36 0.9 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.559 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.522 ' N ' HD22 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -174.41 61.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.832 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 56' ' ' VAL . 14.6 m 30.44 97.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.09 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 72.05 46.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.859 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -148.96 108.97 4.08 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 65' ' ' ASP . 41.7 mtm180 -79.83 153.0 29.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.906 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 61' ' ' SER . 59.9 t80 -91.14 171.78 9.01 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.546 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t -59.9 123.0 15.68 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.218 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.05 66.22 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 90.0 t -84.46 123.93 74.14 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -55.83 138.95 83.29 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.1 1.867 . . . . 0.0 112.02 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 6.1 m-20 -56.29 -18.55 10.94 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.615 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -77.61 27.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.606 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.576 ' CE2' HD21 ' A' ' 78' ' ' LEU . 4.8 m-85 -128.17 129.03 45.87 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.4 104.01 3.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' VAL . . . -110.65 108.15 2.37 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.318 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -143.0 163.37 32.97 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.686 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . -169.9 172.34 43.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.45 -151.23 0.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.632 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.91 -48.81 13.75 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -146.51 35.14 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.444 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -135.64 90.62 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.158 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CG ' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -119.62 155.41 32.35 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.08 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.3 m -146.98 141.03 26.02 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.539 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CE2' ' A' ' 67' ' ' PHE . 5.5 tt -94.02 110.33 22.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 131.39 46.95 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.018 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 82' ' ' ARG . 57.3 mt -117.99 131.58 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.2 m -90.64 -0.5 57.71 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.72 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.779 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.5 tpt180 -169.05 97.32 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 13' ' ' VAL . 99.0 t -74.88 136.66 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.89 163.8 13.81 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.812 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.63 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.28 -27.11 62.27 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -30.91 71.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.474 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 111' ' ' ILE . 85.9 mt -42.94 134.87 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.23 -154.62 25.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 mm -103.62 131.84 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.09 154.95 18.29 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.175 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 38.1 m-85 -147.45 176.88 9.68 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.082 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.71 127.68 4.22 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.401 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 4.8 p -118.74 -170.24 1.87 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.324 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.44 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -158.04 127.39 5.81 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 m -107.12 57.73 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.66 HG21 ' C ' ' A' ' 29' ' ' LEU . 54.6 m -108.93 -50.3 3.03 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.868 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.493 ' CD2' HG21 ' A' ' 2' ' ' VAL . 19.8 m-70 -87.87 -40.01 14.34 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.28 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.597 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.8 OUTLIER 64.94 141.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.315 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -67.78 158.04 84.95 Favored 'Cis proline' 0 C--N 1.319 -1.024 0 C-N-CA 123.55 -1.437 . . . . 0.0 111.362 -0.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.67 114.59 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.938 1.758 . . . . 0.0 111.532 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 2' ' ' VAL . 14.2 p -52.95 -55.19 25.26 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.09 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.6 OUTLIER 61.95 116.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.57 100.09 0.61 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.231 -1.461 . . . . 0.0 111.547 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.505 ' H ' ' HB3' ' A' ' 92' ' ' PHE . . . -100.62 -90.36 2.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.61 93.5 1.35 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.307 -1.425 . . . . 0.0 112.798 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.002 HG21 HG23 ' A' ' 21' ' ' ILE . 2.3 m -158.49 109.17 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.556 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.71 105.39 5.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.202 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.64 94.01 7.48 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.129 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 144.06 50.3 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.675 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.551 HD12 HD21 ' A' ' 88' ' ' LEU . 4.8 mt -76.81 156.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 11.9 mttm . . . . . 0 N--CA 1.487 1.42 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.213 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.691 ' O ' HG21 ' A' ' 102' ' ' THR . 62.9 t . . . . . 0 N--CA 1.475 0.778 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.25 124.99 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.195 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 81.9 mmm -120.68 102.38 8.36 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -96.1 156.7 16.22 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.311 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.592 HE21 ' H ' ' A' ' 106' ' ' GLY . 5.9 tt0 -130.39 151.48 50.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.838 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -157.82 156.55 28.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.97 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.4 176.83 42.02 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.611 -1.412 . . . . 0.0 111.328 -0.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -75.12 -18.27 60.27 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.813 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 p -156.02 140.64 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.085 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.68 91.38 33.98 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.731 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -70.47 105.72 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.97 1.78 . . . . 0.0 111.236 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 83' ' ' VAL . 8.6 m -117.71 -154.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.509 ' HA ' HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -132.44 159.43 39.34 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.493 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 111' ' ' ILE . 19.0 mt -75.34 88.94 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.6 -1.22 5.98 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.5 -177.76 4.19 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 179.39 5.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.107 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -154.44 163.93 39.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 m -155.18 95.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.335 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 77' ' ' THR . 23.2 mt -84.36 165.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.354 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 21' ' ' ILE . 11.0 m -131.07 154.5 48.19 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.735 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.44 126.51 4.65 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.81 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -120.06 145.99 46.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.476 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 85.8 p -107.66 125.17 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.46 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -73.82 32.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.242 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.543 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -160.37 -85.85 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.767 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.755 ' HA ' HG22 ' A' ' 74' ' ' THR . 3.3 t 171.39 146.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.753 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.826 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 46.1 mt -109.83 30.01 7.09 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.5 t -107.29 147.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.439 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 . . . . . 0 N--CA 1.489 1.501 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.726 179.932 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 m . . . . . 0 N--CA 1.488 1.464 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.667 ' HB2' HG23 ' A' ' 97' ' ' THR . 90.3 m-85 -84.44 143.83 29.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.843 HD21 ' HE1' ' A' ' 40' ' ' TRP . 8.7 tp -165.46 146.2 7.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.851 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 2.3 m120 -135.38 156.89 48.18 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.843 ' HE1' HD21 ' A' ' 38' ' ' LEU . 59.5 m95 -137.33 152.66 49.97 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' TRP . 33.4 m-85 -144.56 154.46 42.88 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 10.9 tp -127.42 106.05 8.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.019 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -69.68 105.84 2.86 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.382 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.345 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.477 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 51' ' ' LEU . 34.8 tp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.912 0.387 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.8 mm? -82.25 -69.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.439 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 53' ' ' ILE . 16.7 mm -108.92 127.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.023 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -134.14 25.89 3.88 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.952 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' N ' HD21 ' A' ' 58' ' ' ASN . 4.7 mttt -171.24 27.9 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' ASN . 95.0 t 63.3 119.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.637 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.1 p 34.36 33.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.36 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 55' ' ' LYS . 4.3 p30 -107.33 -32.91 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 1.2 mtm-85 66.52 113.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.553 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 61' ' ' SER . 51.4 t80 -61.61 167.34 3.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.4 t -54.2 -40.58 67.72 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.86 63.91 3.46 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 65' ' ' ASP . 58.8 t -139.61 133.17 15.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.704 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HG2' ' HE ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -67.38 14.39 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 122.221 1.947 . . . . 0.0 112.468 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 5.1 m-20 65.43 -24.18 0.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.59 HH12 ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -65.3 -11.62 43.47 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.328 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HD1' HD21 ' A' ' 78' ' ' LEU . 77.3 m-85 -95.26 132.84 39.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.412 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -147.89 85.69 1.56 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.443 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' THR . . . -86.08 107.09 3.13 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -76.67 163.03 27.24 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.979 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.687 ' HA2' ' CD1' ' A' ' 76' ' ' PHE . . . -142.06 96.26 0.2 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -94.36 82.91 4.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.502 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.16 -82.13 0.13 Allowed Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 28' ' ' SER . 18.6 p -123.31 14.87 9.7 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.791 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.95 132.02 53.97 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.26 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.826 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 24.8 m-85 -138.49 143.89 39.77 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.477 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 21' ' ' ILE . 100.0 m -139.98 112.28 7.73 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.54 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.2 tt -80.68 100.31 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -94.93 134.3 37.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.284 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 19' ' ' ALA . 7.6 mt -113.07 137.29 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 12.0 t -87.01 -44.24 11.73 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.681 -1.207 . . . . 0.0 111.947 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -124.71 102.37 7.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 HG21 ' A' ' 13' ' ' VAL . 69.3 t -89.44 103.6 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.59 ' CD ' HH12 ' A' ' 66' ' ' ARG . 4.0 mt-10 -102.89 177.21 4.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.249 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.16 -27.11 31.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -78.96 -40.23 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.532 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.07 -20.23 23.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.408 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' CD1' ' A' ' 111' ' ' ILE . 97.7 mt -62.68 167.39 4.54 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.756 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.01 180.0 16.07 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.715 -1.231 . . . . 0.0 111.267 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.87 115.5 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.449 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -88.76 143.38 26.95 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.811 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.584 ' HA ' HE22 ' A' ' 6' ' ' GLN . 13.6 m-85 -135.48 158.76 43.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.51 156.64 46.8 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 10.5 t -150.91 -177.05 5.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.546 ' HB2' HD22 ' A' ' 29' ' ' LEU . 1.8 pt20 -129.26 113.8 15.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 37' ' ' TYR . 10.2 t -84.33 34.67 0.52 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.667 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -100.13 -72.27 0.67 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.2 m-70 -78.24 162.11 26.79 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.424 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 45.7 t -137.88 137.57 21.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.586 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.3 Cg_endo -73.46 158.58 98.39 Favored 'Cis proline' 0 C--N 1.318 -1.058 0 C-N-CA 123.568 -1.43 . . . . 0.0 111.472 -1.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.77 151.63 82.9 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.966 1.777 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 2' ' ' VAL . 36.7 p -89.94 -61.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.048 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 3.3 t80 72.83 146.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.008 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.75 170.25 30.43 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.529 ' CA ' ' HB3' ' A' ' 6' ' ' GLN . . . 120.11 -155.38 16.19 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.841 -1.171 . . . . 0.0 111.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.592 ' H ' HE21 ' A' ' 6' ' ' GLN . . . 147.69 60.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 21' ' ' ILE . 52.4 m -81.76 108.28 15.17 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -68.99 89.74 0.43 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.15 87.52 6.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.521 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -121.24 143.25 49.25 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.183 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.93 HD13 ' HG ' ' A' ' 15' ' ' LEU . 8.3 mt -88.34 146.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 mttt . . . . . 0 N--CA 1.488 1.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.809 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.913 HG13 ' H ' ' A' ' 27' ' ' GLN . 39.1 t . . . . . 0 N--CA 1.474 0.737 0 CA-C-O 120.852 0.358 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 4' ' ' MET . 6.7 t -74.51 169.93 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.697 ' SD ' ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -132.64 99.21 4.56 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.541 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -89.57 148.42 23.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.581 ' CB ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -141.54 153.48 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.379 -0.929 . . . . 0.0 110.824 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.29 146.27 11.62 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.726 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HG2' HD12 ' A' ' 11' ' ' LEU . 11.0 Cg_endo -82.12 176.93 35.24 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.806 -1.331 . . . . 0.0 111.342 -0.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.534 HD13 HE22 ' A' ' 6' ' ' GLN . 3.5 mm? -73.08 -27.31 61.65 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -137.72 149.62 46.63 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.879 ' HB3' HD12 ' A' ' 109' ' ' LEU . 3.6 tp -135.43 86.2 30.22 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.924 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CB ' ' HA ' ' A' ' 112' ' ' LYS . 10.2 Cg_endo -72.23 101.77 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.657 1.571 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 112' ' ' LYS . 20.4 m -126.7 -178.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.34 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.2 174.53 5.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 83' ' ' VAL . 21.4 mt -90.11 86.98 6.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.37 -25.65 1.54 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.65 -166.93 0.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.024 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -114.59 138.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -115.53 166.37 11.98 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 p -160.95 100.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' THR . 69.4 mt -98.94 142.53 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -103.34 141.13 36.45 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.802 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.99 94.21 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.564 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.1 163.08 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.186 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.63 166.36 13.28 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.129 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -64.93 -70.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.913 ' H ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.6 162.13 17.33 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 p -59.09 129.61 42.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 76' ' ' PHE . 89.1 mt -85.02 34.73 0.56 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.693 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -96.96 114.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.126 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 . . . . . 0 N--CA 1.487 1.424 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.676 -179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 97' ' ' THR . 21.5 m-30 -105.5 102.66 12.11 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.964 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 76' ' ' PHE . 1.4 tt -149.1 126.91 11.8 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.865 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.563 ' ND2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.21 163.77 15.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.39 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.496 ' CE3' HD13 ' A' ' 78' ' ' LEU . 47.1 m95 -123.56 159.02 30.09 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -144.45 148.28 34.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.026 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.4 HD22 ' OH ' ' A' ' 91' ' ' TYR . 24.5 tp -123.14 79.84 1.71 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.57 30.94 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.45 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt . . . . . 0 N--CA 1.484 1.274 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.625 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.563 HD13 ' ND2' ' A' ' 39' ' ' ASN . 29.5 tp . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.22 -60.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.678 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mm -113.49 131.56 64.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.99 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HB3' HD21 ' A' ' 51' ' ' LEU . 52.2 p90 -108.61 -13.78 14.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.83 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' SER . 1.2 mtpm? -153.93 110.13 3.29 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 57' ' ' SER . 1.2 p 43.56 -73.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.596 ' H ' HG13 ' A' ' 56' ' ' VAL . 16.6 t -136.67 -15.8 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.55 -1.26 . . . . 0.0 113.789 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.59 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -64.4 114.25 4.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.911 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -71.86 143.73 49.31 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.361 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.4 175.43 4.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.473 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 p -61.61 -51.38 68.73 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.579 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.54 71.11 2.98 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 65' ' ' ASP . 46.5 t -139.35 125.68 12.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.803 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 66' ' ' ARG . 1.1 Cg_endo -68.04 14.35 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.031 1.821 . . . . 0.0 111.799 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 35.9 m-20 60.09 -9.38 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.979 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 64' ' ' PRO . 12.1 mtm-85 -76.96 19.63 0.29 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' OH ' ' A' ' 91' ' ' TYR . 89.3 m-85 -137.55 135.81 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.624 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -146.14 96.58 2.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 149.71 37.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m -154.1 113.61 3.78 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.384 -1.327 . . . . 0.0 111.577 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -146.58 135.75 5.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -88.02 -84.29 0.2 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.101 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.5 -57.17 1.47 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.643 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 36.9 p -145.85 56.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 10.4 t70 -161.18 73.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.069 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.722 ' CD1' HD13 ' A' ' 38' ' ' LEU . 10.3 m-85 -95.81 117.42 30.53 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 m -111.72 129.17 56.2 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.574 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' CE3' ' A' ' 40' ' ' TRP . 2.3 tt -85.66 94.19 9.02 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.86 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -91.39 124.63 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.255 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 19' ' ' ALA . 25.2 mt -99.78 131.58 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 p -82.18 -23.19 35.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.331 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -156.61 120.58 4.36 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.99 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.592 HG13 ' OD2' ' A' ' 87' ' ' ASP . 53.6 t -87.85 122.0 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -108.57 171.25 7.53 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.32 70.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.647 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -84.41 -2.3 56.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.0 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.592 ' OD2' HG13 ' A' ' 83' ' ' VAL . 3.0 t70 -89.15 -18.03 28.0 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.707 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 109' ' ' LEU . 13.4 mt -73.92 140.5 45.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.487 ' C ' HD12 ' A' ' 90' ' ' ILE . . . 155.65 -140.25 7.18 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 89' ' ' GLY . 1.6 mp -116.95 113.4 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.883 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' CE2' ' A' ' 67' ' ' PHE . 1.9 m-85 -91.94 112.79 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.739 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' A' ' 106' ' ' GLY . 3.3 m-85 -119.05 -176.49 3.13 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -152.93 -179.44 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.239 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.436 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 74.9 p -171.62 144.41 1.86 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.479 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.481 HE22 ' HB ' ' A' ' 2' ' ' VAL . 19.2 pt20 -109.61 157.42 19.07 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.6 p -132.34 13.44 4.6 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -75.36 -36.97 60.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.677 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.584 ' CD2' HG21 ' A' ' 2' ' ' VAL . 67.2 m-70 -110.03 162.47 14.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.085 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 10.9 p -128.01 138.22 32.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.508 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.8 Cg_endo -71.29 158.2 95.44 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.588 -1.421 . . . . 0.0 111.845 -0.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.52 119.75 7.04 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.786 1.657 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 95' ' ' GLN . 54.6 p -91.24 134.02 34.92 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.958 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.7 138.65 55.24 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.697 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . -72.54 -159.05 4.47 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -73.14 -157.19 4.0 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 92' ' ' PHE . . . -178.23 98.75 0.12 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 8' ' ' PRO . 21.5 m -107.36 143.75 35.22 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.92 133.75 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.282 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.879 HD12 ' HB3' ' A' ' 11' ' ' LEU . 1.2 tp -129.94 89.04 2.75 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -127.6 59.78 1.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.59 HG22 ' N ' ' A' ' 112' ' ' LYS . 19.6 mm 59.0 163.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.404 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.944 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.76 ' O ' HG21 ' A' ' 102' ' ' THR . 59.5 t . . . . . 0 C--O 1.216 -0.707 0 CA-C-O 120.66 0.267 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.74 141.76 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.655 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.21 105.95 7.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.794 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -99.03 112.66 24.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.911 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 9.4 tt0 -95.77 149.91 20.98 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.783 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.2 159.98 24.23 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.711 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HA ' HG22 ' A' ' 7' ' ' THR . 4.4 Cg_endo -72.61 177.62 35.0 Favored 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.603 -1.415 . . . . 0.0 111.259 -0.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.1 mt -82.4 -15.47 52.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.758 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -144.5 135.41 25.02 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.545 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.554 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -128.85 72.0 81.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.433 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.6 106.87 1.34 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.943 1.762 . . . . 0.0 111.377 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 7.6 m -141.77 175.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.313 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 p -99.14 161.11 13.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 111' ' ' ILE . 24.6 mt -74.49 88.13 2.11 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.89 -23.03 0.91 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -71.71 170.99 12.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.326 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.59 137.84 33.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.27 163.38 14.44 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -162.27 95.4 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.205 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.824 ' O ' HG23 ' A' ' 77' ' ' THR . 2.7 mp -81.19 167.34 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 23.1 t -138.92 110.43 7.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.392 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.6 t -117.28 127.6 54.24 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.068 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -116.6 150.42 38.08 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.73 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' HG11 ' A' ' 2' ' ' VAL . 5.8 p -109.9 119.57 39.75 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.9 m -75.25 21.61 0.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' ' 2' ' ' VAL . 1.7 tt0 -149.45 2.72 0.55 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.46 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.459 ' CA ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER 67.73 150.86 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.827 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 80.3 mt -115.52 28.77 8.44 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG22 ' OG1' ' A' ' 36' ' ' THR . 65.3 t -94.71 115.3 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.775 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.6 t-80 . . . . . 0 N--CA 1.487 1.408 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.011 -179.98 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 30' ' ' VAL . 20.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 120.531 0.205 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.779 ' HB3' HG23 ' A' ' 96' ' ' THR . 91.3 m-85 -121.65 132.81 54.86 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 76' ' ' PHE . 1.7 tp -156.47 141.15 16.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 1.5 m120 -124.84 148.07 48.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.471 ' O ' HD12 ' A' ' 51' ' ' LEU . 31.9 m95 -115.23 160.8 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -149.4 156.98 42.89 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp -141.99 113.72 7.9 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.856 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.84 125.91 33.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt . . . . . 0 N--CA 1.489 1.522 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.01 179.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 54' ' ' TYR . 25.9 tp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 120.709 0.29 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.3 mm? -96.81 -71.9 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.488 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -101.54 133.48 44.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.83 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' HB3' HD21 ' A' ' 51' ' ' LEU . 44.9 p90 -122.48 20.23 10.39 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.954 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.591 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 1.6 tppp? -168.97 65.91 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.409 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 t 68.51 -66.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -138.64 11.78 2.72 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.749 -1.18 . . . . 0.0 113.078 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 55' ' ' LYS . 53.2 p-10 -75.18 -156.82 0.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.938 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -153.88 118.22 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.359 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.86 157.74 17.57 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.734 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 p -53.81 138.28 36.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.29 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.51 -26.0 7.66 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 52' ' ' LEU . 60.5 t -64.29 118.78 50.22 Favored Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.028 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.0 144.55 99.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.883 1.722 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.98 -36.21 17.04 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -26.86 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -84.3 107.28 16.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t -134.61 108.44 8.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.535 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.09 170.79 21.91 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.1 t -164.22 -165.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.916 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 151.89 113.39 0.57 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.807 -1.663 . . . . 0.0 111.899 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -98.74 100.63 11.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.1 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 -115.72 4.78 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.557 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 28' ' ' SER . 35.5 p -99.22 18.63 17.05 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.402 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 3.7 m-20 -129.25 136.06 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.582 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.575 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 69.5 m-85 -139.4 151.78 46.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.404 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ILE . 43.0 m -145.73 139.35 26.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.998 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -105.1 91.79 3.95 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.403 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -86.08 116.89 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.375 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.647 HG22 ' H ' ' A' ' 82' ' ' ARG . 37.0 mt -105.71 129.35 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.62 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -90.48 13.15 16.48 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.27 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -176.4 113.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.608 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 87' ' ' ASP . 65.6 t -99.04 143.47 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 15' ' ' LEU . 58.8 mt-10 -123.18 179.05 4.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.834 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.11 18.84 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.256 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -55.26 -29.92 59.05 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -63.52 -36.18 82.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.664 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 111' ' ' ILE . 31.3 mt -48.69 134.07 16.45 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.67 -146.99 12.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.47 112.55 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.281 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -78.78 138.85 38.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.701 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.95 164.21 28.49 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.336 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 105' ' ' GLY . 13.7 p -135.9 142.82 44.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.3 t -143.86 112.45 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.486 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -65.79 149.65 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.676 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.779 HG23 ' HB3' ' A' ' 37' ' ' TYR . 12.1 t -123.43 26.62 7.8 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 37' ' ' TYR . 24.0 m -92.09 -23.83 19.34 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.486 ' H ' HE22 ' A' ' 95' ' ' GLN . 85.0 m-70 -127.88 136.52 51.5 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.715 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 100' ' ' PRO . 50.9 t -109.69 138.37 20.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.436 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HA ' HG13 ' A' ' 99' ' ' VAL . 5.5 Cg_endo -73.71 161.17 94.76 Favored 'Cis proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.634 -1.402 . . . . 0.0 111.757 -0.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.29 136.12 49.82 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.984 1.789 . . . . 0.0 110.75 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 2' ' ' VAL . 26.4 p -61.89 -51.05 69.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.085 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.6 t80 55.34 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.11 82.08 0.06 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 93' ' ' CYS . . . -93.99 -126.13 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.664 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 145.41 80.69 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.805 -1.664 . . . . 0.0 112.274 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' PRO . 97.1 m -154.5 108.39 2.94 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.629 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -79.01 149.32 32.25 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.939 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.421 ' CD2' HD23 ' A' ' 88' ' ' LEU . 4.2 tt -154.2 88.62 1.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 111' ' ' ILE . 6.4 pt-20 -122.23 38.62 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 74.95 168.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.757 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.671 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t -66.79 124.01 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.212 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 32' ' ' SER . 58.8 t-80 -69.69 173.34 6.26 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.472 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 75.0 m -69.93 73.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 176.64 -27.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.421 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 23.57 5.94 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.82 142.77 48.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m -113.12 129.38 56.53 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.736 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -97.6 -167.31 1.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.83 77.78 2.11 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 59.56 3.73 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -134.18 -163.99 1.44 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.699 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.23 124.03 74.49 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.602 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 155.98 49.91 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.849 1.699 . . . . 0.0 111.703 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -138.08 128.44 26.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.769 -0.773 . . . . 0.0 111.232 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp -101.57 131.96 47.48 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.794 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt -88.34 145.36 25.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.346 -1.788 . . . . 0.0 110.514 179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.701 ' O ' HG21 ' A' ' 102' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.727 0.775 . . . . 0.0 110.636 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.546 HG23 ' C ' ' A' ' 1' ' ' ASP . 2.0 t 67.52 99.66 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 114.107 -1.406 . . . . 0.0 111.136 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 4' ' ' MET . 16.3 t -74.76 158.58 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.618 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 29' ' ' LEU . 84.2 mmm -122.43 101.99 7.83 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.986 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.91 136.95 37.42 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.321 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.594 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 34.6 tt0 -126.83 146.4 50.28 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.258 -0.977 . . . . 0.0 111.53 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -159.46 164.99 19.04 Favored Pre-proline 0 N--CA 1.488 1.471 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.423 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HG2' HD12 ' A' ' 11' ' ' LEU . 7.0 Cg_endo -75.71 176.57 43.08 Favored 'Cis proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.412 -1.495 . . . . 0.0 110.99 -1.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.2 mt -75.78 -25.15 56.16 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.131 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.7 m -140.21 143.41 36.02 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.601 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.571 HD12 ' HG2' ' A' ' 8' ' ' PRO . 1.7 tp -134.11 70.07 74.09 Favored Pre-proline 0 N--CA 1.49 1.565 0 C-N-CA 119.752 -0.779 . . . . 0.0 111.279 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.04 113.16 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 C-N-CA 121.936 1.757 . . . . 0.0 111.238 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -140.01 170.36 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.505 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.561 ' O ' ' C ' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -111.27 89.84 3.16 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.106 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.561 ' C ' ' O ' ' A' ' 14' ' ' SER . 67.2 mt -8.69 91.24 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 124.079 0.862 . . . . 0.0 112.871 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 161.87 -35.26 0.37 Allowed Glycine 0 N--CA 1.493 2.46 0 C-N-CA 119.615 -1.278 . . . . 0.0 110.774 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -82.77 179.11 7.88 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.514 -0.875 . . . . 0.0 110.938 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -92.04 161.31 14.83 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.997 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.529 ' O ' ' HA ' ' A' ' 79' ' ' LYS . . . -122.53 165.08 16.99 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.616 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -159.6 88.8 0.86 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.152 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.525 HD12 HD22 ' A' ' 78' ' ' LEU . 7.3 mt -85.61 127.6 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 C-N-CA 119.846 -0.742 . . . . 0.0 110.986 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.5 t -87.4 150.2 23.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.99 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.01 132.79 4.32 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.551 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.91 179.64 6.05 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.217 -0.993 . . . . 0.0 111.028 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.0 p -109.44 157.86 18.53 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.713 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 t -68.67 -23.21 64.38 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.76 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -153.63 -57.14 0.12 Allowed 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.657 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -178.6 137.6 0.16 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.275 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.729 ' O ' HG21 ' A' ' 97' ' ' THR . 74.7 mt -88.36 -45.78 9.72 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.233 -0.987 . . . . 0.0 111.134 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 29' ' ' LEU . 76.2 t -36.62 125.45 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.879 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -64.03 169.21 4.53 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.068 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.9 m -49.44 -27.1 3.84 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.171 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -165.06 62.96 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.364 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -142.55 -131.65 2.61 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.55 -1.309 . . . . 0.0 111.013 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -128.42 179.11 5.83 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.134 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.7 m -87.9 76.48 8.67 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.578 ' HD2' HG23 ' A' ' 97' ' ' THR . 15.3 m-85 -74.09 122.84 23.32 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.187 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -141.51 132.99 26.83 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.035 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.609 ' N ' HD23 ' A' ' 38' ' ' LEU . 2.6 p-10 -124.95 127.01 46.39 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 50.6 m95 -94.44 175.07 6.82 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.514 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -160.55 168.16 25.61 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.88 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD13 ' CE1' ' A' ' 91' ' ' TYR . 4.7 tp -151.89 116.69 5.14 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.873 -1.058 . . . . 0.0 108.77 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' N ' HD12 ' A' ' 42' ' ' LEU . 4.6 tt0 -93.84 132.2 38.48 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.433 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.38 -161.31 0.83 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.124 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.78 -58.37 7.67 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.617 -0.833 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.53 53.89 0.52 Allowed Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -103.48 135.52 44.92 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.476 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.618 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -90.97 -57.55 0.25 Allowed Pre-proline 0 N--CA 1.49 1.553 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.973 179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.618 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 7.4 Cg_endo -73.59 99.86 1.19 Allowed 'Trans proline' 0 C--N 1.322 -0.841 0 C-N-CA 121.623 1.548 . . . . 0.0 110.259 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -127.3 23.72 6.38 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.78 -0.768 . . . . 0.0 111.672 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -87.46 139.07 30.92 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.758 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.456 HD23 HG13 ' A' ' 63' ' ' VAL . 32.0 mt -125.92 -39.82 2.08 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.064 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.01 HD11 ' NH2' ' A' ' 59' ' ' ARG . 16.8 mm -138.83 146.19 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.3 p90 -143.66 32.58 1.29 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.206 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -177.57 55.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.401 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 57' ' ' SER . 48.3 t 36.98 83.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.253 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.495 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER 79.18 70.34 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 121.941 0.877 . . . . 0.0 110.342 -179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -172.05 106.08 0.2 Allowed 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 114.374 -1.284 . . . . 0.0 108.373 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 1.01 ' NH2' HD11 ' A' ' 53' ' ' ILE . 0.0 OUTLIER -77.09 163.42 26.64 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.484 ' CG ' ' N ' ' A' ' 61' ' ' SER . 44.6 t80 -91.77 172.94 8.14 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.492 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.484 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 54.5 p -60.23 -47.04 87.64 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.434 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -91.75 50.92 2.91 Favored Glycine 0 N--CA 1.498 2.8 0 C-N-CA 119.595 -1.288 . . . . 0.0 112.321 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.601 HG11 ' NH1' ' A' ' 59' ' ' ARG . 44.3 t -141.49 122.88 8.93 Favored Pre-proline 0 N--CA 1.495 1.817 0 C-N-CA 119.256 -0.978 . . . . 0.0 111.022 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -68.1 164.23 32.89 Favored 'Trans proline' 0 C--N 1.318 -1.046 0 C-N-CA 121.993 1.795 . . . . 0.0 111.993 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 67' ' ' PHE . 6.6 p-10 -69.74 -7.4 39.17 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.633 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' O ' HG23 ' A' ' 80' ' ' ILE . 8.1 mmt-85 -60.95 0.49 0.22 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.126 -0.629 . . . . 0.0 112.538 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 59' ' ' ARG . 64.9 m-85 -122.68 155.98 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.878 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 31.0 t -161.61 112.05 1.65 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.986 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -112.51 147.11 18.31 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.0 t -161.46 -176.48 5.38 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.158 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.513 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 153.74 171.42 20.83 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.604 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -80.44 0.38 Allowed 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.691 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.4 -49.16 0.06 OUTLIER Glycine 0 N--CA 1.498 2.799 0 C-N-CA 119.546 -1.311 . . . . 0.0 111.066 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 29.7 p -113.62 17.64 18.1 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.72 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.71 133.53 16.92 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.362 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.513 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 55.0 m-85 -147.03 168.93 20.32 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.455 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.7 m -152.76 141.76 21.25 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.341 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.552 ' C ' HD23 ' A' ' 78' ' ' LEU . 10.4 tt -113.22 112.63 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.124 -0.631 . . . . 0.0 109.52 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER -110.3 151.68 27.1 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.468 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.835 HG22 ' H ' ' A' ' 82' ' ' ARG . 97.0 mt -124.71 139.65 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.803 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.63 -23.99 63.58 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.004 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.835 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.9 ptm180 -170.17 113.84 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.111 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -71.8 110.47 4.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.931 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -91.02 172.03 8.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.603 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.78 -35.96 73.64 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.141 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -77.82 -13.73 59.8 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.782 -0.767 . . . . 0.0 111.113 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.43 -26.33 58.25 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.752 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 15' ' ' LEU . 48.3 mt -53.74 150.19 7.62 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.879 -0.729 . . . . 0.0 111.38 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.89 178.9 17.76 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.945 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 15.6 mm -86.0 108.29 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.729 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.532 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.7 m-85 -77.38 156.42 31.23 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.002 -1.079 . . . . 0.0 111.617 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -143.7 164.66 29.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 93' ' ' CYS . 30.8 p -148.55 82.95 1.47 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.673 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 71.1 m -89.18 -178.35 5.63 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.806 -0.758 . . . . 0.0 110.007 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -135.22 157.8 45.99 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.029 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 96' ' ' THR . 8.0 t -127.29 45.22 2.76 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.21 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.729 HG21 ' O ' ' A' ' 29' ' ' LEU . 18.6 m -114.4 -52.62 2.71 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.439 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.509 ' CE1' HG21 ' A' ' 2' ' ' VAL . 65.7 m-70 -86.86 145.68 26.49 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.911 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.501 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 47.1 t -113.82 138.64 22.81 Favored Pre-proline 0 N--CA 1.49 1.529 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.853 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 2.7 Cg_endo -70.55 164.35 81.7 Favored 'Cis proline' 0 C--N 1.319 -1.017 0 C-N-CA 123.668 -1.388 . . . . 0.0 111.504 -0.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -53.81 120.16 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 121.522 1.481 . . . . 0.0 110.67 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.701 HG21 ' O ' ' A' ' 1' ' ' ASP . 1.4 p -91.7 112.63 24.64 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.242 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -84.37 151.51 24.66 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -169.73 157.9 29.79 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.579 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.487 ' HA2' ' CB ' ' A' ' 6' ' ' GLN . . . 134.93 -175.74 20.41 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.319 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.594 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 141.74 55.11 0.04 OUTLIER Glycine 0 N--CA 1.495 2.603 0 C-N-CA 119.161 -1.495 . . . . 0.0 111.857 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.467 ' CB ' HE21 ' A' ' 6' ' ' GLN . 16.2 m -99.06 115.23 28.5 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.617 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 93.97 0.96 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.703 -0.799 . . . . 0.0 112.123 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.9 83.07 6.63 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.729 -0.789 . . . . 0.0 109.724 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.77 153.97 28.17 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.986 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.3 mt -68.0 132.73 32.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.869 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -63.64 157.45 23.93 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.278 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.0 mmt180 . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 116.43 -1.747 . . . . 0.0 110.542 179.924 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 121.134 0.493 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 98' ' ' HIS . 88.2 t -61.61 111.98 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.725 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' N ' ' HB2' ' A' ' 26' ' ' SER . 46.8 t -69.0 153.77 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.313 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.403 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 30.1 mtp -135.06 92.8 2.92 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.186 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 m -79.19 121.1 24.62 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.016 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.54 ' HB2' ' H ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -97.8 129.05 44.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.721 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.31 151.56 37.2 Favored Pre-proline 0 C--N 1.301 -1.535 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.444 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.656 ' O ' HG23 ' A' ' 107' ' ' THR . 8.1 Cg_endo -74.23 -179.82 27.24 Favored 'Cis proline' 0 C--N 1.309 -1.501 0 C-N-CA 123.716 -1.368 . . . . 0.0 111.648 0.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -77.64 -33.29 53.59 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.054 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 m -130.27 153.16 48.91 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.829 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.0 tp -143.3 73.63 17.68 Favored Pre-proline 0 N--CA 1.488 1.439 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.97 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -67.41 106.58 1.25 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 121.886 1.724 . . . . 0.0 110.645 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 112' ' ' LYS . 26.3 m -132.34 170.47 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.787 -0.765 . . . . 0.0 111.299 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -99.45 150.26 22.36 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.741 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD22 ' C ' ' A' ' 84' ' ' GLU . 33.9 mt -73.74 90.54 1.86 Allowed 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.735 -0.786 . . . . 0.0 110.791 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 150.38 -21.3 1.07 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.401 ' HB3' ' H ' ' A' ' 18' ' ' GLN . 7.0 m-20 -84.54 -154.52 0.18 Allowed 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.055 -0.572 . . . . 0.0 110.369 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.408 ' NE2' ' HA ' ' A' ' 81' ' ' SER . 25.8 mt-30 -125.25 164.55 20.08 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.734 -0.786 . . . . 0.0 110.555 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.97 160.95 37.39 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.011 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.1 m -149.94 95.39 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.978 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.642 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mp -91.48 133.12 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.023 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.8 t -92.07 159.51 15.66 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.496 -0.775 . . . . 0.0 112.504 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' SG ' ' CH2' ' A' ' 40' ' ' TRP . 3.3 m -156.47 105.92 2.3 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.548 -1.206 . . . . 0.0 108.865 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' NH1' ' O ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -100.97 124.98 47.5 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.178 -1.009 . . . . 0.0 112.029 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.414 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 78.0 p -87.9 147.34 25.12 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.108 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.431 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -49.03 -68.17 0.2 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.742 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.79 59.46 1.55 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.489 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.59 ' CA ' HG22 ' A' ' 74' ' ' THR . 19.9 t 61.6 173.88 0.12 Allowed 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.966 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.516 HD21 ' OE1' ' A' ' 95' ' ' GLN . 23.5 mt -131.73 21.36 4.63 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.535 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.562 HG22 ' OG1' ' A' ' 36' ' ' THR . 45.6 t -79.89 122.72 35.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.512 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -66.13 179.17 0.98 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.654 -0.819 . . . . 0.0 111.011 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 74.6 m -75.73 60.92 1.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.881 -0.728 . . . . 0.0 111.817 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 178.87 -30.71 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.59 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.09 0.37 Allowed Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.694 -1.241 . . . . 0.0 110.702 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -120.05 105.37 10.96 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.591 -0.844 . . . . 0.0 111.069 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.562 ' OG1' HG22 ' A' ' 30' ' ' VAL . 10.4 m -93.18 140.99 28.92 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.661 -0.815 . . . . 0.0 110.485 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -127.48 156.78 41.61 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.654 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.552 HD22 ' NE1' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -173.31 105.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.54 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -96.54 105.26 17.33 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.625 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' NE1' HD22 ' A' ' 38' ' ' LEU . 43.2 m95 -84.94 148.76 26.06 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.524 -0.87 . . . . 0.0 111.176 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.529 ' CD2' ' CZ ' ' A' ' 103' ' ' PHE . 41.0 m-85 -136.72 157.24 47.22 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.966 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.716 HD13 ' CE1' ' A' ' 91' ' ' TYR . 8.4 tp -136.7 110.43 8.1 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 -95.79 121.77 37.87 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.387 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' CE ' ' HA ' ' A' ' 86' ' ' GLU . 7.4 tttt -90.65 173.81 7.84 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.195 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -57.27 90.31 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.234 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.14 45.77 38.73 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.99 -1.1 . . . . 0.0 111.285 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 161.7 35.23 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.057 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.47 144.68 99.01 Favored Pre-proline 0 N--CA 1.493 1.681 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.263 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -62.11 130.1 29.48 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.899 1.732 . . . . 0.0 111.061 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -99.03 130.69 45.38 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.374 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 40' ' ' TRP . 21.9 tp -85.33 135.79 33.75 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.55 ' HA ' HG21 ' A' ' 63' ' ' VAL . 39.4 mt -120.38 -55.56 2.03 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.802 -0.759 . . . . 0.0 110.224 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.622 HD13 ' HA ' ' A' ' 59' ' ' ARG . 41.5 mm -120.11 158.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 30.1 p90 -138.17 -28.17 0.87 Allowed 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.878 -1.129 . . . . 0.0 112.254 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -101.31 -51.29 3.53 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.759 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG13 ' N ' ' A' ' 57' ' ' SER . 7.4 p -178.31 -41.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.481 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.543 ' N ' HG13 ' A' ' 56' ' ' VAL . 8.9 t -138.47 -31.86 0.73 Allowed 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.837 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.11 120.05 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.622 ' HA ' HD13 ' A' ' 53' ' ' ILE . 36.0 mtm-85 -77.54 157.65 30.27 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.295 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 85.4 t80 -73.77 160.41 31.53 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.791 -0.764 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 38.2 t -62.6 92.56 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 120.004 -0.678 . . . . 0.0 111.349 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 136.7 -19.62 3.52 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.415 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.55 HG21 ' HA ' ' A' ' 52' ' ' LEU . 40.7 t -81.54 118.5 72.45 Favored Pre-proline 0 N--CA 1.487 1.388 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.419 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -59.62 155.98 39.52 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 C-N-CA 121.917 1.745 . . . . 0.0 111.993 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -54.87 -19.29 6.25 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.219 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 -49.52 -26.38 3.4 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.811 -0.755 . . . . 0.0 111.284 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.469 ' CD2' HD13 ' A' ' 52' ' ' LEU . 60.9 m-85 -100.57 128.22 46.7 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.507 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 92.7 p -141.8 128.59 20.49 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.259 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.36 150.53 18.4 Favored Glycine 0 N--CA 1.493 2.47 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.299 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.63 147.54 10.38 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.223 -0.991 . . . . 0.0 111.217 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.604 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . -166.07 125.89 1.4 Allowed Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.5 m -95.1 67.29 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.671 -0.812 . . . . 0.0 113.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 119.79 -91.37 0.5 Allowed Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.114 -1.517 . . . . 0.0 112.144 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.59 HG22 ' CA ' ' A' ' 28' ' ' SER . 37.1 p -121.9 1.55 9.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.432 -0.907 . . . . 0.0 111.348 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.466 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 0.1 OUTLIER -106.16 97.81 7.57 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.954 -179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.604 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 73.4 m-85 -114.41 147.43 39.24 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.839 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 21' ' ' ILE . 17.1 m -149.83 133.88 17.09 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.002 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.465 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 8.4 tt -92.16 112.09 23.9 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.194 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -107.05 129.19 54.85 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.834 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.518 HG22 ' H ' ' A' ' 82' ' ' ARG . 5.1 mt -109.83 134.51 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.692 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 36.7 m -83.41 -19.14 36.52 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 118.844 -1.142 . . . . 0.0 112.276 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.518 ' H ' HG22 ' A' ' 80' ' ' ILE . 4.1 mtt-85 -145.53 97.15 2.94 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.596 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 15' ' ' LEU . 51.6 t -75.68 117.55 20.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.354 -0.939 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.539 ' C ' HD22 ' A' ' 15' ' ' LEU . 7.6 mm-40 -115.65 172.53 7.07 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.989 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.83 -31.5 12.04 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.714 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.47 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . 1.3 mt-10 -68.45 -36.72 79.41 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.851 -0.74 . . . . 0.0 110.582 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -59.96 -15.02 18.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.842 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.43 136.46 51.61 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.329 -0.949 . . . . 0.0 111.608 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.46 -167.42 27.51 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mm -99.25 118.43 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.689 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.716 ' CE1' HD13 ' A' ' 42' ' ' LEU . 3.1 m-85 -84.4 147.51 27.09 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.156 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -141.1 167.28 22.57 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 114.869 -1.059 . . . . 0.0 109.817 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.512 ' N ' HE22 ' A' ' 6' ' ' GLN . 24.1 p -155.95 102.13 2.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.088 -1.045 . . . . 0.0 111.259 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.1 p -88.63 171.25 10.16 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.516 ' OE1' HD21 ' A' ' 29' ' ' LEU . 3.4 pt20 -127.76 112.0 14.3 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.824 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 37.1 p -81.11 55.31 2.47 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.843 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 m -128.52 -53.53 1.26 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.884 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.431 ' CD2' HG21 ' A' ' 2' ' ' VAL . 34.9 m-70 -100.31 177.49 5.04 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.859 -0.736 . . . . 0.0 111.179 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.456 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 96.7 t -145.9 135.51 11.57 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.495 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.456 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.1 Cg_endo -70.87 139.61 58.9 Favored 'Cis proline' 0 C--N 1.317 -1.1 0 C-N-CA 123.558 -1.434 . . . . 0.0 111.462 -0.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 100' ' ' PRO . 1.1 Cg_endo -65.75 118.48 5.52 Favored 'Trans proline' 0 C--N 1.314 -1.254 0 C-N-CA 121.717 1.611 . . . . 0.0 110.933 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 33.4 p -66.45 160.57 24.65 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.946 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.529 ' CZ ' ' CD2' ' A' ' 41' ' ' TYR . 0.9 OUTLIER -112.39 38.2 2.8 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.736 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 70.68 -178.93 31.29 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.62 -1.276 . . . . 0.0 110.464 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.54 ' H ' ' HB2' ' A' ' 6' ' ' GLN . . . -90.83 -50.53 2.86 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.817 -1.182 . . . . 0.0 110.377 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.498 ' H ' ' CB ' ' A' ' 6' ' ' GLN . . . 127.57 95.4 0.88 Allowed Glycine 0 N--CA 1.494 2.563 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.056 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 8' ' ' PRO . 93.8 m -100.37 120.77 40.46 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.11 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -78.5 118.43 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.198 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.9 tt -113.16 100.54 8.67 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.338 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -117.77 159.28 23.28 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.609 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.9 tt -65.14 168.76 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.558 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 13' ' ' VAL . 6.1 tmtt? -81.74 152.89 26.81 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.956 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.351 -1.785 . . . . 0.0 110.529 179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.358 0.599 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.403 ' HB ' ' NE2' ' A' ' 95' ' ' GLN . 58.2 t -140.3 135.49 36.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.587 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.6 t -68.92 132.97 32.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 119.463 -0.895 . . . . 0.0 111.278 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 54.5 mmm -125.46 93.5 3.88 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.354 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 16.5 m -78.71 116.08 18.83 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.733 -0.787 . . . . 0.0 110.859 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.616 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 1.2 mp0 -101.83 148.9 24.75 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 119.518 -0.873 . . . . 0.0 111.927 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -162.58 163.12 18.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.501 -179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.716 ' HG2' HD12 ' A' ' 11' ' ' LEU . 8.2 Cg_endo -77.41 177.29 40.04 Favored 'Cis proline' 0 C--N 1.311 -1.434 0 C-N-CA 123.59 -1.421 . . . . 0.0 110.711 -1.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.9 -26.61 63.3 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.415 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 108' ' ' LYS . 95.7 p -145.43 146.64 31.6 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.701 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.716 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -130.19 78.19 75.02 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.93 108.53 1.94 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.862 1.708 . . . . 0.0 110.862 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 12.5 m -144.52 153.73 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.249 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.93 152.18 26.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.961 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.616 ' HG ' HD11 ' A' ' 111' ' ' ILE . 62.3 mt -69.89 88.76 0.57 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.031 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.65 -27.81 0.6 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.82 171.25 15.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.914 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.404 ' HA ' ' O ' ' A' ' 80' ' ' ILE . 26.5 mt-30 -87.16 134.25 33.55 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.331 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -107.01 155.18 20.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.32 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.404 ' H ' HD21 ' A' ' 11' ' ' LEU . 25.6 m -149.09 97.76 2.73 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.406 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.992 HG23 HG21 ' A' ' 107' ' ' THR . 26.6 mt -84.17 161.34 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.679 -0.808 . . . . 0.0 109.786 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 7' ' ' THR . 1.6 t -122.17 146.22 47.45 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.692 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.616 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 1.9 m -150.34 104.92 3.28 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.531 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 24.8 mtp180 -112.14 134.68 53.54 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.801 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.564 ' HB3' HD11 ' A' ' 29' ' ' LEU . 54.5 p -98.51 152.29 19.71 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.297 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 p -73.02 -35.12 66.72 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.494 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 28' ' ' SER . 7.3 tp60 -121.12 148.72 43.81 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.128 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.623 ' HA ' HG22 ' A' ' 74' ' ' THR . 0.1 OUTLIER -50.3 142.91 9.39 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.26 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.564 HD11 ' HB3' ' A' ' 25' ' ' SER . 69.1 mt -108.55 43.35 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.048 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 66.1 t -102.14 135.5 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.925 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.542 ' CG ' ' H ' ' A' ' 32' ' ' SER . 4.3 t-80 -81.53 -161.01 0.39 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.796 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.542 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 61.4 m -78.61 34.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.504 -0.878 . . . . 0.0 110.981 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 31' ' ' HIS . 50.4 p-10 -166.98 -158.03 0.28 Allowed 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.538 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -94.35 52.62 2.11 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.442 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -140.1 145.2 37.31 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.259 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.494 HG23 ' O ' ' A' ' 29' ' ' LEU . 17.2 m -123.35 120.4 32.93 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.977 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' HB2' HG23 ' A' ' 97' ' ' THR . 6.3 m-30 -86.65 72.86 10.15 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.366 -0.934 . . . . 0.0 111.838 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.5 HD13 ' CG ' ' A' ' 76' ' ' PHE . 4.0 tt -119.34 132.59 55.89 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.845 -0.742 . . . . 0.0 109.532 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.456 ' HB2' HD11 ' A' ' 51' ' ' LEU . 5.1 p30 -126.14 165.48 18.8 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.524 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.731 ' CE3' HD12 ' A' ' 78' ' ' LEU . 50.9 m95 -114.52 154.32 28.46 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.0 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -134.21 163.5 29.47 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.632 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD13 ' CE2' ' A' ' 91' ' ' TYR . 18.6 tp -155.66 136.99 13.95 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.821 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tp60 -115.92 123.29 47.72 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.575 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.553 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 17.7 tptp -88.31 155.89 19.47 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.643 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' N ' ' HG3' ' A' ' 44' ' ' LYS . . . -62.11 86.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.709 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.48 52.51 25.73 Favored Glycine 0 N--CA 1.496 2.665 0 C-N-CA 120.014 -1.089 . . . . 0.0 111.578 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.553 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 1.1 tp-100 -142.82 -167.11 2.44 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.204 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.1 p -92.7 112.84 57.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.0 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.19 158.13 56.28 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.666 1.577 . . . . 0.0 111.669 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.6 ptpt -144.77 165.76 27.16 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.609 HD23 ' CG ' ' A' ' 60' ' ' PHE . 34.7 tp -86.77 140.14 30.03 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.737 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.614 ' O ' HG21 ' A' ' 63' ' ' VAL . 1.0 OUTLIER -96.52 -72.41 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.474 -0.89 . . . . 0.0 110.986 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.536 HG22 ' N ' ' A' ' 54' ' ' TYR . 30.2 mm -120.28 164.67 16.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.479 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' N ' HG22 ' A' ' 53' ' ' ILE . 35.5 p90 -155.69 156.44 34.93 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.364 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 13.6 mttm 48.25 22.33 0.43 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.923 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 54' ' ' TYR . 78.4 t 63.89 127.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.568 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.2 p 41.94 56.86 3.36 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.53 -1.214 . . . . 0.0 113.834 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 54' ' ' TYR . 9.8 m120 -127.67 -21.73 3.71 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.358 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HA ' HD13 ' A' ' 53' ' ' ILE . 3.8 mtt180 54.47 101.78 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 120.236 -0.586 . . . . 0.0 111.97 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.609 ' CG ' HD23 ' A' ' 51' ' ' LEU . 35.0 t80 -60.25 160.21 8.76 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.638 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 p -56.27 112.51 1.25 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.75 -0.78 . . . . 0.0 110.621 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 113.23 7.64 20.77 Favored Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.614 HG21 ' O ' ' A' ' 52' ' ' LEU . 78.7 t -112.05 104.57 56.12 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.152 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.37 155.08 43.0 Favored 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.002 1.801 . . . . 0.0 112.078 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.16 -15.81 0.13 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.789 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.0 OUTLIER -51.98 -34.96 44.79 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.774 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.549 ' HD2' HD21 ' A' ' 78' ' ' LEU . 90.3 m-85 -95.15 129.28 42.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.881 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.86 93.28 3.28 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.7 106.27 2.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.628 -1.272 . . . . 0.0 110.642 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 67.6 m -113.68 -176.64 2.94 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.047 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 154.14 117.8 0.65 Allowed Glycine 0 N--CA 1.497 2.742 0 C-N-CA 119.858 -1.163 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.9 t -98.1 67.76 1.92 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.552 -0.859 . . . . 0.0 113.144 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 121.76 -109.51 1.48 Allowed Glycine 0 N--CA 1.5 2.944 0 C-N-CA 119.247 -1.454 . . . . 0.0 111.549 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.623 HG22 ' HA ' ' A' ' 28' ' ' SER . 65.3 p -101.95 9.65 40.36 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.556 -0.857 . . . . 0.0 110.662 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.519 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 8.2 p-10 -113.73 139.49 49.05 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.096 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.632 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 96.7 m-85 -147.82 156.27 42.54 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.524 -0.87 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 21' ' ' ILE . 28.7 m -150.04 152.75 35.34 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.752 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.731 HD12 ' CE3' ' A' ' 40' ' ' TRP . 6.8 tt -115.96 92.74 3.99 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 6.1 mttt -92.23 126.89 37.5 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.006 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.666 HD12 ' HB3' ' A' ' 19' ' ' ALA . 18.7 mt -114.42 132.44 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.059 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.7 m -60.16 -73.64 0.09 Allowed 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 118.983 -1.087 . . . . 0.0 111.275 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.693 HH12 ' CG ' ' A' ' 84' ' ' GLU . 0.6 OUTLIER -123.39 100.44 6.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.526 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 HG13 ' CB ' ' A' ' 87' ' ' ASP . 72.3 t -54.33 145.89 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.983 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.693 ' CG ' HH12 ' A' ' 82' ' ' ARG . 2.4 mm-40 -126.48 172.84 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.478 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.73 -29.67 54.15 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.49 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.432 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 15.3 mm-40 -66.19 -41.1 90.68 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.98 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.454 ' CB ' HG13 ' A' ' 83' ' ' VAL . 1.0 OUTLIER -52.33 -33.06 41.02 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.083 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.479 HD11 HD12 ' A' ' 111' ' ' ILE . 39.8 mt -53.81 130.87 38.46 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.7 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.54 -141.47 8.75 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.508 ' N ' HD12 ' A' ' 90' ' ' ILE . 3.9 mp -125.64 116.58 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.644 ' CE2' HD13 ' A' ' 42' ' ' LEU . 3.4 m-85 -88.53 153.71 20.92 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.876 -0.73 . . . . 0.0 112.159 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.448 ' CE2' HG22 ' A' ' 90' ' ' ILE . 61.2 m-85 -154.76 179.96 8.59 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 114.722 -1.127 . . . . 0.0 109.215 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 4.1 p -165.22 163.36 20.23 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.942 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.471 ' CB ' ' CD2' ' A' ' 103' ' ' PHE . 8.4 t -147.03 -173.32 4.21 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.485 -0.886 . . . . 0.0 111.834 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.403 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 2.7 pt20 -136.54 108.12 6.97 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.123 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -82.84 43.76 0.87 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.047 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -114.17 -58.16 2.18 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.849 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.403 ' CG ' HG21 ' A' ' 2' ' ' VAL . 78.9 m-70 -88.76 171.78 9.71 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 111.297 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.492 HG13 ' HA ' ' A' ' 100' ' ' PRO . 57.4 t -139.17 138.72 21.31 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 119.88 -0.728 . . . . 0.0 110.506 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.492 ' HA ' HG13 ' A' ' 99' ' ' VAL . 3.1 Cg_endo -71.39 148.8 90.88 Favored 'Cis proline' 0 C--N 1.316 -1.164 0 C-N-CA 123.276 -1.552 . . . . 0.0 111.336 -1.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.62 113.4 1.94 Allowed 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 121.762 1.641 . . . . 0.0 110.084 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.3 p -78.62 87.39 4.56 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.255 -0.978 . . . . 0.0 111.373 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 94' ' ' SER . 1.5 t80 -83.5 111.46 19.08 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.882 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 161.89 152.21 6.61 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.839 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.451 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -167.34 -128.18 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.06 100.27 0.15 Allowed Glycine 0 N--CA 1.487 2.072 0 C-N-CA 117.641 -2.218 . . . . 0.0 113.632 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.992 HG21 HG23 ' A' ' 21' ' ' ILE . 96.7 m -158.35 104.17 1.83 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -89.82 156.19 18.66 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.396 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -134.18 93.89 3.15 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.816 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 111' ' ' ILE . 17.3 pt-20 -106.82 31.94 4.93 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.696 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.616 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.5 OUTLIER 61.91 170.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.444 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.568 ' N ' HG23 ' A' ' 111' ' ' ILE . 3.9 tttm -77.41 138.72 39.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.018 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.427 -1.749 . . . . 0.0 110.618 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 121.688 0.756 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 29' ' ' LEU . 64.1 t 62.07 99.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-N 113.976 -1.465 . . . . 0.0 111.553 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.7 t -75.06 116.27 17.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.0 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 mtp -93.94 89.76 6.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.054 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.0 m -77.08 112.23 13.5 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.64 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.698 ' HG3' ' SG ' ' A' ' 23' ' ' CYS . 38.1 tt0 -100.05 154.95 17.99 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.902 -0.719 . . . . 0.0 112.063 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -161.45 161.4 22.91 Favored Pre-proline 0 N--CA 1.492 1.632 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.307 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' O ' HG23 ' A' ' 107' ' ' THR . 6.7 Cg_endo -77.03 178.12 36.68 Favored 'Cis proline' 0 C--N 1.309 -1.525 0 C-N-CA 123.522 -1.449 . . . . 0.0 110.314 -2.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 9' ' ' LEU . 4.4 mm? -63.26 -21.56 66.32 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.469 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 33.6 p -154.83 152.38 29.74 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.607 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 3.5 tp -129.59 77.51 77.02 Favored Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 119.693 -0.803 . . . . 0.0 112.019 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -69.43 102.75 1.01 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.699 1.599 . . . . 0.0 110.183 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 34.3 m -137.17 -167.94 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 119.466 -0.893 . . . . 0.0 111.805 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.22 153.0 34.61 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.412 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.742 ' HG ' HD11 ' A' ' 111' ' ' ILE . 63.9 mt -75.46 87.03 2.6 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.443 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 156.64 -26.34 0.52 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.58 -170.65 2.91 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.788 -0.765 . . . . 0.0 110.42 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -106.4 139.5 40.79 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.52 -0.872 . . . . 0.0 111.263 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -113.34 146.13 39.94 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.397 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.4 p -138.23 92.03 2.61 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.492 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.518 HG23 HG21 ' A' ' 107' ' ' THR . 4.8 mt -89.56 126.44 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.08 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 7' ' ' THR . 0.3 OUTLIER -86.1 156.56 20.33 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.118 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.698 ' SG ' ' HG3' ' A' ' 6' ' ' GLN . 29.0 m -162.02 111.73 1.53 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.251 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 16.8 ttm180 -111.22 140.66 45.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.548 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.8 t -94.54 167.04 11.74 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.931 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -41.03 26.32 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.316 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -136.77 43.77 2.39 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.433 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.471 ' C ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 m 61.02 -174.99 0.12 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.242 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.849 ' CD1' HD12 ' A' ' 38' ' ' LEU . 13.2 mt -142.92 21.34 1.96 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.946 -0.702 . . . . 0.0 111.35 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 94.9 t -77.11 138.48 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.169 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -64.92 170.88 3.89 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.581 -0.848 . . . . 0.0 110.996 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.5 t -51.02 -35.27 33.33 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.586 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -158.37 39.15 0.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.055 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -128.38 -129.4 3.19 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.822 -1.18 . . . . 0.0 111.183 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -122.4 -159.15 0.81 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.201 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.628 HG23 ' HB2' ' A' ' 29' ' ' LEU . 11.9 m -109.51 96.57 6.36 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.934 -0.706 . . . . 0.0 111.409 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -80.79 68.91 7.2 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.007 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.849 HD12 ' CD1' ' A' ' 29' ' ' LEU . 1.4 tt -89.76 142.13 27.98 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.666 ' OD1' HD12 ' A' ' 51' ' ' LEU . 9.1 t30 -122.42 162.2 22.08 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.077 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.741 ' CD2' HD12 ' A' ' 78' ' ' LEU . 50.6 m95 -125.31 154.31 41.96 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.509 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -127.86 146.24 50.68 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.938 -0.705 . . . . 0.0 111.076 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 11.4 tp -162.7 128.42 3.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -173.42 170.48 4.18 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 118.258 -1.377 . . . . 0.0 112.678 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER -111.37 -158.66 0.65 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.413 179.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.434 ' H ' ' HG3' ' A' ' 44' ' ' LYS . . . -55.98 -19.99 14.67 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.211 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 152.24 83.79 0.04 OUTLIER Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.84 -72.52 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.416 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.447 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 38.5 p -86.94 161.48 46.97 Favored Pre-proline 0 N--CA 1.488 1.463 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.117 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 48' ' ' SER . 3.3 Cg_exo -62.66 172.24 4.82 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 C-N-CA 121.734 1.622 . . . . 0.0 110.385 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.426 ' H ' ' HG2' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -124.26 65.77 1.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.439 -0.904 . . . . 0.0 112.192 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.666 HD12 ' OD1' ' A' ' 39' ' ' ASN . 1.2 tp -172.54 97.54 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.907 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.29 -89.07 0.19 Allowed 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.664 HG21 ' H ' ' A' ' 57' ' ' SER . 2.8 mp -82.43 145.3 8.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.979 -0.689 . . . . 0.0 109.787 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 39' ' ' ASN . 42.2 p90 -139.46 -7.51 1.31 Allowed 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.987 -0.685 . . . . 0.0 110.428 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 2.7 tmtt? -130.84 57.7 1.73 Allowed 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.574 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.427 ' O ' HG13 ' A' ' 56' ' ' VAL . 5.9 p 38.05 79.33 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 115.179 -0.919 . . . . 0.0 112.046 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.664 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.1 OUTLIER 69.26 75.3 0.24 Allowed 'General case' 0 N--CA 1.491 1.62 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.444 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.402 ' ND2' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -151.0 -24.26 0.21 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.61 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.475 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 0.9 OUTLIER 70.49 137.55 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.051 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CG ' ' N ' ' A' ' 61' ' ' SER . 79.4 t80 -90.77 172.22 8.79 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.783 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.572 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 6.7 t -57.89 117.4 4.25 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.689 -0.805 . . . . 0.0 110.837 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.33 -8.21 54.99 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.763 -1.208 . . . . 0.0 110.696 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.488 HG21 ' H ' ' A' ' 60' ' ' PHE . 94.8 t -84.96 124.79 72.04 Favored Pre-proline 0 N--CA 1.489 1.501 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.587 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.25 144.28 95.96 Favored 'Trans proline' 0 C--N 1.318 -1.067 0 C-N-CA 122.136 1.891 . . . . 0.0 112.143 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.475 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 3.0 t0 -58.26 -25.25 61.52 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.809 -0.756 . . . . 0.0 111.326 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -28.7 69.35 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.513 -0.875 . . . . 0.0 111.388 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.441 ' O ' ' NH1' ' A' ' 59' ' ' ARG . 10.0 m-85 -79.91 126.52 31.12 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.67 -0.812 . . . . 0.0 111.933 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 20.3 m -134.77 159.36 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.999 -0.68 . . . . 0.0 109.236 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -152.44 79.53 0.2 Allowed Glycine 0 N--CA 1.498 2.771 0 C-N-CA 119.069 -1.538 . . . . 0.0 111.297 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 76' ' ' PHE . 8.8 t -83.3 -167.75 1.82 Allowed 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.536 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.659 ' HA3' ' CD1' ' A' ' 76' ' ' PHE . . . 151.55 117.26 0.75 Allowed Glycine 0 N--CA 1.493 2.447 0 C-N-CA 119.47 -1.348 . . . . 0.0 111.539 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.3 m -92.35 91.35 7.64 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.377 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 72.87 -75.15 0.91 Allowed Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.429 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 66.6 p -131.65 57.08 1.78 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.438 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.525 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 25.9 t0 -162.62 58.6 0.21 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.728 -0.789 . . . . 0.0 110.443 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.659 ' CD1' ' HA3' ' A' ' 71' ' ' GLY . 58.2 m-85 -80.19 148.79 30.72 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.888 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 59.1 m -148.97 122.8 9.31 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.733 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.741 HD12 ' CD2' ' A' ' 40' ' ' TRP . 4.4 tt -84.68 104.56 14.76 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.517 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -96.12 119.98 35.59 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.309 -0.957 . . . . 0.0 111.99 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.502 HG13 HD23 ' A' ' 78' ' ' LEU . 7.8 mt -109.51 116.17 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.352 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.3 m -69.89 -24.45 63.4 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.875 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.1 mmt-85 -142.61 110.62 5.95 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.188 -1.005 . . . . 0.0 111.853 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -86.73 136.52 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.6 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.624 ' C ' HD22 ' A' ' 15' ' ' LEU . 2.9 mt-10 -129.54 170.06 14.21 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.228 -0.989 . . . . 0.0 111.522 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -43.73 59.41 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.301 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -61.9 -37.67 85.46 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.309 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -58.37 -21.62 50.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.705 -0.798 . . . . 0.0 110.952 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 109' ' ' LEU . 78.6 mt -58.96 146.23 38.72 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.241 -0.984 . . . . 0.0 110.173 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 142.41 -154.58 25.19 Favored Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.529 -1.319 . . . . 0.0 110.074 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.458 ' CG2' ' CZ ' ' A' ' 92' ' ' PHE . 20.9 mt -112.41 140.55 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.125 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -104.42 150.64 24.35 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.664 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.458 ' CZ ' ' CG2' ' A' ' 90' ' ' ILE . 40.5 m-85 -151.08 135.18 16.72 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.768 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -109.11 141.12 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.666 -1.214 . . . . 0.0 110.857 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 9.3 p -144.23 -164.68 1.95 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.347 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.512 ' HG3' HD22 ' A' ' 29' ' ' LEU . 5.5 pm0 -159.14 165.87 32.79 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.096 -1.042 . . . . 0.0 111.505 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 24.6 p -109.2 -21.68 12.45 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.394 -0.821 . . . . 0.0 108.992 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.456 HG21 ' O ' ' A' ' 29' ' ' LEU . 10.3 m -53.16 -55.26 25.53 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.359 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.551 ' CG ' HG21 ' A' ' 2' ' ' VAL . 37.9 m-70 -88.17 131.71 34.62 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.751 -0.779 . . . . 0.0 111.535 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.529 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 62.3 t -135.16 137.44 26.83 Favored Pre-proline 0 N--CA 1.489 1.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.44 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.529 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.2 Cg_endo -68.27 136.71 36.4 Favored 'Cis proline' 0 C--N 1.32 -0.958 0 C-N-CA 123.596 -1.418 . . . . 0.0 111.539 -0.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -64.48 155.18 67.71 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.928 1.752 . . . . 0.0 111.399 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.18 -64.56 1.08 Allowed 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.116 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.2 OUTLIER 65.58 118.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.869 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 155.01 64.49 0.01 OUTLIER Glycine 0 N--CA 1.492 2.4 0 C-N-CA 119.218 -1.468 . . . . 0.0 110.978 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.46 ' CA ' ' HB2' ' A' ' 6' ' ' GLN . . . -65.95 -84.67 0.09 OUTLIER Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 115.63 75.05 0.59 Allowed Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.317 -1.42 . . . . 0.0 112.445 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.518 HG21 HG23 ' A' ' 21' ' ' ILE . 19.9 m -148.86 106.95 3.71 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.553 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.69 139.79 32.55 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.342 -0.943 . . . . 0.0 112.852 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD23 HD23 ' A' ' 88' ' ' LEU . 7.6 tt -131.67 107.27 8.7 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.197 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.401 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -131.33 32.89 4.16 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.317 -0.953 . . . . 0.0 111.162 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.742 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 66.08 163.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.954 -0.698 . . . . 0.0 110.96 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.8 OUTLIER -88.96 57.9 4.33 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.587 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.2 ptt-85 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 116.254 -1.832 . . . . 0.0 111.049 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.451 ' HB2' ' CG2' ' A' ' 102' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.949 0.404 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.422 HG12 ' OG ' ' A' ' 25' ' ' SER . 11.6 t -69.65 94.64 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.869 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' N ' ' HB2' ' A' ' 26' ' ' SER . 16.9 t -63.14 155.85 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.689 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.5 mmm -133.46 110.44 9.98 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.697 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -80.14 147.6 31.28 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.817 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.657 ' NE2' ' SG ' ' A' ' 93' ' ' CYS . 5.3 mp0 -118.75 143.33 46.96 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.586 -0.845 . . . . 0.0 111.342 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.62 141.93 8.02 Favored Pre-proline 0 N--CA 1.49 1.549 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.849 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.43 ' HG2' HD12 ' A' ' 11' ' ' LEU . 9.6 Cg_endo -79.35 175.16 46.9 Favored 'Cis proline' 0 C--N 1.312 -1.372 0 C-N-CA 123.586 -1.422 . . . . 0.0 111.159 -0.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 mp -74.37 -22.82 59.02 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.088 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.8 p -139.7 148.86 42.94 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.049 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.565 HD22 HG13 ' A' ' 21' ' ' ILE . 4.6 tp -126.87 78.57 73.54 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.991 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -69.4 102.74 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.309 0 C-N-CA 121.818 1.679 . . . . 0.0 111.061 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG23 ' N ' ' A' ' 14' ' ' SER . 8.6 m -132.77 -154.25 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 119.866 -0.733 . . . . 0.0 111.21 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 13' ' ' VAL . 3.3 t -147.06 154.02 40.68 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.907 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 HD22 ' C ' ' A' ' 84' ' ' GLU . 14.6 mt -68.56 87.47 0.32 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.227 -0.989 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.402 ' HA2' ' NE ' ' A' ' 82' ' ' ARG . . . 147.04 -31.58 1.44 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 108.971 -1.651 . . . . 0.0 108.971 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.53 173.06 11.99 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.976 -0.689 . . . . 0.0 110.248 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.413 HE21 ' HA ' ' A' ' 81' ' ' SER . 2.2 mt-30 -89.07 166.94 13.54 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.337 -0.945 . . . . 0.0 111.039 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.456 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -147.98 161.12 41.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.218 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.543 ' H ' HD21 ' A' ' 11' ' ' LEU . 0.1 OUTLIER -157.58 109.97 2.4 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.997 -1.081 . . . . 0.0 111.757 179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.565 HG13 HD22 ' A' ' 11' ' ' LEU . 2.2 mp -101.02 118.72 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 7.1 t -93.7 158.43 15.68 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.568 -0.853 . . . . 0.0 112.155 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 9.3 t -160.9 117.86 2.33 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.3 mtt85 -104.3 172.07 6.99 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.9 -0.72 . . . . 0.0 110.823 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.422 ' OG ' HG12 ' A' ' 2' ' ' VAL . 1.8 t -116.86 167.43 11.12 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.164 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.471 ' HB2' ' N ' ' A' ' 3' ' ' VAL . 14.9 t -67.87 -27.18 66.45 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.956 -0.698 . . . . 0.0 111.176 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -145.39 -59.68 0.34 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.269 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.71 155.35 1.7 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.676 ' O ' HG21 ' A' ' 97' ' ' THR . 83.6 mt -114.53 6.86 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.871 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.48 137.8 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.416 -0.914 . . . . 0.0 110.425 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -66.32 -89.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.277 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 33.2 t -91.0 -57.39 2.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.51 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -175.84 41.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.798 -0.761 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 174.59 -53.12 0.14 Allowed Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.223 -1.465 . . . . 0.0 111.006 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 33.7 m-80 -76.96 132.98 39.31 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.698 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 88.4 m -132.26 137.57 47.56 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.826 -0.75 . . . . 0.0 110.793 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.642 ' H ' ' CG2' ' A' ' 97' ' ' THR . 22.6 m-85 -122.73 109.42 14.22 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.997 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.422 ' HB3' HG22 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -130.54 133.54 46.31 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.699 ' OD1' HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -110.51 149.01 30.95 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.868 -0.733 . . . . 0.0 110.454 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.584 ' O ' HD12 ' A' ' 51' ' ' LEU . 22.8 m95 -111.89 172.48 6.87 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.855 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -161.02 162.72 31.87 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.482 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD13 ' CD2' ' A' ' 91' ' ' TYR . 19.7 tp -151.25 127.13 10.32 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.58 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.37 113.36 26.84 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 120.015 -0.674 . . . . 0.0 109.852 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 46' ' ' GLY . 0.1 OUTLIER -76.72 167.76 21.26 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.871 -1.132 . . . . 0.0 110.134 -179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -55.38 84.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.904 -0.719 . . . . 0.0 112.055 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 44' ' ' LYS . . . 68.99 33.23 74.2 Favored Glycine 0 N--CA 1.495 2.61 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.7 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.462 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 1.1 tt0 -123.6 167.44 13.94 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.267 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.0 t -60.87 121.3 60.78 Favored Pre-proline 0 N--CA 1.488 1.431 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.987 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -62.56 151.94 80.44 Favored 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.028 1.819 . . . . 0.0 111.394 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -134.82 152.39 51.71 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD21 ' HB3' ' A' ' 54' ' ' TYR . 9.1 tp -95.36 139.45 31.65 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.839 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 2.8 mm? -101.97 -55.67 2.44 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.83 -0.748 . . . . 0.0 109.799 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.756 HG21 ' H ' ' A' ' 57' ' ' SER . 51.6 mm -124.49 137.37 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.043 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.704 ' HB3' HD21 ' A' ' 51' ' ' LEU . 37.2 p90 -113.12 -30.65 6.9 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.213 -0.995 . . . . 0.0 111.618 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -124.33 48.41 1.94 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.488 -0.885 . . . . 0.0 111.349 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 58' ' ' ASN . 40.8 t 56.12 103.31 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.376 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.756 ' H ' HG21 ' A' ' 53' ' ' ILE . 0.7 OUTLIER 76.48 -29.37 0.18 Allowed 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.925 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 58' ' ' ASN . 1.5 m120 -69.35 94.66 0.73 Allowed 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.973 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HA ' HD13 ' A' ' 53' ' ' ILE . 4.1 mtm180 -66.76 136.97 56.28 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.306 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.639 ' HB3' HG23 ' A' ' 63' ' ' VAL . 25.8 t80 -57.2 157.48 6.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.51 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -53.44 -22.73 8.33 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.734 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -112.26 31.9 6.64 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.658 -1.258 . . . . 0.0 110.956 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.639 HG23 ' HB3' ' A' ' 60' ' ' PHE . 38.8 t -120.44 125.89 27.0 Favored Pre-proline 0 N--CA 1.493 1.679 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.671 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -58.61 149.89 73.1 Favored 'Trans proline' 0 C--N 1.318 -1.061 0 C-N-CA 122.241 1.961 . . . . 0.0 112.436 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -60.23 -25.46 65.66 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.986 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.524 ' HG3' ' NH1' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -53.95 -35.84 62.18 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.486 -0.885 . . . . 0.0 111.588 -179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -79.88 129.37 34.43 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.013 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 t -137.25 138.65 40.32 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.929 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.546 ' H ' ' HA ' ' A' ' 57' ' ' SER . . . -124.03 131.72 8.08 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.822 -1.18 . . . . 0.0 110.499 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.3 p -156.19 146.92 21.91 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.203 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.456 ' CA ' ' O ' ' A' ' 75' ' ' ASP . . . -170.94 114.48 0.54 Allowed Glycine 0 N--CA 1.491 2.349 0 C-N-CA 119.013 -1.565 . . . . 0.0 111.324 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 58.8 m -95.34 145.2 25.28 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 119.841 -0.744 . . . . 0.0 111.201 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 63.75 -101.01 0.42 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 120.034 -1.079 . . . . 0.0 111.909 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 52.7 p -131.04 21.66 4.9 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.566 -0.854 . . . . 0.0 111.71 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 5.9 m-20 -122.17 124.04 42.93 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.649 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 23.8 m-85 -131.47 155.3 47.61 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.894 -0.722 . . . . 0.0 111.345 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 25.8 m -159.49 139.57 11.86 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.156 -0.618 . . . . 0.0 110.988 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.578 HD12 ' CD2' ' A' ' 40' ' ' TRP . 6.4 tt -95.56 104.53 16.45 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.069 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.19 129.24 38.19 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.692 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.721 HG22 ' H ' ' A' ' 82' ' ' ARG . 32.1 mt -116.81 128.28 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.468 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HA ' HE21 ' A' ' 18' ' ' GLN . 8.1 m -85.13 2.33 43.99 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.706 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.721 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -171.37 112.5 0.35 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.841 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 68.5 t -91.75 150.23 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 119.668 -0.813 . . . . 0.0 110.34 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' C ' HD22 ' A' ' 15' ' ' LEU . 4.3 mt-10 -137.28 167.15 22.15 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.469 -0.892 . . . . 0.0 111.197 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -52.28 -42.86 64.08 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.227 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -66.15 -29.66 69.99 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.769 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -71.42 -19.98 62.17 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.66 -0.816 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 109' ' ' LEU . 78.8 mt -65.98 137.08 56.88 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.855 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.15 -137.71 5.64 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 42.3 mm -119.59 106.69 19.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.485 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.477 ' CD2' HD13 ' A' ' 42' ' ' LEU . 0.3 OUTLIER -78.28 130.43 36.21 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 118.879 -1.129 . . . . 0.0 110.311 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 105' ' ' GLY . 1.2 m-85 -118.11 166.61 12.35 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.292 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.657 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 14.7 p -134.85 152.46 51.77 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.073 -0.651 . . . . 0.0 110.715 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.8 t -156.25 155.9 33.15 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.511 -0.875 . . . . 0.0 111.001 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.536 ' CB ' HD22 ' A' ' 29' ' ' LEU . 4.0 pt20 -112.39 163.04 14.89 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.529 -0.868 . . . . 0.0 110.826 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 22.5 m -144.89 46.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.676 HG21 ' O ' ' A' ' 29' ' ' LEU . 2.1 p -124.64 -44.17 1.98 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.097 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -99.5 142.2 31.3 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.994 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.416 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 12.5 p -109.18 137.22 20.13 Favored Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.589 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.416 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 6.1 Cg_endo -74.55 146.45 86.79 Favored 'Cis proline' 0 C--N 1.316 -1.173 0 C-N-CA 123.528 -1.447 . . . . 0.0 111.494 -0.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.04 125.49 15.98 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.72 1.613 . . . . 0.0 110.156 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.451 ' CG2' ' HB2' ' A' ' 1' ' ' ASP . 38.3 p -91.22 107.37 19.16 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.198 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -94.27 139.42 31.07 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.098 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -167.85 -141.05 3.06 Favored Glycine 0 N--CA 1.493 2.453 0 C-N-CA 119.363 -1.398 . . . . 0.0 110.731 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 92' ' ' PHE . . . 132.58 175.19 13.87 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.22 79.23 0.03 OUTLIER Glycine 0 N--CA 1.492 2.395 0 C-N-CA 118.159 -1.972 . . . . 0.0 112.949 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.48 HG21 HG23 ' A' ' 21' ' ' ILE . 93.1 m -149.91 107.41 3.64 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.185 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.9 tttm -75.9 93.61 3.24 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.538 -0.865 . . . . 0.0 112.852 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.56 HD23 HD23 ' A' ' 88' ' ' LEU . 5.0 tt -89.35 83.89 6.43 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.424 ' O ' HG22 ' A' ' 111' ' ' ILE . 2.3 tt0 -124.96 54.97 1.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.143 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.671 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.8 OUTLIER 54.82 176.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.416 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 111' ' ' ILE . 31.8 mtpt -71.0 124.06 23.49 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.869 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.539 HH12 HG22 ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 116.402 -1.761 . . . . 0.0 110.702 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.999 0.428 . . . . 0.0 110.338 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG21 ' CG ' ' A' ' 98' ' ' HIS . 69.0 t -53.74 110.82 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.113 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 4' ' ' MET . 17.1 t -68.61 161.0 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 120.001 -0.68 . . . . 0.0 111.659 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.472 ' N ' HG12 ' A' ' 3' ' ' VAL . 82.0 mmm -139.25 101.46 4.26 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.517 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.7 m -91.89 103.45 15.99 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.73 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -107.35 166.31 10.74 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.743 -179.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.507 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.67 170.35 8.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.583 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.507 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 12.1 Cg_endo -83.72 173.8 41.67 Favored 'Cis proline' 0 C--N 1.312 -1.355 0 C-N-CA 123.794 -1.336 . . . . 0.0 110.72 -2.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 37.3 mt -72.88 -16.69 61.57 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.126 -1.029 . . . . 0.0 109.626 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 54.0 p -154.14 136.18 14.69 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.259 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.547 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 1.4 tp -122.72 86.32 49.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.269 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -68.68 116.81 4.61 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 121.64 1.56 . . . . 0.0 110.232 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.579 HG21 HG11 ' A' ' 83' ' ' VAL . 35.8 m -141.86 -172.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 C-N-CA 119.539 -0.864 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.7 m -114.42 145.75 41.46 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.08 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 111' ' ' ILE . 38.6 mt -70.35 89.43 0.67 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.537 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 136.4 -1.04 3.26 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -95.71 -135.17 0.22 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.61 167.57 21.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.706 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.715 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -150.06 168.79 22.88 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.196 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' LEU . 19.7 p -160.38 91.72 0.94 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.946 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.485 HG23 HG21 ' A' ' 107' ' ' THR . 2.7 mt -78.3 125.86 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.153 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.467 ' N ' ' O ' ' A' ' 7' ' ' THR . 32.4 t -85.57 157.4 20.4 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.268 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 2.0 m -161.89 106.11 1.23 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.161 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' NH1' ' O ' ' A' ' 74' ' ' THR . 55.7 ttm-85 -106.49 144.89 32.52 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.42 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.91 154.8 17.77 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.907 -0.717 . . . . 0.0 110.945 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 21.6 t -63.93 -72.03 0.16 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.012 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -113.22 48.61 1.02 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.971 -0.692 . . . . 0.0 110.228 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 7.2 t 67.97 176.28 0.26 Allowed 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.377 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.77 ' C ' HG21 ' A' ' 97' ' ' THR . 55.6 mt -124.78 52.7 1.53 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.593 -0.843 . . . . 0.0 110.617 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 35' ' ' ASN . 35.1 t -106.65 130.94 57.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.474 ' HB3' ' H ' ' A' ' 34' ' ' GLY . 45.2 t-80 -82.44 171.69 13.87 Favored 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.301 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.441 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 58.3 m -77.1 37.04 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.568 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' HIS . 4.0 p30 175.27 -28.67 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.324 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.474 ' H ' ' HB3' ' A' ' 31' ' ' HIS . . . -78.16 -131.04 0.6 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.636 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.805 ' O ' HG22 ' A' ' 30' ' ' VAL . 6.2 m-80 -158.86 -67.78 0.08 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.937 -0.705 . . . . 0.0 110.688 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.4 m -157.16 126.5 6.01 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.761 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -134.28 139.6 45.83 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.425 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.683 HD13 ' CG ' ' A' ' 76' ' ' PHE . 0.6 OUTLIER -162.26 149.67 13.98 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.115 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.409 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 4.4 p-10 -137.72 170.89 15.28 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.184 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.651 ' CE2' HD13 ' A' ' 78' ' ' LEU . 70.1 m95 -131.9 164.04 26.99 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.979 -0.688 . . . . 0.0 110.525 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 1.5 m-85 -154.73 131.57 10.78 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.507 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.755 HD23 ' HD3' ' A' ' 50' ' ' LYS . 5.4 tp -116.16 117.49 30.21 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.711 -0.796 . . . . 0.0 109.798 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.516 ' N ' HD12 ' A' ' 42' ' ' LEU . 13.6 tm0? -101.42 140.2 36.05 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.865 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -114.04 165.06 13.01 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.779 -0.769 . . . . 0.0 110.493 179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.81 111.03 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.844 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.68 46.16 13.02 Favored Glycine 0 N--CA 1.499 2.853 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.438 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.439 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 29.9 tt0 -135.39 154.06 51.6 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.669 -0.812 . . . . 0.0 111.171 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 26.0 p -61.92 122.48 72.27 Favored Pre-proline 0 C--N 1.304 -1.377 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.231 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.56 113.97 1.78 Allowed 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.674 1.583 . . . . 0.0 111.472 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.755 ' HD3' HD23 ' A' ' 42' ' ' LEU . 0.5 OUTLIER -77.27 156.72 31.2 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.959 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 52' ' ' LEU . 5.9 tp -114.53 139.3 49.68 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.354 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 67' ' ' PHE . 17.5 mt -113.42 -90.08 0.52 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.183 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.748 HD13 HD11 ' A' ' 78' ' ' LEU . 2.8 mp -82.66 145.06 9.07 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.443 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -139.36 -7.19 1.34 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.957 -0.697 . . . . 0.0 110.696 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 1.6 tptt -139.78 56.02 1.65 Allowed 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.899 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.431 ' HB ' ' O ' ' A' ' 55' ' ' LYS . 5.8 t 76.4 -47.54 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.977 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.0 p -171.77 45.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 118.912 -1.115 . . . . 0.0 112.08 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -94.86 -36.57 11.59 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.575 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 36.3 mtt85 68.31 134.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 120.394 -0.523 . . . . 0.0 110.94 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' H ' HG21 ' A' ' 63' ' ' VAL . 4.7 t80 -81.08 168.08 19.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -60.17 -33.12 71.76 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.078 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.02 11.38 22.27 Favored Glycine 0 N--CA 1.495 2.571 0 C-N-CA 119.745 -1.217 . . . . 0.0 110.756 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.583 HG21 ' H ' ' A' ' 60' ' ' PHE . 21.3 t -104.46 128.08 27.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.436 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.47 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 1.2 Cg_endo -67.17 19.34 0.11 Allowed 'Trans proline' 0 C--N 1.317 -1.102 0 C-N-CA 122.119 1.879 . . . . 0.0 112.92 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 63' ' ' VAL . 15.4 t70 68.7 -37.07 0.34 Allowed 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 113.758 1.022 . . . . 0.0 113.758 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -52.72 -18.32 1.77 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.492 -179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.605 ' O ' HD11 ' A' ' 53' ' ' ILE . 57.0 m-85 -87.92 92.81 9.27 Favored 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.208 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.4 m -109.94 158.44 18.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 119.61 -0.836 . . . . 0.0 110.042 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -142.87 -174.04 14.95 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.574 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 38.6 t -148.41 168.03 23.71 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.74 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.665 ' CA ' ' CD2' ' A' ' 76' ' ' PHE . . . -173.19 86.08 0.08 OUTLIER Glycine 0 N--CA 1.49 2.274 0 C-N-CA 119.001 -1.571 . . . . 0.0 111.524 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 4.3 m -92.79 51.92 1.78 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.333 -0.947 . . . . 0.0 111.42 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.03 -59.53 4.27 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.72 -1.228 . . . . 0.0 111.095 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.423 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 3.8 p -125.63 34.47 4.9 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.766 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.05 106.81 1.4 Allowed 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.316 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.685 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 11.6 m-85 -128.59 145.29 51.18 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.711 -0.795 . . . . 0.0 111.395 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.471 HG22 ' H ' ' A' ' 78' ' ' LEU . 19.6 m -149.78 170.85 17.78 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.943 -0.703 . . . . 0.0 110.682 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.748 HD11 HD13 ' A' ' 53' ' ' ILE . 4.7 tp -134.67 94.79 3.24 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.698 -0.801 . . . . 0.0 110.557 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt -77.96 111.52 13.91 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.582 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.715 HD12 ' HB3' ' A' ' 19' ' ' ALA . 77.2 mt -91.54 117.98 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.226 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.598 ' O ' ' CB ' ' A' ' 82' ' ' ARG . 0.3 OUTLIER -92.5 89.01 6.57 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.264 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.598 ' CB ' ' O ' ' A' ' 81' ' ' SER . 0.1 OUTLIER 104.09 76.51 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.23 0 O-C-N 124.475 1.109 . . . . 0.0 110.464 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.579 HG11 HG21 ' A' ' 13' ' ' VAL . 72.2 t -67.59 100.98 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.716 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' HB2' HH12 ' A' ' 66' ' ' ARG . 50.6 mt-10 -94.67 179.03 5.4 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.866 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.19 -28.44 40.6 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.686 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -58.97 -51.42 70.12 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' OD2' HD13 ' A' ' 80' ' ' ILE . 4.4 m-20 -47.39 -26.33 1.28 Allowed 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 114.713 -1.131 . . . . 0.0 112.155 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.454 HD11 HD12 ' A' ' 111' ' ' ILE . 51.1 mt -56.57 144.58 31.23 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 118.852 -1.139 . . . . 0.0 110.85 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.36 -134.72 8.07 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 90' ' ' ILE . 1.0 OUTLIER -133.62 119.15 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.519 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.66 ' CZ ' HD22 ' A' ' 42' ' ' LEU . 3.8 m-85 -89.44 146.75 24.43 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.78 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -140.82 175.23 9.78 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.33 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.456 ' H ' ' HA3' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -160.72 159.05 29.7 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.966 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.9 t -151.24 178.1 9.57 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.606 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.563 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.9 OUTLIER -129.44 124.85 35.14 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.613 -179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 74.3 p -93.15 4.19 54.42 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.324 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.77 HG21 ' C ' ' A' ' 29' ' ' LEU . 99.5 m -70.64 -57.71 4.42 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.651 -0.819 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.595 ' CG ' HG21 ' A' ' 2' ' ' VAL . 75.7 m-70 -91.45 94.51 9.5 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.65 -0.82 . . . . 0.0 111.407 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 100' ' ' PRO . 14.7 p -74.97 139.11 72.91 Favored Pre-proline 0 N--CA 1.489 1.494 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' HA ' HG23 ' A' ' 99' ' ' VAL . 5.4 Cg_endo -72.85 142.83 75.81 Favored 'Cis proline' 0 C--N 1.318 -1.05 0 C-N-CA 123.726 -1.364 . . . . 0.0 111.781 -0.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.25 112.32 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.163 0 C-N-CA 121.863 1.709 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.2 p -72.77 84.84 1.21 Allowed 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 119.044 -1.062 . . . . 0.0 110.948 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.436 ' CG ' ' N ' ' A' ' 104' ' ' GLY . 16.8 t80 -76.83 155.04 33.29 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.236 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.436 ' N ' ' CG ' ' A' ' 103' ' ' PHE . . . 168.17 -52.54 0.22 Allowed Glycine 0 N--CA 1.49 2.236 0 C-N-CA 118.822 -1.656 . . . . 0.0 111.354 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.456 ' HA3' ' H ' ' A' ' 93' ' ' CYS . . . 50.19 -138.05 22.77 Favored Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.159 -1.495 . . . . 0.0 109.52 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 132.94 85.12 0.26 Allowed Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.987 -1.578 . . . . 0.0 112.282 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.485 HG21 HG23 ' A' ' 21' ' ' ILE . 17.3 m -152.84 109.45 3.43 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.072 -0.651 . . . . 0.0 109.748 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.97 97.23 9.69 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.209 -0.996 . . . . 0.0 112.269 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 87' ' ' ASP . 0.1 OUTLIER -90.69 84.23 5.86 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.839 -0.745 . . . . 0.0 109.161 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -116.6 57.18 0.78 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.225 -0.99 . . . . 0.0 112.456 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.693 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER 54.88 178.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.741 -0.783 . . . . 0.0 111.708 179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.693 ' N ' HG23 ' A' ' 111' ' ' ILE . 1.2 tppt? -80.15 147.94 31.14 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.078 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.417 HH11 ' CG ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 116.387 -1.768 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.068 0.461 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 98' ' ' HIS . 65.1 t -69.91 120.84 18.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.999 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.1 150.81 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.662 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.63 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 50.7 mtp -133.5 -174.22 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.507 0.67 . . . . 0.0 109.694 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.0 m -156.55 152.06 26.83 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.462 -1.245 . . . . 0.0 109.849 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 106' ' ' GLY . 0.0 OUTLIER -140.34 150.18 43.65 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.473 -0.891 . . . . 0.0 111.044 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -159.55 166.87 15.26 Favored Pre-proline 0 N--CA 1.494 1.738 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.273 179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HA ' ' CB ' ' A' ' 7' ' ' THR . 5.0 Cg_endo -74.59 178.41 34.32 Favored 'Cis proline' 0 C--N 1.313 -1.339 0 C-N-CA 123.717 -1.368 . . . . 0.0 110.846 -1.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.4 mt -69.12 -36.95 78.05 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.53 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.3 t -140.24 147.55 40.18 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.063 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.2 tp -134.1 83.18 46.16 Favored Pre-proline 0 N--CA 1.487 1.422 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.406 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.413 ' C ' ' HG3' ' A' ' 112' ' ' LYS . 2.0 Cg_endo -68.05 101.17 0.68 Allowed 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.839 1.692 . . . . 0.0 110.241 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.1 m -122.74 -167.78 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.884 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.5 m -127.35 147.73 50.26 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.744 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 85' ' ' ALA . 17.7 mt -67.78 89.34 0.26 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.667 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 141.92 -6.8 2.36 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -90.65 -152.16 0.27 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.949 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -125.05 155.93 38.99 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.67 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.628 ' HB2' HG21 ' A' ' 83' ' ' VAL . . . -129.75 163.53 25.98 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.449 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.7 p -163.32 94.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.075 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.423 HG23 ' OG1' ' A' ' 107' ' ' THR . 2.7 mp -91.36 129.28 42.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.018 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 7' ' ' THR . 37.0 m -87.96 159.39 18.34 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.966 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 2.1 t -160.74 137.11 8.57 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.672 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.99 144.41 45.34 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.836 -0.746 . . . . 0.0 109.966 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 9.7 m -110.77 146.83 35.67 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.565 -0.854 . . . . 0.0 111.319 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 33.4 t -52.14 -38.01 56.22 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.186 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -133.25 167.0 21.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.2 t -63.52 137.99 58.34 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.922 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 29' ' ' LEU . 77.2 mt -94.39 23.48 5.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.208 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.3 t -91.41 139.75 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 35' ' ' ASN . 7.9 t-80 -88.43 -140.4 0.12 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.704 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.405 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 17.8 p -68.01 -74.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.943 -0.703 . . . . 0.0 112.408 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.95 124.31 27.56 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.014 -1.074 . . . . 0.0 112.588 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.79 20.65 1.25 Allowed Glycine 0 N--CA 1.498 2.778 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.115 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 31' ' ' HIS . 2.6 m120 -106.28 91.05 3.55 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.607 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.2 m -101.93 152.79 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.775 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -138.36 137.39 37.28 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.51 -0.876 . . . . 0.0 111.169 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 39' ' ' ASN . 21.1 tp -172.63 151.51 2.38 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.998 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.475 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -154.72 120.71 5.22 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.517 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CE2' ' HB2' ' A' ' 78' ' ' LEU . 29.6 m95 -87.93 149.68 23.92 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.866 -0.734 . . . . 0.0 111.546 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' HB3' ' CD1' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -123.7 155.68 37.37 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.574 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.662 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 6.4 tp -150.91 117.11 5.62 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.499 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -111.94 130.45 55.84 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.898 -0.721 . . . . 0.0 110.976 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -77.9 167.11 22.01 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.63 -34.86 27.84 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.181 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.7 48.33 0.54 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.651 -1.262 . . . . 0.0 110.543 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 30.7 tt0 -144.42 158.76 43.59 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.88 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 70.6 p -61.68 138.09 95.16 Favored Pre-proline 0 N--CA 1.488 1.438 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HA ' ' O ' ' A' ' 42' ' ' LEU . 1.5 Cg_endo -65.83 113.25 2.49 Favored 'Trans proline' 0 C--N 1.314 -1.279 0 C-N-CA 121.806 1.671 . . . . 0.0 111.235 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 20.1 mttm -90.53 133.11 35.3 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.274 -0.97 . . . . 0.0 111.069 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.686 HD21 ' HB3' ' A' ' 54' ' ' TYR . 16.0 tp -71.32 124.7 25.13 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.076 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.443 HD22 ' CD2' ' A' ' 67' ' ' PHE . 33.2 mt -95.48 -88.94 0.25 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.642 -0.823 . . . . 0.0 109.241 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.48 HD13 ' HA ' ' A' ' 59' ' ' ARG . 44.0 mm -88.82 123.05 40.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.63 -0.828 . . . . 0.0 109.028 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.686 ' HB3' HD21 ' A' ' 51' ' ' LEU . 36.0 p90 -110.48 20.17 18.01 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.374 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -172.14 143.77 1.56 Allowed 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.89 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.626 HG13 ' H ' ' A' ' 71' ' ' GLY . 43.1 t -44.09 106.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.081 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 63.06 71.21 0.52 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.419 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -170.71 110.65 0.36 Allowed 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.359 179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.48 ' HA ' HD13 ' A' ' 53' ' ' ILE . 24.6 mtm-85 -77.33 139.76 39.83 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.666 -0.814 . . . . 0.0 111.847 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.441 ' HB3' ' CG2' ' A' ' 63' ' ' VAL . 68.7 t80 -69.85 160.13 32.36 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.057 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.408 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 5.3 m -40.25 -53.73 2.47 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.921 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -89.86 57.44 3.7 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.526 -1.321 . . . . 0.0 111.147 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' CG2' ' HB3' ' A' ' 60' ' ' PHE . 88.9 t -144.59 113.9 5.12 Favored Pre-proline 0 N--CA 1.493 1.706 0 C-N-CA 119.479 -0.888 . . . . 0.0 111.105 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 159.77 37.45 Favored 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 121.966 1.778 . . . . 0.0 111.938 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -58.08 -27.46 63.69 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.549 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.502 ' CG ' ' HB2' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -43.71 -42.12 5.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.322 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.443 ' CD2' HD22 ' A' ' 52' ' ' LEU . 64.7 m-85 -82.51 124.51 30.17 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.448 -0.901 . . . . 0.0 112.623 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -124.63 151.86 44.33 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.722 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -152.35 155.11 25.94 Favored Glycine 0 N--CA 1.492 2.431 0 C-N-CA 118.916 -1.612 . . . . 0.0 111.772 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -149.78 141.83 23.93 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' H ' HG13 ' A' ' 56' ' ' VAL . . . -137.42 128.45 4.32 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.92 -1.609 . . . . 0.0 112.094 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.1 m -94.73 -124.55 0.11 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.17 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.14 -55.89 1.25 Allowed Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.7 p -125.27 20.65 8.09 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.972 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' C ' ' CG ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -132.11 143.25 49.88 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.935 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CD1' HD22 ' A' ' 38' ' ' LEU . 40.4 m-85 -151.13 136.42 17.65 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.5 m -139.37 140.92 37.59 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.447 -0.901 . . . . 0.0 111.597 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 1.8 tt -117.63 111.05 18.66 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.161 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -120.81 138.14 54.18 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.196 -179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.442 HD12 ' HB3' ' A' ' 19' ' ' ALA . 2.8 mp -105.85 138.37 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.616 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.5 m -72.09 -36.17 69.43 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.14 -0.937 . . . . 0.0 111.434 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HB2' ' CG ' ' A' ' 66' ' ' ARG . 3.9 mtt180 -135.25 86.94 2.29 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.058 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.628 HG21 ' HB2' ' A' ' 19' ' ' ALA . 58.1 t -65.8 111.4 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.387 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.491 ' CD ' HH21 ' A' ' 66' ' ' ARG . 24.4 mt-10 -106.65 177.79 4.75 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.005 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.519 ' HB2' HD13 ' A' ' 15' ' ' LEU . . . -52.75 -31.75 39.72 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.139 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.7 mm-40 -67.16 -32.81 74.17 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.952 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -65.82 -20.16 66.15 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.139 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 109' ' ' LEU . 72.9 mt -58.53 139.94 54.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.615 -0.834 . . . . 0.0 111.35 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 140.3 -173.42 23.04 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.872 -1.156 . . . . 0.0 110.419 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.641 ' H ' HD12 ' A' ' 90' ' ' ILE . 5.4 mp -85.25 158.56 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 C-N-CA 119.991 -0.684 . . . . 0.0 110.794 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.662 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 13.2 m-85 -131.51 148.77 52.66 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.945 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.693 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.0 OUTLIER -147.21 165.13 30.99 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.262 -179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.48 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 22.8 p -132.7 102.92 5.87 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.435 ' O ' HD12 ' A' ' 38' ' ' LEU . 5.2 m -83.17 164.32 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.145 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.63 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.9 OUTLIER -130.38 118.2 20.86 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.633 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.22 22.02 4.05 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.548 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.538 ' HB ' ' CD2' ' A' ' 98' ' ' HIS . 3.9 m -89.11 -40.41 12.95 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.801 -0.759 . . . . 0.0 111.737 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.538 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 53.1 m-70 -119.34 152.4 36.83 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.673 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 68.0 t -113.86 137.76 22.46 Favored Pre-proline 0 N--CA 1.49 1.543 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.288 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.442 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.61 142.3 73.96 Favored 'Cis proline' 0 C--N 1.317 -1.112 0 C-N-CA 123.589 -1.421 . . . . 0.0 111.805 -0.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -65.69 110.81 1.74 Allowed 'Trans proline' 0 C--N 1.314 -1.288 0 C-N-CA 121.841 1.694 . . . . 0.0 110.553 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.6 p -64.85 147.86 52.46 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.551 -0.859 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -84.71 -74.82 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.381 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.69 -137.49 8.29 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.182 -1.485 . . . . 0.0 111.598 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.679 ' N ' ' HB3' ' A' ' 92' ' ' PHE . . . 114.0 90.6 1.8 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.642 -2.183 . . . . 0.0 107.642 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.542 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -151.46 8.76 0.66 Allowed Glycine 0 N--CA 1.483 1.827 0 C-N-CA 117.908 -2.091 . . . . 0.0 113.909 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 91' ' ' TYR . 30.6 m -147.73 138.53 23.31 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.436 -1.306 . . . . 0.0 111.885 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 28.4 mtpt -113.6 103.4 11.21 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.358 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.463 HD23 HD23 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -85.86 86.94 7.34 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.523 -179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.62 139.1 45.04 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.721 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.4 tt -55.42 158.53 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.714 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.413 ' HG3' ' C ' ' A' ' 12' ' ' PRO . 3.8 mtmp? -87.33 108.94 19.2 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.959 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.549 ' H ' ' NE ' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 116.27 -1.824 . . . . 0.0 110.667 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.4 p30 . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.947 0.403 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG21 ' CG ' ' A' ' 98' ' ' HIS . 4.3 t -85.26 83.28 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.637 -1.225 . . . . 0.0 110.86 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 30.1 t -66.95 157.09 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.403 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.438 ' CG ' HE22 ' A' ' 95' ' ' GLN . 40.1 mmm -133.31 113.47 12.64 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.024 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.8 m -77.78 127.65 32.75 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.985 -0.686 . . . . 0.0 110.577 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.644 ' CD ' ' SG ' ' A' ' 23' ' ' CYS . 1.6 tp60 -101.57 139.29 37.43 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.75 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -162.18 145.83 9.23 Favored Pre-proline 0 N--CA 1.492 1.656 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.841 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' O ' HG23 ' A' ' 107' ' ' THR . 9.1 Cg_endo -78.62 -179.98 28.71 Favored 'Cis proline' 0 C--N 1.313 -1.313 0 C-N-CA 123.648 -1.397 . . . . 0.0 111.093 -0.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.7 mp -78.01 -29.75 49.71 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.56 -0.856 . . . . 0.0 110.498 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.88 149.63 50.33 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.148 -0.621 . . . . 0.0 110.261 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.8 tp -142.24 83.07 12.59 Favored Pre-proline 0 N--CA 1.49 1.572 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.877 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -67.07 113.97 3.02 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.853 1.702 . . . . 0.0 110.808 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 26.9 m -143.08 162.65 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.326 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.14 158.66 15.52 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.391 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HG ' HD11 ' A' ' 111' ' ' ILE . 25.5 mt -78.96 94.65 5.29 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.734 -0.786 . . . . 0.0 111.1 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' VAL . . . 133.05 16.98 1.18 Allowed Glycine 0 N--CA 1.494 2.544 0 CA-C-N 114.449 -1.251 . . . . 0.0 110.365 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -111.99 -131.68 0.32 Allowed 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.724 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' A' ' 81' ' ' SER . 2.6 mt-30 -139.08 172.52 12.72 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.317 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.761 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -145.65 166.14 26.66 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.354 -0.938 . . . . 0.0 111.556 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.9 p -160.86 80.99 0.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.41 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.755 HG23 HG21 ' A' ' 107' ' ' THR . 2.9 mt -90.63 124.15 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.376 -0.93 . . . . 0.0 110.295 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 m -87.15 151.88 22.81 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.927 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.644 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -160.8 111.09 1.75 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.225 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.38 170.29 8.34 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.999 -1.08 . . . . 0.0 111.821 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.419 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 2.3 t -111.36 155.25 23.38 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.101 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.06 -49.04 25.88 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.186 -1.006 . . . . 0.0 110.878 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 28' ' ' SER . 4.0 tp-100 -97.84 -68.6 0.79 Allowed 'General case' 0 C--N 1.307 -1.259 0 C-N-CA 119.946 -0.702 . . . . 0.0 110.948 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.772 ' HA ' HG22 ' A' ' 74' ' ' THR . 39.3 t 167.45 166.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.982 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 16.5 mt -125.73 20.77 7.77 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.102 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.0 t -89.56 119.3 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.628 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.546 ' O ' ' C ' ' A' ' 32' ' ' SER . 15.3 t-80 -60.11 158.38 11.33 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.678 -0.809 . . . . 0.0 111.476 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.546 ' C ' ' O ' ' A' ' 31' ' ' HIS . 23.4 t -12.41 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 123.994 0.809 . . . . 0.0 112.786 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.72 52.82 0.82 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.953 -0.699 . . . . 0.0 109.931 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.78 -125.58 3.45 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.839 -1.172 . . . . 0.0 111.478 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -114.39 175.99 5.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.6 m -79.35 121.44 25.13 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.446 -0.901 . . . . 0.0 110.478 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.454 ' CG ' ' OG1' ' A' ' 97' ' ' THR . 12.6 m-85 -97.92 159.43 14.94 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.99 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 76' ' ' PHE . 16.1 tp 179.8 151.88 0.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.343 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.555 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 20.8 m120 -137.71 149.09 46.22 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.599 ' CD2' HD12 ' A' ' 78' ' ' LEU . 39.0 m95 -120.42 157.28 29.66 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.804 -0.759 . . . . 0.0 110.97 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -147.75 172.01 14.77 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.577 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.651 HD13 ' CE1' ' A' ' 91' ' ' TYR . 1.1 tp -160.72 120.69 2.76 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.95 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -90.18 116.88 28.52 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.955 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 47' ' ' GLN . 17.8 ttpp -148.55 168.61 22.3 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.545 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' H ' ' HG2' ' A' ' 44' ' ' LYS . . . -56.42 103.74 0.12 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 120.002 -0.679 . . . . 0.0 111.966 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.52 14.66 74.92 Favored Glycine 0 N--CA 1.497 2.75 0 C-N-CA 120.113 -1.042 . . . . 0.0 112.131 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 3.0 tt0 -125.97 5.45 7.26 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.071 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.487 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -57.04 -51.29 82.74 Favored Pre-proline 0 N--CA 1.491 1.585 0 C-N-CA 119.548 -0.861 . . . . 0.0 111.713 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 4.7 Cg_endo -71.3 19.84 0.24 Allowed 'Trans proline' 0 C--N 1.32 -0.97 0 C-N-CA 121.592 1.528 . . . . 0.0 112.027 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 48' ' ' SER . 1.8 ttmm -104.95 126.76 52.36 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.901 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 52' ' ' LEU . 0.1 OUTLIER -105.97 149.67 26.41 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.35 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 51' ' ' LEU . 64.9 mt -102.3 -80.1 0.51 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.167 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.612 HG21 ' O ' ' A' ' 69' ' ' GLY . 3.3 mm -105.5 138.71 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.662 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.474 ' HB3' HD21 ' A' ' 51' ' ' LEU . 32.4 p90 -132.06 28.58 4.45 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.659 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' O ' ' C ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -178.8 68.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.434 179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 56' ' ' VAL . 20.5 m 19.74 94.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.541 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.555 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER 79.42 63.2 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.904 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.452 ' H ' HG23 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -171.46 108.51 0.27 Allowed 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.988 -179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.486 ' CD ' ' HA ' ' A' ' 65' ' ' ASP . 15.4 mtt85 -89.17 153.62 20.8 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.758 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 61' ' ' SER . 40.0 t80 -83.78 160.28 21.26 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.336 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.466 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 12.3 t -42.97 -38.55 2.28 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.099 -0.64 . . . . 0.0 112.029 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.08 52.42 1.09 Allowed Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.643 -1.265 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 75.0 t -146.12 118.93 5.11 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.639 -0.825 . . . . 0.0 110.8 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' O ' ' HD3' ' A' ' 59' ' ' ARG . 4.2 Cg_exo -60.36 138.07 78.5 Favored 'Trans proline' 0 C--N 1.318 -1.064 0 C-N-CA 122.159 1.906 . . . . 0.0 111.919 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' HA ' ' CD ' ' A' ' 59' ' ' ARG . 0.5 OUTLIER -52.22 -23.78 6.17 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.492 HH21 ' CB ' ' A' ' 82' ' ' ARG . 0.0 OUTLIER -67.53 12.65 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.128 -179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.511 ' HD1' HD21 ' A' ' 78' ' ' LEU . 12.2 m-85 -115.74 104.51 11.74 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.395 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 70.0 m -105.68 121.08 43.27 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.12 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' O ' HG21 ' A' ' 53' ' ' ILE . . . -131.15 102.7 0.52 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.55 -1.31 . . . . 0.0 111.152 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.45 ' OG ' ' N ' ' A' ' 71' ' ' GLY . 31.2 t -151.47 175.34 12.39 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.616 -0.834 . . . . 0.0 111.142 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 174.37 147.63 6.19 Favored Glycine 0 N--CA 1.489 2.225 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.462 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.8 p -95.02 160.35 14.61 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.737 -0.785 . . . . 0.0 111.4 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 45.11 -102.79 0.04 OUTLIER Glycine 0 N--CA 1.498 2.798 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.213 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.772 HG22 ' HA ' ' A' ' 28' ' ' SER . 59.1 p -124.55 15.45 8.84 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 119.617 -0.833 . . . . 0.0 112.111 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' O ' ' HA3' ' A' ' 71' ' ' GLY . 0.6 OUTLIER -115.83 125.68 53.0 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.766 -0.774 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CD2' HD22 ' A' ' 38' ' ' LEU . 4.0 m-85 -140.97 168.14 20.5 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.733 -0.787 . . . . 0.0 111.517 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 2.9 m -160.1 155.91 25.95 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.255 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 40' ' ' TRP . 5.3 tt -112.49 102.02 10.15 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.487 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -89.8 125.12 35.19 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.548 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.761 HD12 ' HB3' ' A' ' 19' ' ' ALA . 68.8 mt -110.66 130.3 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.824 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' A' ' 18' ' ' GLN . 22.9 m -84.16 -18.78 35.57 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.019 -0.992 . . . . 0.0 111.877 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.492 ' CB ' HH21 ' A' ' 66' ' ' ARG . 1.1 mmt-85 -148.24 92.85 2.08 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.526 -0.869 . . . . 0.0 110.749 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.449 ' O ' ' N ' ' A' ' 16' ' ' GLY . 86.6 t -76.36 117.95 21.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.108 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' C ' HD22 ' A' ' 15' ' ' LEU . 1.5 mp0 -116.7 -179.55 3.72 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.963 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.5 -22.98 23.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.797 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.439 ' O ' ' HD3' ' A' ' 44' ' ' LYS . 23.1 mt-10 -68.78 -23.83 64.35 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.988 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.493 ' HB3' ' CD2' ' A' ' 109' ' ' LEU . 3.1 m-20 -77.27 -29.65 53.96 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 119.892 -0.723 . . . . 0.0 111.42 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 27.8 mt -51.04 142.38 12.26 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.356 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 128.66 -139.58 11.11 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.407 ' O ' HD12 ' A' ' 42' ' ' LEU . 4.4 mp -124.6 135.15 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 C-N-CA 119.636 -0.826 . . . . 0.0 109.998 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.651 ' CE1' HD13 ' A' ' 42' ' ' LEU . 1.1 m-85 -101.18 141.15 34.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.515 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.423 ' HA ' ' NE2' ' A' ' 6' ' ' GLN . 79.8 m-85 -130.21 175.44 8.92 Favored 'General case' 0 N--CA 1.488 1.425 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.618 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.448 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 25.6 p -156.68 146.41 20.83 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.753 -0.779 . . . . 0.0 110.537 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 97.6 p -149.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.747 -0.781 . . . . 0.0 110.612 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.438 HE22 ' CG ' ' A' ' 4' ' ' MET . 5.3 pm0 -155.18 145.4 21.85 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.427 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 m -107.4 -5.86 17.46 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.448 -0.901 . . . . 0.0 111.213 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.694 HG22 ' CD2' ' A' ' 98' ' ' HIS . 0.6 OUTLIER -69.74 -27.09 64.67 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.807 179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.694 ' CD2' HG22 ' A' ' 97' ' ' THR . 43.4 m-70 -102.62 145.32 29.82 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.015 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.516 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 4.8 t -132.55 129.47 21.41 Favored Pre-proline 0 N--CA 1.487 1.41 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.233 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.8 Cg_endo -67.24 148.48 79.95 Favored 'Cis proline' 0 C--N 1.318 -1.056 0 C-N-CA 123.513 -1.453 . . . . 0.0 111.795 -0.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.88 123.84 12.23 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.969 1.779 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -89.48 125.46 35.19 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.236 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.435 ' CD1' ' C ' ' A' ' 103' ' ' PHE . 6.5 t80 -125.98 136.41 52.97 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.04 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -174.49 -164.67 29.77 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.464 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.24 -172.88 15.37 Favored Glycine 0 N--CA 1.493 2.478 0 C-N-CA 119.626 -1.273 . . . . 0.0 110.734 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 163.24 58.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.206 -1.473 . . . . 0.0 111.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.755 HG21 HG23 ' A' ' 21' ' ' ILE . 82.1 m -80.67 110.12 15.85 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.376 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.6 mttt -64.96 103.11 0.68 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.487 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.493 ' CD2' ' HB3' ' A' ' 87' ' ' ASP . 0.2 OUTLIER -98.45 83.56 3.05 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.71 -0.796 . . . . 0.0 110.119 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -107.61 148.87 28.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.607 -0.837 . . . . 0.0 110.712 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.6 HD11 ' HG ' ' A' ' 15' ' ' LEU . 1.9 tt -52.37 168.11 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.43 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 13' ' ' VAL . 3.2 ttmm -50.94 -56.37 12.68 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.429 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 116.311 -1.804 . . . . 0.0 111.114 -180.0 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-O 121.051 0.453 . . . . 0.0 110.273 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 98' ' ' HIS . 46.6 t -66.79 124.01 21.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.055 -1.058 . . . . 0.0 111.212 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 t -84.86 146.47 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.449 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.559 ' SD ' ' HG2' ' A' ' 95' ' ' GLN . 9.9 mtp -119.07 98.47 6.19 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.661 -0.816 . . . . 0.0 110.74 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.2 m -83.39 106.74 15.4 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.646 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.521 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -81.16 139.06 35.8 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.828 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.16 157.23 21.99 Favored Pre-proline 0 N--CA 1.492 1.651 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.999 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.7 ' O ' HG23 ' A' ' 107' ' ' THR . 7.4 Cg_endo -75.59 177.0 41.17 Favored 'Cis proline' 0 C--N 1.313 -1.318 0 C-N-CA 123.387 -1.505 . . . . 0.0 110.711 -0.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.04 -25.42 58.69 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.302 -0.959 . . . . 0.0 110.629 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.7 m -137.81 143.4 41.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.804 -0.758 . . . . 0.0 110.831 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 2.6 tp -138.81 73.53 39.92 Favored Pre-proline 0 N--CA 1.489 1.505 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.024 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -67.94 106.87 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 121.968 1.779 . . . . 0.0 111.317 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 83' ' ' VAL . 11.6 m -138.31 153.04 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.043 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER -82.86 147.01 28.58 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.56 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD22 ' C ' ' A' ' 84' ' ' GLU . 82.1 mt -63.61 85.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 14' ' ' SER . . . 159.49 -32.15 0.44 Allowed Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -73.47 171.01 13.95 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.654 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -91.59 137.76 32.1 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.547 -0.861 . . . . 0.0 110.729 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -122.61 136.96 55.02 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.331 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.7 m -130.02 104.3 7.27 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.96 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG23 HG21 ' A' ' 107' ' ' THR . 3.0 mt -92.4 135.41 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.838 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 69.1 m -98.39 166.85 11.18 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.807 -0.757 . . . . 0.0 112.803 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 19.2 m -160.66 119.17 2.56 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.697 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' A' ' 4' ' ' MET . 8.5 mtt85 -102.16 147.88 26.09 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.595 -0.842 . . . . 0.0 111.758 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' C ' ' A' ' 26' ' ' SER . 54.0 m -121.02 120.81 36.46 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.618 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.462 ' C ' ' O ' ' A' ' 25' ' ' SER . 23.2 m -25.33 -77.15 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -113.13 46.63 1.21 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.721 -0.791 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.669 ' N ' HG22 ' A' ' 74' ' ' THR . 23.9 t 63.76 166.64 0.14 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.347 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.618 HD12 ' CE2' ' A' ' 76' ' ' PHE . 23.2 mt -113.12 39.18 2.63 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.808 -0.757 . . . . 0.0 110.255 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.7 t -91.95 115.69 31.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.48 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' ND1' ' N ' ' A' ' 32' ' ' SER . 58.8 t-80 -69.69 173.34 6.26 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.869 -0.732 . . . . 0.0 110.663 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.472 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 75.0 m -69.93 73.87 0.44 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.859 -0.736 . . . . 0.0 110.954 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 p30 176.64 -27.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.421 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.5 23.57 5.94 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.873 -1.156 . . . . 0.0 110.574 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -119.82 142.77 48.32 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.873 -0.731 . . . . 0.0 111.118 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 29' ' ' LEU . 21.7 m -113.12 129.38 56.53 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.736 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -115.88 84.61 2.14 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.757 -0.777 . . . . 0.0 111.025 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.56 165.81 12.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.761 -0.776 . . . . 0.0 110.981 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.713 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -149.49 85.89 1.45 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.271 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.669 ' CE3' HD12 ' A' ' 78' ' ' LEU . 34.7 m95 -59.16 156.83 11.45 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 118.94 -1.104 . . . . 0.0 109.974 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' HB3' ' HB2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -149.42 163.68 37.09 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.07 -1.052 . . . . 0.0 112.1 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD13 ' CE1' ' A' ' 91' ' ' TYR . 6.6 tp -157.93 141.49 15.46 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.414 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.463 ' H ' HD12 ' A' ' 42' ' ' LEU . 6.8 tp-100 -149.26 145.12 26.92 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.978 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' HB3' ' HB2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -97.6 -167.31 1.51 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.427 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.83 77.78 2.11 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.765 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 74.68 59.56 3.73 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.605 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -134.18 -163.99 1.44 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.699 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.23 124.03 74.49 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.602 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -61.56 155.98 49.91 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.849 1.699 . . . . 0.0 111.703 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -138.08 128.44 26.2 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.769 -0.773 . . . . 0.0 111.232 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 40' ' ' TRP . 12.8 tp -101.57 131.96 47.48 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 120.208 -0.597 . . . . 0.0 109.794 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.665 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.5 mm? -98.56 -92.53 0.26 Allowed 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.508 -0.877 . . . . 0.0 108.813 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.725 ' N ' HD12 ' A' ' 53' ' ' ILE . 1.8 mp -83.88 149.0 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.681 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -128.28 30.86 5.13 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.709 -0.797 . . . . 0.0 111.146 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.643 ' H ' HG22 ' A' ' 53' ' ' ILE . 0.1 OUTLIER -164.84 -58.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.592 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.424 HG13 ' N ' ' A' ' 57' ' ' SER . 11.0 p -170.88 -34.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.454 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.424 ' N ' HG13 ' A' ' 56' ' ' VAL . 86.6 p -148.6 -34.69 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.844 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 53' ' ' ILE . 58.6 m-20 -52.59 147.37 8.57 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.817 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.516 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 48.1 mtm180 -103.22 134.35 46.77 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.468 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -67.59 163.53 21.07 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.579 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -60.29 123.12 16.29 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.724 -0.79 . . . . 0.0 111.099 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.1 -31.07 6.21 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.794 -1.193 . . . . 0.0 110.409 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.469 ' C ' ' H ' ' A' ' 65' ' ' ASP . 39.1 t -59.2 124.21 73.49 Favored Pre-proline 0 N--CA 1.489 1.5 0 C-N-CA 119.576 -0.85 . . . . 0.0 110.41 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' C ' ' H ' ' A' ' 66' ' ' ARG . 2.2 Cg_endo -65.05 20.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 122.403 2.069 . . . . 0.0 113.828 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.516 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 0.4 OUTLIER 69.84 -28.25 0.17 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 120.292 -0.563 . . . . 0.0 111.96 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' H ' ' C ' ' A' ' 64' ' ' PRO . 53.3 mtt180 -56.8 -21.78 31.29 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.399 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' HB2' ' CG1' ' A' ' 63' ' ' VAL . 55.5 m-85 -89.2 133.2 34.52 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.345 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -138.92 133.8 32.36 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.158 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 53' ' ' ILE . . . -116.51 154.03 17.06 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.646 -1.264 . . . . 0.0 110.479 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.6 p -165.98 -179.11 5.02 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.144 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . 137.09 172.35 12.5 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.241 -1.457 . . . . 0.0 111.229 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 28.9 t -93.96 -105.82 0.13 Allowed 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.659 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -118.57 -60.78 0.28 Allowed Glycine 0 N--CA 1.493 2.449 0 C-N-CA 120.016 -1.087 . . . . 0.0 110.442 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.669 HG22 ' N ' ' A' ' 28' ' ' SER . 24.4 p -91.31 19.31 6.11 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.943 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -151.1 136.59 17.81 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.07 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.618 ' CE2' HD12 ' A' ' 29' ' ' LEU . 94.5 m-85 -143.97 166.1 25.91 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 84.1 m -153.74 154.98 35.05 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.729 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.669 HD12 ' CE3' ' A' ' 40' ' ' TRP . 3.4 tt -128.55 97.27 4.65 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.639 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' HG2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER -89.12 137.91 31.89 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.052 -179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 82' ' ' ARG . 74.5 mt -117.36 129.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.716 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 20.5 m -58.47 -37.99 76.65 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 118.929 -1.108 . . . . 0.0 111.339 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.417 ' H ' HG22 ' A' ' 80' ' ' ILE . 5.9 ptm180 -158.78 134.59 8.86 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.558 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 13' ' ' VAL . 42.6 t -86.34 141.66 14.12 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.748 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' C ' HD22 ' A' ' 15' ' ' LEU . 3.3 mt-10 -122.83 167.54 13.39 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.206 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -50.86 -40.61 56.68 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.48 -0.888 . . . . 0.0 110.943 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -65.18 -38.69 91.28 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.876 -0.73 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.402 ' HB2' ' H ' ' A' ' 84' ' ' GLU . 3.6 t70 -56.37 -31.77 64.11 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD22 ' N ' ' A' ' 111' ' ' ILE . 65.6 mt -55.36 149.37 13.22 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.888 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.23 -141.43 12.67 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.169 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 11.5 mm -118.62 137.51 52.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.707 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 42' ' ' LEU . 2.6 m-85 -104.03 157.92 16.77 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 119.197 -1.001 . . . . 0.0 111.429 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 41' ' ' TYR . 21.1 m-85 -150.38 168.18 24.87 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 2.4 p -146.56 115.99 7.09 Favored 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.938 -0.705 . . . . 0.0 109.663 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.2 t -102.45 -176.93 3.25 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.341 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.559 ' HG2' ' SD ' ' A' ' 4' ' ' MET . 0.0 OUTLIER -162.5 135.04 5.66 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.49 -179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.7 t -108.62 14.31 24.6 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.399 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.452 HG21 ' C ' ' A' ' 29' ' ' LEU . 7.7 m -68.08 -52.71 31.98 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.332 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.476 ' CD2' HG21 ' A' ' 2' ' ' VAL . 32.4 m-70 -102.4 164.69 11.53 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.755 -0.778 . . . . 0.0 111.807 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.467 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 1.4 t -129.03 141.61 42.34 Favored Pre-proline 0 N--CA 1.49 1.532 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.134 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.2 Cg_endo -72.54 166.44 80.51 Favored 'Cis proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.571 -1.429 . . . . 0.0 111.743 -0.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -63.58 147.5 92.92 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 121.974 1.783 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.6 p -84.07 -78.28 0.24 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.411 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 63.39 107.53 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 120.242 -0.583 . . . . 0.0 110.625 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 170.08 -149.19 12.58 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.261 -1.447 . . . . 0.0 110.913 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.23 -172.07 41.15 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 170.48 88.85 0.07 OUTLIER Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.556 -1.783 . . . . 0.0 112.158 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 8' ' ' PRO . 22.0 m -100.17 118.25 36.1 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 119.586 -0.846 . . . . 0.0 108.889 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -70.96 126.77 30.48 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.752 -0.779 . . . . 0.0 112.384 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 88' ' ' LEU . 1.4 tt -137.72 79.52 1.75 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.565 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -114.01 60.17 0.67 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.06 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.634 HG23 ' N ' ' A' ' 112' ' ' LYS . 0.2 OUTLIER 60.62 174.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.926 -0.71 . . . . 0.0 111.879 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.634 ' N ' HG23 ' A' ' 111' ' ' ILE . 24.6 tttt -88.34 145.36 25.87 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.993 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 10.4 mtt85 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 116.346 -1.788 . . . . 0.0 110.514 179.978 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 121.138 0.495 . . . . 0.0 109.849 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' CD2' ' A' ' 98' ' ' HIS . 39.2 t -137.33 143.57 34.02 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.273 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 4' ' ' MET . 47.9 t -81.68 156.25 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.027 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.428 ' CE ' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -136.41 105.87 6.1 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.271 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.3 m -81.59 96.38 7.45 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.565 -0.854 . . . . 0.0 109.741 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.627 ' HG2' ' SG ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -78.98 134.08 36.82 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.581 -0.848 . . . . 0.0 112.11 -179.837 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -161.95 158.24 21.17 Favored Pre-proline 0 N--CA 1.491 1.581 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.391 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -75.99 177.97 37.05 Favored 'Cis proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.603 -1.416 . . . . 0.0 111.248 -1.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -77.57 -27.06 51.33 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.879 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 m -143.21 149.4 37.92 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.939 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 19' ' ' ALA . 8.3 tp -140.71 88.92 10.46 Favored Pre-proline 0 N--CA 1.49 1.542 0 C-N-CA 119.118 -1.033 . . . . 0.0 111.717 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -69.3 117.79 5.27 Favored 'Trans proline' 0 C--N 1.315 -1.205 0 C-N-CA 121.918 1.745 . . . . 0.0 110.872 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.6 m -142.34 -164.11 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.163 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.6 t -118.22 169.37 9.76 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.34 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -84.39 89.7 7.44 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.912 -1.115 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 142.85 -25.58 2.25 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.006 -1.092 . . . . 0.0 110.708 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -65.92 -161.3 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.011 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 81' ' ' SER . 2.0 pm0 -134.84 136.34 42.4 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.266 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 11' ' ' LEU . . . -103.23 178.29 4.6 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 115.551 -0.749 . . . . 0.0 112.478 -179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.1 m -155.9 73.54 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.003 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.466 HG23 HG21 ' A' ' 107' ' ' THR . 2.6 mp -62.54 128.49 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.217 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 7' ' ' THR . 21.8 t -93.26 155.29 17.52 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.881 -0.727 . . . . 0.0 112.304 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 81.5 m -160.86 109.65 1.62 Allowed 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.09 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 -108.82 150.34 27.77 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.281 -0.968 . . . . 0.0 111.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.9 t -104.17 152.36 22.23 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.483 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.8 m -80.34 -22.89 40.99 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -139.81 34.81 1.98 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.852 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.429 ' N ' HG22 ' A' ' 74' ' ' THR . 24.2 t 58.62 -173.69 0.09 Allowed 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.903 -0.719 . . . . 0.0 111.106 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.615 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 12.4 mt -139.93 13.89 2.47 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.079 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 72.5 t -74.91 135.29 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.91 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.412 ' CG ' ' H ' ' A' ' 32' ' ' SER . 17.8 t-80 -79.73 -176.55 5.44 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.009 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.412 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 72.0 p -54.92 -39.46 68.84 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.85 -0.74 . . . . 0.0 111.134 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -102.51 -170.6 1.83 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.83 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -75.32 72.56 1.66 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.769 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -141.57 123.21 15.13 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.945 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.6 m -116.96 100.27 7.64 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.307 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -88.21 149.88 23.61 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.277 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -168.16 157.57 9.54 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.045 -0.662 . . . . 0.0 110.478 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.578 ' H ' HD23 ' A' ' 38' ' ' LEU . 7.8 p-10 -159.96 113.57 2.2 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.16 -1.016 . . . . 0.0 111.396 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.952 ' CD2' HD13 ' A' ' 78' ' ' LEU . 55.9 m95 -90.76 169.71 10.73 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.21 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -158.08 133.52 8.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.797 -0.761 . . . . 0.0 110.54 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.646 HD13 ' CZ ' ' A' ' 91' ' ' TYR . 14.2 tp -107.52 130.51 54.85 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.459 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 42' ' ' LEU . 38.1 tt0 -95.22 125.03 39.58 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.781 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.549 ' NZ ' HD21 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -128.58 -166.85 1.69 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.895 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' H ' ' CG ' ' A' ' 44' ' ' LYS . . . -76.69 -36.73 57.08 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.34 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -143.73 39.73 1.26 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -132.65 -3.91 3.29 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.884 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.508 ' CB ' ' HD3' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -42.16 -56.63 5.13 Favored Pre-proline 0 N--CA 1.491 1.608 0 C-N-CA 119.856 -0.737 . . . . 0.0 111.336 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.508 ' HD3' ' CB ' ' A' ' 48' ' ' SER . 3.8 Cg_endo -67.02 79.67 0.38 Allowed 'Trans proline' 0 C--N 1.32 -0.957 0 C-N-CA 121.444 1.429 . . . . 0.0 110.234 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.497 ' CG ' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -162.77 -154.92 0.32 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.656 -0.817 . . . . 0.0 111.0 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 54' ' ' TYR . 19.8 tp -171.74 139.57 1.21 Allowed 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.064 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.503 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.96 -63.86 1.11 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.479 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 58' ' ' ASN . 43.3 mm -121.52 139.85 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.087 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.731 ' HB3' HD21 ' A' ' 51' ' ' LEU . 50.0 p90 -122.83 30.81 6.27 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.459 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' H ' HG22 ' A' ' 53' ' ' ILE . 1.8 mmtp -174.29 -166.59 0.28 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.422 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.419 ' H ' ' HD2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -82.99 22.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 C-N-CA 118.443 -1.303 . . . . 0.0 111.122 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 175.13 -44.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.041 -1.064 . . . . 0.0 111.647 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.579 ' O ' HG23 ' A' ' 53' ' ' ILE . 1.4 m-80 -46.21 140.44 3.98 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.943 -0.703 . . . . 0.0 111.977 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 5.2 mtm180 -110.29 134.04 52.65 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.976 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' CD1' HD23 ' A' ' 51' ' ' LEU . 65.7 t80 -57.38 162.39 2.84 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.72 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.468 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.1 m -68.43 92.26 0.43 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.723 -0.791 . . . . 0.0 110.835 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.32 32.17 0.45 Allowed Glycine 0 N--CA 1.495 2.607 0 C-N-CA 119.698 -1.239 . . . . 0.0 110.617 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' C ' ' H ' ' A' ' 65' ' ' ASP . 38.8 t -113.67 132.67 22.46 Favored Pre-proline 0 N--CA 1.49 1.547 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.014 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -63.82 13.47 0.08 OUTLIER 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.959 1.773 . . . . 0.0 113.12 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 63' ' ' VAL . 1.1 t70 71.46 -41.78 0.51 Allowed 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -46.36 -26.86 0.9 Allowed 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 120.033 -0.667 . . . . 0.0 112.085 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' CD1' HG12 ' A' ' 80' ' ' ILE . 83.1 m-85 -80.82 123.64 28.41 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.721 -0.791 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.4 m -138.27 101.05 4.29 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.545 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' CA ' HD12 ' A' ' 78' ' ' LEU . . . -92.99 120.01 6.07 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.8 p -151.45 154.52 36.75 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.411 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.56 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -165.84 163.74 36.93 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.918 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 47.1 t -92.94 -115.35 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.719 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.1 -78.28 0.64 Allowed Glycine 0 N--CA 1.495 2.601 0 C-N-CA 120.093 -1.051 . . . . 0.0 111.586 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 28' ' ' SER . 53.0 p -111.37 18.26 19.38 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.349 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -123.42 131.74 53.74 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.896 -0.722 . . . . 0.0 110.717 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 54.3 m-85 -142.51 153.96 44.07 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 119.916 -0.713 . . . . 0.0 110.522 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 21' ' ' ILE . 3.5 m -151.75 145.65 25.16 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.952 HD13 ' CD2' ' A' ' 40' ' ' TRP . 9.7 tp -104.45 93.61 4.88 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -81.17 118.45 22.57 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.094 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.761 HG21 ' OD2' ' A' ' 87' ' ' ASP . 23.0 mt -114.61 103.46 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.627 ' HA ' ' CB ' ' A' ' 18' ' ' GLN . 1.4 m -74.95 39.45 0.14 Allowed 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.046 -1.062 . . . . 0.0 113.524 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 81' ' ' SER . 1.1 mmt85 169.63 97.64 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.696 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.508 HG13 ' HB3' ' A' ' 87' ' ' ASP . 88.4 t -93.49 99.37 9.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.12 -177.01 3.28 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.508 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -55.32 -26.89 43.44 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.821 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -71.83 -36.21 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.964 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.761 ' OD2' HG21 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -62.9 -43.39 98.92 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.91 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.773 HD21 ' CD1' ' A' ' 111' ' ' ILE . 89.3 mt -43.62 148.08 0.38 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.715 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 129.87 -155.02 20.75 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.7 mm -108.61 142.76 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.315 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.646 ' CZ ' HD13 ' A' ' 42' ' ' LEU . 14.0 m-85 -115.22 144.72 43.28 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.15 -1.02 . . . . 0.0 111.906 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -133.59 155.79 49.01 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 115.287 -0.869 . . . . 0.0 110.123 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.494 ' SG ' ' HG2' ' A' ' 6' ' ' GLN . 1.8 p -136.52 102.21 4.87 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.211 -0.996 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.06 158.89 15.35 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.696 179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.485 ' NE2' ' HB ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -110.65 127.9 55.47 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.604 -179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 96' ' ' THR . 17.9 m -83.61 -5.57 59.21 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.004 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 29' ' ' LEU . 53.3 m -62.63 -62.46 1.72 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.29 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.531 ' CD2' ' CG2' ' A' ' 2' ' ' VAL . 66.7 m-70 -89.12 114.78 26.08 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.6 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.43 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 21.8 t -104.59 134.37 19.7 Favored Pre-proline 0 N--CA 1.489 1.489 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.832 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.43 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.4 Cg_endo -72.16 156.98 97.91 Favored 'Cis proline' 0 C--N 1.317 -1.11 0 C-N-CA 123.591 -1.421 . . . . 0.0 111.523 -0.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.38 139.91 85.14 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.034 1.823 . . . . 0.0 110.997 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.28 -43.93 60.13 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.315 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 5.4 t80 68.35 161.63 0.19 Allowed 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.581 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.78 130.87 2.92 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.378 -1.391 . . . . 0.0 110.743 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 145.93 173.78 17.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.086 -1.205 . . . . 0.0 110.086 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.441 ' N ' ' OE1' ' A' ' 6' ' ' GLN . . . 178.86 67.15 0.07 OUTLIER Glycine 0 N--CA 1.49 2.247 0 C-N-CA 119.395 -1.383 . . . . 0.0 110.873 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.466 HG21 HG23 ' A' ' 21' ' ' ILE . 44.8 m -77.1 113.81 15.23 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.232 -0.987 . . . . 0.0 109.888 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -73.84 107.25 5.96 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 119.675 -0.81 . . . . 0.0 111.391 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -100.67 94.85 6.31 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.863 -0.735 . . . . 0.0 109.704 179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -127.32 136.67 52.26 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.626 -0.83 . . . . 0.0 111.14 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.773 ' CD1' HD21 ' A' ' 88' ' ' LEU . 0.5 OUTLIER -69.2 163.64 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 C-N-CA 119.571 -0.852 . . . . 0.0 110.059 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -69.94 155.37 40.67 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.349 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 3.2 mmm180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 116.38 -1.772 . . . . 0.0 110.624 179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.123 0.487 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.525 ' O ' HG21 ' A' ' 102' ' ' THR . 25.2 t -65.66 102.12 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.216 -0.993 . . . . 0.0 110.797 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 4' ' ' MET . 15.6 t -69.5 162.97 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.761 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 25' ' ' SER . 48.6 mmm -126.85 175.51 7.98 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -150.72 93.56 1.97 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.204 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.625 ' NE2' ' SG ' ' A' ' 23' ' ' CYS . 5.7 tp60 -82.5 148.3 28.19 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.784 -0.766 . . . . 0.0 112.232 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 6' ' ' GLN . 0.7 OUTLIER -161.18 165.14 17.49 Favored Pre-proline 0 N--CA 1.488 1.438 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.908 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' THR . 9.1 Cg_endo -76.76 173.97 55.43 Favored 'Cis proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.482 -1.466 . . . . 0.0 110.563 -1.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 mp -66.96 -28.59 68.4 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.592 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -140.97 130.43 23.85 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.497 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.0 tp -125.92 94.16 42.44 Favored Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.699 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo -69.86 121.1 7.77 Favored 'Trans proline' 0 C--N 1.315 -1.19 0 C-N-CA 121.8 1.666 . . . . 0.0 110.537 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 83' ' ' VAL . 24.9 m -134.43 -165.89 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.442 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 2.4 t -146.53 160.48 42.08 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.324 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -74.69 85.69 2.14 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' ' CD ' ' A' ' 82' ' ' ARG . . . 140.43 -22.62 2.71 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 18' ' ' GLN . 31.9 t70 -76.48 177.87 7.06 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.477 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.416 ' H ' ' CG ' ' A' ' 17' ' ' ASP . 54.5 mt-30 -94.63 -173.76 3.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.758 -0.777 . . . . 0.0 110.737 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.445 ' HB3' ' HB ' ' A' ' 80' ' ' ILE . . . -153.73 157.69 39.86 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.544 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 44.9 p -151.52 79.94 1.29 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.617 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.002 HG23 HG21 ' A' ' 107' ' ' THR . 8.8 mt -81.27 117.75 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.906 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 7' ' ' THR . 39.4 t -85.4 155.53 21.24 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.754 -0.778 . . . . 0.0 111.958 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.625 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -162.13 124.38 2.84 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.605 179.873 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.17 155.99 28.42 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.306 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.46 ' HB2' ' SD ' ' A' ' 4' ' ' MET . 3.8 t -112.96 154.23 26.76 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.385 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 96.8 p -74.37 -31.73 62.49 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.683 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.471 ' H ' HG13 ' A' ' 2' ' ' VAL . 4.9 tt0 -136.54 150.56 48.69 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.689 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.6 p -50.75 128.13 19.99 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.66 ' C ' HG21 ' A' ' 97' ' ' THR . 85.8 mt -80.52 27.88 0.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.89 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.5 t -88.81 133.89 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.393 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.464 ' CG ' ' H ' ' A' ' 32' ' ' SER . 6.2 t-80 -82.05 -170.15 2.73 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.614 -0.835 . . . . 0.0 111.41 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.464 ' H ' ' CG ' ' A' ' 31' ' ' HIS . 4.5 p -79.8 18.82 0.73 Allowed 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.997 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.76 -171.47 3.91 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.492 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.6 52.72 4.18 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.638 -1.268 . . . . 0.0 110.689 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -143.96 145.18 32.07 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.783 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 29' ' ' LEU . 84.1 m -141.01 137.21 32.81 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.46 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -112.37 132.72 54.86 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.366 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.543 HD11 ' CG ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -155.24 125.85 6.91 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.957 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' N ' HD22 ' A' ' 38' ' ' LEU . 34.6 p30 -133.24 169.65 16.58 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.501 -1.279 . . . . 0.0 112.256 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 78' ' ' LEU . 36.5 m95 -125.03 150.56 46.63 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.252 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' CD2' ' HB2' ' A' ' 49' ' ' PRO . 0.4 OUTLIER -138.11 147.59 44.13 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.619 -0.832 . . . . 0.0 111.906 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.9 tp -135.62 125.53 25.78 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -116.52 152.75 33.46 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.107 -1.037 . . . . 0.0 112.103 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.444 ' CE ' ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -98.95 -164.6 1.15 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.042 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.48 82.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.33 42.4 96.12 Favored Glycine 0 N--CA 1.495 2.604 0 C-N-CA 119.752 -1.214 . . . . 0.0 110.597 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -124.47 166.33 16.21 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.11 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.3 p -58.86 118.78 31.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 119.759 -0.777 . . . . 0.0 110.434 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.431 ' HB2' ' CD2' ' A' ' 41' ' ' TYR . 1.9 Cg_endo -63.09 148.58 93.17 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.838 1.692 . . . . 0.0 112.114 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.8 mttt -104.07 155.22 18.86 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.899 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.8 tp -103.2 135.27 45.16 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.924 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 14.1 mt -113.34 -71.56 0.75 Allowed 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.261 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 59' ' ' ARG . 31.6 mm -109.46 150.34 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.87 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.413 ' HA ' ' CB ' ' A' ' 39' ' ' ASN . 47.7 p90 -149.19 25.36 0.9 Allowed 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.559 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.522 ' N ' HD22 ' A' ' 58' ' ' ASN . 0.0 OUTLIER -174.41 61.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.832 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 56' ' ' VAL . 14.6 m 30.44 97.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 CA-C-N 115.033 -0.985 . . . . 0.0 113.09 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER 72.05 46.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.859 179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.522 HD22 ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -148.96 108.97 4.08 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 65' ' ' ASP . 41.7 mtm180 -79.83 153.0 29.4 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.84 -0.744 . . . . 0.0 112.906 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.443 ' CG ' ' N ' ' A' ' 61' ' ' SER . 59.9 t80 -91.14 171.78 9.01 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.546 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.443 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 13.0 t -59.9 123.0 15.68 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.218 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.72 -9.05 66.22 Favored Glycine 0 N--CA 1.497 2.745 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.039 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 59' ' ' ARG . 90.0 t -84.46 123.93 74.14 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 119.618 -0.833 . . . . 0.0 110.535 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' HB2' ' HG2' ' A' ' 66' ' ' ARG . 4.4 Cg_exo -55.83 138.95 83.29 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 C-N-CA 122.1 1.867 . . . . 0.0 112.02 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 59' ' ' ARG . 6.1 m-20 -56.29 -18.55 10.94 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.615 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -77.61 27.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 118.799 -1.16 . . . . 0.0 111.606 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.576 ' CE2' HD21 ' A' ' 78' ' ' LEU . 4.8 m-85 -128.17 129.03 45.87 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.632 -0.827 . . . . 0.0 111.012 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.4 104.01 3.48 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.641 -0.823 . . . . 0.0 110.451 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' VAL . . . -110.65 108.15 2.37 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.717 -1.23 . . . . 0.0 110.318 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.5 p -143.0 163.37 32.97 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.686 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 76' ' ' PHE . . . -169.9 172.34 43.73 Favored Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.133 -1.508 . . . . 0.0 111.53 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.45 -151.23 0.1 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.632 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -45.91 -48.81 13.75 Favored Glycine 0 N--CA 1.496 2.698 0 C-N-CA 119.96 -1.114 . . . . 0.0 111.194 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 22.1 p -146.51 35.14 0.96 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.815 -0.754 . . . . 0.0 111.136 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.444 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -135.64 90.62 2.62 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.697 -0.801 . . . . 0.0 111.158 -179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.543 ' CG ' HD11 ' A' ' 38' ' ' LEU . 0.1 OUTLIER -119.62 155.41 32.35 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.08 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.3 m -146.98 141.03 26.02 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.539 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.576 HD21 ' CE2' ' A' ' 67' ' ' PHE . 5.5 tt -94.02 110.33 22.03 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.591 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.04 131.39 46.95 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.018 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 ' H ' ' A' ' 82' ' ' ARG . 57.3 mt -117.99 131.58 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.2 m -90.64 -0.5 57.71 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.72 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.779 ' H ' HG22 ' A' ' 80' ' ' ILE . 1.5 tpt180 -169.05 97.32 0.36 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 120.103 -0.639 . . . . 0.0 109.782 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.458 HG11 HG21 ' A' ' 13' ' ' VAL . 99.0 t -74.88 136.66 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.999 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -111.89 163.8 13.81 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.812 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.03 -25.63 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.92 -0.712 . . . . 0.0 111.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -72.28 -27.11 62.27 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.658 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -30.91 71.96 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.474 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.551 HD21 HD12 ' A' ' 111' ' ' ILE . 85.9 mt -42.94 134.87 3.24 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.738 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.23 -154.62 25.82 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 13.3 mm -103.62 131.84 51.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.582 -0.847 . . . . 0.0 110.189 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -101.09 154.95 18.29 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.175 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.505 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 38.1 m-85 -147.45 176.88 9.68 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.082 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -160.71 127.68 4.22 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.401 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.448 ' CB ' ' HA ' ' A' ' 103' ' ' PHE . 4.8 p -118.74 -170.24 1.87 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.324 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.44 ' HB2' HD22 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -158.04 127.39 5.81 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.154 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 6.3 m -107.12 57.73 0.63 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.168 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.66 HG21 ' C ' ' A' ' 29' ' ' LEU . 54.6 m -108.93 -50.3 3.03 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.868 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.493 ' CD2' HG21 ' A' ' 2' ' ' VAL . 19.8 m-70 -87.87 -40.01 14.34 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.534 -0.866 . . . . 0.0 111.28 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.597 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 0.8 OUTLIER 64.94 141.06 0.06 OUTLIER Pre-proline 0 N--CA 1.491 1.598 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.315 -179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.597 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 1.0 OUTLIER -67.78 158.04 84.95 Favored 'Cis proline' 0 C--N 1.319 -1.024 0 C-N-CA 123.55 -1.437 . . . . 0.0 111.362 -0.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.67 114.59 2.8 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.938 1.758 . . . . 0.0 111.532 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.525 HG21 ' O ' ' A' ' 2' ' ' VAL . 14.2 p -52.95 -55.19 25.26 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.933 -0.707 . . . . 0.0 111.09 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 0.6 OUTLIER 61.95 116.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.158 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.57 100.09 0.61 Allowed Glycine 0 N--CA 1.493 2.45 0 C-N-CA 119.231 -1.461 . . . . 0.0 111.547 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.505 ' H ' ' HB3' ' A' ' 92' ' ' PHE . . . -100.62 -90.36 2.07 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.61 93.5 1.35 Allowed Glycine 0 N--CA 1.493 2.496 0 C-N-CA 119.307 -1.425 . . . . 0.0 112.798 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.002 HG21 HG23 ' A' ' 21' ' ' ILE . 2.3 m -158.49 109.17 2.11 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.251 -0.58 . . . . 0.0 109.556 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.71 105.39 5.0 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.085 -1.046 . . . . 0.0 111.202 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.64 94.01 7.48 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.737 -0.785 . . . . 0.0 110.129 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.47 144.06 50.3 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.675 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.551 HD12 HD21 ' A' ' 88' ' ' LEU . 4.8 mt -76.81 156.6 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.811 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' N ' ' CG2' ' A' ' 111' ' ' ILE . 11.9 mttm -73.11 115.72 12.78 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.694 -0.802 . . . . 0.0 111.213 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 116.327 -1.797 . . . . 0.0 110.771 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 121.05 0.452 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.691 ' O ' HG21 ' A' ' 102' ' ' THR . 62.9 t -106.5 111.81 36.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 118.944 -1.102 . . . . 0.0 111.097 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 96.0 t -66.25 124.99 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.195 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.476 ' SD ' ' HB3' ' A' ' 25' ' ' SER . 81.9 mmm -120.68 102.38 8.36 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.935 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.6 m -96.1 156.7 16.22 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.311 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.592 HE21 ' H ' ' A' ' 106' ' ' GLY . 5.9 tt0 -130.39 151.48 50.83 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.365 -0.934 . . . . 0.0 111.838 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -157.82 156.55 28.58 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.97 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.4 176.83 42.02 Favored 'Cis proline' 0 C--N 1.31 -1.486 0 C-N-CA 123.611 -1.412 . . . . 0.0 111.328 -0.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.3 mp -75.12 -18.27 60.27 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.813 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.0 p -156.02 140.64 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.085 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.7 tp -131.68 91.38 33.98 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 119.585 -0.846 . . . . 0.0 111.731 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -70.47 105.72 1.65 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.97 1.78 . . . . 0.0 111.236 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.748 HG21 HG11 ' A' ' 83' ' ' VAL . 8.6 m -117.71 -154.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.904 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.509 ' HA ' HG23 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -132.44 159.43 39.34 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 120.024 -0.67 . . . . 0.0 110.493 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.93 ' HG ' HD13 ' A' ' 111' ' ' ILE . 19.0 mt -75.34 88.94 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.817 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 129.6 -1.22 5.98 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.5 -177.76 4.19 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.844 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.61 179.39 5.01 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.107 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.529 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -154.44 163.93 39.43 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.226 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 m -155.18 95.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.335 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.705 ' O ' HG23 ' A' ' 77' ' ' THR . 23.2 mt -84.36 165.65 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 119.676 -0.809 . . . . 0.0 109.354 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.464 ' N ' HG22 ' A' ' 21' ' ' ILE . 11.0 m -131.07 154.5 48.19 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.735 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.44 126.51 4.65 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.81 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mtt-85 -120.06 145.99 46.34 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.476 ' HB3' ' SD ' ' A' ' 4' ' ' MET . 85.8 p -107.66 125.17 51.02 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.46 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.8 t -73.82 32.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.587 -0.845 . . . . 0.0 112.242 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.543 ' HB3' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -160.37 -85.85 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.767 179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.755 ' HA ' HG22 ' A' ' 74' ' ' THR . 3.3 t 171.39 146.41 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.894 -0.723 . . . . 0.0 110.753 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.826 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 46.1 mt -109.83 30.01 7.09 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 35' ' ' ASN . 48.5 t -107.29 147.39 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.439 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -104.29 166.34 10.46 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.726 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -47.32 -31.26 3.75 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.589 -0.844 . . . . 0.0 110.844 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -149.27 30.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.111 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.12 -123.92 5.28 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.026 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.625 ' O ' HG22 ' A' ' 30' ' ' VAL . 23.3 m-20 -157.69 -97.76 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.627 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.9 m -149.17 94.85 2.29 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 120.025 -0.67 . . . . 0.0 109.733 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.667 ' HB2' HG23 ' A' ' 97' ' ' THR . 90.3 m-85 -84.44 143.83 29.16 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.007 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.843 HD21 ' HE1' ' A' ' 40' ' ' TRP . 8.7 tp -165.46 146.2 7.06 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.851 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 2.3 m120 -135.38 156.89 48.18 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.104 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.843 ' HE1' HD21 ' A' ' 38' ' ' LEU . 59.5 m95 -137.33 152.66 49.97 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 120.179 -0.609 . . . . 0.0 110.744 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 40' ' ' TRP . 33.4 m-85 -144.56 154.46 42.88 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.949 -0.701 . . . . 0.0 110.851 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 91' ' ' TYR . 10.9 tp -127.42 106.05 8.94 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.87 -0.732 . . . . 0.0 110.019 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -69.68 105.84 2.86 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 120.053 -0.659 . . . . 0.0 112.382 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' HG3' ' H ' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -113.61 -163.67 0.87 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 120.081 -0.647 . . . . 0.0 109.477 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' H ' ' HG3' ' A' ' 44' ' ' LYS . . . -79.06 -121.02 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.386 -0.925 . . . . 0.0 110.165 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -84.03 50.41 4.4 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -89.99 149.83 22.39 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.258 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.54 ' H ' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -91.06 -56.7 0.25 Allowed Pre-proline 0 N--CA 1.489 1.499 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.041 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' A' ' 48' ' ' SER . 3.4 Cg_exo -60.92 145.05 99.62 Favored 'Trans proline' 0 C--N 1.32 -0.948 0 C-N-CA 121.491 1.46 . . . . 0.0 111.309 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.09 57.87 0.16 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.716 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 51' ' ' LEU . 34.8 tp -166.21 96.89 0.6 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.437 -0.905 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.596 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.8 mm? -82.25 -69.35 0.63 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.439 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 53' ' ' ILE . 16.7 mm -108.92 127.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.023 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' CG ' ' A' ' 54' ' ' TYR . 0.9 OUTLIER -134.14 25.89 3.88 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.499 -0.88 . . . . 0.0 110.952 -179.932 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' N ' HD21 ' A' ' 58' ' ' ASN . 4.7 mttt -171.24 27.9 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.891 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' O ' ' N ' ' A' ' 58' ' ' ASN . 95.0 t 63.3 119.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.637 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.1 p 34.36 33.16 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 114.773 -1.103 . . . . 0.0 113.36 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 55' ' ' LYS . 4.3 p30 -107.33 -32.91 7.56 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.974 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.509 ' HD2' ' HA ' ' A' ' 65' ' ' ASP . 1.2 mtm-85 66.52 113.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.553 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CG ' ' N ' ' A' ' 61' ' ' SER . 51.4 t80 -61.61 167.34 3.55 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.719 -0.793 . . . . 0.0 110.483 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.457 ' N ' ' CG ' ' A' ' 60' ' ' PHE . 9.4 t -54.2 -40.58 67.72 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.762 -0.775 . . . . 0.0 111.627 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -88.86 63.91 3.46 Favored Glycine 0 N--CA 1.495 2.625 0 C-N-CA 119.659 -1.258 . . . . 0.0 110.815 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 65' ' ' ASP . 58.8 t -139.61 133.17 15.58 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.704 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.497 ' HG2' ' HE ' ' A' ' 66' ' ' ARG . 2.7 Cg_endo -67.38 14.39 0.14 Allowed 'Trans proline' 0 C--N 1.319 -1.02 0 C-N-CA 122.221 1.947 . . . . 0.0 112.468 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.509 ' HA ' ' HD2' ' A' ' 59' ' ' ARG . 5.1 m-20 65.43 -24.18 0.09 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.59 HH12 ' CD ' ' A' ' 84' ' ' GLU . 0.0 OUTLIER -65.3 -11.62 43.47 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.69 -0.804 . . . . 0.0 112.328 -179.865 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.524 ' HD1' HD21 ' A' ' 78' ' ' LEU . 77.3 m-85 -95.26 132.84 39.81 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.412 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 3.2 m -147.89 85.69 1.56 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.443 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' THR . . . -86.08 107.09 3.13 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.693 -1.242 . . . . 0.0 110.855 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.2 t -76.67 163.03 27.24 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.976 -1.09 . . . . 0.0 109.979 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.687 ' HA2' ' CD1' ' A' ' 76' ' ' PHE . . . -142.06 96.26 0.2 Allowed Glycine 0 N--CA 1.49 2.292 0 C-N-CA 118.787 -1.673 . . . . 0.0 111.65 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -94.36 82.91 4.11 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.502 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.16 -82.13 0.13 Allowed Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.736 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.755 HG22 ' HA ' ' A' ' 28' ' ' SER . 18.6 p -123.31 14.87 9.7 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.657 -0.817 . . . . 0.0 111.791 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -122.95 132.02 53.97 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.821 -0.752 . . . . 0.0 110.26 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.826 ' CZ ' HD12 ' A' ' 29' ' ' LEU . 24.8 m-85 -138.49 143.89 39.77 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.376 -0.93 . . . . 0.0 111.477 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 21' ' ' ILE . 100.0 m -139.98 112.28 7.73 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.54 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.57 ' O ' HD23 ' A' ' 78' ' ' LEU . 10.2 tt -80.68 100.31 8.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.203 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -94.93 134.3 37.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.284 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.529 HD12 ' HB3' ' A' ' 19' ' ' ALA . 7.6 mt -113.07 137.29 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 C-N-CA 119.843 -0.743 . . . . 0.0 110.158 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.403 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 12.0 t -87.01 -44.24 11.73 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 118.681 -1.207 . . . . 0.0 111.947 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 8.4 mmp_? -124.71 102.37 7.56 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.242 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.748 HG11 HG21 ' A' ' 13' ' ' VAL . 69.3 t -89.44 103.6 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.913 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.59 ' CD ' HH12 ' A' ' 66' ' ' ARG . 4.0 mt-10 -102.89 177.21 4.91 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.249 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -54.16 -27.11 31.58 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.484 -0.886 . . . . 0.0 111.096 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -78.96 -40.23 32.34 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.532 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -57.07 -20.23 23.79 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.459 -0.792 . . . . 0.0 111.408 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.688 HD21 ' CD1' ' A' ' 111' ' ' ILE . 97.7 mt -62.68 167.39 4.54 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.756 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 127.01 180.0 16.07 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.715 -1.231 . . . . 0.0 111.267 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 5.1 mm -87.87 115.5 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.449 ' HE1' HD23 ' A' ' 52' ' ' LEU . 0.4 OUTLIER -88.76 143.38 26.95 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.791 -1.164 . . . . 0.0 111.811 -179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.584 ' HA ' HE22 ' A' ' 6' ' ' GLN . 13.6 m-85 -135.48 158.76 43.56 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.158 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 12.1 p -139.51 156.64 46.8 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.807 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.474 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 10.5 t -150.91 -177.05 5.78 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.961 -0.696 . . . . 0.0 110.511 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.546 ' HB2' HD22 ' A' ' 29' ' ' LEU . 1.8 pt20 -129.26 113.8 15.47 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.391 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 37' ' ' TYR . 10.2 t -84.33 34.67 0.52 Allowed 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.802 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.667 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -100.13 -72.27 0.67 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.663 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.402 ' CD2' ' HB ' ' A' ' 97' ' ' THR . 44.2 m-70 -78.24 162.11 26.79 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.424 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 45.7 t -137.88 137.57 21.74 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.767 -0.773 . . . . 0.0 110.586 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.424 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 5.3 Cg_endo -73.46 158.58 98.39 Favored 'Cis proline' 0 C--N 1.318 -1.058 0 C-N-CA 123.568 -1.43 . . . . 0.0 111.472 -1.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.77 151.63 82.9 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 121.966 1.777 . . . . 0.0 111.048 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.691 HG21 ' O ' ' A' ' 2' ' ' VAL . 36.7 p -89.94 -61.62 1.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.39 -0.924 . . . . 0.0 111.048 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.474 ' CD2' ' HB2' ' A' ' 94' ' ' SER . 3.3 t80 72.83 146.85 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.008 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 165.75 170.25 30.43 Favored Glycine 0 N--CA 1.495 2.601 0 C-N-CA 119.467 -1.349 . . . . 0.0 110.915 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.529 ' CA ' ' HB3' ' A' ' 6' ' ' GLN . . . 120.11 -155.38 16.19 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.841 -1.171 . . . . 0.0 111.233 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.592 ' H ' HE21 ' A' ' 6' ' ' GLN . . . 147.69 60.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 21' ' ' ILE . 52.4 m -81.76 108.28 15.17 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.966 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -68.99 89.74 0.43 Allowed 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 119.601 -0.84 . . . . 0.0 109.922 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 2.3 tp -81.15 87.52 6.06 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.521 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.435 ' HA ' HD22 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -121.24 143.25 49.25 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.183 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.93 HD13 ' HG ' ' A' ' 15' ' ' LEU . 8.3 mt -88.34 146.92 5.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.932 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -68.38 103.07 1.54 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.809 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 116.282 -1.818 . . . . 0.0 110.959 179.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 t70 . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.913 HG13 ' H ' ' A' ' 27' ' ' GLN . 39.1 t -62.05 113.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 4' ' ' MET . 6.7 t -74.51 169.93 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.811 -0.756 . . . . 0.0 110.209 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.697 ' SD ' ' HA2' ' A' ' 104' ' ' GLY . 0.3 OUTLIER -132.64 99.21 4.56 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.541 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.2 m -89.57 148.42 23.38 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.635 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.581 ' CB ' ' HA3' ' A' ' 105' ' ' GLY . 0.0 OUTLIER -141.54 153.48 44.89 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 119.379 -0.929 . . . . 0.0 110.824 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.532 ' N ' ' HG2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -160.29 146.27 11.62 Favored Pre-proline 0 N--CA 1.487 1.413 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.726 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HG2' HD12 ' A' ' 11' ' ' LEU . 11.0 Cg_endo -82.12 176.93 35.24 Favored 'Cis proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.806 -1.331 . . . . 0.0 111.342 -0.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.534 HD13 HE22 ' A' ' 6' ' ' GLN . 3.5 mm? -73.08 -27.31 61.65 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.043 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.2 m -137.72 149.62 46.63 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.043 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.879 ' HB3' HD12 ' A' ' 109' ' ' LEU . 3.6 tp -135.43 86.2 30.22 Favored Pre-proline 0 N--CA 1.489 1.482 0 C-N-CA 119.313 -0.955 . . . . 0.0 111.924 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.58 ' CB ' ' HA ' ' A' ' 112' ' ' LYS . 10.2 Cg_endo -72.23 101.77 1.28 Allowed 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 121.657 1.571 . . . . 0.0 110.047 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 112' ' ' LYS . 20.4 m -126.7 -178.46 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.654 -0.818 . . . . 0.0 111.34 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -115.2 174.53 5.94 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.626 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD23 HG12 ' A' ' 83' ' ' VAL . 21.4 mt -90.11 86.98 6.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.583 -0.847 . . . . 0.0 111.118 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 147.37 -25.65 1.54 Allowed Glycine 0 N--CA 1.493 2.479 0 C-N-CA 119.748 -1.215 . . . . 0.0 110.595 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.65 -166.93 0.84 Allowed 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.024 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -114.59 138.38 50.72 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.641 ' HB3' HD12 ' A' ' 80' ' ' ILE . . . -115.53 166.37 11.98 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.843 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.0 p -160.95 100.03 1.24 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.248 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.569 ' O ' HG23 ' A' ' 77' ' ' THR . 69.4 mt -98.94 142.53 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.791 -0.763 . . . . 0.0 109.598 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.7 m -103.34 141.13 36.45 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.981 -0.687 . . . . 0.0 111.802 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 42.0 t -148.99 94.21 2.22 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.564 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' CB ' ' CZ ' ' A' ' 24' ' ' ARG . 0.1 OUTLIER -106.1 163.08 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.753 -0.779 . . . . 0.0 112.186 -179.881 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB2' HD11 ' A' ' 29' ' ' LEU . 0.3 OUTLIER -119.63 166.36 13.28 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.129 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.7 m -64.93 -70.9 0.2 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.917 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.913 ' H ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -87.6 162.13 17.33 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.994 -179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 p -59.09 129.61 42.99 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.897 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 HD12 ' CE1' ' A' ' 76' ' ' PHE . 89.1 mt -85.02 34.73 0.56 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.693 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.9 t -96.96 114.1 33.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.126 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.451 ' ND1' ' N ' ' A' ' 32' ' ' SER . 55.5 t-80 -66.58 170.3 6.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.028 -1.069 . . . . 0.0 110.676 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.451 ' N ' ' ND1' ' A' ' 31' ' ' HIS . 10.5 t -59.88 -17.73 39.2 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.666 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -86.18 -5.75 59.13 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.177 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.94 -18.05 58.08 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 119.775 -1.203 . . . . 0.0 111.622 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -78.78 128.51 33.49 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.358 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.18 126.18 30.41 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.648 -0.821 . . . . 0.0 109.862 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.582 ' HB2' HG23 ' A' ' 97' ' ' THR . 21.5 m-30 -105.5 102.66 12.11 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.964 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.722 HD13 ' CD1' ' A' ' 76' ' ' PHE . 1.4 tt -149.1 126.91 11.8 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.865 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.563 ' ND2' HD13 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -116.21 163.77 15.49 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.39 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.496 ' CE3' HD13 ' A' ' 78' ' ' LEU . 47.1 m95 -123.56 159.02 30.09 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -144.45 148.28 34.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.026 -1.07 . . . . 0.0 112.026 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.4 HD22 ' OH ' ' A' ' 91' ' ' TYR . 24.5 tp -123.14 79.84 1.71 Allowed 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.017 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.57 30.94 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.45 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 47' ' ' GLN . 8.5 ttmt -129.26 170.72 13.24 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.625 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.45 94.61 0.41 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.668 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.73 50.42 64.25 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.367 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -138.9 -174.68 3.91 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 119.674 -0.811 . . . . 0.0 110.589 179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.5 t -91.8 115.24 64.21 Favored Pre-proline 0 N--CA 1.492 1.643 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.958 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.18 140.75 60.41 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.742 1.628 . . . . 0.0 111.16 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -110.97 140.0 45.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.427 -0.909 . . . . 0.0 111.287 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.563 HD13 ' ND2' ' A' ' 39' ' ' ASN . 29.5 tp -101.46 120.36 40.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.092 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.465 HD12 ' HA ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -97.22 -60.46 1.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.678 179.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.0 mm -113.49 131.56 64.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.99 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.459 ' HB3' HD21 ' A' ' 51' ' ' LEU . 52.2 p90 -108.61 -13.78 14.75 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.83 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.553 ' O ' ' N ' ' A' ' 57' ' ' SER . 1.2 mtpm? -153.93 110.13 3.29 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.32 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.596 HG13 ' H ' ' A' ' 57' ' ' SER . 1.2 p 43.56 -73.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.596 ' H ' HG13 ' A' ' 56' ' ' VAL . 16.6 t -136.67 -15.8 1.57 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.55 -1.26 . . . . 0.0 113.789 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.59 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.0 OUTLIER -64.4 114.25 4.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 117.891 -1.524 . . . . 0.0 109.911 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -71.86 143.73 49.31 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.361 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -70.4 175.43 4.74 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.473 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.0 p -61.61 -51.38 68.73 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 119.681 -0.808 . . . . 0.0 111.579 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.54 71.11 2.98 Favored Glycine 0 N--CA 1.494 2.54 0 C-N-CA 119.73 -1.224 . . . . 0.0 110.967 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.561 HG12 ' H ' ' A' ' 65' ' ' ASP . 46.5 t -139.35 125.68 12.36 Favored Pre-proline 0 N--CA 1.491 1.622 0 C-N-CA 119.502 -0.879 . . . . 0.0 110.803 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' C ' ' H ' ' A' ' 66' ' ' ARG . 1.1 Cg_endo -68.04 14.35 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 C-N-CA 122.031 1.821 . . . . 0.0 111.799 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.561 ' H ' HG12 ' A' ' 63' ' ' VAL . 35.9 m-20 60.09 -9.38 0.05 Allowed 'General case' 0 N--CA 1.493 1.711 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.979 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.493 ' H ' ' C ' ' A' ' 64' ' ' PRO . 12.1 mtm-85 -76.96 19.63 0.29 Allowed 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.203 -0.999 . . . . 0.0 110.927 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.459 ' CE2' ' OH ' ' A' ' 91' ' ' TYR . 89.3 m-85 -137.55 135.81 37.05 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 120.17 -0.612 . . . . 0.0 110.624 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.0 m -146.14 96.58 2.81 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.426 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.38 149.71 37.5 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.468 -1.853 . . . . 0.0 108.468 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.1 m -154.1 113.61 3.78 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 118.384 -1.327 . . . . 0.0 111.577 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . -146.58 135.75 5.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 p -88.02 -84.29 0.2 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.101 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.5 -57.17 1.47 Allowed Glycine 0 N--CA 1.492 2.371 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.643 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.463 ' O ' ' NH1' ' A' ' 24' ' ' ARG . 36.9 p -145.85 56.83 1.21 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.817 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.426 ' HA ' ' HB3' ' A' ' 24' ' ' ARG . 10.4 t70 -161.18 73.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.544 -0.862 . . . . 0.0 111.069 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.722 ' CD1' HD13 ' A' ' 38' ' ' LEU . 10.3 m-85 -95.81 117.42 30.53 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.479 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 m -111.72 129.17 56.2 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.574 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD13 ' CE3' ' A' ' 40' ' ' TRP . 2.3 tt -85.66 94.19 9.02 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.86 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -91.39 124.63 35.72 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.255 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.641 HD12 ' HB3' ' A' ' 19' ' ' ALA . 25.2 mt -99.78 131.58 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.806 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.5 p -82.18 -23.19 35.63 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.073 -1.051 . . . . 0.0 111.331 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.431 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -156.61 120.58 4.36 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.99 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.592 HG13 ' OD2' ' A' ' 87' ' ' ASP . 53.6 t -87.85 122.0 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.906 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -108.57 171.25 7.53 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 119.885 -0.726 . . . . 0.0 110.09 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.32 70.31 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.647 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -84.41 -2.3 56.94 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.699 -0.8 . . . . 0.0 111.0 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.592 ' OD2' HG13 ' A' ' 83' ' ' VAL . 3.0 t70 -89.15 -18.03 28.0 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.707 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.437 ' HA ' HD23 ' A' ' 109' ' ' LEU . 13.4 mt -73.92 140.5 45.66 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.487 ' C ' HD12 ' A' ' 90' ' ' ILE . . . 155.65 -140.25 7.18 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.487 HD12 ' C ' ' A' ' 89' ' ' GLY . 1.6 mp -116.95 113.4 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.883 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' CE2' ' A' ' 67' ' ' PHE . 1.9 m-85 -91.94 112.79 24.86 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.661 -0.816 . . . . 0.0 111.739 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' A' ' 106' ' ' GLY . 3.3 m-85 -119.05 -176.49 3.13 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 120.174 -0.611 . . . . 0.0 110.305 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.468 ' SG ' ' N ' ' A' ' 105' ' ' GLY . 0.1 OUTLIER -152.93 -179.44 7.66 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.239 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.436 ' HA ' ' N ' ' A' ' 104' ' ' GLY . 74.9 p -171.62 144.41 1.86 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.479 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.481 HE22 ' HB ' ' A' ' 2' ' ' VAL . 19.2 pt20 -109.61 157.42 19.07 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.091 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 65.6 p -132.34 13.44 4.6 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.714 -0.794 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.582 HG23 ' HB2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -75.36 -36.97 60.87 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.677 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.584 ' CD2' HG21 ' A' ' 2' ' ' VAL . 67.2 m-70 -110.03 162.47 14.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.839 -0.744 . . . . 0.0 111.085 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.481 ' HA ' ' C ' ' A' ' 100' ' ' PRO . 10.9 p -128.01 138.22 32.48 Favored Pre-proline 0 N--CA 1.487 1.41 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.508 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.481 ' C ' ' HA ' ' A' ' 99' ' ' VAL . 3.8 Cg_endo -71.29 158.2 95.44 Favored 'Cis proline' 0 C--N 1.317 -1.095 0 C-N-CA 123.588 -1.421 . . . . 0.0 111.845 -0.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -61.52 119.75 7.04 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.786 1.657 . . . . 0.0 110.179 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.413 ' OG1' ' NE2' ' A' ' 95' ' ' GLN . 54.6 p -91.24 134.02 34.92 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.958 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.7 138.65 55.24 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.348 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.697 ' HA2' ' SD ' ' A' ' 4' ' ' MET . . . -72.54 -159.05 4.47 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 119.925 -1.131 . . . . 0.0 110.942 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 6' ' ' GLN . . . -73.14 -157.19 4.0 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.281 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 92' ' ' PHE . . . -178.23 98.75 0.12 Allowed Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.756 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 8' ' ' PRO . 21.5 m -107.36 143.75 35.22 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 120.214 -0.594 . . . . 0.0 110.527 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -88.92 133.75 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.282 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.879 HD12 ' HB3' ' A' ' 11' ' ' LEU . 1.2 tp -129.94 89.04 2.75 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -127.6 59.78 1.44 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 119.227 -0.989 . . . . 0.0 111.299 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.59 HG22 ' N ' ' A' ' 112' ' ' LYS . 19.6 mm 59.0 163.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.939 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.59 ' N ' HG22 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -86.08 106.54 17.3 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.928 -1.109 . . . . 0.0 109.944 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.514 ' H ' ' HD3' ' A' ' 113' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.565 0 CA-C-O 116.393 -1.765 . . . . 0.0 110.86 -179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.1 0.476 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.76 ' O ' HG21 ' A' ' 102' ' ' THR . 59.5 t -121.5 132.67 70.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 118.948 -1.101 . . . . 0.0 111.307 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -68.74 141.76 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 C-N-CA 119.155 -1.018 . . . . 0.0 109.655 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.9 mtt -133.21 105.95 7.3 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.326 -0.95 . . . . 0.0 111.794 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.0 m -99.03 112.66 24.73 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.911 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.664 ' NE2' ' H ' ' A' ' 106' ' ' GLY . 9.4 tt0 -95.77 149.91 20.98 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.783 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.595 HG22 ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -161.2 159.98 24.23 Favored Pre-proline 0 N--CA 1.49 1.531 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.711 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.595 ' HA ' HG22 ' A' ' 7' ' ' THR . 4.4 Cg_endo -72.61 177.62 35.0 Favored 'Cis proline' 0 C--N 1.31 -1.472 0 C-N-CA 123.603 -1.415 . . . . 0.0 111.259 -0.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 56.1 mt -82.4 -15.47 52.58 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.466 -0.893 . . . . 0.0 110.758 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -144.5 135.41 25.02 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.545 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.554 HD12 ' HG2' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -128.85 72.0 81.53 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.985 -0.686 . . . . 0.0 111.433 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.6 106.87 1.34 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.943 1.762 . . . . 0.0 111.377 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 111' ' ' ILE . 7.6 m -141.77 175.36 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.313 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.1 p -99.14 161.11 13.8 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 119.823 -0.751 . . . . 0.0 109.151 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.562 ' HG ' HD11 ' A' ' 111' ' ' ILE . 24.6 mt -74.49 88.13 2.11 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.71 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.89 -23.03 0.91 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -71.71 170.99 12.38 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.326 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.59 137.84 33.21 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 119.302 -0.959 . . . . 0.0 111.021 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -112.27 163.38 14.44 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.4 p -162.27 95.4 0.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.556 -0.858 . . . . 0.0 111.205 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.824 ' O ' HG23 ' A' ' 77' ' ' THR . 2.7 mp -81.19 167.34 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.141 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.576 ' N ' HG22 ' A' ' 21' ' ' ILE . 23.1 t -138.92 110.43 7.03 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.248 -0.981 . . . . 0.0 112.392 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 37.6 t -117.28 127.6 54.24 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.068 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.5 mtt-85 -116.6 150.42 38.08 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.108 -1.037 . . . . 0.0 111.73 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.511 ' HB2' HG11 ' A' ' 2' ' ' VAL . 5.8 p -109.9 119.57 39.75 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.918 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.9 m -75.25 21.61 0.13 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.681 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.544 ' HB2' HG13 ' A' ' 2' ' ' VAL . 1.7 tt0 -149.45 2.72 0.55 Allowed 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.605 -0.838 . . . . 0.0 111.46 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.459 ' CA ' HG22 ' A' ' 74' ' ' THR . 0.6 OUTLIER 67.73 150.86 0.07 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.211 -0.596 . . . . 0.0 110.827 -179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.498 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 80.3 mt -115.52 28.77 8.44 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.264 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG22 ' OG1' ' A' ' 36' ' ' THR . 65.3 t -94.71 115.3 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 C-N-CA 119.291 -0.964 . . . . 0.0 109.775 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.562 ' O ' ' N ' ' A' ' 33' ' ' ASN . 10.6 t-80 -61.5 175.44 0.6 Allowed 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.011 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.8 m -41.68 88.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.19 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 31' ' ' HIS . 1.6 p-10 39.16 52.0 2.05 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.098 -0.956 . . . . 0.0 111.214 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -131.47 -113.21 1.51 Allowed Glycine 0 N--CA 1.494 2.546 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.205 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -111.84 -179.99 3.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.718 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.408 ' OG1' HG22 ' A' ' 30' ' ' VAL . 20.1 m -113.78 139.08 49.42 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.702 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.779 ' HB3' HG23 ' A' ' 96' ' ' THR . 91.3 m-85 -121.65 132.81 54.86 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.561 HD22 ' CD2' ' A' ' 76' ' ' PHE . 1.7 tp -156.47 141.15 16.94 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.66 -0.816 . . . . 0.0 111.154 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' N ' ' HG ' ' A' ' 38' ' ' LEU . 1.5 m120 -124.84 148.07 48.42 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.517 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.471 ' O ' HD12 ' A' ' 51' ' ' LEU . 31.9 m95 -115.23 160.8 19.3 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.541 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -149.4 156.98 42.89 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.727 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.9 tp -141.99 113.72 7.9 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.856 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -85.84 125.91 33.64 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.039 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -92.43 -170.93 2.62 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.45 -0.9 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -69.14 87.52 0.4 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.909 -0.716 . . . . 0.0 111.76 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.52 49.91 73.46 Favored Glycine 0 N--CA 1.496 2.695 0 C-N-CA 120.06 -1.067 . . . . 0.0 111.565 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -132.31 -157.44 0.82 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.829 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 52.5 p -90.4 147.86 37.63 Favored Pre-proline 0 N--CA 1.491 1.586 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.111 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.49 112.33 1.56 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.972 1.782 . . . . 0.0 111.129 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttmt -79.58 131.56 36.04 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.485 HD21 ' HB3' ' A' ' 54' ' ' TYR . 25.9 tp -98.14 121.64 40.31 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.958 -0.697 . . . . 0.0 110.502 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.687 HD22 ' N ' ' A' ' 52' ' ' LEU . 1.3 mm? -96.81 -71.9 0.66 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.488 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -101.54 133.48 44.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.83 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' HB3' HD21 ' A' ' 51' ' ' LEU . 44.9 p90 -122.48 20.23 10.39 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 118.59 -1.244 . . . . 0.0 111.954 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.591 ' CB ' ' ND2' ' A' ' 58' ' ' ASN . 1.6 tppp? -168.97 65.91 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.627 -0.829 . . . . 0.0 111.409 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.8 t 68.51 -66.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.2 p -138.64 11.78 2.72 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.749 -1.18 . . . . 0.0 113.078 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.591 ' ND2' ' CB ' ' A' ' 55' ' ' LYS . 53.2 p-10 -75.18 -156.82 0.06 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.054 -1.058 . . . . 0.0 109.938 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 mtm-85 -153.88 118.22 4.86 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 119.486 -0.885 . . . . 0.0 110.359 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -61.86 157.74 17.57 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.734 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.2 p -53.81 138.28 36.24 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.679 -0.808 . . . . 0.0 111.29 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.51 -26.0 7.66 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.78 -1.2 . . . . 0.0 111.149 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 52' ' ' LEU . 60.5 t -64.29 118.78 50.22 Favored Pre-proline 0 N--CA 1.49 1.533 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.028 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -61.0 144.55 99.59 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.883 1.722 . . . . 0.0 111.512 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.98 -36.21 17.04 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.987 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.77 -26.86 2.59 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.822 -0.751 . . . . 0.0 112.068 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -84.3 107.28 16.5 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.723 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.0 t -134.61 108.44 8.06 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.535 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -101.09 170.79 21.91 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.729 -1.224 . . . . 0.0 111.157 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.1 t -164.22 -165.79 1.03 Allowed 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 120.335 -0.546 . . . . 0.0 109.916 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.575 ' HA3' ' CD2' ' A' ' 76' ' ' PHE . . . 151.89 113.39 0.57 Allowed Glycine 0 N--CA 1.494 2.547 0 C-N-CA 118.807 -1.663 . . . . 0.0 111.899 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.7 m -98.74 100.63 11.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.852 -0.739 . . . . 0.0 112.1 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.38 -115.72 4.78 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.503 -1.332 . . . . 0.0 112.557 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.459 HG22 ' CA ' ' A' ' 28' ' ' SER . 35.5 p -99.22 18.63 17.05 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.885 -0.726 . . . . 0.0 112.402 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.549 ' O ' ' CA ' ' A' ' 71' ' ' GLY . 3.7 m-20 -129.25 136.06 49.6 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.582 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.575 ' CD2' ' HA3' ' A' ' 71' ' ' GLY . 69.5 m-85 -139.4 151.78 46.56 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.959 -0.697 . . . . 0.0 110.404 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 21' ' ' ILE . 43.0 m -145.73 139.35 26.44 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.998 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -105.1 91.79 3.95 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.403 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.5 mttm -86.08 116.89 24.57 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.792 -0.763 . . . . 0.0 112.375 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.647 HG22 ' H ' ' A' ' 82' ' ' ARG . 37.0 mt -105.71 129.35 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.62 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 60.5 p -90.48 13.15 16.48 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 118.681 -1.208 . . . . 0.0 112.27 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -176.4 113.47 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.608 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.513 HG13 ' OD1' ' A' ' 87' ' ' ASP . 65.6 t -99.04 143.47 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 119.602 -0.839 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' C ' HD22 ' A' ' 15' ' ' LEU . 58.8 mt-10 -123.18 179.05 4.83 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.834 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.83 -55.11 18.84 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.256 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -55.26 -29.92 59.05 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.784 -0.766 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.513 ' OD1' HG13 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -63.52 -36.18 82.92 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.827 -0.749 . . . . 0.0 110.664 179.892 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 111' ' ' ILE . 31.3 mt -48.69 134.07 16.45 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.844 -0.742 . . . . 0.0 111.342 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 163.67 -146.99 12.2 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.1 mt -112.47 112.55 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.281 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -78.78 138.85 38.4 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.701 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -135.95 164.21 28.49 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.336 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.503 ' SG ' ' HA2' ' A' ' 105' ' ' GLY . 13.7 p -135.9 142.82 44.73 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.231 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.3 t -143.86 112.45 6.52 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.381 -0.928 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.486 HE22 ' H ' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -65.79 149.65 49.81 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.676 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.779 HG23 ' HB3' ' A' ' 37' ' ' TYR . 12.1 t -123.43 26.62 7.8 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.621 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 37' ' ' TYR . 24.0 m -92.09 -23.83 19.34 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.19 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.486 ' H ' HE22 ' A' ' 95' ' ' GLN . 85.0 m-70 -127.88 136.52 51.5 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.715 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 100' ' ' PRO . 50.9 t -109.69 138.37 20.63 Favored Pre-proline 0 N--CA 1.49 1.544 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.436 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.451 ' HA ' HG13 ' A' ' 99' ' ' VAL . 5.5 Cg_endo -73.71 161.17 94.76 Favored 'Cis proline' 0 C--N 1.317 -1.083 0 C-N-CA 123.634 -1.402 . . . . 0.0 111.757 -0.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.29 136.12 49.82 Favored 'Trans proline' 0 C--N 1.314 -1.24 0 C-N-CA 121.984 1.789 . . . . 0.0 110.75 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 2' ' ' VAL . 26.4 p -61.89 -51.05 69.75 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.085 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 9.6 t80 55.34 95.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 120.248 -0.581 . . . . 0.0 111.755 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.11 82.08 0.06 OUTLIER Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.228 -1.463 . . . . 0.0 111.078 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.503 ' HA2' ' SG ' ' A' ' 93' ' ' CYS . . . -93.99 -126.13 4.38 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.664 ' H ' ' NE2' ' A' ' 6' ' ' GLN . . . 145.41 80.69 0.04 OUTLIER Glycine 0 N--CA 1.492 2.414 0 C-N-CA 118.805 -1.664 . . . . 0.0 112.274 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 8' ' ' PRO . 97.1 m -154.5 108.39 2.94 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.629 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.1 mtpm? -79.01 149.32 32.25 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 119.495 -0.882 . . . . 0.0 111.939 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.421 ' CD2' HD23 ' A' ' 88' ' ' LEU . 4.2 tt -154.2 88.62 1.24 Allowed 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.42 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.408 ' O ' ' CB ' ' A' ' 111' ' ' ILE . 6.4 pt-20 -122.23 38.62 4.1 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.051 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER 74.95 168.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.757 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' N ' HG23 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -47.92 -41.24 24.14 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.671 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.545 ' H ' HG23 ' A' ' 111' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.47 0 CA-C-O 116.568 -1.682 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 stop_ save_